data_1x58_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1x58 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.77 158.81 31.55 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 162.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -55.34 -26.96 44.11 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.276 -1.345 . . . . 0.0 111.706 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -67.41 -46.45 73.17 Favored 'General case' 0 CA--C 1.526 0.05 0 CA-C-N 119.735 1.152 . . . . 0.0 111.377 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -38.74 91.99 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.397 0.999 . . . . 0.0 109.189 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.7 t -67.19 -27.45 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 119.265 0.939 . . . . 0.0 110.855 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -57.46 -60.2 4.01 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -61.14 -30.38 70.35 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.77 -58.86 6.75 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -71.96 -35.7 69.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 118.383 -0.818 . . . . 0.0 111.736 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -54.61 -45.2 73.63 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.273 0.942 . . . . 0.0 109.494 176.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.95 -64.36 3.72 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 125.464 1.506 . . . . 0.0 110.364 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.8 t -54.42 -27.93 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 118.964 1.382 . . . . 0.0 112.045 -174.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -67.02 -29.73 69.62 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.208 1.403 . . . . 0.0 111.518 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.1 t -97.17 -55.85 2.73 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.003 1.321 . . . . 0.0 112.085 167.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.0 mmt -61.36 -29.34 69.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.825 2.05 . . . . 0.0 113.171 -168.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.49 -153.82 48.79 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -153.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -76.07 19.89 0.21 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.137 1.375 . . . . 0.0 112.782 -168.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -81.55 97.77 7.99 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.299 -1.5 . . . . 0.0 108.733 -171.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -81.72 -47.9 12.34 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.033 -164.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -58.18 -43.51 87.55 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.656 0.662 . . . . 0.0 109.48 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.2 m -54.93 -49.93 70.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.781 1.632 . . . . 0.0 111.532 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 60.6 mt -58.56 -48.65 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 124.399 1.08 . . . . 0.0 109.562 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.73 -37.15 63.05 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.504 1.121 . . . . 0.0 111.423 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 14.3 m0 -85.08 -34.6 22.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.032 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.8 t -69.81 -30.41 67.93 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.672 1.124 . . . . 0.0 113.224 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -124.94 154.37 71.08 Favored Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 119.804 1.184 . . . . 0.0 110.355 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.08 117.81 5.32 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 121.867 1.711 . . . . 0.0 109.478 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -129.25 161.93 29.06 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.033 1.333 . . . . 0.0 110.616 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -47.64 129.3 13.66 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.689 1.596 . . . . 0.0 111.298 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -57.84 150.8 19.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.488 0.661 . . . . 0.0 109.573 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.6 4.25 44.98 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 117.685 -1.619 . . . . 0.0 114.634 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -53.22 164.01 0.49 Allowed 'General case' 0 C--N 1.343 0.308 0 CA-C-N 119.557 1.679 . . . . 0.0 110.649 170.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -121.45 158.5 28.26 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 163.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.35 -25.79 68.09 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.388 0.54 . . . . 0.0 111.327 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.71 -34.75 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.55 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -56.87 -35.14 68.57 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.95 0.5 . . . . 0.0 109.921 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.8 mt -66.18 -53.97 31.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.02 0.928 . . . . 0.0 109.297 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.23 -38.51 76.98 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.841 1.256 . . . . 0.0 110.379 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -75.48 -42.89 51.86 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.714 1.606 . . . . 0.0 110.623 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -65.59 -45.78 81.9 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.386 -0.821 . . . . 0.0 109.347 172.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -54.9 -48.6 72.83 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 126.099 1.759 . . . . 0.0 110.722 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -46.51 -58.14 4.06 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.386 1.074 . . . . 0.0 109.784 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -61.92 -33.4 74.18 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.216 -0.927 . . . . 0.0 112.519 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 mt -63.71 -44.32 93.97 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.959 0.799 . . . . 0.0 110.071 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.0 pt . . . . . 0 CA--C 1.542 0.644 0 CA-C-N 119.485 1.039 . . . . 0.0 112.479 178.277 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 . . . . . 0 C--O 1.238 0.475 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 p -68.33 167.41 14.58 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.476 0.58 . . . . 0.0 110.153 170.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -57.76 -34.24 69.34 Favored 'General case' 0 N--CA 1.462 0.139 0 O-C-N 121.129 -0.982 . . . . 0.0 110.29 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.96 -54.73 37.64 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.053 0.941 . . . . 0.0 109.658 175.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -60.49 -42.69 96.82 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 123.031 0.532 . . . . 0.0 110.841 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.2 t -65.21 -35.1 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 O-C-N 121.367 -0.833 . . . . 0.0 110.885 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -63.67 -50.66 68.37 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 172.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -61.07 -33.32 73.15 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 118.771 0.714 . . . . 0.0 111.333 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.82 -56.28 24.28 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.92 0.888 . . . . 0.0 108.923 174.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -60.36 -44.73 95.31 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.152 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -56.99 -44.36 82.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.96 0.904 . . . . 0.0 109.721 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.84 -63.1 5.6 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 126.679 2.085 . . . . 0.0 110.423 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.23 -22.03 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 118.895 1.347 . . . . 0.0 111.162 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -73.7 -30.46 62.88 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 119.972 -1.705 . . . . 0.0 110.974 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.7 t -95.59 -57.71 2.31 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.709 0.804 . . . . 0.0 109.45 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -70.0 -27.14 64.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.413 1.485 . . . . 0.0 112.659 -174.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.93 -148.69 45.47 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -153.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -76.82 15.27 0.68 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.67 1.188 . . . . 0.0 113.994 -159.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -84.5 97.46 9.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 120.144 1.338 . . . . 0.0 110.093 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -71.82 -42.42 67.04 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.502 0.721 . . . . 0.0 112.455 -175.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -64.39 -40.91 96.73 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 118.619 0.645 . . . . 0.0 109.666 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.16 -54.53 38.49 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 123.4 0.68 . . . . 0.0 109.435 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.9 mt -54.57 -52.05 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 126.111 1.765 . . . . 0.0 109.831 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -47.16 69.33 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.299 1.44 . . . . 0.0 110.836 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -74.99 -39.79 61.06 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.696 -0.668 . . . . 0.0 110.602 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -59.92 -71.6 0.13 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.581 1.152 . . . . 0.0 110.565 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -87.17 153.15 53.87 Favored Pre-proline 0 N--CA 1.453 -0.301 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -166.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.15 110.52 3.13 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.588 1.525 . . . . 0.0 109.081 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -111.11 174.17 5.99 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.071 0.948 . . . . 0.0 108.698 172.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -63.98 155.85 29.73 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.939 0.876 . . . . 0.0 111.358 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -62.55 139.03 58.6 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.453 1.101 . . . . 0.0 109.043 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.55 23.31 76.66 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 117.689 0.222 . . . . 0.0 112.599 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -70.47 165.42 22.63 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 121.406 -1.055 . . . . 0.0 111.495 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -118.13 161.25 20.17 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.698 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.03 86.05 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 165.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.43 -26.34 33.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 O-C-N 121.546 -0.721 . . . . 0.0 111.761 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.6 -41.81 86.69 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.6 mt -65.14 -52.26 56.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.14 1.776 . . . . 0.0 109.111 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.02 -46.43 82.34 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.521 1.128 . . . . 0.0 108.089 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -63.72 -54.43 35.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.96 1.304 . . . . 0.0 110.899 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.88 -47.2 77.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.772 0.715 . . . . 0.0 109.299 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -60.07 -49.94 75.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.581 1.552 . . . . 0.0 111.193 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -55.59 -41.2 73.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.82 1.248 . . . . 0.0 111.059 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mmm-85 -68.86 -42.96 76.33 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.936 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.9 mt -58.27 -49.99 75.18 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.886 1.221 . . . . 0.0 112.527 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt . . . . . 0 CA--C 1.539 0.557 0 C-N-CA 123.093 0.557 . . . . 0.0 112.045 176.331 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 . . . . . 0 C--O 1.243 0.72 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.4 p -61.7 176.64 0.5 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.453 1.121 . . . . 0.0 110.719 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -58.92 -42.73 90.38 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 120.656 -1.278 . . . . 0.0 110.487 173.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -55.93 -54.47 44.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 124.708 1.255 . . . . 0.0 108.741 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -62.04 -41.79 98.49 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.332 1.053 . . . . 0.0 111.517 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.1 t -64.34 -38.02 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.029 0.831 . . . . 0.0 109.917 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -62.78 -47.95 81.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -60.36 -34.47 73.91 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.338 0.655 . . . . 0.0 112.389 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.0 -55.24 37.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -60.79 -46.95 88.49 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.813 0.445 . . . . 0.0 111.256 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -35.05 71.0 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.712 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -78.36 -51.54 5.61 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 125.923 1.725 . . . . 0.0 111.171 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.0 t -58.66 -28.99 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 118.249 1.024 . . . . 0.0 110.468 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -49.72 74.62 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 124.265 1.026 . . . . 0.0 110.34 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 t -96.77 -21.63 17.43 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.847 1.659 . . . . 0.0 113.647 -167.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.8 mtp -128.53 -6.56 5.22 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.204 1.002 . . . . 0.0 112.587 -170.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.86 -158.07 53.45 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 119.232 0.923 . . . . 0.0 111.385 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -72.0 21.54 0.06 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.289 1.036 . . . . 0.0 112.193 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -82.91 97.72 8.83 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -176.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -82.37 -45.07 15.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.047 -163.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -50.11 -49.5 51.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.598 0.759 . . . . 0.0 109.282 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -54.8 -54.78 37.69 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 128.063 2.545 . . . . 0.0 110.351 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 67.6 mt -59.21 -44.91 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.084 0.954 . . . . 0.0 110.355 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -34.64 64.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.379 1.472 . . . . 0.0 110.925 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -88.74 -37.26 15.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.101 0.96 . . . . 0.0 111.848 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 t -67.3 -18.66 65.27 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -140.68 154.09 68.64 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 119.881 1.218 . . . . 0.0 110.021 -173.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.12 109.58 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.159 1.906 . . . . 0.0 110.823 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -107.58 -178.53 3.65 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.668 1.187 . . . . 0.0 109.67 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -67.7 162.95 22.61 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.671 -0.643 . . . . 0.0 110.785 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.9 147.58 50.09 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 121.669 -0.644 . . . . 0.0 109.931 176.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.4 5.8 37.71 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.107 -0.83 . . . . 0.0 113.759 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -59.49 135.79 57.78 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 118.348 1.074 . . . . 0.0 108.299 169.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -90.5 167.06 12.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 171.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.81 -38.48 78.71 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.712 -0.617 . . . . 0.0 110.614 169.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.1 m -63.75 -27.58 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 123.386 0.674 . . . . 0.0 112.081 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -59.65 -37.69 79.4 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 47.6 mt -65.85 -50.01 66.1 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.738 1.215 . . . . 0.0 109.713 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.39 -41.7 90.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.922 0.889 . . . . 0.0 109.337 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -68.19 -52.54 33.2 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 124.114 0.966 . . . . 0.0 110.259 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -44.21 93.58 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 120.868 -1.145 . . . . 0.0 108.985 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -55.34 -50.59 69.24 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.567 1.147 . . . . 0.0 111.13 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -51.42 -46.13 62.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.557 1.143 . . . . 0.0 110.081 175.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -71.91 -26.33 62.26 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.465 1.106 . . . . 0.0 112.477 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.8 mt -70.57 -58.53 3.59 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.918 1.236 . . . . 0.0 109.028 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 pt . . . . . 0 CA--C 1.537 0.461 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.154 -177.446 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.441 ' CD2' ' HG2' ' A' ' 51' ' ' LYS . 34.0 m-85 . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 121.469 0.652 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.8 p -65.6 155.13 36.78 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.761 -0.587 . . . . 0.0 110.675 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -52.48 -37.25 56.75 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.069 -1.019 . . . . 0.0 111.554 174.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.58 -50.98 70.45 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 124.954 1.302 . . . . 0.0 110.224 176.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -63.67 -28.19 69.73 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.943 -1.098 . . . . 0.0 110.856 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.6 t -69.33 -35.91 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 120.388 1.449 . . . . 0.0 109.311 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -50.29 -60.59 2.82 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 170.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -61.99 -31.04 71.37 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.033 0.933 . . . . 0.0 112.715 -176.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -61.9 2.28 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -64.14 -47.94 77.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.736 0.414 . . . . 0.0 110.585 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.92 -40.65 70.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.187 1.395 . . . . 0.0 110.3 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.55 -56.91 11.23 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 125.337 1.446 . . . . 0.0 111.022 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.7 t -56.69 -32.17 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 118.598 1.199 . . . . 0.0 111.427 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -61.04 -42.0 97.64 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 119.665 1.121 . . . . 0.0 110.405 -175.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.7 t -95.43 -44.88 7.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.787 0.835 . . . . 0.0 109.689 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 6.8 mmt -69.78 -25.58 63.86 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.129 1.372 . . . . 0.0 112.022 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.39 -161.25 34.92 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -151.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -72.67 8.51 1.43 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -166.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -70.0 97.8 1.2 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 121.056 1.753 . . . . 0.0 110.472 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -71.12 -40.91 71.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.806 0.842 . . . . 0.0 111.06 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -57.48 -46.5 83.64 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.869 0.868 . . . . 0.0 109.749 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.07 -61.11 2.53 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.718 0.807 . . . . 0.0 109.472 173.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.0 mt -52.26 -48.4 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 126.125 1.77 . . . . 0.0 110.905 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -24.02 63.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.706 0.802 . . . . 0.0 112.038 -174.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -100.67 -41.32 6.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.65 0.78 . . . . 0.0 111.231 175.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.3 -15.69 60.73 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -176.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -134.25 155.01 80.28 Favored Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 125.26 1.424 . . . . 0.0 108.313 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.0 110.62 2.35 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.803 2.336 . . . . 0.0 109.778 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -118.27 159.43 23.38 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.56 1.144 . . . . 0.0 109.012 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -54.0 145.93 15.58 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.546 1.138 . . . . 0.0 112.084 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -61.43 133.75 56.13 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.75 -8.42 73.91 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 118.838 -0.979 . . . . 0.0 112.579 176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.6 mmp_? -61.48 153.49 27.14 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 118.867 1.333 . . . . 0.0 108.676 162.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.7 mtm105 -124.96 174.08 8.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.32 1.448 . . . . 0.0 107.401 167.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.53 -33.41 69.84 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 122.278 0.231 . . . . 0.0 110.639 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 m -63.8 -33.9 64.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 C-N-CA 123.473 0.709 . . . . 0.0 112.471 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.94 -41.11 86.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.8 mt -63.1 -52.0 64.37 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.982 1.313 . . . . 0.0 109.633 178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.82 -45.07 82.53 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.743 1.217 . . . . 0.0 109.266 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -63.52 -54.34 37.72 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.716 1.207 . . . . 0.0 110.432 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.441 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 52.9 tptt -61.19 -44.75 96.79 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.97 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -56.58 -54.81 41.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.568 1.147 . . . . 0.0 110.383 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -50.28 60.77 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 123.558 0.536 . . . . 0.0 109.68 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -56.57 -45.6 81.2 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.473 1.109 . . . . 0.0 111.777 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.0 mt -63.33 -56.22 18.17 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.797 0.839 . . . . 0.0 110.759 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.5 pt . . . . . 0 CA--C 1.538 0.516 0 CA-C-N 118.014 0.37 . . . . 0.0 111.195 177.117 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 . . . . . 0 C--O 1.237 0.399 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t -83.47 178.44 8.02 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 164.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -55.27 -35.05 64.6 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-O 117.607 -1.187 . . . . 0.0 111.462 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.06 -57.66 11.87 Favored 'General case' 0 C--O 1.225 -0.197 0 O-C-N 123.827 0.705 . . . . 0.0 112.067 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -59.46 -40.22 86.18 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.688 1.131 . . . . 0.0 111.732 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.2 t -60.56 -40.62 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 118.839 -0.601 . . . . 0.0 111.374 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -57.42 -52.18 66.43 Favored 'General case' 0 C--O 1.226 -0.141 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.5 m-30 -61.03 -33.56 73.48 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.417 1.087 . . . . 0.0 111.716 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.38 -56.82 16.04 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -64.15 -43.1 96.26 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 117.791 -1.1 . . . . 0.0 111.769 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -55.52 -54.42 44.21 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.875 1.27 . . . . 0.0 109.262 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.85 -59.25 10.61 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 125.425 1.488 . . . . 0.0 111.648 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.4 t -61.74 -21.99 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 O-C-N 121.561 -0.964 . . . . 0.0 111.562 -177.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -76.1 -44.18 39.87 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 120.117 -1.614 . . . . 0.0 109.499 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.9 t -95.36 -16.58 22.25 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.571 0.749 . . . . 0.0 112.195 -169.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.4 mtp -126.71 -9.77 6.15 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.599 1.16 . . . . 0.0 112.257 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.04 -152.83 42.84 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -167.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -73.22 18.88 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.735 1.614 . . . . 0.0 113.648 -164.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -75.94 97.28 3.94 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.789 1.632 . . . . 0.0 109.482 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -75.15 -44.21 48.09 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.28 -0.888 . . . . 0.0 112.218 -171.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -62.33 -48.16 81.07 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.2 m -53.85 -47.03 71.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.903 0.881 . . . . 0.0 111.037 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.88 -46.65 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 119.926 1.239 . . . . 0.0 110.268 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.28 -24.09 17.59 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.027 1.331 . . . . 0.0 112.016 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -108.61 -31.64 7.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.681 1.192 . . . . 0.0 110.73 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -58.73 -23.2 59.36 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.274 1.429 . . . . 0.0 112.15 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -138.16 157.86 72.05 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 125.711 1.605 . . . . 0.0 108.003 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.87 109.12 1.94 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 N-CA-C 107.776 -1.663 . . . . 0.0 107.776 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -101.54 164.89 11.53 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.282 -0.886 . . . . 0.0 109.102 175.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -53.47 142.54 21.82 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -70.51 158.97 35.13 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.494 0.664 . . . . 0.0 110.261 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.2 -3.39 22.88 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.755 -1.581 . . . . 0.0 113.543 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 mmp_? -64.57 141.19 58.86 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 120.479 2.139 . . . . 0.0 109.566 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.6 mtt85 -82.8 159.87 22.37 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.04 78.51 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.262 -0.899 . . . . 0.0 109.903 166.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 m -65.15 -24.42 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 118.334 -0.841 . . . . 0.0 111.974 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -61.59 -31.73 71.8 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.7 mt -68.62 -49.76 56.75 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.507 1.523 . . . . 0.0 109.709 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.34 98.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.468 1.107 . . . . 0.0 109.758 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -65.71 -46.53 78.63 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.364 1.466 . . . . 0.0 110.197 178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -60.9 -47.12 87.85 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -56.81 -45.27 82.36 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.783 1.233 . . . . 0.0 111.471 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -51.61 -39.82 58.71 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.647 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -81.4 -20.21 40.94 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.857 1.662 . . . . 0.0 113.288 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.6 mt -74.96 -11.42 60.11 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.406 -0.809 . . . . 0.0 111.47 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.5 pt . . . . . 0 CA--C 1.541 0.604 0 CA-C-N 119.612 1.096 . . . . 0.0 111.67 168.881 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 . . . . . 0 C--O 1.238 0.45 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 t -72.7 168.95 17.67 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -40.05 62.05 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.092 0.957 . . . . 0.0 112.196 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -56.81 -50.85 71.11 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.811 1.244 . . . . 0.0 108.033 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -70.13 -25.39 63.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.123 0.969 . . . . 0.0 111.889 -174.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.6 t -73.96 -41.61 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 118.82 0.736 . . . . 0.0 109.341 173.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -58.76 -48.33 81.57 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.738 -0.649 . . . . 0.0 109.359 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -60.22 -35.35 75.24 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.966 0.906 . . . . 0.0 111.451 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.36 -53.94 52.4 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -72.14 -24.9 61.53 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -66.1 -55.06 18.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 170.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.84 -62.14 6.18 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 125.891 1.71 . . . . 0.0 111.319 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.6 t -61.75 -25.38 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 118.182 0.991 . . . . 0.0 111.65 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -70.71 -46.51 62.96 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 121.011 -1.056 . . . . 0.0 109.27 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -95.08 -20.32 19.41 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.354 0.525 . . . . 0.0 111.544 -168.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.3 mtp -124.09 -9.24 7.66 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.905 1.282 . . . . 0.0 111.997 -172.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.35 -154.14 50.45 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -73.55 14.68 0.32 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.31 1.044 . . . . 0.0 113.69 -166.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -78.71 96.87 5.67 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 120.797 1.635 . . . . 0.0 107.84 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -76.16 -42.42 46.64 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.729 -0.607 . . . . 0.0 110.423 -173.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -59.32 -42.66 91.95 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 m -60.66 -54.35 46.33 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.605 1.162 . . . . 0.0 112.35 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.3 mt -56.79 -43.27 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 125.407 1.483 . . . . 0.0 110.565 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -14.98 37.74 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -175.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -110.38 -29.17 8.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.024 1.329 . . . . 0.0 111.356 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.419 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 3.1 t -60.75 -18.17 53.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.593 0.757 . . . . 0.0 112.471 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.419 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 70.3 m-85 -144.58 158.03 54.5 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 125.098 1.359 . . . . 0.0 108.049 -176.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.4 109.89 3.0 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.734 1.623 . . . . 0.0 109.385 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -113.17 166.38 11.5 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.218 1.407 . . . . 0.0 109.596 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -56.87 151.38 14.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.99 1.316 . . . . 0.0 111.009 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.3 142.28 50.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -176.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.05 8.15 57.82 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.009 -1.439 . . . . 0.0 113.965 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -64.35 165.26 9.92 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 120.822 2.311 . . . . 0.0 109.661 169.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -120.72 159.58 25.09 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.645 1.178 . . . . 0.0 108.11 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.26 -40.35 64.56 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.626 0.37 . . . . 0.0 110.744 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.3 m -62.62 -27.98 43.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 C-N-CA 123.688 0.795 . . . . 0.0 112.336 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -62.09 -35.06 77.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 54.9 mt -66.95 -46.29 75.17 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 126.493 1.917 . . . . 0.0 110.129 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.02 -51.07 69.49 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -55.78 -48.4 75.38 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.466 1.107 . . . . 0.0 110.594 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -61.79 -48.02 82.51 Favored 'General case' 0 C--O 1.223 -0.29 0 O-C-N 121.234 -0.916 . . . . 0.0 110.998 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -55.48 -46.48 76.89 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 125.475 1.51 . . . . 0.0 110.991 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 49.3 m170 -53.77 -54.76 33.69 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.475 1.11 . . . . 0.0 109.028 172.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -55.77 -38.64 70.16 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 121.442 -0.786 . . . . 0.0 112.397 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.3 mt -68.33 -39.15 82.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 117.642 -1.17 . . . . 0.0 111.521 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt . . . . . 0 N--CA 1.469 0.479 0 CA-C-N 120.164 1.347 . . . . 0.0 111.569 173.424 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.415 ' CD2' ' HG2' ' A' ' 51' ' ' LYS . 10.7 m-85 . . . . . 0 C--O 1.232 0.149 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -84.1 -166.96 1.57 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.811 0.844 . . . . 0.0 109.957 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -74.05 -24.77 59.58 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 120.97 -1.081 . . . . 0.0 111.116 161.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -77.19 -49.48 15.07 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 119.23 0.923 . . . . 0.0 109.193 -171.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -41.36 92.07 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.6 t -59.78 -38.0 74.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 C-N-CA 124.151 0.98 . . . . 0.0 110.337 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -56.09 -54.56 43.58 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -65.8 -26.86 67.88 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.68 -52.43 63.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -59.28 -44.84 92.45 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.24 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -51.46 -52.85 42.89 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.638 1.175 . . . . 0.0 111.064 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.34 -58.54 8.52 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 124.23 0.919 . . . . 0.0 111.162 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -56.98 -25.56 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 118.507 1.154 . . . . 0.0 110.877 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -59.4 -45.71 90.73 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 121.317 -0.865 . . . . 0.0 110.52 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.2 t -96.5 -21.61 17.6 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.936 1.294 . . . . 0.0 112.065 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.3 mtp -116.86 -1.91 11.92 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.75 -1.219 . . . . 0.0 113.707 -166.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.27 -113.0 1.99 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -104.73 8.58 35.07 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.513 0.725 . . . . 0.0 112.698 -168.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -76.55 96.48 4.13 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 120.094 1.315 . . . . 0.0 109.514 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -78.7 -44.84 22.66 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.642 -172.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -61.35 -41.19 96.65 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 119.502 -0.285 . . . . 0.0 110.581 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 m -56.57 -53.92 51.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.207 0.603 . . . . 0.0 110.609 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 55.0 mt -53.3 -45.14 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.024 1.33 . . . . 0.0 110.893 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -31.06 68.0 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.325 0.65 . . . . 0.0 112.167 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -86.88 -35.09 19.19 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.947 0.499 . . . . 0.0 111.247 171.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.404 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 8.3 t -60.32 -31.05 69.92 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.128 1.371 . . . . 0.0 113.33 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 74.1 m-85 -135.27 155.14 79.0 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 123.93 0.892 . . . . 0.0 109.058 -171.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.89 109.3 2.19 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.852 1.701 . . . . 0.0 109.638 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -109.04 176.2 5.18 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.982 0.913 . . . . 0.0 111.036 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -56.55 155.9 6.8 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.481 1.112 . . . . 0.0 111.018 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.46 121.75 20.12 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -172.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.75 21.84 65.36 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.416 -0.658 . . . . 0.0 113.952 169.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -57.47 163.37 2.4 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 122.105 0.955 . . . . 0.0 111.389 171.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -103.05 167.58 9.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.948 162.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.5 -34.63 78.67 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.641 -0.662 . . . . 0.0 109.3 166.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 m -62.43 -29.34 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 O-C-N 121.701 -0.624 . . . . 0.0 112.259 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -55.97 -43.1 77.25 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.0 mt -67.05 -44.28 80.59 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.8 0.84 . . . . 0.0 110.061 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.84 -45.97 87.12 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.431 0.693 . . . . 0.0 109.374 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -60.39 -52.98 62.93 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.066 1.347 . . . . 0.0 109.063 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 57.7 tptt -59.94 -39.98 87.4 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.687 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -62.29 -46.28 89.49 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 119.68 1.127 . . . . 0.0 111.206 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -51.76 -54.2 31.23 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -53.81 -42.12 68.07 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.666 0.666 . . . . 0.0 112.307 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.69 -37.24 85.91 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 117.882 -1.056 . . . . 0.0 110.98 -176.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.5 pt . . . . . 0 CA--C 1.536 0.432 0 CA-C-N 119.491 1.042 . . . . 0.0 110.253 174.909 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 C--O 1.235 0.337 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.9 p -74.1 173.14 10.5 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 120.574 -1.329 . . . . 0.0 108.064 169.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -55.23 -21.55 14.55 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.022 0.929 . . . . 0.0 112.232 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.07 -32.74 17.41 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.626 1.171 . . . . 0.0 112.037 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.48 -41.98 75.43 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 119.842 1.201 . . . . 0.0 108.329 171.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.54 -29.42 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 122.004 -0.435 . . . . 0.0 110.206 174.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -57.78 -59.0 5.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 118.817 -0.611 . . . . 0.0 109.599 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -60.41 -28.3 68.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.82 -58.17 5.57 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -68.17 -28.41 67.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 119.312 -0.375 . . . . 0.0 111.607 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.91 -43.28 93.33 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.866 0.866 . . . . 0.0 109.674 173.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.77 -44.07 8.62 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 124.101 0.858 . . . . 0.0 111.062 -168.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.7 t -62.7 -26.62 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.603 0.702 . . . . 0.0 110.39 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -64.04 -33.55 76.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.495 1.043 . . . . 0.0 110.739 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . 0.252 11.5 t -95.75 -61.73 1.41 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -23.76 56.21 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -167.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.7 -150.95 48.78 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -160.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -69.51 9.17 0.51 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.013 2.525 . . . . 0.0 114.88 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -71.44 96.96 1.55 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 121.199 1.818 . . . . 0.0 108.876 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.2 m95 -81.14 -46.03 15.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.364 -0.826 . . . . 0.0 111.453 -170.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -54.52 -41.81 70.1 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.281 0.946 . . . . 0.0 109.96 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -53.53 57.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 123.503 0.721 . . . . 0.0 110.623 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 59.9 mt -55.5 -46.1 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.607 1.163 . . . . 0.0 109.617 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -16.36 43.0 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.961 1.304 . . . . 0.0 112.782 -176.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -109.94 -29.68 8.15 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.447 1.099 . . . . 0.0 112.186 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.78 -26.49 68.66 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.951 0.796 . . . . 0.0 112.101 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -135.31 156.42 78.0 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 124.557 1.143 . . . . 0.0 109.994 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.8 138.48 31.74 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 N-CA-C 108.552 -1.365 . . . . 0.0 108.552 170.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -132.23 -174.5 3.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 170.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -71.26 171.95 10.18 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.307 -0.871 . . . . 0.0 111.067 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 165.14 19.94 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.783 -0.573 . . . . 0.0 110.291 171.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.65 -3.15 1.48 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.378 1.466 . . . . 0.0 115.483 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -63.09 157.83 21.21 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 119.072 1.436 . . . . 0.0 110.356 -175.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -120.84 166.66 13.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.687 1.595 . . . . 0.0 107.51 168.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.9 77.52 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.707 -0.621 . . . . 0.0 110.802 169.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.3 m -63.14 -24.86 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 123.53 0.732 . . . . 0.0 112.373 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -65.46 -42.25 92.49 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 mt -62.31 -36.58 82.6 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.12 -43.81 86.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 119.256 0.935 . . . . 0.0 109.944 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.43 -55.4 12.0 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.949 1.299 . . . . 0.0 112.308 -172.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -58.56 -47.45 84.21 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -54.81 -48.42 72.8 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 125.106 1.362 . . . . 0.0 110.156 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -51.86 -47.42 64.47 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.957 0.503 . . . . 0.0 110.843 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -67.33 -31.19 71.3 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.736 -0.602 . . . . 0.0 110.713 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.2 mt -71.44 -41.16 69.82 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.186 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.7 pt . . . . . 0 N--CA 1.475 0.8 0 CA-C-N 120.638 1.563 . . . . 0.0 112.5 178.385 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 . . . . . 0 C--O 1.239 0.52 0 CA-C-O 120.812 0.339 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.7 p -72.16 170.63 13.59 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.707 0.803 . . . . 0.0 109.377 167.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -56.39 -27.98 57.92 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.456 -0.778 . . . . 0.0 110.886 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -68.78 -56.18 8.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.335 -0.853 . . . . 0.0 109.399 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -59.37 -34.4 72.36 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.041 0.536 . . . . 0.0 111.304 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.437 HG23 ' HE2' ' A' ' 51' ' ' LYS . 54.0 t -66.42 -40.2 85.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.012 175.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -65.03 -45.16 86.61 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 118.468 0.577 . . . . 0.0 109.448 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -60.15 -37.74 81.04 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.084 0.954 . . . . 0.0 110.811 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.77 -56.89 13.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.933 0.893 . . . . 0.0 109.235 171.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -69.69 -29.94 67.48 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.601 -0.714 . . . . 0.0 112.536 -175.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -61.51 -58.55 7.71 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.81 1.187 . . . . 0.0 108.129 170.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.22 -60.96 4.8 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 125.868 1.699 . . . . 0.0 111.756 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.5 t -63.38 -20.04 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.423 1.112 . . . . 0.0 112.238 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.02 -40.62 45.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 120.322 -1.486 . . . . 0.0 109.635 177.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.8 t -95.82 -19.9 19.24 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.234 0.925 . . . . 0.0 113.087 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 10.0 mtt -117.88 0.4 11.91 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.254 1.422 . . . . 0.0 112.751 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.71 -103.63 0.12 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.586 1.089 . . . . 0.0 111.957 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -114.78 12.47 17.02 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 118.224 1.012 . . . . 0.0 110.506 -167.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.06 97.68 4.77 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 173.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -81.66 -46.61 14.1 Favored 'General case' 0 CA--C 1.521 -0.143 0 O-C-N 121.178 -0.951 . . . . 0.0 110.992 -172.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -54.7 -44.98 73.92 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.841 0.856 . . . . 0.0 109.918 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.7 m -57.48 -48.62 78.74 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.948 1.699 . . . . 0.0 111.803 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.9 mt -59.28 -45.3 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 O-C-N 120.909 -1.119 . . . . 0.0 109.94 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -23.94 48.17 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 125.542 1.537 . . . . 0.0 112.58 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 3.8 m0 -112.11 -29.6 7.54 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.522 -0.752 . . . . 0.0 111.086 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 t -68.87 -22.21 64.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.152 0.887 . . . . 0.0 111.981 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -121.85 156.01 59.75 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 123.951 0.9 . . . . 0.0 108.583 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.84 110.25 3.08 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.957 1.771 . . . . 0.0 108.174 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -111.18 168.18 9.71 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.137 0.975 . . . . 0.0 108.749 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -55.68 163.49 1.35 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.577 1.551 . . . . 0.0 111.468 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -64.68 161.4 17.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.366 164.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.79 -15.63 2.93 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.775 1.179 . . . . 0.0 114.242 170.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -63.4 163.21 11.13 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 124.509 1.124 . . . . 0.0 111.455 -174.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -127.88 170.36 12.9 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.756 1.222 . . . . 0.0 109.548 171.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.4 -34.97 69.43 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.96 0.504 . . . . 0.0 110.939 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.78 -30.85 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 CA-C-N 118.224 0.465 . . . . 0.0 112.084 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.04 -38.14 72.79 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.412 0.445 . . . . 0.0 110.581 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.2 mt -67.41 -49.51 63.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.015 1.726 . . . . 0.0 110.548 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.98 -52.96 63.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -54.16 -46.55 72.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.476 1.11 . . . . 0.0 111.781 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.437 ' HE2' HG23 ' A' ' 16' ' ' VAL . 7.0 tptt -54.98 -60.27 3.6 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.11 0.564 . . . . 0.0 110.202 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -54.78 -46.02 74.35 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 126.331 1.852 . . . . 0.0 110.933 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -59.92 -47.05 87.38 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.153 0.981 . . . . 0.0 110.128 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -56.54 -41.1 76.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.461 1.028 . . . . 0.0 110.75 171.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.5 mt -74.71 -7.03 52.04 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.4 pt . . . . . 0 N--CA 1.471 0.623 0 CA-C-N 120.415 1.462 . . . . 0.0 111.772 166.08 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 p -62.31 166.77 4.68 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.412 0.685 . . . . 0.0 110.097 167.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -61.69 -25.66 67.55 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.114 -0.992 . . . . 0.0 110.083 168.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -62.27 -49.36 75.98 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 122.085 0.945 . . . . 0.0 108.527 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -72.46 -36.99 68.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.562 0.745 . . . . 0.0 110.917 -174.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.63 -32.0 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 119.372 0.987 . . . . 0.0 109.744 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -59.38 -59.07 6.03 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 170.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -57.0 -32.08 65.75 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.58 1.152 . . . . 0.0 112.189 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -63.03 1.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.79 0.836 . . . . 0.0 108.845 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -68.92 -31.66 70.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.452 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -59.31 -49.38 78.03 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 120.204 1.366 . . . . 0.0 109.334 175.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.46 -63.27 5.46 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 124.764 1.173 . . . . 0.0 110.495 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.2 t -55.46 -23.33 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 118.267 1.033 . . . . 0.0 111.603 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -71.22 -53.72 13.41 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 120.134 1.334 . . . . 0.0 109.618 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.6 t -81.47 -8.51 59.74 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.845 0.858 . . . . 0.0 111.107 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.5 mtp -128.86 -93.82 0.44 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.282 1.833 . . . . 0.0 108.033 -171.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.16 -126.44 2.1 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -168.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.57 7.91 17.53 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 117.498 0.649 . . . . 0.0 111.715 -172.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -69.94 98.67 1.3 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.994 1.27 . . . . 0.0 108.414 167.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -74.92 -42.43 57.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.308 -0.377 . . . . 0.0 111.073 -170.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -54.9 -36.62 65.39 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 118.746 -0.645 . . . . 0.0 112.058 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.4 m -61.77 -55.13 33.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.222 0.609 . . . . 0.0 110.06 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.6 mt -53.04 -47.9 53.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 125.988 1.715 . . . . 0.0 110.167 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -31.36 64.92 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.843 1.257 . . . . 0.0 111.32 -175.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -85.31 -42.95 14.14 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.516 0.726 . . . . 0.0 112.105 170.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.6 t -57.19 -35.63 69.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.881 1.273 . . . . 0.0 111.93 -167.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -127.37 157.91 71.21 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 124.132 0.973 . . . . 0.0 108.524 -174.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.46 108.65 2.18 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 CA-C-N 119.747 0.946 . . . . 0.0 109.934 -175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -104.1 166.64 10.28 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.466 1.106 . . . . 0.0 108.864 173.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -52.16 162.73 0.45 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.46 1.104 . . . . 0.0 111.705 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 160.32 24.6 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.3 7.68 20.31 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.293 -0.726 . . . . 0.0 114.427 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.7 mmp_? -71.26 161.31 31.29 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 119.025 1.412 . . . . 0.0 108.938 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -118.41 162.99 17.4 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 174.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.71 -36.17 66.89 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.314 -0.866 . . . . 0.0 111.282 170.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 m -66.55 -23.78 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.004 0.922 . . . . 0.0 112.605 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.57 -46.49 70.29 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.642 0.734 . . . . 0.0 109.145 176.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.9 mt -65.84 -44.79 84.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.323 1.449 . . . . 0.0 109.119 -178.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.1 -49.57 75.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.051 1.341 . . . . 0.0 108.847 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -55.02 -61.72 2.13 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.871 1.268 . . . . 0.0 110.09 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -52.94 -54.14 39.32 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 122.586 0.355 . . . . 0.0 110.131 -174.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -52.12 -51.38 58.15 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 126.196 1.799 . . . . 0.0 111.231 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -57.03 -49.06 76.96 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.852 0.296 . . . . 0.0 110.491 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -58.14 -43.22 87.19 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.662 -0.685 . . . . 0.0 109.3 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.7 mt -62.43 -53.47 54.39 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.805 0.842 . . . . 0.0 111.643 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.0 pt . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 119.403 1.001 . . . . 0.0 110.653 176.79 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -74.17 173.17 10.49 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -48.06 -50.27 28.58 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.284 1.034 . . . . 0.0 109.797 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.08 -37.07 73.79 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.612 -172.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -35.3 43.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 119.692 -0.803 . . . . 0.0 108.946 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.5 t -62.88 -37.99 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 121.134 -0.979 . . . . 0.0 109.873 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -53.53 -51.31 63.28 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.443 0.697 . . . . 0.0 109.689 172.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -67.62 -29.09 68.33 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.46 -53.77 52.1 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 175.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -60.54 -50.67 72.59 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 118.578 -0.725 . . . . 0.0 111.62 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.18 -49.27 74.5 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.013 0.925 . . . . 0.0 110.551 -177.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.95 -53.31 43.96 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 124.74 1.162 . . . . 0.0 110.656 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.3 t -60.1 -28.55 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 117.622 0.711 . . . . 0.0 110.228 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -70.89 -37.9 73.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 120.964 -1.085 . . . . 0.0 110.403 -176.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.6 t -95.39 -19.37 19.97 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.905 0.882 . . . . 0.0 112.21 -176.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 41.3 mtt -116.37 -20.6 9.65 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.47 1.032 . . . . 0.0 113.777 -175.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.31 -151.17 39.75 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -160.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -68.93 24.32 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.607 2.763 . . . . 0.0 116.441 -169.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -81.05 103.14 10.66 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 165.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -84.62 -39.02 19.17 Favored 'General case' 0 CA--C 1.527 0.091 0 O-C-N 121.129 -0.982 . . . . 0.0 111.25 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -58.71 -48.9 79.56 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.045 0.538 . . . . 0.0 110.864 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.3 m -56.95 -49.11 76.66 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.51 1.124 . . . . 0.0 112.346 176.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.1 mt -55.29 -47.47 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.049 1.339 . . . . 0.0 109.566 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -30.04 44.63 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.035 0.934 . . . . 0.0 111.987 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -98.84 -26.74 14.2 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.434 0.694 . . . . 0.0 112.253 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 t -63.04 -22.22 66.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.618 1.167 . . . . 0.0 112.352 -173.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -134.61 161.95 60.65 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 125.009 1.324 . . . . 0.0 107.443 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.65 109.13 2.56 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 N-CA-C 107.239 -1.87 . . . . 0.0 107.239 170.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -99.67 172.15 7.46 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -55.91 149.98 14.11 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.433 1.093 . . . . 0.0 109.237 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.08 155.82 39.87 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 121.291 -0.881 . . . . 0.0 110.335 -176.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.15 21.22 71.75 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.718 1.152 . . . . 0.0 113.89 173.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.448 ' HE ' ' HA ' ' A' ' 43' ' ' ARG . 2.9 mmp_? -82.25 162.58 22.28 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.426 1.09 . . . . 0.0 111.039 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -112.54 162.51 15.56 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.645 1.978 . . . . 0.0 107.43 167.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.91 -26.8 67.78 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.491 -0.756 . . . . 0.0 111.161 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.3 m -67.63 -24.4 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 O-C-N 120.793 -1.192 . . . . 0.0 112.753 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -62.85 -38.0 89.05 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.307 0.643 . . . . 0.0 109.293 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 67.4 mt -62.22 -50.87 70.03 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 126.755 2.022 . . . . 0.0 109.479 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.33 -37.88 89.05 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.957 0.903 . . . . 0.0 109.177 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -60.78 -54.42 45.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 122.05 -0.406 . . . . 0.0 110.093 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -56.56 -42.09 78.01 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 118.644 0.657 . . . . 0.0 111.071 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -58.72 -49.28 78.18 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.755 1.622 . . . . 0.0 111.107 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -20.73 64.64 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.827 -0.606 . . . . 0.0 112.328 175.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -77.66 -49.7 13.98 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.89 1.677 . . . . 0.0 109.685 165.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.5 mt -55.26 -56.19 22.82 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.508 0.594 . . . . 0.0 112.038 -173.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt . . . . . 0 N--CA 1.468 0.448 0 O-C-N 121.968 -0.458 . . . . 0.0 111.758 -173.787 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 . . . . . 0 C--O 1.238 0.465 0 CA-C-O 122.149 0.976 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.1 t -61.6 154.43 25.04 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.488 163.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -59.31 -20.75 57.0 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.396 1.078 . . . . 0.0 113.013 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.45 -58.57 5.53 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.264 1.026 . . . . 0.0 108.441 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -36.22 78.81 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.308 1.043 . . . . 0.0 110.94 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.49 -39.41 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 120.952 -1.092 . . . . 0.0 110.921 176.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -59.91 -46.38 89.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.227 -0.892 . . . . 0.0 109.761 173.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -61.57 -29.36 69.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.507 1.049 . . . . 0.0 112.558 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.32 -58.03 8.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.79 0.723 . . . . 0.0 109.859 175.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -64.94 -32.8 74.7 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.684 0.394 . . . . 0.0 111.327 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -65.15 -44.13 89.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.663 1.185 . . . . 0.0 109.858 174.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.02 -56.96 19.43 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 127.027 2.251 . . . . 0.0 110.924 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.8 t -63.13 -25.43 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 118.389 1.095 . . . . 0.0 110.593 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -68.31 -39.3 82.07 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 120.585 -1.322 . . . . 0.0 110.08 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.2 t -94.98 -28.69 15.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.137 0.575 . . . . 0.0 111.573 -172.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -107.94 -26.28 10.78 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.161 0.984 . . . . 0.0 112.687 -174.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.8 -155.11 52.73 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -162.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.96 38.49 0.08 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.555 1.542 . . . . 0.0 113.214 -172.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -109.16 97.79 7.34 Favored 'General case' 0 C--N 1.338 0.105 0 O-C-N 120.598 -1.314 . . . . 0.0 107.69 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -81.15 -38.91 26.38 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.383 -167.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -62.33 -42.87 99.74 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 123.669 0.606 . . . . 0.0 109.853 -175.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.3 t -55.67 -57.47 11.86 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 124.382 1.073 . . . . 0.0 111.046 171.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.7 mt -48.01 -51.92 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.631 1.572 . . . . 0.0 110.351 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.56 -37.95 52.04 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.568 1.547 . . . . 0.0 111.689 -177.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -85.81 -40.28 16.19 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.593 0.757 . . . . 0.0 111.454 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 t -62.92 -20.88 65.61 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -168.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -134.46 155.58 79.58 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 124.757 1.223 . . . . 0.0 107.863 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.63 110.43 2.31 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 N-CA-C 107.326 -1.836 . . . . 0.0 107.326 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -110.14 172.37 6.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 162.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.79 146.97 54.12 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -65.63 173.56 2.71 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.594 0.758 . . . . 0.0 110.058 169.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.56 -13.0 0.45 Allowed Glycine 0 CA--C 1.537 1.427 0 CA-C-O 119.197 -0.78 . . . . 0.0 114.014 -176.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 mmt85 -58.3 134.82 56.9 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.569 1.684 . . . . 0.0 108.061 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -87.41 165.87 15.25 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 162.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.17 -27.92 69.29 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.0 -1.062 . . . . 0.0 111.023 171.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 m -67.31 -27.75 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.313 1.045 . . . . 0.0 112.093 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.88 -45.52 64.18 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.898 0.879 . . . . 0.0 109.009 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.5 mt -66.1 -49.6 66.97 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.794 1.638 . . . . 0.0 109.966 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.7 -40.14 91.97 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.972 1.309 . . . . 0.0 109.875 -173.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -68.47 -51.36 44.33 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.957 0.903 . . . . 0.0 110.249 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -55.0 -45.08 75.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.824 0.738 . . . . 0.0 110.608 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -58.14 -47.43 83.35 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.041 1.337 . . . . 0.0 110.942 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -56.89 -43.08 80.96 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 118.947 -0.549 . . . . 0.0 111.196 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -71.2 -28.85 64.51 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.355 0.662 . . . . 0.0 112.069 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.72 -57.04 12.38 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.042 0.837 . . . . 0.0 109.596 171.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.2 pt . . . . . 0 CA--C 1.542 0.651 0 CA-C-N 118.958 0.799 . . . . 0.0 111.663 -179.577 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 122.561 1.172 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.98 159.36 32.84 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 130.611 3.565 . . . . 0.0 113.836 -169.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -54.08 -46.49 72.04 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 126.253 1.821 . . . . 0.0 111.868 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -71.54 -42.04 68.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.559 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -34.85 74.52 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.894 0.478 . . . . 0.0 109.941 -175.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.4 t -58.56 -41.62 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.03 -50.52 73.16 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.769 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -60.21 -34.48 73.71 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 118.514 0.597 . . . . 0.0 112.248 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.88 -53.36 59.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.145 0.978 . . . . 0.0 108.644 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -65.83 -47.82 73.73 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.652 -0.69 . . . . 0.0 111.393 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -56.74 -35.17 68.29 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.039 0.836 . . . . 0.0 110.409 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.39 -67.89 1.9 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 127.49 2.471 . . . . 0.0 110.849 170.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.1 t -56.23 -27.61 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.999 1.9 . . . . 0.0 111.466 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -62.1 -40.46 95.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.248 -0.907 . . . . 0.0 109.643 -177.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 t -96.07 -42.41 8.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.686 1.194 . . . . 0.0 111.379 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.74 -26.0 40.91 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 124.437 1.095 . . . . 0.0 113.918 -172.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.42 -116.54 8.04 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -164.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.91 12.16 32.77 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.191 1.495 . . . . 0.0 113.444 -172.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -73.76 97.11 2.65 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -80.36 -43.0 21.86 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 121.225 -0.922 . . . . 0.0 109.598 176.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -54.38 -41.18 68.92 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.215 0.606 . . . . 0.0 110.66 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.8 m -74.45 -38.49 62.97 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.661 1.184 . . . . 0.0 111.814 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 60.7 mt -59.92 -45.11 95.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -28.47 64.73 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.089 0.956 . . . . 0.0 112.227 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -85.14 -41.54 15.6 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.782 0.833 . . . . 0.0 110.084 173.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.3 t -67.22 -14.16 62.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 117.255 -1.355 . . . . 0.0 114.578 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -151.93 160.84 30.95 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 120.737 1.608 . . . . 0.0 109.715 -177.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -74.68 143.57 30.38 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.604 1.536 . . . . 0.0 109.526 168.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -137.38 113.51 9.91 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 169.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.25 45.4 mt-30 37.36 -124.94 0.21 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.967 1.707 . . . . 0.0 108.998 -168.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -133.56 143.01 48.43 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 158.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.93 62.32 5.33 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.085 0.85 . . . . 0.0 112.155 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -109.48 164.5 12.45 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.897 0.856 . . . . 0.0 113.258 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -99.53 165.78 11.47 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.941 1.696 . . . . 0.0 108.574 168.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.56 -31.83 73.21 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.589 -0.695 . . . . 0.0 109.935 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.6 m -64.08 -24.7 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.201 -0.937 . . . . 0.0 112.357 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.48 -11.74 61.08 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.824 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.3 mt -94.89 -18.87 20.76 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.162 1.385 . . . . 0.0 112.071 169.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.8 -43.57 22.19 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.039 171.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -74.63 -57.75 3.73 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -164.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -59.06 -39.39 81.93 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 116.412 -1.756 . . . . 0.0 110.867 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -50.79 -47.75 59.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 121.42 1.918 . . . . 0.0 110.891 168.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.49 -37.81 65.72 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.122 0.569 . . . . 0.0 112.006 176.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -76.59 -35.24 58.26 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.897 0.879 . . . . 0.0 112.167 173.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.2 mt -61.34 -45.93 92.37 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.522 1.055 . . . . 0.0 109.409 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 pt . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 175.344 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 . . . . . 0 C--O 1.238 0.49 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.2 p -75.72 178.96 5.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.356 1.062 . . . . 0.0 109.804 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 pttt -63.07 -31.75 72.96 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 120.189 -1.57 . . . . 0.0 112.24 165.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.62 -54.0 9.16 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.692 0.797 . . . . 0.0 108.923 -168.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -63.53 -23.75 67.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.461 -175.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.3 t -74.49 -39.21 47.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 119.078 0.854 . . . . 0.0 110.059 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -60.27 -47.93 83.9 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.6 m-30 -64.21 -30.9 71.94 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.799 0.84 . . . . 0.0 113.008 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.48 -54.79 42.87 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 174.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -61.45 -47.81 84.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.843 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.418 ' O ' ' HE3' ' A' ' 24' ' ' LYS . 4.0 m-70 -59.88 -36.08 76.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.268 0.94 . . . . 0.0 111.21 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.18 -54.46 20.58 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 125.684 1.612 . . . . 0.0 110.518 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.3 t -59.57 -28.13 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 118.296 1.048 . . . . 0.0 110.903 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -66.07 -36.98 84.66 Favored 'General case' 0 CA--C 1.521 -0.142 0 O-C-N 120.81 -1.181 . . . . 0.0 110.002 -178.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 t -95.46 -35.45 11.7 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.203 0.601 . . . . 0.0 111.84 -176.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -95.29 -11.98 26.96 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.908 0.883 . . . . 0.0 112.782 -173.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 57.82 -144.12 41.79 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 107.965 -2.054 . . . . 0.0 107.965 -157.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -61.86 -1.8 0.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -174.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -82.48 97.36 8.37 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 122.24 2.291 . . . . 0.0 109.831 -157.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -68.01 -41.88 81.54 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.573 -170.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -61.62 -43.05 99.58 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.8 m -60.03 -47.23 86.73 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.477 1.511 . . . . 0.0 112.008 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.2 mt -57.58 -46.73 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 123.933 0.893 . . . . 0.0 109.162 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -21.56 63.31 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.06 0.544 . . . . 0.0 112.257 -175.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -96.27 -32.41 12.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.376 0.67 . . . . 0.0 111.572 173.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -18.3 65.0 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -134.12 149.97 72.95 Favored Pre-proline 0 C--O 1.236 0.384 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.12 107.2 2.43 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 N-CA-C 105.704 -2.46 . . . . 0.0 105.704 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -99.08 178.32 4.96 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -62.74 152.36 35.9 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.144 -0.973 . . . . 0.0 109.986 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -58.59 159.86 6.1 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.894 0.477 . . . . 0.0 109.908 164.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.16 9.44 29.22 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.9 mmt-85 -73.45 165.03 25.83 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 118.726 1.263 . . . . 0.0 110.484 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -132.14 158.71 40.95 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.56 -36.01 77.43 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 m -63.18 -27.71 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 124.135 0.974 . . . . 0.0 112.164 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -61.81 -40.58 95.75 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.2 mt -66.42 -47.96 71.56 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.154 1.382 . . . . 0.0 110.103 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.75 -46.57 88.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -61.31 -53.05 61.76 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 118.934 -0.555 . . . . 0.0 110.232 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.512 ' HZ2' HD21 ' A' ' 55' ' ' LEU . 2.6 tmtt? -50.22 -54.75 18.83 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.766 1.226 . . . . 0.0 109.318 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -57.59 -44.72 85.58 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 125.239 1.416 . . . . 0.0 111.812 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -57.93 -48.49 79.76 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -63.31 -25.62 68.39 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.749 0.704 . . . . 0.0 111.566 175.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.512 HD21 ' HZ2' ' A' ' 51' ' ' LYS . 70.5 mt -80.17 -15.88 56.08 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 175.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.9 pt . . . . . 0 CA--C 1.539 0.557 0 CA-C-N 119.808 1.185 . . . . 0.0 111.646 169.055 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.456 ' CD2' ' HG2' ' A' ' 51' ' ' LYS . 4.7 m-85 . . . . . 0 C--O 1.233 0.237 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -69.15 167.64 15.72 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.885 0.766 . . . . 0.0 111.787 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -32.65 74.39 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.476 -1.39 . . . . 0.0 110.592 175.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -67.46 -47.2 70.81 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -59.87 -44.71 94.02 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.753 -0.641 . . . . 0.0 110.541 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.09 -40.9 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 119.067 0.848 . . . . 0.0 109.468 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -60.19 -49.82 76.13 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 119.77 -0.157 . . . . 0.0 111.31 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -55.13 -40.96 71.13 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.8 0.84 . . . . 0.0 110.295 173.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.49 -51.56 64.7 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.538 -1.351 . . . . 0.0 109.808 -175.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -63.43 -47.6 81.25 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.745 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -55.11 -48.58 73.43 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.783 0.833 . . . . 0.0 110.912 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.43 -56.49 24.17 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 125.343 1.449 . . . . 0.0 109.865 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.5 t -60.7 -16.63 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 117.881 0.84 . . . . 0.0 112.684 -176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -68.33 -57.23 6.24 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 120.434 -1.416 . . . . 0.0 109.191 172.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.0 t -80.83 -42.38 21.71 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.778 0.831 . . . . 0.0 109.566 -173.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -77.55 -27.71 51.64 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.45 -0.786 . . . . 0.0 112.809 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.8 -143.59 48.69 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -156.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -73.99 7.13 2.82 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.33 98.32 3.21 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 121.325 1.875 . . . . 0.0 109.446 -175.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -71.82 -45.11 62.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 119.185 -0.435 . . . . 0.0 109.914 -178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -48.92 -53.88 17.8 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.371 1.068 . . . . 0.0 111.967 176.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.6 m -55.24 -49.63 71.52 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.884 0.874 . . . . 0.0 111.317 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.1 mt -57.85 -49.94 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 125.818 1.647 . . . . 0.0 110.105 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -34.54 74.27 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.742 1.217 . . . . 0.0 111.583 -173.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -73.58 -47.86 37.27 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.839 -0.538 . . . . 0.0 111.077 166.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.4 t -62.63 -28.76 70.13 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -167.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -134.28 148.85 69.46 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 119.62 1.1 . . . . 0.0 108.654 -174.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.52 110.55 2.45 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.869 2.379 . . . . 0.0 110.603 -174.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -111.51 113.51 25.98 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.849 1.26 . . . . 0.0 109.473 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 31.09 -141.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.891 2.476 . . . . 0.0 111.121 -166.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -106.83 160.52 15.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 144.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 61.74 49.08 79.8 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 124.864 1.221 . . . . 0.0 114.315 166.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.423 ' HE ' ' HA ' ' A' ' 43' ' ' ARG . 1.5 mmp_? -105.1 165.56 11.0 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.581 1.19 . . . . 0.0 111.511 174.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -122.36 161.75 22.85 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.772 1.629 . . . . 0.0 107.588 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.05 -44.17 70.83 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.137 0.426 . . . . 0.0 110.722 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 m -62.29 -27.25 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.572 0.749 . . . . 0.0 112.722 -176.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.38 -41.35 84.64 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.2 mt -66.78 -39.22 87.74 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.794 1.238 . . . . 0.0 109.838 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.04 -54.15 29.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.261 1.024 . . . . 0.0 108.342 -177.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.97 -50.46 64.05 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 122.674 0.39 . . . . 0.0 111.351 174.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.456 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 42.6 tptt -56.67 -54.19 49.02 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -54.89 -48.53 72.89 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.029 1.332 . . . . 0.0 110.234 -173.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -55.77 -48.03 76.0 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -62.75 -34.42 77.19 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.403 -0.81 . . . . 0.0 112.884 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.3 mt -68.42 -39.13 81.71 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 119.53 1.059 . . . . 0.0 111.414 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.9 pt . . . . . 0 CA--C 1.534 0.349 0 CA-C-N 118.842 0.746 . . . . 0.0 111.965 -174.533 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t -73.37 164.85 26.09 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.157 1.383 . . . . 0.0 108.773 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -52.94 -36.37 59.71 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 118.607 -0.711 . . . . 0.0 112.729 -172.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.25 -54.97 18.63 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -174.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.45 -37.09 82.29 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 124.236 1.014 . . . . 0.0 110.784 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.13 -36.43 73.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 O-C-N 121.405 -0.809 . . . . 0.0 110.582 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -68.45 -45.28 72.91 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 117.782 -1.104 . . . . 0.0 109.392 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -59.74 -35.16 74.0 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 119.689 1.131 . . . . 0.0 111.47 174.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.96 -56.02 27.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.709 0.804 . . . . 0.0 108.881 175.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -62.35 -44.38 96.6 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 119.049 -0.5 . . . . 0.0 110.73 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -53.44 -44.8 69.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.568 1.147 . . . . 0.0 110.073 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.85 -56.63 15.41 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 126.649 2.071 . . . . 0.0 111.58 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.3 t -65.23 -16.97 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 121.359 -1.083 . . . . 0.0 110.934 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -80.74 -39.89 26.19 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.124 -1.61 . . . . 0.0 109.924 174.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.6 t -95.69 -12.22 25.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.164 0.986 . . . . 0.0 112.292 -170.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 33.2 mtt -125.62 -48.48 1.66 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.146 1.378 . . . . 0.0 111.327 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.21 -154.67 19.86 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -165.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -61.97 15.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.492 2.317 . . . . 0.0 116.32 -175.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -78.8 97.37 5.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 120.447 1.476 . . . . 0.0 107.455 170.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -76.3 -47.15 24.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.7 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -62.57 -43.35 99.03 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.358 0.663 . . . . 0.0 109.299 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.9 m -59.78 -49.81 76.28 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.698 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.8 mt -58.33 -44.58 88.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 119.665 1.12 . . . . 0.0 109.241 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.11 -47.29 65.37 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.413 1.485 . . . . 0.0 110.555 -177.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -85.86 -28.57 24.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 119.322 -0.37 . . . . 0.0 111.143 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 t -59.32 -69.97 0.18 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.464 0.706 . . . . 0.0 109.932 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -84.99 148.9 51.92 Favored Pre-proline 0 C--O 1.235 0.335 0 O-C-N 121.313 -0.867 . . . . 0.0 109.179 -171.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.57 108.43 1.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 N-CA-C 108.628 -1.336 . . . . 0.0 108.628 -173.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -111.02 154.46 24.15 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.352 0.661 . . . . 0.0 110.317 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -54.9 130.49 41.51 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.381 1.072 . . . . 0.0 110.123 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -64.07 117.73 7.5 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.33 -24.34 4.72 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.064 1.792 . . . . 0.0 110.681 -166.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 145.05 56.6 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.449 1.124 . . . . 0.0 110.664 173.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -120.09 175.17 6.06 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.468 1.907 . . . . 0.0 107.6 167.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.31 -41.33 84.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.483 -0.761 . . . . 0.0 109.972 166.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.5 m -65.02 -31.4 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.183 0.593 . . . . 0.0 112.285 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.14 -50.08 65.27 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.0 mt -64.95 -50.27 67.07 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.104 1.762 . . . . 0.0 109.767 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.79 -49.2 78.57 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 124.71 1.256 . . . . 0.0 107.662 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -60.66 -51.86 67.61 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.184 0.594 . . . . 0.0 111.029 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -48.61 71.64 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.571 0.748 . . . . 0.0 109.3 -177.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -63.77 -49.85 71.37 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.453 1.101 . . . . 0.0 110.686 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -57.37 -38.11 73.7 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.307 1.443 . . . . 0.0 111.397 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -65.66 -53.59 39.18 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 118.339 -0.839 . . . . 0.0 109.728 167.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.6 mt -57.78 -27.68 63.31 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.1 pt . . . . . 0 CA--C 1.532 0.285 0 CA-C-N 119.656 1.116 . . . . 0.0 112.01 176.73 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 t -62.92 154.94 28.66 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 161.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.16 -29.48 68.7 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.343 -0.848 . . . . 0.0 111.367 -173.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -58.84 -50.27 74.62 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.747 0.819 . . . . 0.0 110.286 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -62.41 -30.68 71.39 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.089 -0.481 . . . . 0.0 110.903 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.1 t -70.15 -31.56 47.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 119.477 1.035 . . . . 0.0 111.477 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -66.45 -52.3 47.78 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 174.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -60.71 -33.14 72.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.339 0.656 . . . . 0.0 111.619 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -58.14 9.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.844 0.858 . . . . 0.0 109.345 173.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -57.95 -48.34 80.24 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 122.945 0.498 . . . . 0.0 110.562 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -58.82 -38.6 79.0 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.396 0.678 . . . . 0.0 110.992 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.11 -55.62 25.31 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 125.246 1.403 . . . . 0.0 110.806 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.64 -23.81 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 118.464 1.132 . . . . 0.0 111.285 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -72.28 -41.44 66.68 Favored 'General case' 0 C--O 1.224 -0.253 0 O-C-N 120.922 -1.111 . . . . 0.0 109.991 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 t -96.32 -37.2 10.6 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.578 0.751 . . . . 0.0 111.207 -172.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -86.29 -105.22 0.06 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 167.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.17 -81.92 0.15 Allowed Glycine 0 C--O 1.226 -0.406 0 CA-C-O 118.335 -1.259 . . . . 0.0 110.759 -173.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.68 4.29 9.52 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.437 2.119 . . . . 0.0 112.396 173.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -75.9 98.73 4.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -79.41 -35.2 40.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.869 1.268 . . . . 0.0 110.534 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -55.05 -47.26 75.03 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.941 0.896 . . . . 0.0 110.44 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.6 m -55.55 -59.27 5.06 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.773 1.629 . . . . 0.0 111.224 174.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 76.6 mt -53.08 -44.6 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 125.666 1.587 . . . . 0.0 110.165 -173.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -17.18 40.71 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -174.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -111.89 -29.51 7.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.681 1.192 . . . . 0.0 111.499 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.14 -19.92 65.62 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.054 0.942 . . . . 0.0 113.059 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -139.31 155.0 72.43 Favored Pre-proline 0 C--O 1.235 0.29 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.85 110.05 3.01 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.843 1.695 . . . . 0.0 110.061 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -115.72 157.24 24.58 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.906 1.282 . . . . 0.0 109.131 174.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -49.7 149.65 2.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.612 1.165 . . . . 0.0 112.549 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -61.72 144.78 54.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.66 -2.4 40.04 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.819 -1.545 . . . . 0.0 114.415 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -58.41 153.39 15.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 120.266 2.033 . . . . 0.0 110.283 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -112.31 160.8 17.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.04 0.936 . . . . 0.0 108.69 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.44 -30.99 63.52 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 122.192 -0.317 . . . . 0.0 110.651 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.1 m -65.02 -29.06 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 C-N-CA 123.723 0.809 . . . . 0.0 112.544 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -57.16 -41.52 79.37 Favored 'General case' 0 CA--C 1.516 -0.36 0 O-C-N 124.363 1.04 . . . . 0.0 109.517 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.7 mt -65.63 -48.95 70.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.737 1.215 . . . . 0.0 109.584 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.17 -44.19 95.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.845 0.858 . . . . 0.0 108.796 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -67.03 -46.38 74.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.143 0.577 . . . . 0.0 111.324 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -60.52 -39.66 88.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 119.512 1.051 . . . . 0.0 110.889 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.68 -42.94 99.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.475 0.71 . . . . 0.0 110.257 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -60.13 -47.76 84.57 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.77 172.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -52.09 -42.73 63.46 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.47 1.032 . . . . 0.0 109.986 173.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.6 mt -68.09 -60.62 2.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 119.049 -0.5 . . . . 0.0 111.091 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt . . . . . 0 N--CA 1.468 0.441 0 CA-C-N 118.97 0.804 . . . . 0.0 112.242 -172.846 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.507 ' CG ' ' HE2' ' A' ' 51' ' ' LYS . 2.4 m-30 . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 122.899 1.333 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 p -69.59 163.21 26.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.235 1.414 . . . . 0.0 108.28 160.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -57.93 -34.42 69.85 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.478 164.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -56.03 -59.86 4.3 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 126.056 1.743 . . . . 0.0 110.338 172.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -37.45 82.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.598 1.09 . . . . 0.0 111.01 -176.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.45 -41.08 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 118.606 0.639 . . . . 0.0 110.758 173.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -60.68 -47.73 84.94 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.57 0.748 . . . . 0.0 110.465 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -66.98 -31.95 72.86 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.83 0.452 . . . . 0.0 111.566 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.08 -53.07 61.43 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 170.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.16 -46.24 89.84 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.466 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -55.56 -41.94 74.0 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.427 0.691 . . . . 0.0 110.896 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.04 -54.24 22.3 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 126.651 2.072 . . . . 0.0 111.369 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.1 t -64.67 -22.97 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 121.166 -1.196 . . . . 0.0 111.417 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -67.91 -45.89 73.1 Favored 'General case' 0 C--O 1.225 -0.191 0 O-C-N 121.041 -1.037 . . . . 0.0 109.82 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 t -95.58 -40.97 9.16 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.665 0.786 . . . . 0.0 110.957 -162.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -80.47 -66.19 0.91 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 166.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.81 -164.0 12.1 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 -146.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -78.89 23.47 0.34 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.84 0.856 . . . . 0.0 111.944 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -75.06 96.75 3.28 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 120.969 1.713 . . . . 0.0 107.122 165.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -72.62 -36.34 68.04 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.011 -1.449 . . . . 0.0 109.621 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -13.59 62.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.358 0.663 . . . . 0.0 112.184 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -86.29 -58.1 2.76 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 124.296 1.038 . . . . 0.0 108.805 169.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 92.4 mt -52.04 -44.9 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 C-N-CA 126.672 1.989 . . . . 0.0 111.372 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.91 -23.36 52.96 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.572 1.149 . . . . 0.0 112.72 -175.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -109.91 -35.88 6.04 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.885 1.274 . . . . 0.0 111.281 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.93 -29.57 69.69 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.962 0.801 . . . . 0.0 112.167 175.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -127.0 150.99 73.47 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 124.331 1.052 . . . . 0.0 108.629 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -87.82 107.55 0.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 CA-C-N 119.836 0.977 . . . . 0.0 110.004 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -94.11 161.14 14.4 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.414 -0.804 . . . . 0.0 109.405 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -66.0 147.1 53.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 173.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -53.68 146.04 14.21 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.511 0.725 . . . . 0.0 109.852 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.85 -15.13 56.67 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.373 -1.237 . . . . 0.0 112.32 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.2 111.05 3.25 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 120.421 2.11 . . . . 0.0 106.999 160.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -83.15 175.35 10.03 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 159.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.62 78.12 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.875 -1.14 . . . . 0.0 110.838 170.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.5 m -65.15 -30.32 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.025 0.93 . . . . 0.0 112.46 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.56 -41.45 90.15 Favored 'General case' 0 C--O 1.222 -0.371 0 O-C-N 124.133 0.896 . . . . 0.0 108.994 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.98 -43.39 87.98 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.226 0.61 . . . . 0.0 109.641 -178.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.06 -49.04 77.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -58.38 -51.76 68.45 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.953 0.901 . . . . 0.0 111.155 178.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.507 ' HE2' ' CG ' ' A' ' 11' ' ' PHE . 48.0 tptt -55.92 -50.14 71.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.718 1.207 . . . . 0.0 110.091 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -61.62 -50.46 72.48 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.867 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -50.6 -47.87 58.03 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.037 0.835 . . . . 0.0 110.722 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.7 mmt-85 -65.88 -36.86 84.59 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 118.17 -0.919 . . . . 0.0 112.817 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.2 mt -65.97 -53.05 43.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.528 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.7 pt . . . . . 0 CA--C 1.529 0.138 0 CA-C-N 119.11 0.868 . . . . 0.0 111.58 -175.998 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 . . . . . 0 C--O 1.237 0.437 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.0 p -61.91 164.47 6.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.45 173.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -55.01 -31.85 61.37 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.545 -0.722 . . . . 0.0 110.587 170.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.41 -50.99 61.59 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.563 1.545 . . . . 0.0 108.654 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -63.92 -38.1 89.84 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.306 -0.871 . . . . 0.0 110.454 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.95 -25.31 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.459 1.027 . . . . 0.0 110.193 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -60.15 -60.02 4.48 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.468 -0.77 . . . . 0.0 109.096 169.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -63.94 -28.56 69.91 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.245 1.018 . . . . 0.0 112.556 -174.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.48 -56.23 24.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.952 0.901 . . . . 0.0 109.925 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -67.41 -42.36 83.39 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -52.17 -35.44 48.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.941 0.897 . . . . 0.0 111.337 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.54 -49.55 4.1 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 126.695 2.093 . . . . 0.0 111.825 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.5 t -61.46 -36.83 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 119.244 1.522 . . . . 0.0 110.007 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -63.7 -28.38 69.86 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.548 -0.72 . . . . 0.0 110.833 -174.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -95.2 -59.07 1.97 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.085 0.954 . . . . 0.0 108.81 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 33.8 mtt -71.3 -28.0 63.81 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.058 -1.026 . . . . 0.0 113.555 -170.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.33 -157.46 52.07 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -150.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -83.44 33.07 0.46 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.586 1.154 . . . . 0.0 111.963 -162.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -82.23 96.47 7.87 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -79.29 -46.21 18.19 Favored 'General case' 0 C--O 1.224 -0.255 0 O-C-N 121.778 -0.576 . . . . 0.0 110.194 -170.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -49.26 -52.22 28.71 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.647 1.579 . . . . 0.0 110.829 172.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.3 m -55.74 -54.55 43.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.035 0.934 . . . . 0.0 111.01 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.8 mt -54.27 -45.46 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.781 1.232 . . . . 0.0 110.518 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -22.66 20.52 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.98 1.312 . . . . 0.0 112.245 -177.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -106.54 -34.57 7.33 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.397 1.079 . . . . 0.0 111.575 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 t -60.93 -30.48 70.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.516 0.727 . . . . 0.0 111.246 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -133.88 152.01 77.88 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -176.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.86 110.57 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.942 2.428 . . . . 0.0 110.996 -172.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -110.03 170.63 7.95 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.556 0.742 . . . . 0.0 110.202 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -58.58 160.43 5.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 123.043 1.401 . . . . 0.0 112.884 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.12 138.68 57.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.041 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.8 6.8 57.19 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 117.895 -1.503 . . . . 0.0 114.543 175.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -61.82 158.3 16.19 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 120.286 2.043 . . . . 0.0 110.064 173.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -112.33 161.36 16.73 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.066 1.347 . . . . 0.0 107.472 170.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.21 -35.01 69.13 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.934 -0.479 . . . . 0.0 110.997 176.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 m -61.13 -25.14 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.469 1.108 . . . . 0.0 112.746 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -64.21 -33.37 75.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.8 mt -71.41 -41.06 70.06 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.633 1.573 . . . . 0.0 110.476 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.28 -52.3 64.25 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 172.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -59.89 -53.51 57.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.674 -0.641 . . . . 0.0 112.205 -167.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -64.71 -40.48 95.43 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.165 -173.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -56.82 -53.43 58.0 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.982 1.713 . . . . 0.0 110.34 174.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -53.73 -47.07 70.95 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.435 1.094 . . . . 0.0 109.526 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -64.82 -42.64 94.82 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.148 -0.93 . . . . 0.0 110.727 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.4 mt -61.05 -53.49 56.55 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.932 1.242 . . . . 0.0 112.023 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 CA--C 1.535 0.371 0 CA-C-N 119.357 0.981 . . . . 0.0 110.197 -178.744 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.484 ' CD2' ' HG3' ' A' ' 51' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 t -68.83 160.08 31.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.336 1.054 . . . . 0.0 110.262 -170.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -58.56 -31.43 67.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.224 1.01 . . . . 0.0 111.995 -168.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -68.67 -51.08 45.77 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 127.899 2.48 . . . . 0.0 108.639 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -60.94 -33.58 73.39 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 119.332 -0.366 . . . . 0.0 110.676 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.03 -32.91 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 120.486 -1.384 . . . . 0.0 109.707 176.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -61.94 -52.12 65.33 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -62.55 -36.89 84.08 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.434 1.094 . . . . 0.0 111.899 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.03 -54.8 42.84 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -63.26 -40.84 98.54 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.139 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -56.66 -57.55 11.91 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.814 0.734 . . . . 0.0 109.435 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -50.83 -55.24 18.76 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 125.653 1.597 . . . . 0.0 111.828 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.44 -24.21 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 118.148 0.974 . . . . 0.0 111.097 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -75.13 -33.72 61.59 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 120.87 -1.144 . . . . 0.0 111.213 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 t -90.56 -47.85 7.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.73 1.15 . . . . 0.0 109.487 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.9 mtt -80.72 -66.37 0.89 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.682 0.674 . . . . 0.0 109.537 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.07 -152.62 16.76 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 -158.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -72.41 16.1 0.15 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.553 2.341 . . . . 0.0 112.645 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -78.53 97.76 5.85 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 120.205 1.366 . . . . 0.0 107.324 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -79.22 -51.38 9.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.045 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -56.74 -45.49 81.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.165 0.439 . . . . 0.0 110.952 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.2 m -58.25 -51.97 67.54 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.051 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.2 mt -56.14 -44.4 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 119.736 1.153 . . . . 0.0 110.075 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.07 -30.35 15.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.082 1.353 . . . . 0.0 111.487 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.4 m0 -103.38 -35.25 8.45 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.771 1.228 . . . . 0.0 111.545 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -63.45 -24.17 67.71 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.207 1.403 . . . . 0.0 112.762 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -123.19 153.12 64.72 Favored Pre-proline 0 C--O 1.236 0.389 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 175.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -79.45 109.35 2.47 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 N-CA-C 107.774 -1.664 . . . . 0.0 107.774 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -106.31 156.37 18.57 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.462 0.705 . . . . 0.0 109.623 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -59.3 154.82 15.71 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.15 0.98 . . . . 0.0 111.443 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 167.88 18.19 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.561 0.696 . . . . 0.0 112.321 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.98 -7.2 29.88 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.695 1.14 . . . . 0.0 112.864 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.6 165.6 12.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.396 1.478 . . . . 0.0 113.163 -176.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -141.6 165.7 26.78 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.658 1.983 . . . . 0.0 107.288 171.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.84 -32.16 67.35 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.003 -1.06 . . . . 0.0 111.048 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 m -75.54 -20.0 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.056 1.343 . . . . 0.0 112.55 -174.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.63 -53.39 58.69 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 171.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 43.1 mt -53.29 -54.31 38.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.565 1.946 . . . . 0.0 110.343 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.48 -48.12 80.98 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.924 1.289 . . . . 0.0 108.989 -173.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -64.71 -46.96 80.1 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HG3' ' CD2' ' A' ' 11' ' ' PHE . 1.3 tmtm? -58.99 -49.71 76.86 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 124.726 1.21 . . . . 0.0 109.308 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.45 -47.92 78.13 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.154 0.982 . . . . 0.0 110.616 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -54.33 -48.5 71.3 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.457 -0.782 . . . . 0.0 110.439 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 mtt85 -62.87 -26.6 68.86 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.818 1.247 . . . . 0.0 113.273 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 74.8 mt -76.67 -52.35 9.8 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.347 -0.846 . . . . 0.0 111.088 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.3 pt . . . . . 0 CA--C 1.536 0.441 0 CA-C-N 118.616 0.644 . . . . 0.0 110.922 -173.319 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.434 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -164.29 104.73 0.86 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.361 1.464 . . . . 0.0 107.152 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 t -136.11 170.8 15.43 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 121.551 -0.718 . . . . 0.0 110.656 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.01 169.09 37.82 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.612 1.577 . . . . 0.0 111.21 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.9 p -157.66 23.0 0.28 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.582 1.153 . . . . 0.0 112.43 -162.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.7 m -80.45 117.24 21.01 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.456 -1.402 . . . . 0.0 109.125 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.05 53.45 1.88 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.476 1.036 . . . . 0.0 110.876 -177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -154.1 172.65 17.2 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.908 0.854 . . . . 0.0 110.389 -172.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -51.72 92.4 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.121 2.168 . . . . 0.0 111.087 174.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -153.65 -179.84 8.17 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.894 2.878 . . . . 0.0 105.361 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -73.91 138.33 44.23 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 119.995 -1.69 . . . . 0.0 109.15 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.77 158.81 31.55 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 162.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -55.34 -26.96 44.11 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.276 -1.345 . . . . 0.0 111.706 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -67.41 -46.45 73.17 Favored 'General case' 0 CA--C 1.526 0.05 0 CA-C-N 119.735 1.152 . . . . 0.0 111.377 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -38.74 91.99 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.397 0.999 . . . . 0.0 109.189 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.7 t -67.19 -27.45 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 119.265 0.939 . . . . 0.0 110.855 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -57.46 -60.2 4.01 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -61.14 -30.38 70.35 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.77 -58.86 6.75 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -71.96 -35.7 69.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 118.383 -0.818 . . . . 0.0 111.736 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -54.61 -45.2 73.63 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.273 0.942 . . . . 0.0 109.494 176.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.95 -64.36 3.72 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 125.464 1.506 . . . . 0.0 110.364 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.8 t -54.42 -27.93 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 118.964 1.382 . . . . 0.0 112.045 -174.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -67.02 -29.73 69.62 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.208 1.403 . . . . 0.0 111.518 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.1 t -97.17 -55.85 2.73 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.003 1.321 . . . . 0.0 112.085 167.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.0 mmt -61.36 -29.34 69.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.825 2.05 . . . . 0.0 113.171 -168.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.49 -153.82 48.79 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -153.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -76.07 19.89 0.21 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.137 1.375 . . . . 0.0 112.782 -168.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -81.55 97.77 7.99 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.299 -1.5 . . . . 0.0 108.733 -171.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -81.72 -47.9 12.34 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.033 -164.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -58.18 -43.51 87.55 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.656 0.662 . . . . 0.0 109.48 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.2 m -54.93 -49.93 70.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.781 1.632 . . . . 0.0 111.532 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 60.6 mt -58.56 -48.65 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 124.399 1.08 . . . . 0.0 109.562 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.73 -37.15 63.05 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.504 1.121 . . . . 0.0 111.423 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 14.3 m0 -85.08 -34.6 22.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.032 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.8 t -69.81 -30.41 67.93 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.672 1.124 . . . . 0.0 113.224 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -124.94 154.37 71.08 Favored Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 119.804 1.184 . . . . 0.0 110.355 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.08 117.81 5.32 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 121.867 1.711 . . . . 0.0 109.478 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -129.25 161.93 29.06 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.033 1.333 . . . . 0.0 110.616 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -47.64 129.3 13.66 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.689 1.596 . . . . 0.0 111.298 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -57.84 150.8 19.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.488 0.661 . . . . 0.0 109.573 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.6 4.25 44.98 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 117.685 -1.619 . . . . 0.0 114.634 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -53.22 164.01 0.49 Allowed 'General case' 0 C--N 1.343 0.308 0 CA-C-N 119.557 1.679 . . . . 0.0 110.649 170.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -121.45 158.5 28.26 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 163.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.35 -25.79 68.09 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.388 0.54 . . . . 0.0 111.327 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.71 -34.75 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.55 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -56.87 -35.14 68.57 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.95 0.5 . . . . 0.0 109.921 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.8 mt -66.18 -53.97 31.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.02 0.928 . . . . 0.0 109.297 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.23 -38.51 76.98 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.841 1.256 . . . . 0.0 110.379 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -75.48 -42.89 51.86 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.714 1.606 . . . . 0.0 110.623 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -65.59 -45.78 81.9 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.386 -0.821 . . . . 0.0 109.347 172.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -54.9 -48.6 72.83 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 126.099 1.759 . . . . 0.0 110.722 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -46.51 -58.14 4.06 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.386 1.074 . . . . 0.0 109.784 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -61.92 -33.4 74.18 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.216 -0.927 . . . . 0.0 112.519 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 mt -63.71 -44.32 93.97 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.959 0.799 . . . . 0.0 110.071 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.0 pt -81.29 -8.23 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 119.485 1.039 . . . . 0.0 112.479 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.8 m -80.04 -4.92 54.7 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.68 1.192 . . . . 0.0 113.013 161.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.33 -166.66 14.38 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 118.849 0.75 . . . . 0.0 113.401 167.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -83.41 152.5 13.7 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.873 3.049 . . . . 0.0 111.415 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.2 m 55.2 174.6 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.849 1.66 . . . . 0.0 113.263 -174.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.1 m 48.28 74.97 0.15 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.532 1.533 . . . . 0.0 112.255 -172.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.336 0 CA-C-O 116.527 -2.263 . . . . 0.0 112.306 171.076 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.931 0 N-CA-C 112.571 -0.212 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 t -155.62 112.23 3.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 172.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 t -143.11 169.66 17.17 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 158.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.81 -71.94 0.11 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 125.929 1.728 . . . . 0.0 109.438 -177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.0 t -94.99 17.88 13.08 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.594 1.158 . . . . 0.0 112.08 -173.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.6 m -121.28 82.43 1.93 Allowed 'General case' 0 CA--C 1.521 -0.15 0 O-C-N 120.275 -1.516 . . . . 0.0 109.979 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.98 137.27 11.05 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 162.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -157.51 -49.41 0.07 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.807 1.243 . . . . 0.0 110.728 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -136.96 -178.83 5.36 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.825 1.25 . . . . 0.0 112.103 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.5 t70 47.13 -152.72 0.08 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -141.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -91.54 136.45 33.11 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 120.976 1.716 . . . . 0.0 108.72 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 p -68.33 167.41 14.58 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.476 0.58 . . . . 0.0 110.153 170.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -57.76 -34.24 69.34 Favored 'General case' 0 N--CA 1.462 0.139 0 O-C-N 121.129 -0.982 . . . . 0.0 110.29 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.96 -54.73 37.64 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.053 0.941 . . . . 0.0 109.658 175.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -60.49 -42.69 96.82 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 123.031 0.532 . . . . 0.0 110.841 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.2 t -65.21 -35.1 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 O-C-N 121.367 -0.833 . . . . 0.0 110.885 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -63.67 -50.66 68.37 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 172.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -61.07 -33.32 73.15 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 118.771 0.714 . . . . 0.0 111.333 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.82 -56.28 24.28 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.92 0.888 . . . . 0.0 108.923 174.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -60.36 -44.73 95.31 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.152 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -56.99 -44.36 82.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.96 0.904 . . . . 0.0 109.721 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.84 -63.1 5.6 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 126.679 2.085 . . . . 0.0 110.423 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.23 -22.03 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 118.895 1.347 . . . . 0.0 111.162 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -73.7 -30.46 62.88 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 119.972 -1.705 . . . . 0.0 110.974 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.7 t -95.59 -57.71 2.31 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.709 0.804 . . . . 0.0 109.45 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -70.0 -27.14 64.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.413 1.485 . . . . 0.0 112.659 -174.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.93 -148.69 45.47 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -153.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -76.82 15.27 0.68 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.67 1.188 . . . . 0.0 113.994 -159.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -84.5 97.46 9.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 120.144 1.338 . . . . 0.0 110.093 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -71.82 -42.42 67.04 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.502 0.721 . . . . 0.0 112.455 -175.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -64.39 -40.91 96.73 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 118.619 0.645 . . . . 0.0 109.666 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.16 -54.53 38.49 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 123.4 0.68 . . . . 0.0 109.435 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.9 mt -54.57 -52.05 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 126.111 1.765 . . . . 0.0 109.831 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -47.16 69.33 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.299 1.44 . . . . 0.0 110.836 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -74.99 -39.79 61.06 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.696 -0.668 . . . . 0.0 110.602 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -59.92 -71.6 0.13 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.581 1.152 . . . . 0.0 110.565 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -87.17 153.15 53.87 Favored Pre-proline 0 N--CA 1.453 -0.301 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -166.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.15 110.52 3.13 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.588 1.525 . . . . 0.0 109.081 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -111.11 174.17 5.99 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.071 0.948 . . . . 0.0 108.698 172.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -63.98 155.85 29.73 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.939 0.876 . . . . 0.0 111.358 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -62.55 139.03 58.6 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.453 1.101 . . . . 0.0 109.043 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.55 23.31 76.66 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 117.689 0.222 . . . . 0.0 112.599 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -70.47 165.42 22.63 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 121.406 -1.055 . . . . 0.0 111.495 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -118.13 161.25 20.17 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.698 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.03 86.05 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 165.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.43 -26.34 33.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 O-C-N 121.546 -0.721 . . . . 0.0 111.761 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.6 -41.81 86.69 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.6 mt -65.14 -52.26 56.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.14 1.776 . . . . 0.0 109.111 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.02 -46.43 82.34 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.521 1.128 . . . . 0.0 108.089 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -63.72 -54.43 35.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.96 1.304 . . . . 0.0 110.899 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.88 -47.2 77.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.772 0.715 . . . . 0.0 109.299 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -60.07 -49.94 75.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.581 1.552 . . . . 0.0 111.193 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -55.59 -41.2 73.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.82 1.248 . . . . 0.0 111.059 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mmm-85 -68.86 -42.96 76.33 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.936 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.9 mt -58.27 -49.99 75.18 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.886 1.221 . . . . 0.0 112.527 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -73.24 -4.56 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.093 0.557 . . . . 0.0 112.045 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 32.6 79.65 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 129.534 3.134 . . . . 0.0 111.608 -167.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -46.61 131.26 11.99 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.011 -1.438 . . . . 0.0 110.474 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.39 165.42 29.01 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.003 2.469 . . . . 0.0 112.338 -168.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.5 p -147.63 132.92 18.46 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.77 1.228 . . . . 0.0 108.858 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.9 t 55.83 178.05 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.593 2.357 . . . . 0.0 114.298 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.966 0 C-N-CA 125.356 1.455 . . . . 0.0 110.039 174.547 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.778 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.8 t -172.16 -147.77 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.52 2.328 . . . . 0.0 104.823 170.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -58.0 168.01 1.08 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.927 1.691 . . . . 0.0 112.25 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.8 80.47 1.48 Allowed Glycine 0 C--N 1.334 0.458 0 N-CA-C 108.494 -1.843 . . . . 0.0 108.494 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.1 p -62.04 166.09 5.01 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 117.283 0.542 . . . . 0.0 111.282 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.9 m 59.57 156.69 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.547 1.939 . . . . 0.0 114.057 -171.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.56 -87.67 1.28 Allowed Glycine 0 C--N 1.333 0.407 0 N-CA-C 108.048 -2.021 . . . . 0.0 108.048 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.22 -62.53 0.79 Allowed 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 148.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -137.48 -78.55 0.38 Allowed 'General case' 0 N--CA 1.461 0.092 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 174.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -53.49 123.24 11.52 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.752 1.221 . . . . 0.0 109.498 169.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 54.68 94.75 0.02 OUTLIER 'General case' 0 C--O 1.243 0.72 0 C-N-CA 126.78 2.032 . . . . 0.0 113.194 -174.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.4 p -61.7 176.64 0.5 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.453 1.121 . . . . 0.0 110.719 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -58.92 -42.73 90.38 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 120.656 -1.278 . . . . 0.0 110.487 173.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -55.93 -54.47 44.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 124.708 1.255 . . . . 0.0 108.741 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -62.04 -41.79 98.49 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.332 1.053 . . . . 0.0 111.517 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.1 t -64.34 -38.02 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.029 0.831 . . . . 0.0 109.917 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -62.78 -47.95 81.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -60.36 -34.47 73.91 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.338 0.655 . . . . 0.0 112.389 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.0 -55.24 37.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -60.79 -46.95 88.49 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.813 0.445 . . . . 0.0 111.256 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -35.05 71.0 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.712 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -78.36 -51.54 5.61 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 125.923 1.725 . . . . 0.0 111.171 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.0 t -58.66 -28.99 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 118.249 1.024 . . . . 0.0 110.468 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -49.72 74.62 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 124.265 1.026 . . . . 0.0 110.34 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 t -96.77 -21.63 17.43 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.847 1.659 . . . . 0.0 113.647 -167.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.8 mtp -128.53 -6.56 5.22 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.204 1.002 . . . . 0.0 112.587 -170.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.86 -158.07 53.45 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 119.232 0.923 . . . . 0.0 111.385 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -72.0 21.54 0.06 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.289 1.036 . . . . 0.0 112.193 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -82.91 97.72 8.83 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -176.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -82.37 -45.07 15.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.047 -163.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -50.11 -49.5 51.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.598 0.759 . . . . 0.0 109.282 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -54.8 -54.78 37.69 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 128.063 2.545 . . . . 0.0 110.351 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 67.6 mt -59.21 -44.91 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.084 0.954 . . . . 0.0 110.355 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -34.64 64.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.379 1.472 . . . . 0.0 110.925 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -88.74 -37.26 15.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.101 0.96 . . . . 0.0 111.848 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 t -67.3 -18.66 65.27 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -140.68 154.09 68.64 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 119.881 1.218 . . . . 0.0 110.021 -173.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.12 109.58 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.159 1.906 . . . . 0.0 110.823 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -107.58 -178.53 3.65 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.668 1.187 . . . . 0.0 109.67 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -67.7 162.95 22.61 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.671 -0.643 . . . . 0.0 110.785 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.9 147.58 50.09 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 121.669 -0.644 . . . . 0.0 109.931 176.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.4 5.8 37.71 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.107 -0.83 . . . . 0.0 113.759 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -59.49 135.79 57.78 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 118.348 1.074 . . . . 0.0 108.299 169.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -90.5 167.06 12.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 171.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.81 -38.48 78.71 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.712 -0.617 . . . . 0.0 110.614 169.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.1 m -63.75 -27.58 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 123.386 0.674 . . . . 0.0 112.081 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -59.65 -37.69 79.4 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 47.6 mt -65.85 -50.01 66.1 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.738 1.215 . . . . 0.0 109.713 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.39 -41.7 90.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.922 0.889 . . . . 0.0 109.337 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -68.19 -52.54 33.2 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 124.114 0.966 . . . . 0.0 110.259 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -44.21 93.58 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 120.868 -1.145 . . . . 0.0 108.985 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -55.34 -50.59 69.24 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.567 1.147 . . . . 0.0 111.13 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -51.42 -46.13 62.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.557 1.143 . . . . 0.0 110.081 175.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -71.91 -26.33 62.26 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.465 1.106 . . . . 0.0 112.477 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.8 mt -70.57 -58.53 3.59 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.918 1.236 . . . . 0.0 109.028 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 pt -64.63 -28.23 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.154 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.5 m 68.93 -77.41 0.05 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.238 2.215 . . . . 0.0 109.335 -167.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.42 172.8 13.86 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 119.466 1.03 . . . . 0.0 113.015 171.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -80.91 62.52 8.57 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.986 3.124 . . . . 0.0 111.59 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.2 t -83.03 98.14 9.12 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 120.551 -1.343 . . . . 0.0 107.981 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.9 t 65.01 85.09 0.14 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.377 1.871 . . . . 0.0 110.032 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.356 0 CA-C-O 116.186 -2.452 . . . . 0.0 107.272 165.8 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.664 0 CA-C-O 118.739 -1.034 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.6 m 38.98 94.34 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.162 2.585 . . . . 0.0 114.288 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 m 64.29 84.22 0.15 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.942 1.697 . . . . 0.0 110.331 175.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.04 165.14 39.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 167.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.5 m -138.75 58.13 1.66 Allowed 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.339 0.656 . . . . 0.0 110.313 -168.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.9 m -55.63 161.94 1.87 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.936 -0.477 . . . . 0.0 111.707 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.02 -177.01 30.72 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 171.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -132.33 -45.33 0.91 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.464 1.106 . . . . 0.0 110.532 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -135.0 142.83 46.53 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.109 1.364 . . . . 0.0 108.221 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.3 t70 65.72 104.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 127.841 2.457 . . . . 0.0 108.524 -169.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.441 ' CD2' ' HG2' ' A' ' 51' ' ' LYS . 34.0 m-85 67.62 88.79 0.11 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.63 1.572 . . . . 0.0 111.264 -175.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.8 p -65.6 155.13 36.78 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.761 -0.587 . . . . 0.0 110.675 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -52.48 -37.25 56.75 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.069 -1.019 . . . . 0.0 111.554 174.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.58 -50.98 70.45 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 124.954 1.302 . . . . 0.0 110.224 176.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -63.67 -28.19 69.73 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.943 -1.098 . . . . 0.0 110.856 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.6 t -69.33 -35.91 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 120.388 1.449 . . . . 0.0 109.311 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -50.29 -60.59 2.82 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 170.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -61.99 -31.04 71.37 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.033 0.933 . . . . 0.0 112.715 -176.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -61.9 2.28 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -64.14 -47.94 77.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.736 0.414 . . . . 0.0 110.585 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.92 -40.65 70.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.187 1.395 . . . . 0.0 110.3 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.55 -56.91 11.23 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 125.337 1.446 . . . . 0.0 111.022 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.7 t -56.69 -32.17 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 118.598 1.199 . . . . 0.0 111.427 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -61.04 -42.0 97.64 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 119.665 1.121 . . . . 0.0 110.405 -175.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.7 t -95.43 -44.88 7.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.787 0.835 . . . . 0.0 109.689 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 6.8 mmt -69.78 -25.58 63.86 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.129 1.372 . . . . 0.0 112.022 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.39 -161.25 34.92 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -151.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -72.67 8.51 1.43 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -166.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -70.0 97.8 1.2 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 121.056 1.753 . . . . 0.0 110.472 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -71.12 -40.91 71.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.806 0.842 . . . . 0.0 111.06 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -57.48 -46.5 83.64 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.869 0.868 . . . . 0.0 109.749 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.07 -61.11 2.53 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.718 0.807 . . . . 0.0 109.472 173.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.0 mt -52.26 -48.4 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 126.125 1.77 . . . . 0.0 110.905 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -24.02 63.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.706 0.802 . . . . 0.0 112.038 -174.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -100.67 -41.32 6.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.65 0.78 . . . . 0.0 111.231 175.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.3 -15.69 60.73 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -176.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -134.25 155.01 80.28 Favored Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 125.26 1.424 . . . . 0.0 108.313 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.0 110.62 2.35 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.803 2.336 . . . . 0.0 109.778 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -118.27 159.43 23.38 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.56 1.144 . . . . 0.0 109.012 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -54.0 145.93 15.58 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.546 1.138 . . . . 0.0 112.084 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -61.43 133.75 56.13 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.75 -8.42 73.91 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 118.838 -0.979 . . . . 0.0 112.579 176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.6 mmp_? -61.48 153.49 27.14 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 118.867 1.333 . . . . 0.0 108.676 162.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.7 mtm105 -124.96 174.08 8.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.32 1.448 . . . . 0.0 107.401 167.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.53 -33.41 69.84 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 122.278 0.231 . . . . 0.0 110.639 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 m -63.8 -33.9 64.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 C-N-CA 123.473 0.709 . . . . 0.0 112.471 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.94 -41.11 86.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.8 mt -63.1 -52.0 64.37 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.982 1.313 . . . . 0.0 109.633 178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.82 -45.07 82.53 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.743 1.217 . . . . 0.0 109.266 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -63.52 -54.34 37.72 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.716 1.207 . . . . 0.0 110.432 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.441 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 52.9 tptt -61.19 -44.75 96.79 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.97 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -56.58 -54.81 41.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.568 1.147 . . . . 0.0 110.383 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -50.28 60.77 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 123.558 0.536 . . . . 0.0 109.68 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -56.57 -45.6 81.2 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.473 1.109 . . . . 0.0 111.777 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.0 mt -63.33 -56.22 18.17 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.797 0.839 . . . . 0.0 110.759 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.5 pt -63.62 -13.18 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 118.014 0.37 . . . . 0.0 111.195 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 m 67.81 19.71 9.53 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.44 1.896 . . . . 0.0 112.402 168.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.65 166.4 39.25 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.187 0.899 . . . . 0.0 111.922 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.7 174.53 8.42 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.183 2.589 . . . . 0.0 112.567 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 m 27.66 73.07 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.438 2.695 . . . . 0.0 114.356 157.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.8 t -54.9 -47.87 73.78 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.918 0.887 . . . . 0.0 110.243 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 N-CA-C 105.846 -2.902 . . . . 0.0 105.846 177.829 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.642 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.2 m -129.66 149.1 51.56 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.536 1.534 . . . . 0.0 109.163 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.1 t -67.14 151.41 47.62 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.31 -82.02 0.07 OUTLIER Glycine 0 CA--C 1.52 0.348 0 N-CA-C 106.886 -2.486 . . . . 0.0 106.886 173.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.5 t 61.86 25.94 15.65 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.203 1.401 . . . . 0.0 111.928 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 t -122.74 173.49 7.71 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.436 1.094 . . . . 0.0 110.404 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.58 -166.14 38.3 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 129.602 3.477 . . . . 0.0 106.28 -162.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 73.53 156.36 0.17 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.314 2.245 . . . . 0.0 109.262 -170.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp 45.18 84.48 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 127.743 2.417 . . . . 0.0 110.471 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 59.28 103.08 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 126.314 1.846 . . . . 0.0 110.029 -170.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 104.93 132.87 0.01 OUTLIER 'General case' 0 C--O 1.237 0.399 0 C-N-CA 129.902 3.281 . . . . 0.0 107.087 169.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t -83.47 178.44 8.02 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 164.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -55.27 -35.05 64.6 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-O 117.607 -1.187 . . . . 0.0 111.462 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.06 -57.66 11.87 Favored 'General case' 0 C--O 1.225 -0.197 0 O-C-N 123.827 0.705 . . . . 0.0 112.067 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -59.46 -40.22 86.18 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.688 1.131 . . . . 0.0 111.732 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.2 t -60.56 -40.62 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 118.839 -0.601 . . . . 0.0 111.374 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -57.42 -52.18 66.43 Favored 'General case' 0 C--O 1.226 -0.141 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.5 m-30 -61.03 -33.56 73.48 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.417 1.087 . . . . 0.0 111.716 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.38 -56.82 16.04 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -64.15 -43.1 96.26 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 117.791 -1.1 . . . . 0.0 111.769 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -55.52 -54.42 44.21 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.875 1.27 . . . . 0.0 109.262 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.85 -59.25 10.61 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 125.425 1.488 . . . . 0.0 111.648 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.4 t -61.74 -21.99 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 O-C-N 121.561 -0.964 . . . . 0.0 111.562 -177.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -76.1 -44.18 39.87 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 120.117 -1.614 . . . . 0.0 109.499 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.9 t -95.36 -16.58 22.25 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.571 0.749 . . . . 0.0 112.195 -169.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.4 mtp -126.71 -9.77 6.15 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.599 1.16 . . . . 0.0 112.257 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.04 -152.83 42.84 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -167.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -73.22 18.88 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.735 1.614 . . . . 0.0 113.648 -164.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -75.94 97.28 3.94 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.789 1.632 . . . . 0.0 109.482 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -75.15 -44.21 48.09 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.28 -0.888 . . . . 0.0 112.218 -171.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -62.33 -48.16 81.07 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.2 m -53.85 -47.03 71.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.903 0.881 . . . . 0.0 111.037 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.88 -46.65 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 119.926 1.239 . . . . 0.0 110.268 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.28 -24.09 17.59 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.027 1.331 . . . . 0.0 112.016 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -108.61 -31.64 7.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.681 1.192 . . . . 0.0 110.73 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -58.73 -23.2 59.36 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.274 1.429 . . . . 0.0 112.15 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -138.16 157.86 72.05 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 125.711 1.605 . . . . 0.0 108.003 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.87 109.12 1.94 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 N-CA-C 107.776 -1.663 . . . . 0.0 107.776 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -101.54 164.89 11.53 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.282 -0.886 . . . . 0.0 109.102 175.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -53.47 142.54 21.82 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -70.51 158.97 35.13 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.494 0.664 . . . . 0.0 110.261 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.2 -3.39 22.88 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.755 -1.581 . . . . 0.0 113.543 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 mmp_? -64.57 141.19 58.86 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 120.479 2.139 . . . . 0.0 109.566 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.6 mtt85 -82.8 159.87 22.37 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.04 78.51 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.262 -0.899 . . . . 0.0 109.903 166.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 m -65.15 -24.42 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 118.334 -0.841 . . . . 0.0 111.974 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -61.59 -31.73 71.8 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.7 mt -68.62 -49.76 56.75 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.507 1.523 . . . . 0.0 109.709 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.34 98.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.468 1.107 . . . . 0.0 109.758 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -65.71 -46.53 78.63 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.364 1.466 . . . . 0.0 110.197 178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -60.9 -47.12 87.85 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -56.81 -45.27 82.36 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.783 1.233 . . . . 0.0 111.471 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -51.61 -39.82 58.71 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.647 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -81.4 -20.21 40.94 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.857 1.662 . . . . 0.0 113.288 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.6 mt -74.96 -11.42 60.11 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.406 -0.809 . . . . 0.0 111.47 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.5 pt -110.18 -25.25 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 119.612 1.096 . . . . 0.0 111.67 168.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 m -104.83 72.47 1.02 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 127.223 2.209 . . . . 0.0 108.721 171.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.48 153.86 17.34 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 169.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.12 3.2 7.83 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 CA-C-N 119.874 1.837 . . . . 0.0 113.222 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.8 t -149.85 143.77 25.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.935 1.243 . . . . 0.0 108.437 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.6 m -154.5 77.88 1.06 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.441 2.296 . . . . 0.0 106.595 171.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 117.752 -1.582 . . . . 0.0 111.574 -176.892 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.503 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -148.38 -171.17 3.78 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.573 1.149 . . . . 0.0 108.529 -169.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.1 m 49.79 -97.26 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.144 1.778 . . . . 0.0 111.966 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.27 -106.45 1.12 Allowed Glycine 0 C--N 1.335 0.521 0 CA-C-N 119.983 1.265 . . . . 0.0 110.845 170.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.3 t 27.62 82.11 0.02 OUTLIER 'General case' 0 C--O 1.233 0.195 0 C-N-CA 129.596 3.158 . . . . 0.0 111.225 -176.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.4 p -156.98 133.9 10.26 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.27 165.17 36.01 Favored Glycine 0 CA--C 1.524 0.606 0 O-C-N 121.005 -1.059 . . . . 0.0 112.753 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -142.21 67.66 1.32 Allowed 'General case' 0 C--O 1.234 0.287 0 O-C-N 121.751 -0.852 . . . . 0.0 109.257 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -138.83 -70.04 0.42 Allowed 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -144.18 -79.83 0.19 Allowed 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -172.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -54.45 114.59 1.72 Allowed 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.742 1.217 . . . . 0.0 108.578 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 t -72.7 168.95 17.67 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -40.05 62.05 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.092 0.957 . . . . 0.0 112.196 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -56.81 -50.85 71.11 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.811 1.244 . . . . 0.0 108.033 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -70.13 -25.39 63.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.123 0.969 . . . . 0.0 111.889 -174.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.6 t -73.96 -41.61 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 118.82 0.736 . . . . 0.0 109.341 173.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -58.76 -48.33 81.57 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.738 -0.649 . . . . 0.0 109.359 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -60.22 -35.35 75.24 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.966 0.906 . . . . 0.0 111.451 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.36 -53.94 52.4 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -72.14 -24.9 61.53 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -66.1 -55.06 18.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 170.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.84 -62.14 6.18 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 125.891 1.71 . . . . 0.0 111.319 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.6 t -61.75 -25.38 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 118.182 0.991 . . . . 0.0 111.65 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -70.71 -46.51 62.96 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 121.011 -1.056 . . . . 0.0 109.27 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -95.08 -20.32 19.41 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.354 0.525 . . . . 0.0 111.544 -168.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.3 mtp -124.09 -9.24 7.66 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.905 1.282 . . . . 0.0 111.997 -172.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.35 -154.14 50.45 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -73.55 14.68 0.32 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.31 1.044 . . . . 0.0 113.69 -166.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -78.71 96.87 5.67 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 120.797 1.635 . . . . 0.0 107.84 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -76.16 -42.42 46.64 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.729 -0.607 . . . . 0.0 110.423 -173.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -59.32 -42.66 91.95 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 m -60.66 -54.35 46.33 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.605 1.162 . . . . 0.0 112.35 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.3 mt -56.79 -43.27 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 125.407 1.483 . . . . 0.0 110.565 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -14.98 37.74 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -175.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -110.38 -29.17 8.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.024 1.329 . . . . 0.0 111.356 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.419 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 3.1 t -60.75 -18.17 53.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.593 0.757 . . . . 0.0 112.471 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.419 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 70.3 m-85 -144.58 158.03 54.5 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 125.098 1.359 . . . . 0.0 108.049 -176.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.4 109.89 3.0 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.734 1.623 . . . . 0.0 109.385 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -113.17 166.38 11.5 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.218 1.407 . . . . 0.0 109.596 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -56.87 151.38 14.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.99 1.316 . . . . 0.0 111.009 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.3 142.28 50.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -176.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.05 8.15 57.82 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.009 -1.439 . . . . 0.0 113.965 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -64.35 165.26 9.92 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 120.822 2.311 . . . . 0.0 109.661 169.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -120.72 159.58 25.09 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.645 1.178 . . . . 0.0 108.11 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.26 -40.35 64.56 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.626 0.37 . . . . 0.0 110.744 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.3 m -62.62 -27.98 43.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 C-N-CA 123.688 0.795 . . . . 0.0 112.336 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -62.09 -35.06 77.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 54.9 mt -66.95 -46.29 75.17 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 126.493 1.917 . . . . 0.0 110.129 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.02 -51.07 69.49 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -55.78 -48.4 75.38 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.466 1.107 . . . . 0.0 110.594 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -61.79 -48.02 82.51 Favored 'General case' 0 C--O 1.223 -0.29 0 O-C-N 121.234 -0.916 . . . . 0.0 110.998 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -55.48 -46.48 76.89 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 125.475 1.51 . . . . 0.0 110.991 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 49.3 m170 -53.77 -54.76 33.69 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.475 1.11 . . . . 0.0 109.028 172.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -55.77 -38.64 70.16 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 121.442 -0.786 . . . . 0.0 112.397 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.3 mt -68.33 -39.15 82.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 117.642 -1.17 . . . . 0.0 111.521 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -72.56 -20.42 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 120.164 1.347 . . . . 0.0 111.569 173.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.8 t 64.04 8.56 4.05 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.376 1.47 . . . . 0.0 112.436 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.5 -177.71 51.81 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.949 1.261 . . . . 0.0 112.285 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.1 171.86 10.74 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.542 2.828 . . . . 0.0 111.824 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t 85.62 99.12 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 128.43 2.692 . . . . 0.0 105.702 -170.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.7 m 58.92 19.98 7.65 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.457 1.503 . . . . 0.0 112.848 -173.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.213 0 C-N-CA 125.673 1.606 . . . . 0.0 111.686 -176.506 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.52 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.3 m -131.13 -4.89 3.89 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.587 0.755 . . . . 0.0 112.093 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.1 m -144.63 138.6 27.49 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.62 60.91 0.29 Allowed Glycine 0 C--N 1.333 0.405 0 CA-C-N 118.292 0.497 . . . . 0.0 111.977 -171.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.34 105.96 0.34 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.437 1.495 . . . . 0.0 110.836 176.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.5 m -153.69 168.98 24.43 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 128.217 2.607 . . . . 0.0 107.555 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.55 157.65 42.41 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -99.01 -10.66 22.36 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 127.236 2.214 . . . . 0.0 112.36 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -82.65 106.66 14.68 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.3 t70 130.96 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 131.45 3.9 . . . . 0.0 110.366 171.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.415 ' CD2' ' HG2' ' A' ' 51' ' ' LYS . 10.7 m-85 -141.23 134.27 29.2 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 167.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -84.1 -166.96 1.57 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.811 0.844 . . . . 0.0 109.957 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -74.05 -24.77 59.58 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 120.97 -1.081 . . . . 0.0 111.116 161.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -77.19 -49.48 15.07 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 119.23 0.923 . . . . 0.0 109.193 -171.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -41.36 92.07 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.6 t -59.78 -38.0 74.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 C-N-CA 124.151 0.98 . . . . 0.0 110.337 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -56.09 -54.56 43.58 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -65.8 -26.86 67.88 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.68 -52.43 63.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -59.28 -44.84 92.45 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.24 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -51.46 -52.85 42.89 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.638 1.175 . . . . 0.0 111.064 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.34 -58.54 8.52 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 124.23 0.919 . . . . 0.0 111.162 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -56.98 -25.56 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 118.507 1.154 . . . . 0.0 110.877 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -59.4 -45.71 90.73 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 121.317 -0.865 . . . . 0.0 110.52 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.2 t -96.5 -21.61 17.6 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.936 1.294 . . . . 0.0 112.065 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.3 mtp -116.86 -1.91 11.92 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.75 -1.219 . . . . 0.0 113.707 -166.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.27 -113.0 1.99 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -104.73 8.58 35.07 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.513 0.725 . . . . 0.0 112.698 -168.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -76.55 96.48 4.13 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 120.094 1.315 . . . . 0.0 109.514 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -78.7 -44.84 22.66 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.642 -172.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -61.35 -41.19 96.65 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 119.502 -0.285 . . . . 0.0 110.581 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 m -56.57 -53.92 51.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.207 0.603 . . . . 0.0 110.609 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 55.0 mt -53.3 -45.14 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.024 1.33 . . . . 0.0 110.893 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -31.06 68.0 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.325 0.65 . . . . 0.0 112.167 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -86.88 -35.09 19.19 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.947 0.499 . . . . 0.0 111.247 171.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.404 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 8.3 t -60.32 -31.05 69.92 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.128 1.371 . . . . 0.0 113.33 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 74.1 m-85 -135.27 155.14 79.0 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 123.93 0.892 . . . . 0.0 109.058 -171.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.89 109.3 2.19 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.852 1.701 . . . . 0.0 109.638 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -109.04 176.2 5.18 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.982 0.913 . . . . 0.0 111.036 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -56.55 155.9 6.8 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.481 1.112 . . . . 0.0 111.018 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.46 121.75 20.12 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -172.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.75 21.84 65.36 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.416 -0.658 . . . . 0.0 113.952 169.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -57.47 163.37 2.4 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 122.105 0.955 . . . . 0.0 111.389 171.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -103.05 167.58 9.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.948 162.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.5 -34.63 78.67 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.641 -0.662 . . . . 0.0 109.3 166.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 m -62.43 -29.34 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 O-C-N 121.701 -0.624 . . . . 0.0 112.259 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -55.97 -43.1 77.25 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.0 mt -67.05 -44.28 80.59 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.8 0.84 . . . . 0.0 110.061 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.84 -45.97 87.12 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.431 0.693 . . . . 0.0 109.374 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -60.39 -52.98 62.93 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.066 1.347 . . . . 0.0 109.063 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 57.7 tptt -59.94 -39.98 87.4 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.687 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -62.29 -46.28 89.49 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 119.68 1.127 . . . . 0.0 111.206 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -51.76 -54.2 31.23 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -53.81 -42.12 68.07 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.666 0.666 . . . . 0.0 112.307 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.69 -37.24 85.91 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 117.882 -1.056 . . . . 0.0 110.98 -176.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.5 pt -75.51 -48.98 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 119.491 1.042 . . . . 0.0 110.253 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 t -156.96 132.89 9.55 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.951 1.3 . . . . 0.0 108.755 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.59 151.91 48.62 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 120.77 -1.206 . . . . 0.0 110.3 168.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -81.7 -12.87 10.93 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.676 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.6 t -144.82 18.27 1.63 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.74 1.616 . . . . 0.0 110.059 -166.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.03 -57.55 9.33 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.168 1.387 . . . . 0.0 109.519 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 1 N-CA-C 102.223 -4.351 . . . . 0.0 102.223 -155.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.642 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.7 m 59.02 -33.34 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.534 2.334 . . . . 0.0 117.091 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.9 m -57.21 130.3 45.58 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 120.45 1.477 . . . . 0.0 111.353 -169.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.68 7.41 65.51 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.274 -1.292 . . . . 0.0 112.951 -173.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.2 m -61.34 166.58 3.78 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.964 1.382 . . . . 0.0 112.522 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 p -159.91 165.01 33.0 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.894 1.278 . . . . 0.0 108.572 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.19 142.95 14.06 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 108.649 -1.781 . . . . 0.0 108.649 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -161.6 164.99 29.03 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.933 1.693 . . . . 0.0 106.704 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? 56.76 -92.75 0.03 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-O 117.54 -1.219 . . . . 0.0 109.439 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -101.67 121.23 41.64 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 124.768 1.227 . . . . 0.0 108.101 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 70.64 122.07 0.03 OUTLIER 'General case' 0 C--O 1.235 0.337 0 C-N-CA 128.443 2.697 . . . . 0.0 108.564 -166.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.9 p -74.1 173.14 10.5 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 120.574 -1.329 . . . . 0.0 108.064 169.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -55.23 -21.55 14.55 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.022 0.929 . . . . 0.0 112.232 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.07 -32.74 17.41 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.626 1.171 . . . . 0.0 112.037 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.48 -41.98 75.43 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 119.842 1.201 . . . . 0.0 108.329 171.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.54 -29.42 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 122.004 -0.435 . . . . 0.0 110.206 174.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -57.78 -59.0 5.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 118.817 -0.611 . . . . 0.0 109.599 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -60.41 -28.3 68.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.82 -58.17 5.57 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -68.17 -28.41 67.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 119.312 -0.375 . . . . 0.0 111.607 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.91 -43.28 93.33 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.866 0.866 . . . . 0.0 109.674 173.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.77 -44.07 8.62 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 124.101 0.858 . . . . 0.0 111.062 -168.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.7 t -62.7 -26.62 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.603 0.702 . . . . 0.0 110.39 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -64.04 -33.55 76.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.495 1.043 . . . . 0.0 110.739 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . 0.252 11.5 t -95.75 -61.73 1.41 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -23.76 56.21 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -167.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.7 -150.95 48.78 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -160.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -69.51 9.17 0.51 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.013 2.525 . . . . 0.0 114.88 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -71.44 96.96 1.55 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 121.199 1.818 . . . . 0.0 108.876 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.2 m95 -81.14 -46.03 15.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.364 -0.826 . . . . 0.0 111.453 -170.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -54.52 -41.81 70.1 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.281 0.946 . . . . 0.0 109.96 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -53.53 57.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 123.503 0.721 . . . . 0.0 110.623 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 59.9 mt -55.5 -46.1 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.607 1.163 . . . . 0.0 109.617 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -16.36 43.0 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.961 1.304 . . . . 0.0 112.782 -176.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -109.94 -29.68 8.15 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.447 1.099 . . . . 0.0 112.186 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.78 -26.49 68.66 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.951 0.796 . . . . 0.0 112.101 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -135.31 156.42 78.0 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 124.557 1.143 . . . . 0.0 109.994 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.8 138.48 31.74 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 N-CA-C 108.552 -1.365 . . . . 0.0 108.552 170.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -132.23 -174.5 3.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 170.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -71.26 171.95 10.18 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.307 -0.871 . . . . 0.0 111.067 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 165.14 19.94 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.783 -0.573 . . . . 0.0 110.291 171.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.65 -3.15 1.48 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.378 1.466 . . . . 0.0 115.483 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -63.09 157.83 21.21 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 119.072 1.436 . . . . 0.0 110.356 -175.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -120.84 166.66 13.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.687 1.595 . . . . 0.0 107.51 168.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.9 77.52 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.707 -0.621 . . . . 0.0 110.802 169.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.3 m -63.14 -24.86 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 123.53 0.732 . . . . 0.0 112.373 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -65.46 -42.25 92.49 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 mt -62.31 -36.58 82.6 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.12 -43.81 86.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 119.256 0.935 . . . . 0.0 109.944 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.43 -55.4 12.0 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.949 1.299 . . . . 0.0 112.308 -172.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -58.56 -47.45 84.21 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -54.81 -48.42 72.8 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 125.106 1.362 . . . . 0.0 110.156 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -51.86 -47.42 64.47 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.957 0.503 . . . . 0.0 110.843 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -67.33 -31.19 71.3 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.736 -0.602 . . . . 0.0 110.713 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.2 mt -71.44 -41.16 69.82 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.186 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.7 pt -76.52 -16.27 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 120.638 1.563 . . . . 0.0 112.5 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.0 m -111.65 66.36 0.63 Allowed 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.25 1.42 . . . . 0.0 108.608 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.43 -179.35 6.57 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.217 1.389 . . . . 0.0 112.105 173.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -58.89 -48.43 14.57 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.597 2.198 . . . . 0.0 111.551 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.6 p -75.14 111.18 10.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 165.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 72.1 p -135.35 88.0 2.38 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.527 0.603 . . . . 0.0 110.126 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.838 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 178.059 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.748 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 m -116.35 153.71 31.52 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.822 0.811 . . . . 0.0 109.061 167.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.0 p -146.81 169.25 19.48 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.542 1.537 . . . . 0.0 107.764 175.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.91 133.07 43.55 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 174.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.1 m -157.47 -176.01 5.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.542 1.937 . . . . 0.0 108.527 -176.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.1 p -62.71 175.24 0.85 Allowed 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.271 -0.893 . . . . 0.0 110.54 158.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.92 -49.19 0.17 Allowed Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 171.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.0 mtp-105 -133.85 162.15 32.8 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.183 0.593 . . . . 0.0 110.856 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -70.65 -166.57 0.15 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.86 0.864 . . . . 0.0 110.446 165.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 56.89 -101.89 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.54 1.936 . . . . 0.0 108.276 -162.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -58.6 135.01 57.24 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 119.185 0.902 . . . . 0.0 111.879 -168.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.7 p -72.16 170.63 13.59 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.707 0.803 . . . . 0.0 109.377 167.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -56.39 -27.98 57.92 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.456 -0.778 . . . . 0.0 110.886 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -68.78 -56.18 8.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.335 -0.853 . . . . 0.0 109.399 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -59.37 -34.4 72.36 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.041 0.536 . . . . 0.0 111.304 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.437 HG23 ' HE2' ' A' ' 51' ' ' LYS . 54.0 t -66.42 -40.2 85.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.012 175.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -65.03 -45.16 86.61 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 118.468 0.577 . . . . 0.0 109.448 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -60.15 -37.74 81.04 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.084 0.954 . . . . 0.0 110.811 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.77 -56.89 13.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.933 0.893 . . . . 0.0 109.235 171.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -69.69 -29.94 67.48 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.601 -0.714 . . . . 0.0 112.536 -175.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -61.51 -58.55 7.71 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.81 1.187 . . . . 0.0 108.129 170.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.22 -60.96 4.8 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 125.868 1.699 . . . . 0.0 111.756 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.5 t -63.38 -20.04 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.423 1.112 . . . . 0.0 112.238 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.02 -40.62 45.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 120.322 -1.486 . . . . 0.0 109.635 177.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.8 t -95.82 -19.9 19.24 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.234 0.925 . . . . 0.0 113.087 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 10.0 mtt -117.88 0.4 11.91 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.254 1.422 . . . . 0.0 112.751 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.71 -103.63 0.12 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.586 1.089 . . . . 0.0 111.957 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -114.78 12.47 17.02 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 118.224 1.012 . . . . 0.0 110.506 -167.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.06 97.68 4.77 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 173.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -81.66 -46.61 14.1 Favored 'General case' 0 CA--C 1.521 -0.143 0 O-C-N 121.178 -0.951 . . . . 0.0 110.992 -172.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -54.7 -44.98 73.92 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.841 0.856 . . . . 0.0 109.918 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.7 m -57.48 -48.62 78.74 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.948 1.699 . . . . 0.0 111.803 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.9 mt -59.28 -45.3 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 O-C-N 120.909 -1.119 . . . . 0.0 109.94 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -23.94 48.17 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 125.542 1.537 . . . . 0.0 112.58 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 3.8 m0 -112.11 -29.6 7.54 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.522 -0.752 . . . . 0.0 111.086 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 t -68.87 -22.21 64.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.152 0.887 . . . . 0.0 111.981 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -121.85 156.01 59.75 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 123.951 0.9 . . . . 0.0 108.583 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.84 110.25 3.08 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.957 1.771 . . . . 0.0 108.174 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -111.18 168.18 9.71 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.137 0.975 . . . . 0.0 108.749 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -55.68 163.49 1.35 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.577 1.551 . . . . 0.0 111.468 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -64.68 161.4 17.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.366 164.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.79 -15.63 2.93 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.775 1.179 . . . . 0.0 114.242 170.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -63.4 163.21 11.13 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 124.509 1.124 . . . . 0.0 111.455 -174.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -127.88 170.36 12.9 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.756 1.222 . . . . 0.0 109.548 171.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.4 -34.97 69.43 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.96 0.504 . . . . 0.0 110.939 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.78 -30.85 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 CA-C-N 118.224 0.465 . . . . 0.0 112.084 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.04 -38.14 72.79 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.412 0.445 . . . . 0.0 110.581 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.2 mt -67.41 -49.51 63.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.015 1.726 . . . . 0.0 110.548 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.98 -52.96 63.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -54.16 -46.55 72.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.476 1.11 . . . . 0.0 111.781 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.437 ' HE2' HG23 ' A' ' 16' ' ' VAL . 7.0 tptt -54.98 -60.27 3.6 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.11 0.564 . . . . 0.0 110.202 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -54.78 -46.02 74.35 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 126.331 1.852 . . . . 0.0 110.933 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -59.92 -47.05 87.38 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.153 0.981 . . . . 0.0 110.128 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -56.54 -41.1 76.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.461 1.028 . . . . 0.0 110.75 171.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.5 mt -74.71 -7.03 52.04 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.4 pt -105.18 -12.24 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 120.415 1.462 . . . . 0.0 111.772 166.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 m -75.27 68.21 1.97 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.054 1.342 . . . . 0.0 110.061 162.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 138.35 159.28 8.05 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.969 1.271 . . . . 0.0 111.947 168.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.46 -32.47 4.86 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.32 2.68 . . . . 0.0 111.24 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.3 t -168.87 121.88 0.81 Allowed 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.9 m -121.63 90.47 3.32 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.409 1.084 . . . . 0.0 108.481 -169.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 174.365 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.81 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.2 m 56.01 84.72 0.08 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.971 1.708 . . . . 0.0 113.441 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.0 t 58.14 -154.98 0.35 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.452 1.101 . . . . 0.0 110.337 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.13 -178.41 51.4 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 123.963 0.792 . . . . 0.0 113.205 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.1 t 119.17 139.29 0.0 OUTLIER 'General case' 0 C--O 1.236 0.381 1 C-N-CA 132.848 4.459 . . . . 0.0 107.007 -175.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.2 m -77.96 106.25 9.69 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 170.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.37 178.71 46.94 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -126.46 -49.02 1.54 Allowed 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.561 1.944 . . . . 0.0 110.767 -174.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.486 ' HA ' ' HE2' ' A' ' 9' ' ' LYS . 9.1 mmpt? -141.86 17.39 2.14 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.794 1.237 . . . . 0.0 111.298 -175.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.76 51.58 1.32 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 128.337 2.655 . . . . 0.0 110.746 -161.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 97.17 123.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 1 C-N-CA 133.712 4.805 . . . . 0.0 106.985 -170.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 p -62.31 166.77 4.68 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.412 0.685 . . . . 0.0 110.097 167.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -61.69 -25.66 67.55 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.114 -0.992 . . . . 0.0 110.083 168.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -62.27 -49.36 75.98 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 122.085 0.945 . . . . 0.0 108.527 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -72.46 -36.99 68.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.562 0.745 . . . . 0.0 110.917 -174.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.63 -32.0 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 119.372 0.987 . . . . 0.0 109.744 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -59.38 -59.07 6.03 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 170.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -57.0 -32.08 65.75 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.58 1.152 . . . . 0.0 112.189 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -63.03 1.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.79 0.836 . . . . 0.0 108.845 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -68.92 -31.66 70.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.452 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -59.31 -49.38 78.03 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 120.204 1.366 . . . . 0.0 109.334 175.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.46 -63.27 5.46 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 124.764 1.173 . . . . 0.0 110.495 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.2 t -55.46 -23.33 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 118.267 1.033 . . . . 0.0 111.603 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -71.22 -53.72 13.41 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 120.134 1.334 . . . . 0.0 109.618 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.6 t -81.47 -8.51 59.74 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.845 0.858 . . . . 0.0 111.107 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.5 mtp -128.86 -93.82 0.44 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.282 1.833 . . . . 0.0 108.033 -171.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.16 -126.44 2.1 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -168.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.57 7.91 17.53 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 117.498 0.649 . . . . 0.0 111.715 -172.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -69.94 98.67 1.3 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.994 1.27 . . . . 0.0 108.414 167.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -74.92 -42.43 57.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.308 -0.377 . . . . 0.0 111.073 -170.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -54.9 -36.62 65.39 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 118.746 -0.645 . . . . 0.0 112.058 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.4 m -61.77 -55.13 33.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.222 0.609 . . . . 0.0 110.06 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.6 mt -53.04 -47.9 53.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 125.988 1.715 . . . . 0.0 110.167 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -31.36 64.92 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.843 1.257 . . . . 0.0 111.32 -175.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -85.31 -42.95 14.14 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.516 0.726 . . . . 0.0 112.105 170.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.6 t -57.19 -35.63 69.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.881 1.273 . . . . 0.0 111.93 -167.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -127.37 157.91 71.21 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 124.132 0.973 . . . . 0.0 108.524 -174.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.46 108.65 2.18 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 CA-C-N 119.747 0.946 . . . . 0.0 109.934 -175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -104.1 166.64 10.28 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.466 1.106 . . . . 0.0 108.864 173.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -52.16 162.73 0.45 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.46 1.104 . . . . 0.0 111.705 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 160.32 24.6 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.3 7.68 20.31 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.293 -0.726 . . . . 0.0 114.427 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.7 mmp_? -71.26 161.31 31.29 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 119.025 1.412 . . . . 0.0 108.938 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -118.41 162.99 17.4 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 174.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.71 -36.17 66.89 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.314 -0.866 . . . . 0.0 111.282 170.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 m -66.55 -23.78 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.004 0.922 . . . . 0.0 112.605 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.57 -46.49 70.29 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.642 0.734 . . . . 0.0 109.145 176.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.9 mt -65.84 -44.79 84.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.323 1.449 . . . . 0.0 109.119 -178.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.1 -49.57 75.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.051 1.341 . . . . 0.0 108.847 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -55.02 -61.72 2.13 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.871 1.268 . . . . 0.0 110.09 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -52.94 -54.14 39.32 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 122.586 0.355 . . . . 0.0 110.131 -174.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -52.12 -51.38 58.15 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 126.196 1.799 . . . . 0.0 111.231 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -57.03 -49.06 76.96 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.852 0.296 . . . . 0.0 110.491 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -58.14 -43.22 87.19 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.662 -0.685 . . . . 0.0 109.3 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.7 mt -62.43 -53.47 54.39 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.805 0.842 . . . . 0.0 111.643 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.0 pt -62.17 -25.88 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 119.403 1.001 . . . . 0.0 110.653 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.0 m 55.62 37.47 28.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.174 1.39 . . . . 0.0 111.088 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.86 169.82 52.46 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.787 0.708 . . . . 0.0 112.609 -171.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.18 120.78 6.15 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.616 2.877 . . . . 0.0 109.234 174.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.7 m -154.06 173.12 16.45 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.466 1.506 . . . . 0.0 108.08 165.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.1 t 75.06 -43.8 0.52 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 127.379 2.272 . . . . 0.0 112.246 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 N-CA-C 105.93 -2.868 . . . . 0.0 105.93 -166.754 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.594 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p -150.41 -22.42 0.24 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 m 46.9 49.12 14.83 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.366 1.866 . . . . 0.0 114.14 165.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.91 112.02 4.17 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.1 p -152.24 166.12 32.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.794 2.038 . . . . 0.0 109.353 -173.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 p -69.05 157.3 37.08 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.813 0.845 . . . . 0.0 111.41 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.56 161.66 33.99 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -149.57 149.48 30.76 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.838 1.255 . . . . 0.0 108.461 172.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt 60.7 -41.9 0.11 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 129.814 3.246 . . . . 0.0 114.843 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -64.6 175.6 1.37 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 123.009 1.385 . . . . 0.0 109.397 166.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.11 130.52 44.31 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -74.17 173.17 10.49 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -48.06 -50.27 28.58 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.284 1.034 . . . . 0.0 109.797 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.08 -37.07 73.79 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.612 -172.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -35.3 43.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 119.692 -0.803 . . . . 0.0 108.946 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.5 t -62.88 -37.99 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 121.134 -0.979 . . . . 0.0 109.873 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -53.53 -51.31 63.28 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.443 0.697 . . . . 0.0 109.689 172.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -67.62 -29.09 68.33 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.46 -53.77 52.1 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 175.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -60.54 -50.67 72.59 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 118.578 -0.725 . . . . 0.0 111.62 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.18 -49.27 74.5 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.013 0.925 . . . . 0.0 110.551 -177.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.95 -53.31 43.96 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 124.74 1.162 . . . . 0.0 110.656 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.3 t -60.1 -28.55 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 117.622 0.711 . . . . 0.0 110.228 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -70.89 -37.9 73.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 120.964 -1.085 . . . . 0.0 110.403 -176.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.6 t -95.39 -19.37 19.97 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.905 0.882 . . . . 0.0 112.21 -176.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 41.3 mtt -116.37 -20.6 9.65 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.47 1.032 . . . . 0.0 113.777 -175.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.31 -151.17 39.75 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -160.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -68.93 24.32 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.607 2.763 . . . . 0.0 116.441 -169.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -81.05 103.14 10.66 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 165.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -84.62 -39.02 19.17 Favored 'General case' 0 CA--C 1.527 0.091 0 O-C-N 121.129 -0.982 . . . . 0.0 111.25 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -58.71 -48.9 79.56 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.045 0.538 . . . . 0.0 110.864 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.3 m -56.95 -49.11 76.66 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.51 1.124 . . . . 0.0 112.346 176.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.1 mt -55.29 -47.47 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.049 1.339 . . . . 0.0 109.566 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -30.04 44.63 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.035 0.934 . . . . 0.0 111.987 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -98.84 -26.74 14.2 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.434 0.694 . . . . 0.0 112.253 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 t -63.04 -22.22 66.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.618 1.167 . . . . 0.0 112.352 -173.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -134.61 161.95 60.65 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 125.009 1.324 . . . . 0.0 107.443 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.65 109.13 2.56 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 N-CA-C 107.239 -1.87 . . . . 0.0 107.239 170.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -99.67 172.15 7.46 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -55.91 149.98 14.11 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.433 1.093 . . . . 0.0 109.237 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.08 155.82 39.87 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 121.291 -0.881 . . . . 0.0 110.335 -176.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.15 21.22 71.75 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.718 1.152 . . . . 0.0 113.89 173.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.448 ' HE ' ' HA ' ' A' ' 43' ' ' ARG . 2.9 mmp_? -82.25 162.58 22.28 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.426 1.09 . . . . 0.0 111.039 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -112.54 162.51 15.56 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.645 1.978 . . . . 0.0 107.43 167.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.91 -26.8 67.78 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.491 -0.756 . . . . 0.0 111.161 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.3 m -67.63 -24.4 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 O-C-N 120.793 -1.192 . . . . 0.0 112.753 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -62.85 -38.0 89.05 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.307 0.643 . . . . 0.0 109.293 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 67.4 mt -62.22 -50.87 70.03 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 126.755 2.022 . . . . 0.0 109.479 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.33 -37.88 89.05 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.957 0.903 . . . . 0.0 109.177 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -60.78 -54.42 45.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 122.05 -0.406 . . . . 0.0 110.093 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -56.56 -42.09 78.01 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 118.644 0.657 . . . . 0.0 111.071 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -58.72 -49.28 78.18 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.755 1.622 . . . . 0.0 111.107 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -20.73 64.64 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.827 -0.606 . . . . 0.0 112.328 175.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -77.66 -49.7 13.98 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.89 1.677 . . . . 0.0 109.685 165.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.5 mt -55.26 -56.19 22.82 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.508 0.594 . . . . 0.0 112.038 -173.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -65.87 -22.57 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 O-C-N 121.968 -0.458 . . . . 0.0 111.758 -173.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -72.05 -8.86 56.97 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.605 1.162 . . . . 0.0 112.175 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.78 -162.8 16.31 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 119.267 0.94 . . . . 0.0 111.213 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.37 58.1 6.74 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 124.533 3.488 . . . . 0.0 112.539 -165.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.1 t -56.26 118.61 4.9 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.362 1.065 . . . . 0.0 110.037 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.3 t -155.0 -61.16 0.12 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.206 1.402 . . . . 0.0 108.473 173.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.403 0 CA-C-O 118.614 -1.103 . . . . 0.0 110.813 -176.475 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.503 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.7 m 63.15 96.25 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.887 1.675 . . . . 0.0 113.004 168.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.5 m 58.09 -161.52 0.23 Allowed 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.607 1.163 . . . . 0.0 110.688 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.63 164.55 23.14 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 123.253 0.454 . . . . 0.0 112.147 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -154.24 124.66 6.97 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.55 1.54 . . . . 0.0 107.733 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.7 m -145.46 172.85 12.61 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.714 1.605 . . . . 0.0 108.685 170.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.92 -174.7 13.83 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 125.863 1.697 . . . . 0.0 110.486 173.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -134.17 -67.41 0.58 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.564 2.345 . . . . 0.0 107.333 166.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -147.41 -50.55 0.19 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.477 1.511 . . . . 0.0 108.989 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.31 117.41 5.17 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.588 1.155 . . . . 0.0 108.834 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 70.09 115.26 0.04 OUTLIER 'General case' 0 C--O 1.238 0.465 0 C-N-CA 129.532 3.133 . . . . 0.0 112.218 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.1 t -61.6 154.43 25.04 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.488 163.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -59.31 -20.75 57.0 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.396 1.078 . . . . 0.0 113.013 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.45 -58.57 5.53 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.264 1.026 . . . . 0.0 108.441 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -36.22 78.81 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.308 1.043 . . . . 0.0 110.94 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.49 -39.41 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 120.952 -1.092 . . . . 0.0 110.921 176.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -59.91 -46.38 89.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.227 -0.892 . . . . 0.0 109.761 173.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -61.57 -29.36 69.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.507 1.049 . . . . 0.0 112.558 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.32 -58.03 8.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.79 0.723 . . . . 0.0 109.859 175.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -64.94 -32.8 74.7 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.684 0.394 . . . . 0.0 111.327 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -65.15 -44.13 89.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.663 1.185 . . . . 0.0 109.858 174.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.02 -56.96 19.43 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 127.027 2.251 . . . . 0.0 110.924 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.8 t -63.13 -25.43 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 118.389 1.095 . . . . 0.0 110.593 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -68.31 -39.3 82.07 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 120.585 -1.322 . . . . 0.0 110.08 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.2 t -94.98 -28.69 15.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.137 0.575 . . . . 0.0 111.573 -172.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -107.94 -26.28 10.78 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.161 0.984 . . . . 0.0 112.687 -174.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.8 -155.11 52.73 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -162.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.96 38.49 0.08 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.555 1.542 . . . . 0.0 113.214 -172.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -109.16 97.79 7.34 Favored 'General case' 0 C--N 1.338 0.105 0 O-C-N 120.598 -1.314 . . . . 0.0 107.69 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -81.15 -38.91 26.38 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.383 -167.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -62.33 -42.87 99.74 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 123.669 0.606 . . . . 0.0 109.853 -175.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.3 t -55.67 -57.47 11.86 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 124.382 1.073 . . . . 0.0 111.046 171.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.7 mt -48.01 -51.92 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.631 1.572 . . . . 0.0 110.351 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.56 -37.95 52.04 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.568 1.547 . . . . 0.0 111.689 -177.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -85.81 -40.28 16.19 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.593 0.757 . . . . 0.0 111.454 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 t -62.92 -20.88 65.61 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -168.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -134.46 155.58 79.58 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 124.757 1.223 . . . . 0.0 107.863 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.63 110.43 2.31 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 N-CA-C 107.326 -1.836 . . . . 0.0 107.326 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -110.14 172.37 6.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 162.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.79 146.97 54.12 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -65.63 173.56 2.71 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.594 0.758 . . . . 0.0 110.058 169.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.56 -13.0 0.45 Allowed Glycine 0 CA--C 1.537 1.427 0 CA-C-O 119.197 -0.78 . . . . 0.0 114.014 -176.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 mmt85 -58.3 134.82 56.9 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.569 1.684 . . . . 0.0 108.061 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -87.41 165.87 15.25 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 162.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.17 -27.92 69.29 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.0 -1.062 . . . . 0.0 111.023 171.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 m -67.31 -27.75 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.313 1.045 . . . . 0.0 112.093 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.88 -45.52 64.18 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.898 0.879 . . . . 0.0 109.009 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.5 mt -66.1 -49.6 66.97 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.794 1.638 . . . . 0.0 109.966 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.7 -40.14 91.97 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.972 1.309 . . . . 0.0 109.875 -173.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -68.47 -51.36 44.33 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.957 0.903 . . . . 0.0 110.249 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -55.0 -45.08 75.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.824 0.738 . . . . 0.0 110.608 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -58.14 -47.43 83.35 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.041 1.337 . . . . 0.0 110.942 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -56.89 -43.08 80.96 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 118.947 -0.549 . . . . 0.0 111.196 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -71.2 -28.85 64.51 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.355 0.662 . . . . 0.0 112.069 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.72 -57.04 12.38 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.042 0.837 . . . . 0.0 109.596 171.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.2 pt -63.41 -44.07 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 118.958 0.799 . . . . 0.0 111.663 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 t -92.44 80.67 4.89 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.97 -118.84 0.07 OUTLIER Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.649 1.595 . . . . 0.0 110.538 169.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.24 86.42 0.65 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.527 3.485 . . . . 0.0 108.889 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.4 m -157.76 148.8 21.26 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 127.472 2.309 . . . . 0.0 107.114 -175.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 p -170.61 162.93 8.11 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 126.472 1.909 . . . . 0.0 109.419 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -179.907 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.454 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 m -68.09 154.15 42.26 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.638 0.719 . . . . 0.0 110.297 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -162.82 -174.79 4.08 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.814 2.446 . . . . 0.0 105.741 169.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.74 77.29 0.18 Allowed Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.302 0.953 . . . . 0.0 113.214 164.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.9 t -160.95 165.5 29.87 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.285 1.043 . . . . 0.0 109.337 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.7 m -53.82 -20.57 5.96 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.116 1.766 . . . . 0.0 115.503 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 52.83 62.05 6.26 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.392 0.996 . . . . 0.0 111.131 -173.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -145.42 137.87 25.84 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.161 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt 128.27 -163.86 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 1 C-N-CA 132.496 4.319 . . . . 0.0 106.037 -170.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -71.13 161.61 30.83 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 167.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 68.15 111.55 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.467 1.507 . . . . 0.0 111.351 173.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.98 159.36 32.84 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 130.611 3.565 . . . . 0.0 113.836 -169.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -54.08 -46.49 72.04 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 126.253 1.821 . . . . 0.0 111.868 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -71.54 -42.04 68.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.559 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -34.85 74.52 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.894 0.478 . . . . 0.0 109.941 -175.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.4 t -58.56 -41.62 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.03 -50.52 73.16 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.769 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -60.21 -34.48 73.71 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 118.514 0.597 . . . . 0.0 112.248 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.88 -53.36 59.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.145 0.978 . . . . 0.0 108.644 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -65.83 -47.82 73.73 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.652 -0.69 . . . . 0.0 111.393 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -56.74 -35.17 68.29 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.039 0.836 . . . . 0.0 110.409 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.39 -67.89 1.9 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 127.49 2.471 . . . . 0.0 110.849 170.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.1 t -56.23 -27.61 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.999 1.9 . . . . 0.0 111.466 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -62.1 -40.46 95.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.248 -0.907 . . . . 0.0 109.643 -177.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 t -96.07 -42.41 8.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.686 1.194 . . . . 0.0 111.379 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.74 -26.0 40.91 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 124.437 1.095 . . . . 0.0 113.918 -172.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.42 -116.54 8.04 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -164.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.91 12.16 32.77 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.191 1.495 . . . . 0.0 113.444 -172.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -73.76 97.11 2.65 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -80.36 -43.0 21.86 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 121.225 -0.922 . . . . 0.0 109.598 176.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -54.38 -41.18 68.92 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.215 0.606 . . . . 0.0 110.66 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.8 m -74.45 -38.49 62.97 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.661 1.184 . . . . 0.0 111.814 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 60.7 mt -59.92 -45.11 95.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -28.47 64.73 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.089 0.956 . . . . 0.0 112.227 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -85.14 -41.54 15.6 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.782 0.833 . . . . 0.0 110.084 173.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.3 t -67.22 -14.16 62.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 117.255 -1.355 . . . . 0.0 114.578 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -151.93 160.84 30.95 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 120.737 1.608 . . . . 0.0 109.715 -177.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -74.68 143.57 30.38 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.604 1.536 . . . . 0.0 109.526 168.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -137.38 113.51 9.91 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 169.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.25 45.4 mt-30 37.36 -124.94 0.21 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.967 1.707 . . . . 0.0 108.998 -168.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -133.56 143.01 48.43 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 158.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.93 62.32 5.33 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.085 0.85 . . . . 0.0 112.155 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -109.48 164.5 12.45 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.897 0.856 . . . . 0.0 113.258 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -99.53 165.78 11.47 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.941 1.696 . . . . 0.0 108.574 168.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.56 -31.83 73.21 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.589 -0.695 . . . . 0.0 109.935 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.6 m -64.08 -24.7 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.201 -0.937 . . . . 0.0 112.357 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.48 -11.74 61.08 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.824 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.3 mt -94.89 -18.87 20.76 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.162 1.385 . . . . 0.0 112.071 169.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.8 -43.57 22.19 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.039 171.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -74.63 -57.75 3.73 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -164.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -59.06 -39.39 81.93 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 116.412 -1.756 . . . . 0.0 110.867 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -50.79 -47.75 59.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 121.42 1.918 . . . . 0.0 110.891 168.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.49 -37.81 65.72 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.122 0.569 . . . . 0.0 112.006 176.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -76.59 -35.24 58.26 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.897 0.879 . . . . 0.0 112.167 173.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.2 mt -61.34 -45.93 92.37 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.522 1.055 . . . . 0.0 109.409 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 pt -70.04 -6.83 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.0 71.65 5.47 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.822 1.192 . . . . 0.0 109.159 175.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.2 -178.96 48.68 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.857 1.218 . . . . 0.0 111.892 176.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.11 -28.82 23.09 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.913 2.409 . . . . 0.0 113.169 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.74 135.56 13.66 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 -167.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . 0.258 6.6 m 52.07 -83.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 128.333 2.653 . . . . 0.0 114.003 -175.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 -158.337 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.656 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 p -149.5 167.35 26.49 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 122.012 -0.699 . . . . 0.0 111.145 -163.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 t -156.94 152.06 26.23 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.33 0.652 . . . . 0.0 110.096 162.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.36 -160.31 18.86 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.606 2.05 . . . . 0.0 112.638 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.0 m -57.06 123.66 16.01 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.707 0.753 . . . . 0.0 109.619 174.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.3 m -149.69 106.0 3.49 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.73 1.612 . . . . 0.0 108.244 170.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.54 56.75 4.16 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 170.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -76.37 -72.56 0.32 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 167.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.24 53.88 10.2 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.91 1.284 . . . . 0.0 108.937 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -65.47 -54.89 21.88 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.563 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -69.03 143.95 54.17 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.2 p -75.72 178.96 5.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.356 1.062 . . . . 0.0 109.804 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 pttt -63.07 -31.75 72.96 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 120.189 -1.57 . . . . 0.0 112.24 165.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.62 -54.0 9.16 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.692 0.797 . . . . 0.0 108.923 -168.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -63.53 -23.75 67.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.461 -175.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.3 t -74.49 -39.21 47.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 119.078 0.854 . . . . 0.0 110.059 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -60.27 -47.93 83.9 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.6 m-30 -64.21 -30.9 71.94 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.799 0.84 . . . . 0.0 113.008 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.48 -54.79 42.87 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 174.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -61.45 -47.81 84.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.843 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.418 ' O ' ' HE3' ' A' ' 24' ' ' LYS . 4.0 m-70 -59.88 -36.08 76.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.268 0.94 . . . . 0.0 111.21 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.18 -54.46 20.58 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 125.684 1.612 . . . . 0.0 110.518 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.3 t -59.57 -28.13 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 118.296 1.048 . . . . 0.0 110.903 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -66.07 -36.98 84.66 Favored 'General case' 0 CA--C 1.521 -0.142 0 O-C-N 120.81 -1.181 . . . . 0.0 110.002 -178.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 t -95.46 -35.45 11.7 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.203 0.601 . . . . 0.0 111.84 -176.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -95.29 -11.98 26.96 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.908 0.883 . . . . 0.0 112.782 -173.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 57.82 -144.12 41.79 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 107.965 -2.054 . . . . 0.0 107.965 -157.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -61.86 -1.8 0.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -174.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -82.48 97.36 8.37 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 122.24 2.291 . . . . 0.0 109.831 -157.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -68.01 -41.88 81.54 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.573 -170.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -61.62 -43.05 99.58 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.8 m -60.03 -47.23 86.73 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.477 1.511 . . . . 0.0 112.008 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.2 mt -57.58 -46.73 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 123.933 0.893 . . . . 0.0 109.162 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -21.56 63.31 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.06 0.544 . . . . 0.0 112.257 -175.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -96.27 -32.41 12.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.376 0.67 . . . . 0.0 111.572 173.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -18.3 65.0 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -134.12 149.97 72.95 Favored Pre-proline 0 C--O 1.236 0.384 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.12 107.2 2.43 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 N-CA-C 105.704 -2.46 . . . . 0.0 105.704 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -99.08 178.32 4.96 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -62.74 152.36 35.9 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.144 -0.973 . . . . 0.0 109.986 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -58.59 159.86 6.1 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.894 0.477 . . . . 0.0 109.908 164.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.16 9.44 29.22 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.9 mmt-85 -73.45 165.03 25.83 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 118.726 1.263 . . . . 0.0 110.484 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -132.14 158.71 40.95 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.56 -36.01 77.43 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 m -63.18 -27.71 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 124.135 0.974 . . . . 0.0 112.164 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -61.81 -40.58 95.75 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.2 mt -66.42 -47.96 71.56 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.154 1.382 . . . . 0.0 110.103 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.75 -46.57 88.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -61.31 -53.05 61.76 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 118.934 -0.555 . . . . 0.0 110.232 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.512 ' HZ2' HD21 ' A' ' 55' ' ' LEU . 2.6 tmtt? -50.22 -54.75 18.83 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.766 1.226 . . . . 0.0 109.318 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -57.59 -44.72 85.58 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 125.239 1.416 . . . . 0.0 111.812 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -57.93 -48.49 79.76 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -63.31 -25.62 68.39 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.749 0.704 . . . . 0.0 111.566 175.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.512 HD21 ' HZ2' ' A' ' 51' ' ' LYS . 70.5 mt -80.17 -15.88 56.08 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 175.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.9 pt -99.88 -20.83 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 119.808 1.185 . . . . 0.0 111.646 169.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 t -162.45 83.54 0.54 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.496 1.919 . . . . 0.0 107.163 -171.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.19 -168.54 30.45 Favored Glycine 0 CA--C 1.527 0.813 0 O-C-N 121.36 -0.837 . . . . 0.0 112.815 -175.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -81.41 44.35 1.72 Allowed 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 124.85 3.7 . . . . 0.0 110.522 176.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.1 t -61.73 122.73 16.07 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.343 -0.848 . . . . 0.0 108.872 -172.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.3 m -161.09 165.06 30.25 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 127.389 2.275 . . . . 0.0 106.774 174.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.911 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -178.129 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.529 ' HA2' ' CD2' ' A' ' 20' ' ' PHE . . . . . . . . 0 N--CA 1.469 0.883 0 CA-C-O 119.392 -0.671 . . . . 0.0 112.377 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m -68.61 166.78 16.46 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.164 0.986 . . . . 0.0 112.586 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.7 p -65.11 143.26 58.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.131 0.973 . . . . 0.0 111.257 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.71 33.32 2.59 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.333 0.968 . . . . 0.0 111.888 170.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.6 m -59.62 -64.46 0.94 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-N 119.364 1.582 . . . . 0.0 110.79 -174.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.8 t -77.72 79.25 4.21 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -175.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.07 -92.37 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 O-C-N 120.903 -1.123 . . . . 0.0 110.832 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 61.68 -43.08 0.14 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 129.943 3.297 . . . . 0.0 116.517 171.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -65.34 -57.28 8.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.412 1.46 . . . . 0.0 110.103 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.67 -23.88 58.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.596 1.558 . . . . 0.0 110.058 -171.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.456 ' CD2' ' HG2' ' A' ' 51' ' ' LYS . 4.7 m-85 -145.39 110.46 5.2 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.53 1.532 . . . . 0.0 107.079 -168.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -69.15 167.64 15.72 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.885 0.766 . . . . 0.0 111.787 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -32.65 74.39 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.476 -1.39 . . . . 0.0 110.592 175.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -67.46 -47.2 70.81 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -59.87 -44.71 94.02 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.753 -0.641 . . . . 0.0 110.541 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.09 -40.9 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 119.067 0.848 . . . . 0.0 109.468 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -60.19 -49.82 76.13 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 119.77 -0.157 . . . . 0.0 111.31 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -55.13 -40.96 71.13 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.8 0.84 . . . . 0.0 110.295 173.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.49 -51.56 64.7 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.538 -1.351 . . . . 0.0 109.808 -175.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.529 ' CD2' ' HA2' ' A' ' 1' ' ' GLY . 65.4 m-85 -63.43 -47.6 81.25 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.745 177.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -55.11 -48.58 73.43 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.783 0.833 . . . . 0.0 110.912 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.43 -56.49 24.17 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 125.343 1.449 . . . . 0.0 109.865 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.5 t -60.7 -16.63 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 117.881 0.84 . . . . 0.0 112.684 -176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -68.33 -57.23 6.24 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 120.434 -1.416 . . . . 0.0 109.191 172.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.0 t -80.83 -42.38 21.71 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.778 0.831 . . . . 0.0 109.566 -173.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -77.55 -27.71 51.64 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.45 -0.786 . . . . 0.0 112.809 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.8 -143.59 48.69 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -156.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -73.99 7.13 2.82 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.33 98.32 3.21 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 121.325 1.875 . . . . 0.0 109.446 -175.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -71.82 -45.11 62.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 119.185 -0.435 . . . . 0.0 109.914 -178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -48.92 -53.88 17.8 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.371 1.068 . . . . 0.0 111.967 176.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.6 m -55.24 -49.63 71.52 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.884 0.874 . . . . 0.0 111.317 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.1 mt -57.85 -49.94 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 125.818 1.647 . . . . 0.0 110.105 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -34.54 74.27 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.742 1.217 . . . . 0.0 111.583 -173.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -73.58 -47.86 37.27 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.839 -0.538 . . . . 0.0 111.077 166.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.4 t -62.63 -28.76 70.13 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -167.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -134.28 148.85 69.46 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 119.62 1.1 . . . . 0.0 108.654 -174.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.52 110.55 2.45 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.869 2.379 . . . . 0.0 110.603 -174.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -111.51 113.51 25.98 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.849 1.26 . . . . 0.0 109.473 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 31.09 -141.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.891 2.476 . . . . 0.0 111.121 -166.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -106.83 160.52 15.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 144.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 61.74 49.08 79.8 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 124.864 1.221 . . . . 0.0 114.315 166.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.423 ' HE ' ' HA ' ' A' ' 43' ' ' ARG . 1.5 mmp_? -105.1 165.56 11.0 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.581 1.19 . . . . 0.0 111.511 174.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -122.36 161.75 22.85 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.772 1.629 . . . . 0.0 107.588 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.05 -44.17 70.83 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.137 0.426 . . . . 0.0 110.722 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 m -62.29 -27.25 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.572 0.749 . . . . 0.0 112.722 -176.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.38 -41.35 84.64 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.2 mt -66.78 -39.22 87.74 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.794 1.238 . . . . 0.0 109.838 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.04 -54.15 29.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.261 1.024 . . . . 0.0 108.342 -177.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.97 -50.46 64.05 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 122.674 0.39 . . . . 0.0 111.351 174.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.456 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 42.6 tptt -56.67 -54.19 49.02 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -54.89 -48.53 72.89 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.029 1.332 . . . . 0.0 110.234 -173.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -55.77 -48.03 76.0 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -62.75 -34.42 77.19 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.403 -0.81 . . . . 0.0 112.884 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.3 mt -68.42 -39.13 81.71 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 119.53 1.059 . . . . 0.0 111.414 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.9 pt -93.56 -26.33 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 118.842 0.746 . . . . 0.0 111.965 -174.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.4 m -138.98 75.36 1.51 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.17 146.56 18.17 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.79 -1.005 . . . . 0.0 111.881 -169.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.96 65.64 6.88 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.452 2.768 . . . . 0.0 109.528 169.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.9 m -66.0 160.15 24.27 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.567 0.747 . . . . 0.0 109.188 173.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 t -145.07 10.55 1.32 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -161.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.628 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -159.403 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.649 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.7 m 62.06 73.2 0.48 Allowed 'General case' 0 C--O 1.231 0.117 0 C-N-CA 124.202 1.001 . . . . 0.0 109.046 -163.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 p -95.26 -28.81 14.82 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.256 1.422 . . . . 0.0 111.093 173.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.7 -54.33 4.92 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 120.464 -1.398 . . . . 0.0 111.79 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.3 m 40.42 72.81 0.14 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.439 2.296 . . . . 0.0 114.892 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.1 m -134.72 147.18 50.01 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.877 1.271 . . . . 0.0 108.372 161.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 150.42 143.6 3.77 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 126.168 1.842 . . . . 0.0 110.685 175.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -146.84 -87.27 0.1 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.021 1.411 . . . . 0.0 110.834 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 mttp -57.28 -53.88 53.14 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.595 1.158 . . . . 0.0 110.128 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -68.35 -49.11 62.54 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.865 -166.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -141.83 95.73 2.86 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 -176.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t -73.37 164.85 26.09 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.157 1.383 . . . . 0.0 108.773 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -52.94 -36.37 59.71 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 118.607 -0.711 . . . . 0.0 112.729 -172.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.25 -54.97 18.63 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -174.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.45 -37.09 82.29 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 124.236 1.014 . . . . 0.0 110.784 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.13 -36.43 73.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 O-C-N 121.405 -0.809 . . . . 0.0 110.582 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -68.45 -45.28 72.91 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 117.782 -1.104 . . . . 0.0 109.392 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -59.74 -35.16 74.0 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 119.689 1.131 . . . . 0.0 111.47 174.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.96 -56.02 27.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.709 0.804 . . . . 0.0 108.881 175.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -62.35 -44.38 96.6 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 119.049 -0.5 . . . . 0.0 110.73 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -53.44 -44.8 69.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.568 1.147 . . . . 0.0 110.073 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.85 -56.63 15.41 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 126.649 2.071 . . . . 0.0 111.58 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.3 t -65.23 -16.97 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 121.359 -1.083 . . . . 0.0 110.934 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -80.74 -39.89 26.19 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.124 -1.61 . . . . 0.0 109.924 174.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.6 t -95.69 -12.22 25.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.164 0.986 . . . . 0.0 112.292 -170.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 33.2 mtt -125.62 -48.48 1.66 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.146 1.378 . . . . 0.0 111.327 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.21 -154.67 19.86 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -165.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -61.97 15.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.492 2.317 . . . . 0.0 116.32 -175.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -78.8 97.37 5.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 120.447 1.476 . . . . 0.0 107.455 170.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -76.3 -47.15 24.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.7 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -62.57 -43.35 99.03 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.358 0.663 . . . . 0.0 109.299 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.9 m -59.78 -49.81 76.28 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.698 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.8 mt -58.33 -44.58 88.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 119.665 1.12 . . . . 0.0 109.241 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.11 -47.29 65.37 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.413 1.485 . . . . 0.0 110.555 -177.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -85.86 -28.57 24.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 119.322 -0.37 . . . . 0.0 111.143 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 t -59.32 -69.97 0.18 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.464 0.706 . . . . 0.0 109.932 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -84.99 148.9 51.92 Favored Pre-proline 0 C--O 1.235 0.335 0 O-C-N 121.313 -0.867 . . . . 0.0 109.179 -171.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.57 108.43 1.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 N-CA-C 108.628 -1.336 . . . . 0.0 108.628 -173.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -111.02 154.46 24.15 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.352 0.661 . . . . 0.0 110.317 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -54.9 130.49 41.51 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.381 1.072 . . . . 0.0 110.123 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -64.07 117.73 7.5 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.33 -24.34 4.72 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.064 1.792 . . . . 0.0 110.681 -166.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 145.05 56.6 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.449 1.124 . . . . 0.0 110.664 173.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -120.09 175.17 6.06 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.468 1.907 . . . . 0.0 107.6 167.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.31 -41.33 84.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.483 -0.761 . . . . 0.0 109.972 166.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.5 m -65.02 -31.4 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.183 0.593 . . . . 0.0 112.285 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.14 -50.08 65.27 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.0 mt -64.95 -50.27 67.07 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.104 1.762 . . . . 0.0 109.767 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.79 -49.2 78.57 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 124.71 1.256 . . . . 0.0 107.662 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -60.66 -51.86 67.61 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.184 0.594 . . . . 0.0 111.029 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -48.61 71.64 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.571 0.748 . . . . 0.0 109.3 -177.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -63.77 -49.85 71.37 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.453 1.101 . . . . 0.0 110.686 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -57.37 -38.11 73.7 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.307 1.443 . . . . 0.0 111.397 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -65.66 -53.59 39.18 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 118.339 -0.839 . . . . 0.0 109.728 167.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.6 mt -57.78 -27.68 63.31 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.1 pt -82.79 -12.59 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 119.656 1.116 . . . . 0.0 112.01 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 m 51.53 21.77 1.35 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.265 1.426 . . . . 0.0 113.679 -177.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.2 162.88 54.39 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.926 -0.93 . . . . 0.0 112.387 -164.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.78 99.73 0.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.726 2.95 . . . . 0.0 108.859 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.7 t -179.17 108.2 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.532 1.933 . . . . 0.0 106.165 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.4 m 44.93 61.34 2.54 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.404 1.882 . . . . 0.0 110.434 172.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 117.545 -1.697 . . . . 0.0 109.159 -175.617 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.551 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -159.21 104.67 1.68 Allowed 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 166.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.1 m -60.39 160.82 8.14 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.452 0.701 . . . . 0.0 110.879 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.33 163.09 26.45 Favored Glycine 0 C--N 1.331 0.302 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 p -141.29 138.45 33.18 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.645 1.578 . . . . 0.0 108.444 -170.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m -148.56 -33.05 0.23 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.077 0.951 . . . . 0.0 110.92 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.12 -75.0 0.35 Allowed Glycine 0 C--N 1.337 0.617 0 C-N-CA 125.483 1.516 . . . . 0.0 109.488 -161.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -136.21 173.43 11.72 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.265 1.426 . . . . 0.0 109.449 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt 54.16 -169.16 0.06 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.019 1.328 . . . . 0.0 110.118 -174.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 47.29 -155.77 0.05 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.216 1.406 . . . . 0.0 109.175 -161.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -83.74 126.92 33.39 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 155.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 t -62.92 154.94 28.66 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 161.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.16 -29.48 68.7 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.343 -0.848 . . . . 0.0 111.367 -173.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -58.84 -50.27 74.62 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.747 0.819 . . . . 0.0 110.286 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -62.41 -30.68 71.39 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.089 -0.481 . . . . 0.0 110.903 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.1 t -70.15 -31.56 47.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 119.477 1.035 . . . . 0.0 111.477 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -66.45 -52.3 47.78 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 174.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -60.71 -33.14 72.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.339 0.656 . . . . 0.0 111.619 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -58.14 9.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.844 0.858 . . . . 0.0 109.345 173.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -57.95 -48.34 80.24 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 122.945 0.498 . . . . 0.0 110.562 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -58.82 -38.6 79.0 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.396 0.678 . . . . 0.0 110.992 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.11 -55.62 25.31 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 125.246 1.403 . . . . 0.0 110.806 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.64 -23.81 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 118.464 1.132 . . . . 0.0 111.285 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -72.28 -41.44 66.68 Favored 'General case' 0 C--O 1.224 -0.253 0 O-C-N 120.922 -1.111 . . . . 0.0 109.991 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 t -96.32 -37.2 10.6 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.578 0.751 . . . . 0.0 111.207 -172.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -86.29 -105.22 0.06 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 167.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.17 -81.92 0.15 Allowed Glycine 0 C--O 1.226 -0.406 0 CA-C-O 118.335 -1.259 . . . . 0.0 110.759 -173.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.68 4.29 9.52 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.437 2.119 . . . . 0.0 112.396 173.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -75.9 98.73 4.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -79.41 -35.2 40.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.869 1.268 . . . . 0.0 110.534 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -55.05 -47.26 75.03 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.941 0.896 . . . . 0.0 110.44 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.6 m -55.55 -59.27 5.06 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.773 1.629 . . . . 0.0 111.224 174.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 76.6 mt -53.08 -44.6 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 125.666 1.587 . . . . 0.0 110.165 -173.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -17.18 40.71 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -174.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -111.89 -29.51 7.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.681 1.192 . . . . 0.0 111.499 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.14 -19.92 65.62 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.054 0.942 . . . . 0.0 113.059 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -139.31 155.0 72.43 Favored Pre-proline 0 C--O 1.235 0.29 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.85 110.05 3.01 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.843 1.695 . . . . 0.0 110.061 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -115.72 157.24 24.58 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.906 1.282 . . . . 0.0 109.131 174.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -49.7 149.65 2.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.612 1.165 . . . . 0.0 112.549 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -61.72 144.78 54.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.66 -2.4 40.04 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.819 -1.545 . . . . 0.0 114.415 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -58.41 153.39 15.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 120.266 2.033 . . . . 0.0 110.283 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -112.31 160.8 17.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.04 0.936 . . . . 0.0 108.69 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.44 -30.99 63.52 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 122.192 -0.317 . . . . 0.0 110.651 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.1 m -65.02 -29.06 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 C-N-CA 123.723 0.809 . . . . 0.0 112.544 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -57.16 -41.52 79.37 Favored 'General case' 0 CA--C 1.516 -0.36 0 O-C-N 124.363 1.04 . . . . 0.0 109.517 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.7 mt -65.63 -48.95 70.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.737 1.215 . . . . 0.0 109.584 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.17 -44.19 95.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.845 0.858 . . . . 0.0 108.796 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -67.03 -46.38 74.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.143 0.577 . . . . 0.0 111.324 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -60.52 -39.66 88.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 119.512 1.051 . . . . 0.0 110.889 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.68 -42.94 99.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.475 0.71 . . . . 0.0 110.257 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -60.13 -47.76 84.57 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.77 172.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -52.09 -42.73 63.46 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.47 1.032 . . . . 0.0 109.986 173.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.6 mt -68.09 -60.62 2.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 119.049 -0.5 . . . . 0.0 111.091 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -63.06 -30.49 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 118.97 0.804 . . . . 0.0 112.242 -172.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.8 m -149.37 105.4 3.48 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 177.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.16 173.39 20.56 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 123.642 0.639 . . . . 0.0 112.213 -173.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.77 108.75 1.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.441 3.427 . . . . 0.0 109.501 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.8 m -141.36 161.41 37.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.491 0.716 . . . . 0.0 110.073 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.0 p -74.94 169.04 18.77 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.805 0.842 . . . . 0.0 111.811 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.313 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.799 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.9 m -57.83 129.37 41.59 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.459 1.104 . . . . 0.0 110.195 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 t -138.67 -85.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 172.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.99 -66.41 2.11 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 118.986 0.812 . . . . 0.0 112.256 -173.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 m -60.41 -63.88 1.14 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.24 1.016 . . . . 0.0 111.428 -175.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t 55.57 -164.57 0.13 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.997 0.919 . . . . 0.0 113.23 172.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.48 97.3 0.96 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 174.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -127.09 -19.47 4.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 117.906 -1.045 . . . . 0.0 113.676 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -137.46 86.53 2.2 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -175.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 t0 56.4 162.69 0.02 OUTLIER 'General case' 0 C--O 1.236 0.359 0 C-N-CA 128.491 2.717 . . . . 0.0 112.293 -162.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.507 ' CG ' ' HE2' ' A' ' 51' ' ' LYS . 2.4 m-30 62.39 144.57 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 130.528 3.531 . . . . 0.0 111.073 -169.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 p -69.59 163.21 26.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.235 1.414 . . . . 0.0 108.28 160.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -57.93 -34.42 69.85 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.478 164.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -56.03 -59.86 4.3 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 126.056 1.743 . . . . 0.0 110.338 172.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -37.45 82.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.598 1.09 . . . . 0.0 111.01 -176.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.45 -41.08 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 118.606 0.639 . . . . 0.0 110.758 173.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -60.68 -47.73 84.94 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.57 0.748 . . . . 0.0 110.465 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -66.98 -31.95 72.86 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.83 0.452 . . . . 0.0 111.566 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.08 -53.07 61.43 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 170.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.16 -46.24 89.84 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.466 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -55.56 -41.94 74.0 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.427 0.691 . . . . 0.0 110.896 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.04 -54.24 22.3 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 126.651 2.072 . . . . 0.0 111.369 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.1 t -64.67 -22.97 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 121.166 -1.196 . . . . 0.0 111.417 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -67.91 -45.89 73.1 Favored 'General case' 0 C--O 1.225 -0.191 0 O-C-N 121.041 -1.037 . . . . 0.0 109.82 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 t -95.58 -40.97 9.16 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.665 0.786 . . . . 0.0 110.957 -162.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -80.47 -66.19 0.91 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 166.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.81 -164.0 12.1 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 -146.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -78.89 23.47 0.34 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.84 0.856 . . . . 0.0 111.944 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -75.06 96.75 3.28 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 120.969 1.713 . . . . 0.0 107.122 165.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -72.62 -36.34 68.04 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.011 -1.449 . . . . 0.0 109.621 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -13.59 62.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.358 0.663 . . . . 0.0 112.184 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -86.29 -58.1 2.76 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 124.296 1.038 . . . . 0.0 108.805 169.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 92.4 mt -52.04 -44.9 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 C-N-CA 126.672 1.989 . . . . 0.0 111.372 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.91 -23.36 52.96 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.572 1.149 . . . . 0.0 112.72 -175.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -109.91 -35.88 6.04 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.885 1.274 . . . . 0.0 111.281 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.93 -29.57 69.69 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.962 0.801 . . . . 0.0 112.167 175.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -127.0 150.99 73.47 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 124.331 1.052 . . . . 0.0 108.629 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -87.82 107.55 0.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 CA-C-N 119.836 0.977 . . . . 0.0 110.004 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -94.11 161.14 14.4 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.414 -0.804 . . . . 0.0 109.405 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -66.0 147.1 53.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 173.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -53.68 146.04 14.21 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.511 0.725 . . . . 0.0 109.852 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.85 -15.13 56.67 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.373 -1.237 . . . . 0.0 112.32 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.2 111.05 3.25 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 120.421 2.11 . . . . 0.0 106.999 160.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -83.15 175.35 10.03 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 159.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.62 78.12 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.875 -1.14 . . . . 0.0 110.838 170.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.5 m -65.15 -30.32 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.025 0.93 . . . . 0.0 112.46 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.56 -41.45 90.15 Favored 'General case' 0 C--O 1.222 -0.371 0 O-C-N 124.133 0.896 . . . . 0.0 108.994 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.98 -43.39 87.98 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.226 0.61 . . . . 0.0 109.641 -178.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.06 -49.04 77.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -58.38 -51.76 68.45 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.953 0.901 . . . . 0.0 111.155 178.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.507 ' HE2' ' CG ' ' A' ' 11' ' ' PHE . 48.0 tptt -55.92 -50.14 71.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.718 1.207 . . . . 0.0 110.091 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -61.62 -50.46 72.48 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.867 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -50.6 -47.87 58.03 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.037 0.835 . . . . 0.0 110.722 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.7 mmt-85 -65.88 -36.86 84.59 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 118.17 -0.919 . . . . 0.0 112.817 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.2 mt -65.97 -53.05 43.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.528 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.7 pt -62.97 -36.73 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 119.11 0.868 . . . . 0.0 111.58 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.0 m -160.22 118.44 2.63 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.521 1.055 . . . . 0.0 109.271 169.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.94 -171.47 15.57 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 123.513 0.577 . . . . 0.0 112.282 174.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.13 71.54 1.19 Allowed 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.481 2.788 . . . . 0.0 108.9 163.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.4 m -143.21 16.39 1.89 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.338 2.255 . . . . 0.0 110.875 -159.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.7 m -65.79 -11.13 43.61 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.332 1.453 . . . . 0.0 113.651 -172.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 N-CA-C 104.817 -3.313 . . . . 0.0 104.817 153.678 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.874 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.74 85.96 1.19 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.005 0.907 . . . . 0.0 110.123 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.7 m -65.98 167.37 9.86 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 159.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.04 -25.56 4.1 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 118.018 -1.434 . . . . 0.0 113.49 173.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.2 m -96.88 115.04 26.74 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.292 1.546 . . . . 0.0 109.449 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 t -129.57 137.41 50.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.395 1.478 . . . . 0.0 109.415 -162.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.33 147.12 4.9 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -133.21 -36.38 1.0 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 117.973 -1.013 . . . . 0.0 112.54 -175.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -83.84 164.75 19.3 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.612 1.096 . . . . 0.0 110.464 176.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 64.95 -53.45 0.32 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 130.106 3.362 . . . . 0.0 113.093 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -133.95 124.83 27.01 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 161.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.0 p -61.91 164.47 6.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.45 173.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -55.01 -31.85 61.37 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.545 -0.722 . . . . 0.0 110.587 170.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.41 -50.99 61.59 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.563 1.545 . . . . 0.0 108.654 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -63.92 -38.1 89.84 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.306 -0.871 . . . . 0.0 110.454 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.95 -25.31 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.459 1.027 . . . . 0.0 110.193 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -60.15 -60.02 4.48 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.468 -0.77 . . . . 0.0 109.096 169.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -63.94 -28.56 69.91 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.245 1.018 . . . . 0.0 112.556 -174.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.48 -56.23 24.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.952 0.901 . . . . 0.0 109.925 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -67.41 -42.36 83.39 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -52.17 -35.44 48.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.941 0.897 . . . . 0.0 111.337 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.54 -49.55 4.1 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 126.695 2.093 . . . . 0.0 111.825 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.5 t -61.46 -36.83 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 119.244 1.522 . . . . 0.0 110.007 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -63.7 -28.38 69.86 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.548 -0.72 . . . . 0.0 110.833 -174.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -95.2 -59.07 1.97 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.085 0.954 . . . . 0.0 108.81 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 33.8 mtt -71.3 -28.0 63.81 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.058 -1.026 . . . . 0.0 113.555 -170.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.33 -157.46 52.07 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -150.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -83.44 33.07 0.46 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.586 1.154 . . . . 0.0 111.963 -162.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -82.23 96.47 7.87 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -79.29 -46.21 18.19 Favored 'General case' 0 C--O 1.224 -0.255 0 O-C-N 121.778 -0.576 . . . . 0.0 110.194 -170.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -49.26 -52.22 28.71 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.647 1.579 . . . . 0.0 110.829 172.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.3 m -55.74 -54.55 43.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.035 0.934 . . . . 0.0 111.01 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.8 mt -54.27 -45.46 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.781 1.232 . . . . 0.0 110.518 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -22.66 20.52 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.98 1.312 . . . . 0.0 112.245 -177.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -106.54 -34.57 7.33 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.397 1.079 . . . . 0.0 111.575 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 t -60.93 -30.48 70.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.516 0.727 . . . . 0.0 111.246 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -133.88 152.01 77.88 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -176.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.86 110.57 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.942 2.428 . . . . 0.0 110.996 -172.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -110.03 170.63 7.95 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.556 0.742 . . . . 0.0 110.202 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -58.58 160.43 5.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 123.043 1.401 . . . . 0.0 112.884 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.12 138.68 57.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.041 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.8 6.8 57.19 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 117.895 -1.503 . . . . 0.0 114.543 175.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -61.82 158.3 16.19 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 120.286 2.043 . . . . 0.0 110.064 173.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -112.33 161.36 16.73 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.066 1.347 . . . . 0.0 107.472 170.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.21 -35.01 69.13 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.934 -0.479 . . . . 0.0 110.997 176.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 m -61.13 -25.14 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.469 1.108 . . . . 0.0 112.746 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -64.21 -33.37 75.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.8 mt -71.41 -41.06 70.06 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.633 1.573 . . . . 0.0 110.476 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.28 -52.3 64.25 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 172.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -59.89 -53.51 57.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.674 -0.641 . . . . 0.0 112.205 -167.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -64.71 -40.48 95.43 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.165 -173.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -56.82 -53.43 58.0 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.982 1.713 . . . . 0.0 110.34 174.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -53.73 -47.07 70.95 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.435 1.094 . . . . 0.0 109.526 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -64.82 -42.64 94.82 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.148 -0.93 . . . . 0.0 110.727 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.4 mt -61.05 -53.49 56.55 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.932 1.242 . . . . 0.0 112.023 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.1 pt -60.48 -36.62 70.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 119.357 0.981 . . . . 0.0 110.197 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.7 m -58.95 -60.72 3.41 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.833 0.853 . . . . 0.0 110.592 173.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.6 -175.13 16.76 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.654 1.597 . . . . 0.0 111.19 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.81 -47.99 2.31 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.37 2.713 . . . . 0.0 111.559 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.6 p -80.81 76.02 7.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.3 1.04 . . . . 0.0 109.883 -174.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t 62.36 -170.57 0.17 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.532 1.133 . . . . 0.0 111.341 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.816 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 145.58 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.498 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.59 167.63 21.79 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.732 1.213 . . . . 0.0 108.508 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -69.27 136.34 51.78 Favored 'General case' 0 C--O 1.239 0.546 0 O-C-N 121.426 -0.797 . . . . 0.0 110.078 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.01 88.14 0.25 Allowed Glycine 0 C--O 1.224 -0.484 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.7 m 55.5 -2.89 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.943 2.497 . . . . 0.0 117.714 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -68.68 -85.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.994 1.724 . . . . 0.0 110.678 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.07 175.93 30.59 Favored Glycine 0 C--N 1.338 0.655 0 O-C-N 120.493 -1.38 . . . . 0.0 112.202 -175.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.5 ttp-105 -127.34 -13.24 5.56 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.81 1.244 . . . . 0.0 112.291 -176.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -123.91 143.74 50.19 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 119.91 1.232 . . . . 0.0 109.371 173.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -152.31 49.47 0.77 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.03 2.132 . . . . 0.0 106.165 168.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.484 ' CD2' ' HG3' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -141.79 104.01 4.45 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 -176.833 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 t -68.83 160.08 31.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.336 1.054 . . . . 0.0 110.262 -170.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -58.56 -31.43 67.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.224 1.01 . . . . 0.0 111.995 -168.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -68.67 -51.08 45.77 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 127.899 2.48 . . . . 0.0 108.639 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -60.94 -33.58 73.39 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 119.332 -0.366 . . . . 0.0 110.676 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.03 -32.91 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 120.486 -1.384 . . . . 0.0 109.707 176.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -61.94 -52.12 65.33 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -62.55 -36.89 84.08 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.434 1.094 . . . . 0.0 111.899 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.03 -54.8 42.84 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -63.26 -40.84 98.54 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.139 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -56.66 -57.55 11.91 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.814 0.734 . . . . 0.0 109.435 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -50.83 -55.24 18.76 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 125.653 1.597 . . . . 0.0 111.828 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.44 -24.21 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 118.148 0.974 . . . . 0.0 111.097 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -75.13 -33.72 61.59 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 120.87 -1.144 . . . . 0.0 111.213 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 t -90.56 -47.85 7.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.73 1.15 . . . . 0.0 109.487 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.9 mtt -80.72 -66.37 0.89 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.682 0.674 . . . . 0.0 109.537 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.07 -152.62 16.76 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 -158.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -72.41 16.1 0.15 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.553 2.341 . . . . 0.0 112.645 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -78.53 97.76 5.85 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 120.205 1.366 . . . . 0.0 107.324 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -79.22 -51.38 9.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.045 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -56.74 -45.49 81.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.165 0.439 . . . . 0.0 110.952 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.2 m -58.25 -51.97 67.54 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.051 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.2 mt -56.14 -44.4 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 119.736 1.153 . . . . 0.0 110.075 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.07 -30.35 15.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.082 1.353 . . . . 0.0 111.487 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.4 m0 -103.38 -35.25 8.45 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.771 1.228 . . . . 0.0 111.545 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -63.45 -24.17 67.71 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.207 1.403 . . . . 0.0 112.762 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -123.19 153.12 64.72 Favored Pre-proline 0 C--O 1.236 0.389 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 175.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -79.45 109.35 2.47 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 N-CA-C 107.774 -1.664 . . . . 0.0 107.774 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -106.31 156.37 18.57 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.462 0.705 . . . . 0.0 109.623 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -59.3 154.82 15.71 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.15 0.98 . . . . 0.0 111.443 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 167.88 18.19 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.561 0.696 . . . . 0.0 112.321 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.98 -7.2 29.88 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.695 1.14 . . . . 0.0 112.864 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.6 165.6 12.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.396 1.478 . . . . 0.0 113.163 -176.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -141.6 165.7 26.78 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.658 1.983 . . . . 0.0 107.288 171.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.84 -32.16 67.35 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.003 -1.06 . . . . 0.0 111.048 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 m -75.54 -20.0 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.056 1.343 . . . . 0.0 112.55 -174.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.63 -53.39 58.69 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 171.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 43.1 mt -53.29 -54.31 38.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.565 1.946 . . . . 0.0 110.343 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.48 -48.12 80.98 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.924 1.289 . . . . 0.0 108.989 -173.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -64.71 -46.96 80.1 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HG3' ' CD2' ' A' ' 11' ' ' PHE . 1.3 tmtm? -58.99 -49.71 76.86 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 124.726 1.21 . . . . 0.0 109.308 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.45 -47.92 78.13 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.154 0.982 . . . . 0.0 110.616 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -54.33 -48.5 71.3 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.457 -0.782 . . . . 0.0 110.439 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 mtt85 -62.87 -26.6 68.86 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.818 1.247 . . . . 0.0 113.273 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 74.8 mt -76.67 -52.35 9.8 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.347 -0.846 . . . . 0.0 111.088 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.3 pt -64.75 -30.67 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 118.616 0.644 . . . . 0.0 110.922 -173.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -159.2 -179.49 8.04 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.86 1.209 . . . . 0.0 108.223 158.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.03 176.07 44.86 Favored Glycine 0 CA--C 1.521 0.469 0 O-C-N 120.394 -1.441 . . . . 0.0 112.774 174.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.9 -9.21 22.13 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.254 2.636 . . . . 0.0 113.573 -172.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.8 t 49.53 -137.29 1.04 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -163.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 p -105.69 151.73 24.04 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 145.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 N-CA-C 105.403 -3.079 . . . . 0.0 105.403 161.811 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.77 158.81 31.55 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 162.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -55.34 -26.96 44.11 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.276 -1.345 . . . . 0.0 111.706 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -67.41 -46.45 73.17 Favored 'General case' 0 CA--C 1.526 0.05 0 CA-C-N 119.735 1.152 . . . . 0.0 111.377 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -38.74 91.99 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.397 0.999 . . . . 0.0 109.189 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.7 t -67.19 -27.45 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 119.265 0.939 . . . . 0.0 110.855 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -57.46 -60.2 4.01 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -61.14 -30.38 70.35 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -58.77 -58.86 6.75 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -71.96 -35.7 69.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 118.383 -0.818 . . . . 0.0 111.736 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -54.61 -45.2 73.63 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.273 0.942 . . . . 0.0 109.494 176.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.95 -64.36 3.72 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 125.464 1.506 . . . . 0.0 110.364 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.8 t -54.42 -27.93 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 118.964 1.382 . . . . 0.0 112.045 -174.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -67.02 -29.73 69.62 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.208 1.403 . . . . 0.0 111.518 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.1 t -97.17 -55.85 2.73 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.003 1.321 . . . . 0.0 112.085 167.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.0 mmt -61.36 -29.34 69.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.825 2.05 . . . . 0.0 113.171 -168.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.49 -153.82 48.79 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -153.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -76.07 19.89 0.21 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.137 1.375 . . . . 0.0 112.782 -168.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -81.55 97.77 7.99 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.299 -1.5 . . . . 0.0 108.733 -171.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -81.72 -47.9 12.34 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.033 -164.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -58.18 -43.51 87.55 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.656 0.662 . . . . 0.0 109.48 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.2 m -54.93 -49.93 70.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.781 1.632 . . . . 0.0 111.532 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 60.6 mt -58.56 -48.65 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 124.399 1.08 . . . . 0.0 109.562 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.73 -37.15 63.05 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.504 1.121 . . . . 0.0 111.423 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 14.3 m0 -85.08 -34.6 22.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.032 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.8 t -69.81 -30.41 67.93 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.672 1.124 . . . . 0.0 113.224 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -124.94 154.37 71.08 Favored Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 119.804 1.184 . . . . 0.0 110.355 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.08 117.81 5.32 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 121.867 1.711 . . . . 0.0 109.478 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -129.25 161.93 29.06 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.033 1.333 . . . . 0.0 110.616 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -47.64 129.3 13.66 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.689 1.596 . . . . 0.0 111.298 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -57.84 150.8 19.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.488 0.661 . . . . 0.0 109.573 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.6 4.25 44.98 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 117.685 -1.619 . . . . 0.0 114.634 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -53.22 164.01 0.49 Allowed 'General case' 0 C--N 1.343 0.308 0 CA-C-N 119.557 1.679 . . . . 0.0 110.649 170.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -121.45 158.5 28.26 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 163.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.35 -25.79 68.09 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.388 0.54 . . . . 0.0 111.327 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.71 -34.75 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.55 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -56.87 -35.14 68.57 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.95 0.5 . . . . 0.0 109.921 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.8 mt -66.18 -53.97 31.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.02 0.928 . . . . 0.0 109.297 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.23 -38.51 76.98 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.841 1.256 . . . . 0.0 110.379 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -75.48 -42.89 51.86 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.714 1.606 . . . . 0.0 110.623 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -65.59 -45.78 81.9 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.386 -0.821 . . . . 0.0 109.347 172.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -54.9 -48.6 72.83 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 126.099 1.759 . . . . 0.0 110.722 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -46.51 -58.14 4.06 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.386 1.074 . . . . 0.0 109.784 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -61.92 -33.4 74.18 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.216 -0.927 . . . . 0.0 112.519 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 mt -63.71 -44.32 93.97 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.959 0.799 . . . . 0.0 110.071 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.0 pt . . . . . 0 CA--C 1.542 0.644 0 CA-C-N 119.485 1.039 . . . . 0.0 112.479 178.277 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 . . . . . 0 C--O 1.238 0.475 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 p -68.33 167.41 14.58 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.476 0.58 . . . . 0.0 110.153 170.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -57.76 -34.24 69.34 Favored 'General case' 0 N--CA 1.462 0.139 0 O-C-N 121.129 -0.982 . . . . 0.0 110.29 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.96 -54.73 37.64 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.053 0.941 . . . . 0.0 109.658 175.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -60.49 -42.69 96.82 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 123.031 0.532 . . . . 0.0 110.841 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.2 t -65.21 -35.1 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 O-C-N 121.367 -0.833 . . . . 0.0 110.885 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -63.67 -50.66 68.37 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 172.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -61.07 -33.32 73.15 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 118.771 0.714 . . . . 0.0 111.333 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -58.82 -56.28 24.28 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.92 0.888 . . . . 0.0 108.923 174.287 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -60.36 -44.73 95.31 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.152 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -56.99 -44.36 82.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.96 0.904 . . . . 0.0 109.721 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.84 -63.1 5.6 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 126.679 2.085 . . . . 0.0 110.423 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.23 -22.03 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 118.895 1.347 . . . . 0.0 111.162 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -73.7 -30.46 62.88 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 119.972 -1.705 . . . . 0.0 110.974 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.7 t -95.59 -57.71 2.31 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.709 0.804 . . . . 0.0 109.45 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -70.0 -27.14 64.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.413 1.485 . . . . 0.0 112.659 -174.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.93 -148.69 45.47 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -153.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -76.82 15.27 0.68 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.67 1.188 . . . . 0.0 113.994 -159.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -84.5 97.46 9.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 120.144 1.338 . . . . 0.0 110.093 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -71.82 -42.42 67.04 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.502 0.721 . . . . 0.0 112.455 -175.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -64.39 -40.91 96.73 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 118.619 0.645 . . . . 0.0 109.666 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.16 -54.53 38.49 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 123.4 0.68 . . . . 0.0 109.435 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.9 mt -54.57 -52.05 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 126.111 1.765 . . . . 0.0 109.831 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -47.16 69.33 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.299 1.44 . . . . 0.0 110.836 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -74.99 -39.79 61.06 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.696 -0.668 . . . . 0.0 110.602 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -59.92 -71.6 0.13 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.581 1.152 . . . . 0.0 110.565 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -87.17 153.15 53.87 Favored Pre-proline 0 N--CA 1.453 -0.301 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -166.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.15 110.52 3.13 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.588 1.525 . . . . 0.0 109.081 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -111.11 174.17 5.99 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.071 0.948 . . . . 0.0 108.698 172.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -63.98 155.85 29.73 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.939 0.876 . . . . 0.0 111.358 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -62.55 139.03 58.6 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.453 1.101 . . . . 0.0 109.043 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.55 23.31 76.66 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 117.689 0.222 . . . . 0.0 112.599 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -70.47 165.42 22.63 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 121.406 -1.055 . . . . 0.0 111.495 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -118.13 161.25 20.17 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.698 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.03 86.05 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 165.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.43 -26.34 33.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 O-C-N 121.546 -0.721 . . . . 0.0 111.761 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.6 -41.81 86.69 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HB3' HD21 ' A' ' 19' ' ' LEU . 55.6 mt -65.14 -52.26 56.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.14 1.776 . . . . 0.0 109.111 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.02 -46.43 82.34 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.521 1.128 . . . . 0.0 108.089 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -63.72 -54.43 35.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.96 1.304 . . . . 0.0 110.899 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.88 -47.2 77.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.772 0.715 . . . . 0.0 109.299 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -60.07 -49.94 75.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.581 1.552 . . . . 0.0 111.193 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -55.59 -41.2 73.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.82 1.248 . . . . 0.0 111.059 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mmm-85 -68.86 -42.96 76.33 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.936 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.9 mt -58.27 -49.99 75.18 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.886 1.221 . . . . 0.0 112.527 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt . . . . . 0 CA--C 1.539 0.557 0 C-N-CA 123.093 0.557 . . . . 0.0 112.045 176.331 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 . . . . . 0 C--O 1.243 0.72 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.4 p -61.7 176.64 0.5 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.453 1.121 . . . . 0.0 110.719 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -58.92 -42.73 90.38 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 120.656 -1.278 . . . . 0.0 110.487 173.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -55.93 -54.47 44.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 124.708 1.255 . . . . 0.0 108.741 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -62.04 -41.79 98.49 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.332 1.053 . . . . 0.0 111.517 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.1 t -64.34 -38.02 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.029 0.831 . . . . 0.0 109.917 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -62.78 -47.95 81.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -60.36 -34.47 73.91 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.338 0.655 . . . . 0.0 112.389 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -57.0 -55.24 37.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -60.79 -46.95 88.49 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.813 0.445 . . . . 0.0 111.256 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -35.05 71.0 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.712 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -78.36 -51.54 5.61 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 125.923 1.725 . . . . 0.0 111.171 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.0 t -58.66 -28.99 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 118.249 1.024 . . . . 0.0 110.468 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -49.72 74.62 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 124.265 1.026 . . . . 0.0 110.34 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 t -96.77 -21.63 17.43 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.847 1.659 . . . . 0.0 113.647 -167.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.8 mtp -128.53 -6.56 5.22 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.204 1.002 . . . . 0.0 112.587 -170.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.86 -158.07 53.45 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 119.232 0.923 . . . . 0.0 111.385 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -72.0 21.54 0.06 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.289 1.036 . . . . 0.0 112.193 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -82.91 97.72 8.83 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -176.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -82.37 -45.07 15.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.047 -163.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -50.11 -49.5 51.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.598 0.759 . . . . 0.0 109.282 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -54.8 -54.78 37.69 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 128.063 2.545 . . . . 0.0 110.351 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 67.6 mt -59.21 -44.91 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.084 0.954 . . . . 0.0 110.355 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -34.64 64.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.379 1.472 . . . . 0.0 110.925 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -88.74 -37.26 15.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.101 0.96 . . . . 0.0 111.848 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 t -67.3 -18.66 65.27 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -140.68 154.09 68.64 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 119.881 1.218 . . . . 0.0 110.021 -173.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.12 109.58 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.159 1.906 . . . . 0.0 110.823 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -107.58 -178.53 3.65 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.668 1.187 . . . . 0.0 109.67 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -67.7 162.95 22.61 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.671 -0.643 . . . . 0.0 110.785 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.9 147.58 50.09 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 121.669 -0.644 . . . . 0.0 109.931 176.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.4 5.8 37.71 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.107 -0.83 . . . . 0.0 113.759 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -59.49 135.79 57.78 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 118.348 1.074 . . . . 0.0 108.299 169.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -90.5 167.06 12.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 171.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.81 -38.48 78.71 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.712 -0.617 . . . . 0.0 110.614 169.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.1 m -63.75 -27.58 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 123.386 0.674 . . . . 0.0 112.081 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -59.65 -37.69 79.4 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.422 ' HB3' HD21 ' A' ' 19' ' ' LEU . 47.6 mt -65.85 -50.01 66.1 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.738 1.215 . . . . 0.0 109.713 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.39 -41.7 90.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.922 0.889 . . . . 0.0 109.337 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -68.19 -52.54 33.2 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 124.114 0.966 . . . . 0.0 110.259 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -44.21 93.58 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 120.868 -1.145 . . . . 0.0 108.985 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -55.34 -50.59 69.24 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.567 1.147 . . . . 0.0 111.13 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -51.42 -46.13 62.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.557 1.143 . . . . 0.0 110.081 175.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -71.91 -26.33 62.26 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.465 1.106 . . . . 0.0 112.477 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.8 mt -70.57 -58.53 3.59 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.918 1.236 . . . . 0.0 109.028 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 pt . . . . . 0 CA--C 1.537 0.461 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.154 -177.446 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.463 ' CD2' ' HG2' ' A' ' 51' ' ' LYS . 34.0 m-85 . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 121.469 0.652 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.8 p -65.6 155.13 36.78 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.761 -0.587 . . . . 0.0 110.675 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -52.48 -37.25 56.75 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.069 -1.019 . . . . 0.0 111.554 174.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.58 -50.98 70.45 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 124.954 1.302 . . . . 0.0 110.224 176.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -63.67 -28.19 69.73 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.943 -1.098 . . . . 0.0 110.856 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.6 t -69.33 -35.91 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 120.388 1.449 . . . . 0.0 109.311 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -50.29 -60.59 2.82 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 170.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -61.99 -31.04 71.37 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.033 0.933 . . . . 0.0 112.715 -176.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -59.55 -61.9 2.28 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -64.14 -47.94 77.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.736 0.414 . . . . 0.0 110.585 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.92 -40.65 70.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.187 1.395 . . . . 0.0 110.3 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.55 -56.91 11.23 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 125.337 1.446 . . . . 0.0 111.022 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.7 t -56.69 -32.17 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 118.598 1.199 . . . . 0.0 111.427 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -61.04 -42.0 97.64 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 119.665 1.121 . . . . 0.0 110.405 -175.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.7 t -95.43 -44.88 7.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.787 0.835 . . . . 0.0 109.689 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 6.8 mmt -69.78 -25.58 63.86 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.129 1.372 . . . . 0.0 112.022 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.39 -161.25 34.92 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -151.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -72.67 8.51 1.43 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -166.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -70.0 97.8 1.2 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 121.056 1.753 . . . . 0.0 110.472 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -71.12 -40.91 71.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.806 0.842 . . . . 0.0 111.06 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -57.48 -46.5 83.64 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.869 0.868 . . . . 0.0 109.749 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.07 -61.11 2.53 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.718 0.807 . . . . 0.0 109.472 173.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.0 mt -52.26 -48.4 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 126.125 1.77 . . . . 0.0 110.905 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -24.02 63.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.706 0.802 . . . . 0.0 112.038 -174.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -100.67 -41.32 6.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.65 0.78 . . . . 0.0 111.231 175.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.3 -15.69 60.73 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -176.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -134.25 155.01 80.28 Favored Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 125.26 1.424 . . . . 0.0 108.313 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.0 110.62 2.35 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.803 2.336 . . . . 0.0 109.778 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -118.27 159.43 23.38 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.56 1.144 . . . . 0.0 109.012 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -54.0 145.93 15.58 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.546 1.138 . . . . 0.0 112.084 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -61.43 133.75 56.13 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.75 -8.42 73.91 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 118.838 -0.979 . . . . 0.0 112.579 176.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.6 mmp_? -61.48 153.49 27.14 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 118.867 1.333 . . . . 0.0 108.676 162.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.7 mtm105 -124.96 174.08 8.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.32 1.448 . . . . 0.0 107.401 167.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.53 -33.41 69.84 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 122.278 0.231 . . . . 0.0 110.639 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 m -63.8 -33.9 64.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 C-N-CA 123.473 0.709 . . . . 0.0 112.471 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.94 -41.11 86.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.44 ' HB3' HD21 ' A' ' 19' ' ' LEU . 53.8 mt -63.1 -52.0 64.37 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.982 1.313 . . . . 0.0 109.633 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.82 -45.07 82.53 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.743 1.217 . . . . 0.0 109.266 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -63.52 -54.34 37.72 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.716 1.207 . . . . 0.0 110.432 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.463 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 52.9 tptt -61.19 -44.75 96.79 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.97 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -56.58 -54.81 41.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.568 1.147 . . . . 0.0 110.383 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -50.28 60.77 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 123.558 0.536 . . . . 0.0 109.68 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -56.57 -45.6 81.2 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.473 1.109 . . . . 0.0 111.777 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.0 mt -63.33 -56.22 18.17 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.797 0.839 . . . . 0.0 110.759 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.5 pt . . . . . 0 CA--C 1.538 0.516 0 CA-C-N 118.014 0.37 . . . . 0.0 111.195 177.117 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 . . . . . 0 C--O 1.237 0.399 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.444 HG22 ' OE1' ' A' ' 15' ' ' GLU . 8.8 t -83.47 178.44 8.02 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 164.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -55.27 -35.05 64.6 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-O 117.607 -1.187 . . . . 0.0 111.462 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.06 -57.66 11.87 Favored 'General case' 0 C--O 1.225 -0.197 0 O-C-N 123.827 0.705 . . . . 0.0 112.067 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.444 ' OE1' HG22 ' A' ' 12' ' ' THR . 3.0 mp0 -59.46 -40.22 86.18 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.688 1.131 . . . . 0.0 111.732 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.2 t -60.56 -40.62 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 118.839 -0.601 . . . . 0.0 111.374 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -57.42 -52.18 66.43 Favored 'General case' 0 C--O 1.226 -0.141 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.5 m-30 -61.03 -33.56 73.48 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.417 1.087 . . . . 0.0 111.716 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -61.38 -56.82 16.04 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.082 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -64.15 -43.1 96.26 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 117.791 -1.1 . . . . 0.0 111.769 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -55.52 -54.42 44.21 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.875 1.27 . . . . 0.0 109.262 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.85 -59.25 10.61 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 125.425 1.488 . . . . 0.0 111.648 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.4 t -61.74 -21.99 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 O-C-N 121.561 -0.964 . . . . 0.0 111.562 -177.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -76.1 -44.18 39.87 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 120.117 -1.614 . . . . 0.0 109.499 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.9 t -95.36 -16.58 22.25 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.571 0.749 . . . . 0.0 112.195 -169.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.4 mtp -126.71 -9.77 6.15 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.599 1.16 . . . . 0.0 112.257 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.04 -152.83 42.84 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -167.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -73.22 18.88 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.735 1.614 . . . . 0.0 113.648 -164.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -75.94 97.28 3.94 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.789 1.632 . . . . 0.0 109.482 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -75.15 -44.21 48.09 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.28 -0.888 . . . . 0.0 112.218 -171.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -62.33 -48.16 81.07 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.2 m -53.85 -47.03 71.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.903 0.881 . . . . 0.0 111.037 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.88 -46.65 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 119.926 1.239 . . . . 0.0 110.268 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.28 -24.09 17.59 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.027 1.331 . . . . 0.0 112.016 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -108.61 -31.64 7.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.681 1.192 . . . . 0.0 110.73 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -58.73 -23.2 59.36 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.274 1.429 . . . . 0.0 112.15 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -138.16 157.86 72.05 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 125.711 1.605 . . . . 0.0 108.003 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.87 109.12 1.94 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 N-CA-C 107.776 -1.663 . . . . 0.0 107.776 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -101.54 164.89 11.53 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.282 -0.886 . . . . 0.0 109.102 175.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -53.47 142.54 21.82 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -70.51 158.97 35.13 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.494 0.664 . . . . 0.0 110.261 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.2 -3.39 22.88 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.755 -1.581 . . . . 0.0 113.543 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.418 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 7.7 mmp_? -64.57 141.19 58.86 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 120.479 2.139 . . . . 0.0 109.566 176.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.6 mtt85 -82.8 159.87 22.37 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.04 78.51 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.262 -0.899 . . . . 0.0 109.903 166.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 m -65.15 -24.42 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 118.334 -0.841 . . . . 0.0 111.974 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -61.59 -31.73 71.8 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' HB3' HD21 ' A' ' 19' ' ' LEU . 59.7 mt -68.62 -49.76 56.75 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.507 1.523 . . . . 0.0 109.709 175.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.34 98.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.468 1.107 . . . . 0.0 109.758 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -65.71 -46.53 78.63 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.364 1.466 . . . . 0.0 110.197 178.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -60.9 -47.12 87.85 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -56.81 -45.27 82.36 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.783 1.233 . . . . 0.0 111.471 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -51.61 -39.82 58.71 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.647 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -81.4 -20.21 40.94 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.857 1.662 . . . . 0.0 113.288 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.6 mt -74.96 -11.42 60.11 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.406 -0.809 . . . . 0.0 111.47 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.5 pt . . . . . 0 CA--C 1.541 0.604 0 CA-C-N 119.612 1.096 . . . . 0.0 111.67 168.881 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 . . . . . 0 C--O 1.238 0.45 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 t -72.7 168.95 17.67 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -40.05 62.05 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.092 0.957 . . . . 0.0 112.196 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -56.81 -50.85 71.11 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.811 1.244 . . . . 0.0 108.033 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -70.13 -25.39 63.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.123 0.969 . . . . 0.0 111.889 -174.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.6 t -73.96 -41.61 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 118.82 0.736 . . . . 0.0 109.341 173.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -58.76 -48.33 81.57 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.738 -0.649 . . . . 0.0 109.359 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -60.22 -35.35 75.24 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.966 0.906 . . . . 0.0 111.451 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.43 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -59.36 -53.94 52.4 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.598 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -72.14 -24.9 61.53 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -66.1 -55.06 18.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 170.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.84 -62.14 6.18 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 125.891 1.71 . . . . 0.0 111.319 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.6 t -61.75 -25.38 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 118.182 0.991 . . . . 0.0 111.65 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -70.71 -46.51 62.96 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 121.011 -1.056 . . . . 0.0 109.27 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -95.08 -20.32 19.41 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.354 0.525 . . . . 0.0 111.544 -168.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.3 mtp -124.09 -9.24 7.66 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.905 1.282 . . . . 0.0 111.997 -172.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.35 -154.14 50.45 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -73.55 14.68 0.32 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.31 1.044 . . . . 0.0 113.69 -166.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -78.71 96.87 5.67 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 120.797 1.635 . . . . 0.0 107.84 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -76.16 -42.42 46.64 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.729 -0.607 . . . . 0.0 110.423 -173.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -59.32 -42.66 91.95 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 m -60.66 -54.35 46.33 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.605 1.162 . . . . 0.0 112.35 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.3 mt -56.79 -43.27 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 125.407 1.483 . . . . 0.0 110.565 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -14.98 37.74 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -175.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -110.38 -29.17 8.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.024 1.329 . . . . 0.0 111.356 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 3.1 t -60.75 -18.17 53.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.593 0.757 . . . . 0.0 112.471 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 70.3 m-85 -144.58 158.03 54.5 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 125.098 1.359 . . . . 0.0 108.049 -176.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.4 109.89 3.0 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.734 1.623 . . . . 0.0 109.385 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -113.17 166.38 11.5 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.218 1.407 . . . . 0.0 109.596 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -56.87 151.38 14.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.99 1.316 . . . . 0.0 111.009 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.3 142.28 50.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -176.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.05 8.15 57.82 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.009 -1.439 . . . . 0.0 113.965 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -64.35 165.26 9.92 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 120.822 2.311 . . . . 0.0 109.661 169.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -120.72 159.58 25.09 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.645 1.178 . . . . 0.0 108.11 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.26 -40.35 64.56 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.626 0.37 . . . . 0.0 110.744 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.3 m -62.62 -27.98 43.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 C-N-CA 123.688 0.795 . . . . 0.0 112.336 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -62.09 -35.06 77.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.43 ' HB3' HD21 ' A' ' 19' ' ' LEU . 54.9 mt -66.95 -46.29 75.17 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 126.493 1.917 . . . . 0.0 110.129 175.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.02 -51.07 69.49 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -55.78 -48.4 75.38 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.466 1.107 . . . . 0.0 110.594 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -61.79 -48.02 82.51 Favored 'General case' 0 C--O 1.223 -0.29 0 O-C-N 121.234 -0.916 . . . . 0.0 110.998 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -55.48 -46.48 76.89 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 125.475 1.51 . . . . 0.0 110.991 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 49.3 m170 -53.77 -54.76 33.69 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.475 1.11 . . . . 0.0 109.028 172.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -55.77 -38.64 70.16 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 121.442 -0.786 . . . . 0.0 112.397 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.3 mt -68.33 -39.15 82.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 117.642 -1.17 . . . . 0.0 111.521 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt . . . . . 0 N--CA 1.469 0.479 0 CA-C-N 120.164 1.347 . . . . 0.0 111.569 173.424 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.422 ' CD2' ' HG2' ' A' ' 51' ' ' LYS . 10.7 m-85 . . . . . 0 C--O 1.232 0.149 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -84.1 -166.96 1.57 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.811 0.844 . . . . 0.0 109.957 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -74.05 -24.77 59.58 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 120.97 -1.081 . . . . 0.0 111.116 161.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -77.19 -49.48 15.07 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 119.23 0.923 . . . . 0.0 109.193 -171.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -41.36 92.07 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.6 t -59.78 -38.0 74.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 C-N-CA 124.151 0.98 . . . . 0.0 110.337 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -56.09 -54.56 43.58 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -65.8 -26.86 67.88 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -62.68 -52.43 63.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.027 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -59.28 -44.84 92.45 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.24 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -51.46 -52.85 42.89 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.638 1.175 . . . . 0.0 111.064 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.34 -58.54 8.52 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 124.23 0.919 . . . . 0.0 111.162 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -56.98 -25.56 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 118.507 1.154 . . . . 0.0 110.877 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -59.4 -45.71 90.73 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 121.317 -0.865 . . . . 0.0 110.52 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.2 t -96.5 -21.61 17.6 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.936 1.294 . . . . 0.0 112.065 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.3 mtp -116.86 -1.91 11.92 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.75 -1.219 . . . . 0.0 113.707 -166.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.27 -113.0 1.99 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -104.73 8.58 35.07 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.513 0.725 . . . . 0.0 112.698 -168.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -76.55 96.48 4.13 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 120.094 1.315 . . . . 0.0 109.514 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -78.7 -44.84 22.66 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.642 -172.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -61.35 -41.19 96.65 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 119.502 -0.285 . . . . 0.0 110.581 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 m -56.57 -53.92 51.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.207 0.603 . . . . 0.0 110.609 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 55.0 mt -53.3 -45.14 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.024 1.33 . . . . 0.0 110.893 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -31.06 68.0 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.325 0.65 . . . . 0.0 112.167 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -86.88 -35.09 19.19 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.947 0.499 . . . . 0.0 111.247 171.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.442 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 8.3 t -60.32 -31.05 69.92 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.128 1.371 . . . . 0.0 113.33 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 74.1 m-85 -135.27 155.14 79.0 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 123.93 0.892 . . . . 0.0 109.058 -171.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.89 109.3 2.19 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.852 1.701 . . . . 0.0 109.638 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -109.04 176.2 5.18 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.982 0.913 . . . . 0.0 111.036 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -56.55 155.9 6.8 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.481 1.112 . . . . 0.0 111.018 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.46 121.75 20.12 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -172.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.75 21.84 65.36 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.416 -0.658 . . . . 0.0 113.952 169.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -57.47 163.37 2.4 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 122.105 0.955 . . . . 0.0 111.389 171.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -103.05 167.58 9.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.948 162.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.5 -34.63 78.67 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.641 -0.662 . . . . 0.0 109.3 166.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 m -62.43 -29.34 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 O-C-N 121.701 -0.624 . . . . 0.0 112.259 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -55.97 -43.1 77.25 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.402 ' HB3' HD21 ' A' ' 19' ' ' LEU . 46.0 mt -67.05 -44.28 80.59 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.8 0.84 . . . . 0.0 110.061 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.84 -45.97 87.12 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.431 0.693 . . . . 0.0 109.374 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -60.39 -52.98 62.93 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.066 1.347 . . . . 0.0 109.063 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 57.7 tptt -59.94 -39.98 87.4 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.687 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -62.29 -46.28 89.49 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 119.68 1.127 . . . . 0.0 111.206 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -51.76 -54.2 31.23 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -53.81 -42.12 68.07 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.666 0.666 . . . . 0.0 112.307 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.69 -37.24 85.91 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 117.882 -1.056 . . . . 0.0 110.98 -176.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.5 pt . . . . . 0 CA--C 1.536 0.432 0 CA-C-N 119.491 1.042 . . . . 0.0 110.253 174.909 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 C--O 1.235 0.337 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.9 p -74.1 173.14 10.5 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 120.574 -1.329 . . . . 0.0 108.064 169.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -55.23 -21.55 14.55 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.022 0.929 . . . . 0.0 112.232 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.07 -32.74 17.41 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.626 1.171 . . . . 0.0 112.037 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.48 -41.98 75.43 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 119.842 1.201 . . . . 0.0 108.329 171.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.54 -29.42 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 122.004 -0.435 . . . . 0.0 110.206 174.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -57.78 -59.0 5.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 118.817 -0.611 . . . . 0.0 109.599 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -60.41 -28.3 68.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.82 -58.17 5.57 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -68.17 -28.41 67.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 119.312 -0.375 . . . . 0.0 111.607 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.91 -43.28 93.33 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.866 0.866 . . . . 0.0 109.674 173.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.77 -44.07 8.62 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 124.101 0.858 . . . . 0.0 111.062 -168.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.7 t -62.7 -26.62 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.603 0.702 . . . . 0.0 110.39 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -64.04 -33.55 76.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.495 1.043 . . . . 0.0 110.739 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . 0.252 11.5 t -95.75 -61.73 1.41 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -23.76 56.21 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -167.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.7 -150.95 48.78 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -160.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -69.51 9.17 0.51 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.013 2.525 . . . . 0.0 114.88 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -71.44 96.96 1.55 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 121.199 1.818 . . . . 0.0 108.876 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.2 m95 -81.14 -46.03 15.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.364 -0.826 . . . . 0.0 111.453 -170.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -54.52 -41.81 70.1 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.281 0.946 . . . . 0.0 109.96 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -53.53 57.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 123.503 0.721 . . . . 0.0 110.623 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 59.9 mt -55.5 -46.1 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.607 1.163 . . . . 0.0 109.617 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -16.36 43.0 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.961 1.304 . . . . 0.0 112.782 -176.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -109.94 -29.68 8.15 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.447 1.099 . . . . 0.0 112.186 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.4 ' HB3' ' CD2' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -63.78 -26.49 68.66 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.951 0.796 . . . . 0.0 112.101 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 36' ' ' SER . 84.4 m-85 -135.31 156.42 78.0 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 124.557 1.143 . . . . 0.0 109.994 -174.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.8 138.48 31.74 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 N-CA-C 108.552 -1.365 . . . . 0.0 108.552 170.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -132.23 -174.5 3.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 170.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -71.26 171.95 10.18 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.307 -0.871 . . . . 0.0 111.067 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.415 ' CA ' ' HE3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -68.63 165.14 19.94 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.783 -0.573 . . . . 0.0 110.291 171.687 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.65 -3.15 1.48 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.378 1.466 . . . . 0.0 115.483 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -63.09 157.83 21.21 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 119.072 1.436 . . . . 0.0 110.356 -175.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -120.84 166.66 13.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.687 1.595 . . . . 0.0 107.51 168.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.9 77.52 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.707 -0.621 . . . . 0.0 110.802 169.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.3 m -63.14 -24.86 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 123.53 0.732 . . . . 0.0 112.373 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -65.46 -42.25 92.49 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 mt -62.31 -36.58 82.6 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.12 -43.81 86.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 119.256 0.935 . . . . 0.0 109.944 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.43 -55.4 12.0 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.949 1.299 . . . . 0.0 112.308 -172.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -58.56 -47.45 84.21 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -54.81 -48.42 72.8 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 125.106 1.362 . . . . 0.0 110.156 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -51.86 -47.42 64.47 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.957 0.503 . . . . 0.0 110.843 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -67.33 -31.19 71.3 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.736 -0.602 . . . . 0.0 110.713 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.2 mt -71.44 -41.16 69.82 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.186 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.7 pt . . . . . 0 N--CA 1.475 0.8 0 CA-C-N 120.638 1.563 . . . . 0.0 112.5 178.385 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 . . . . . 0 C--O 1.239 0.52 0 CA-C-O 120.812 0.339 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.7 p -72.16 170.63 13.59 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.707 0.803 . . . . 0.0 109.377 167.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -56.39 -27.98 57.92 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.456 -0.778 . . . . 0.0 110.886 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -68.78 -56.18 8.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.335 -0.853 . . . . 0.0 109.399 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -59.37 -34.4 72.36 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.041 0.536 . . . . 0.0 111.304 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.651 HG22 ' HE2' ' A' ' 51' ' ' LYS . 54.0 t -66.42 -40.2 85.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.012 175.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -65.03 -45.16 86.61 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 118.468 0.577 . . . . 0.0 109.448 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -60.15 -37.74 81.04 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.084 0.954 . . . . 0.0 110.811 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.77 -56.89 13.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.933 0.893 . . . . 0.0 109.235 171.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -69.69 -29.94 67.48 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.601 -0.714 . . . . 0.0 112.536 -175.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -61.51 -58.55 7.71 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.81 1.187 . . . . 0.0 108.129 170.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.22 -60.96 4.8 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 125.868 1.699 . . . . 0.0 111.756 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.5 t -63.38 -20.04 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.423 1.112 . . . . 0.0 112.238 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.02 -40.62 45.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 120.322 -1.486 . . . . 0.0 109.635 177.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.8 t -95.82 -19.9 19.24 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.234 0.925 . . . . 0.0 113.087 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 10.0 mtt -117.88 0.4 11.91 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.254 1.422 . . . . 0.0 112.751 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.71 -103.63 0.12 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.586 1.089 . . . . 0.0 111.957 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -114.78 12.47 17.02 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 118.224 1.012 . . . . 0.0 110.506 -167.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.06 97.68 4.77 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 173.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -81.66 -46.61 14.1 Favored 'General case' 0 CA--C 1.521 -0.143 0 O-C-N 121.178 -0.951 . . . . 0.0 110.992 -172.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -54.7 -44.98 73.92 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.841 0.856 . . . . 0.0 109.918 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.7 m -57.48 -48.62 78.74 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.948 1.699 . . . . 0.0 111.803 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.9 mt -59.28 -45.3 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 O-C-N 120.909 -1.119 . . . . 0.0 109.94 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -23.94 48.17 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 125.542 1.537 . . . . 0.0 112.58 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 3.8 m0 -112.11 -29.6 7.54 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.522 -0.752 . . . . 0.0 111.086 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 t -68.87 -22.21 64.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.152 0.887 . . . . 0.0 111.981 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -121.85 156.01 59.75 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 123.951 0.9 . . . . 0.0 108.583 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.84 110.25 3.08 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.957 1.771 . . . . 0.0 108.174 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -111.18 168.18 9.71 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.137 0.975 . . . . 0.0 108.749 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -55.68 163.49 1.35 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.577 1.551 . . . . 0.0 111.468 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -64.68 161.4 17.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.366 164.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.79 -15.63 2.93 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.775 1.179 . . . . 0.0 114.242 170.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -63.4 163.21 11.13 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 124.509 1.124 . . . . 0.0 111.455 -174.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -127.88 170.36 12.9 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.756 1.222 . . . . 0.0 109.548 171.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.4 -34.97 69.43 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.96 0.504 . . . . 0.0 110.939 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.78 -30.85 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 CA-C-N 118.224 0.465 . . . . 0.0 112.084 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.04 -38.14 72.79 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.412 0.445 . . . . 0.0 110.581 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.2 mt -67.41 -49.51 63.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.015 1.726 . . . . 0.0 110.548 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.98 -52.96 63.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -54.16 -46.55 72.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.476 1.11 . . . . 0.0 111.781 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.651 ' HE2' HG22 ' A' ' 16' ' ' VAL . 7.0 tptt -54.98 -60.27 3.6 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.11 0.564 . . . . 0.0 110.202 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -54.78 -46.02 74.35 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 126.331 1.852 . . . . 0.0 110.933 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -59.92 -47.05 87.38 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.153 0.981 . . . . 0.0 110.128 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -56.54 -41.1 76.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.461 1.028 . . . . 0.0 110.75 171.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.5 mt -74.71 -7.03 52.04 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.4 pt . . . . . 0 N--CA 1.471 0.623 0 CA-C-N 120.415 1.462 . . . . 0.0 111.772 166.08 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 p -62.31 166.77 4.68 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.412 0.685 . . . . 0.0 110.097 167.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -61.69 -25.66 67.55 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.114 -0.992 . . . . 0.0 110.083 168.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -62.27 -49.36 75.98 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 122.085 0.945 . . . . 0.0 108.527 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -72.46 -36.99 68.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.562 0.745 . . . . 0.0 110.917 -174.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.63 -32.0 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 119.372 0.987 . . . . 0.0 109.744 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -59.38 -59.07 6.03 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 170.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -57.0 -32.08 65.75 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.58 1.152 . . . . 0.0 112.189 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -57.2 -63.03 1.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.79 0.836 . . . . 0.0 108.845 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -68.92 -31.66 70.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.452 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -59.31 -49.38 78.03 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 120.204 1.366 . . . . 0.0 109.334 175.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.46 -63.27 5.46 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 124.764 1.173 . . . . 0.0 110.495 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.2 t -55.46 -23.33 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 118.267 1.033 . . . . 0.0 111.603 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -71.22 -53.72 13.41 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 120.134 1.334 . . . . 0.0 109.618 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.6 t -81.47 -8.51 59.74 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.845 0.858 . . . . 0.0 111.107 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.5 mtp -128.86 -93.82 0.44 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.282 1.833 . . . . 0.0 108.033 -171.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.16 -126.44 2.1 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -168.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.57 7.91 17.53 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 117.498 0.649 . . . . 0.0 111.715 -172.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -69.94 98.67 1.3 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.994 1.27 . . . . 0.0 108.414 167.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -74.92 -42.43 57.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.308 -0.377 . . . . 0.0 111.073 -170.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -54.9 -36.62 65.39 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 118.746 -0.645 . . . . 0.0 112.058 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.4 m -61.77 -55.13 33.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.222 0.609 . . . . 0.0 110.06 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.6 mt -53.04 -47.9 53.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 125.988 1.715 . . . . 0.0 110.167 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -31.36 64.92 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.843 1.257 . . . . 0.0 111.32 -175.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -85.31 -42.95 14.14 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.516 0.726 . . . . 0.0 112.105 170.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.424 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 9.6 t -57.19 -35.63 69.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.881 1.273 . . . . 0.0 111.93 -167.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 57.3 m-85 -127.37 157.91 71.21 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 124.132 0.973 . . . . 0.0 108.524 -174.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.46 108.65 2.18 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 CA-C-N 119.747 0.946 . . . . 0.0 109.934 -175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -104.1 166.64 10.28 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.466 1.106 . . . . 0.0 108.864 173.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -52.16 162.73 0.45 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.46 1.104 . . . . 0.0 111.705 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 160.32 24.6 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.3 7.68 20.31 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.293 -0.726 . . . . 0.0 114.427 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.7 mmp_? -71.26 161.31 31.29 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 119.025 1.412 . . . . 0.0 108.938 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -118.41 162.99 17.4 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 174.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.71 -36.17 66.89 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.314 -0.866 . . . . 0.0 111.282 170.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 m -66.55 -23.78 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.004 0.922 . . . . 0.0 112.605 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.57 -46.49 70.29 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.642 0.734 . . . . 0.0 109.145 176.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.411 HD22 ' CD2' ' A' ' 19' ' ' LEU . 35.9 mt -65.84 -44.79 84.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.323 1.449 . . . . 0.0 109.119 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.1 -49.57 75.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.051 1.341 . . . . 0.0 108.847 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -55.02 -61.72 2.13 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.871 1.268 . . . . 0.0 110.09 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -52.94 -54.14 39.32 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 122.586 0.355 . . . . 0.0 110.131 -174.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -52.12 -51.38 58.15 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 126.196 1.799 . . . . 0.0 111.231 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -57.03 -49.06 76.96 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.852 0.296 . . . . 0.0 110.491 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -58.14 -43.22 87.19 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.662 -0.685 . . . . 0.0 109.3 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.7 mt -62.43 -53.47 54.39 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.805 0.842 . . . . 0.0 111.643 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.0 pt . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 119.403 1.001 . . . . 0.0 110.653 176.79 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -74.17 173.17 10.49 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -48.06 -50.27 28.58 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.284 1.034 . . . . 0.0 109.797 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.08 -37.07 73.79 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.612 -172.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -35.3 43.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 119.692 -0.803 . . . . 0.0 108.946 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.5 t -62.88 -37.99 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 121.134 -0.979 . . . . 0.0 109.873 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -53.53 -51.31 63.28 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.443 0.697 . . . . 0.0 109.689 172.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -67.62 -29.09 68.33 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -61.46 -53.77 52.1 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 175.149 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -60.54 -50.67 72.59 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 118.578 -0.725 . . . . 0.0 111.62 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.18 -49.27 74.5 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.013 0.925 . . . . 0.0 110.551 -177.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.95 -53.31 43.96 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 124.74 1.162 . . . . 0.0 110.656 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.3 t -60.1 -28.55 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 117.622 0.711 . . . . 0.0 110.228 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -70.89 -37.9 73.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 120.964 -1.085 . . . . 0.0 110.403 -176.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.6 t -95.39 -19.37 19.97 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.905 0.882 . . . . 0.0 112.21 -176.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 41.3 mtt -116.37 -20.6 9.65 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.47 1.032 . . . . 0.0 113.777 -175.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.31 -151.17 39.75 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -160.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -68.93 24.32 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.607 2.763 . . . . 0.0 116.441 -169.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -81.05 103.14 10.66 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 165.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -84.62 -39.02 19.17 Favored 'General case' 0 CA--C 1.527 0.091 0 O-C-N 121.129 -0.982 . . . . 0.0 111.25 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -58.71 -48.9 79.56 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.045 0.538 . . . . 0.0 110.864 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.3 m -56.95 -49.11 76.66 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.51 1.124 . . . . 0.0 112.346 176.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.1 mt -55.29 -47.47 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.049 1.339 . . . . 0.0 109.566 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -30.04 44.63 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.035 0.934 . . . . 0.0 111.987 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -98.84 -26.74 14.2 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.434 0.694 . . . . 0.0 112.253 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 t -63.04 -22.22 66.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.618 1.167 . . . . 0.0 112.352 -173.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -134.61 161.95 60.65 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 125.009 1.324 . . . . 0.0 107.443 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.65 109.13 2.56 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 N-CA-C 107.239 -1.87 . . . . 0.0 107.239 170.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -99.67 172.15 7.46 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -55.91 149.98 14.11 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.433 1.093 . . . . 0.0 109.237 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.08 155.82 39.87 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 121.291 -0.881 . . . . 0.0 110.335 -176.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.15 21.22 71.75 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.718 1.152 . . . . 0.0 113.89 173.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -82.25 162.58 22.28 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.426 1.09 . . . . 0.0 111.039 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -112.54 162.51 15.56 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.645 1.978 . . . . 0.0 107.43 167.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.91 -26.8 67.78 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.491 -0.756 . . . . 0.0 111.161 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.3 m -67.63 -24.4 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 O-C-N 120.793 -1.192 . . . . 0.0 112.753 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -62.85 -38.0 89.05 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.307 0.643 . . . . 0.0 109.293 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.436 ' HB3' HD21 ' A' ' 19' ' ' LEU . 67.4 mt -62.22 -50.87 70.03 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 126.755 2.022 . . . . 0.0 109.479 175.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.33 -37.88 89.05 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.957 0.903 . . . . 0.0 109.177 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -60.78 -54.42 45.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 122.05 -0.406 . . . . 0.0 110.093 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -56.56 -42.09 78.01 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 118.644 0.657 . . . . 0.0 111.071 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -58.72 -49.28 78.18 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.755 1.622 . . . . 0.0 111.107 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -20.73 64.64 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.827 -0.606 . . . . 0.0 112.328 175.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -77.66 -49.7 13.98 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.89 1.677 . . . . 0.0 109.685 165.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.5 mt -55.26 -56.19 22.82 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.508 0.594 . . . . 0.0 112.038 -173.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt . . . . . 0 N--CA 1.468 0.448 0 O-C-N 121.968 -0.458 . . . . 0.0 111.758 -173.787 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 . . . . . 0 C--O 1.238 0.465 0 CA-C-O 122.149 0.976 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.1 t -61.6 154.43 25.04 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.488 163.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -59.31 -20.75 57.0 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.396 1.078 . . . . 0.0 113.013 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.45 -58.57 5.53 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.264 1.026 . . . . 0.0 108.441 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -36.22 78.81 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.308 1.043 . . . . 0.0 110.94 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.49 -39.41 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 120.952 -1.092 . . . . 0.0 110.921 176.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -59.91 -46.38 89.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.227 -0.892 . . . . 0.0 109.761 173.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -61.57 -29.36 69.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.507 1.049 . . . . 0.0 112.558 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -63.32 -58.03 8.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.79 0.723 . . . . 0.0 109.859 175.493 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -64.94 -32.8 74.7 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.684 0.394 . . . . 0.0 111.327 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -65.15 -44.13 89.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.663 1.185 . . . . 0.0 109.858 174.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.02 -56.96 19.43 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 127.027 2.251 . . . . 0.0 110.924 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.8 t -63.13 -25.43 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 118.389 1.095 . . . . 0.0 110.593 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -68.31 -39.3 82.07 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 120.585 -1.322 . . . . 0.0 110.08 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.2 t -94.98 -28.69 15.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.137 0.575 . . . . 0.0 111.573 -172.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -107.94 -26.28 10.78 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.161 0.984 . . . . 0.0 112.687 -174.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.8 -155.11 52.73 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -162.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.96 38.49 0.08 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.555 1.542 . . . . 0.0 113.214 -172.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -109.16 97.79 7.34 Favored 'General case' 0 C--N 1.338 0.105 0 O-C-N 120.598 -1.314 . . . . 0.0 107.69 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -81.15 -38.91 26.38 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.383 -167.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -62.33 -42.87 99.74 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 123.669 0.606 . . . . 0.0 109.853 -175.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.3 t -55.67 -57.47 11.86 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 124.382 1.073 . . . . 0.0 111.046 171.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.7 mt -48.01 -51.92 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.631 1.572 . . . . 0.0 110.351 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.56 -37.95 52.04 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.568 1.547 . . . . 0.0 111.689 -177.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -85.81 -40.28 16.19 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.593 0.757 . . . . 0.0 111.454 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 t -62.92 -20.88 65.61 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -168.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -134.46 155.58 79.58 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 124.757 1.223 . . . . 0.0 107.863 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.63 110.43 2.31 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 N-CA-C 107.326 -1.836 . . . . 0.0 107.326 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -110.14 172.37 6.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 162.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.79 146.97 54.12 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -65.63 173.56 2.71 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.594 0.758 . . . . 0.0 110.058 169.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.56 -13.0 0.45 Allowed Glycine 0 CA--C 1.537 1.427 0 CA-C-O 119.197 -0.78 . . . . 0.0 114.014 -176.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 mmt85 -58.3 134.82 56.9 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.569 1.684 . . . . 0.0 108.061 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -87.41 165.87 15.25 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 162.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.17 -27.92 69.29 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.0 -1.062 . . . . 0.0 111.023 171.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 m -67.31 -27.75 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.313 1.045 . . . . 0.0 112.093 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.88 -45.52 64.18 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.898 0.879 . . . . 0.0 109.009 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.5 mt -66.1 -49.6 66.97 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.794 1.638 . . . . 0.0 109.966 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.7 -40.14 91.97 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.972 1.309 . . . . 0.0 109.875 -173.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -68.47 -51.36 44.33 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.957 0.903 . . . . 0.0 110.249 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -55.0 -45.08 75.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.824 0.738 . . . . 0.0 110.608 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -58.14 -47.43 83.35 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.041 1.337 . . . . 0.0 110.942 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -56.89 -43.08 80.96 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 118.947 -0.549 . . . . 0.0 111.196 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -71.2 -28.85 64.51 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.355 0.662 . . . . 0.0 112.069 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.72 -57.04 12.38 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.042 0.837 . . . . 0.0 109.596 171.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.2 pt . . . . . 0 CA--C 1.542 0.651 0 CA-C-N 118.958 0.799 . . . . 0.0 111.663 -179.577 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 122.561 1.172 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.98 159.36 32.84 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 130.611 3.565 . . . . 0.0 113.836 -169.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -54.08 -46.49 72.04 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 126.253 1.821 . . . . 0.0 111.868 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -71.54 -42.04 68.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.559 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -34.85 74.52 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.894 0.478 . . . . 0.0 109.941 -175.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.4 t -58.56 -41.62 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.03 -50.52 73.16 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.769 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -60.21 -34.48 73.71 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 118.514 0.597 . . . . 0.0 112.248 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.88 -53.36 59.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.145 0.978 . . . . 0.0 108.644 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -65.83 -47.82 73.73 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.652 -0.69 . . . . 0.0 111.393 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -56.74 -35.17 68.29 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.039 0.836 . . . . 0.0 110.409 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.39 -67.89 1.9 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 127.49 2.471 . . . . 0.0 110.849 170.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.1 t -56.23 -27.61 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.999 1.9 . . . . 0.0 111.466 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -62.1 -40.46 95.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.248 -0.907 . . . . 0.0 109.643 -177.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 t -96.07 -42.41 8.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.686 1.194 . . . . 0.0 111.379 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.74 -26.0 40.91 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 124.437 1.095 . . . . 0.0 113.918 -172.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.42 -116.54 8.04 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -164.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.91 12.16 32.77 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.191 1.495 . . . . 0.0 113.444 -172.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -73.76 97.11 2.65 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -80.36 -43.0 21.86 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 121.225 -0.922 . . . . 0.0 109.598 176.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -54.38 -41.18 68.92 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.215 0.606 . . . . 0.0 110.66 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.8 m -74.45 -38.49 62.97 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.661 1.184 . . . . 0.0 111.814 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 60.7 mt -59.92 -45.11 95.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -28.47 64.73 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.089 0.956 . . . . 0.0 112.227 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -85.14 -41.54 15.6 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.782 0.833 . . . . 0.0 110.084 173.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.3 t -67.22 -14.16 62.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 117.255 -1.355 . . . . 0.0 114.578 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.413 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 73.2 m-85 -151.93 160.84 30.95 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 120.737 1.608 . . . . 0.0 109.715 -177.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -74.68 143.57 30.38 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.604 1.536 . . . . 0.0 109.526 168.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' A' ' 37' ' ' PHE . 90.5 m-85 -137.38 113.51 9.91 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 169.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.25 45.4 mt-30 37.36 -124.94 0.21 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.967 1.707 . . . . 0.0 108.998 -168.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -133.56 143.01 48.43 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 158.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.93 62.32 5.33 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.085 0.85 . . . . 0.0 112.155 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -109.48 164.5 12.45 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.897 0.856 . . . . 0.0 113.258 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -99.53 165.78 11.47 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.941 1.696 . . . . 0.0 108.574 168.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.56 -31.83 73.21 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.589 -0.695 . . . . 0.0 109.935 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.6 m -64.08 -24.7 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.201 -0.937 . . . . 0.0 112.357 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.48 -11.74 61.08 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.824 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.3 mt -94.89 -18.87 20.76 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.162 1.385 . . . . 0.0 112.071 169.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.8 -43.57 22.19 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.039 171.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -74.63 -57.75 3.73 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -164.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -59.06 -39.39 81.93 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 116.412 -1.756 . . . . 0.0 110.867 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -50.79 -47.75 59.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 121.42 1.918 . . . . 0.0 110.891 168.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.49 -37.81 65.72 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.122 0.569 . . . . 0.0 112.006 176.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -76.59 -35.24 58.26 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.897 0.879 . . . . 0.0 112.167 173.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.2 mt -61.34 -45.93 92.37 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.522 1.055 . . . . 0.0 109.409 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 pt . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 175.344 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 . . . . . 0 C--O 1.238 0.49 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.2 p -75.72 178.96 5.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.356 1.062 . . . . 0.0 109.804 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 pttt -63.07 -31.75 72.96 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 120.189 -1.57 . . . . 0.0 112.24 165.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.62 -54.0 9.16 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.692 0.797 . . . . 0.0 108.923 -168.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -63.53 -23.75 67.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.461 -175.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.3 t -74.49 -39.21 47.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 119.078 0.854 . . . . 0.0 110.059 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -60.27 -47.93 83.9 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.6 m-30 -64.21 -30.9 71.94 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.799 0.84 . . . . 0.0 113.008 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.41 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -57.48 -54.79 42.87 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 174.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -61.45 -47.81 84.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.843 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.432 ' O ' ' HE3' ' A' ' 24' ' ' LYS . 4.0 m-70 -59.88 -36.08 76.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.268 0.94 . . . . 0.0 111.21 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.18 -54.46 20.58 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 125.684 1.612 . . . . 0.0 110.518 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.3 t -59.57 -28.13 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 118.296 1.048 . . . . 0.0 110.903 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -66.07 -36.98 84.66 Favored 'General case' 0 CA--C 1.521 -0.142 0 O-C-N 120.81 -1.181 . . . . 0.0 110.002 -178.887 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 t -95.46 -35.45 11.7 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.203 0.601 . . . . 0.0 111.84 -176.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -95.29 -11.98 26.96 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.908 0.883 . . . . 0.0 112.782 -173.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 57.82 -144.12 41.79 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 107.965 -2.054 . . . . 0.0 107.965 -157.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -61.86 -1.8 0.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -174.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -82.48 97.36 8.37 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 122.24 2.291 . . . . 0.0 109.831 -157.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -68.01 -41.88 81.54 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.573 -170.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -61.62 -43.05 99.58 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.8 m -60.03 -47.23 86.73 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.477 1.511 . . . . 0.0 112.008 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.2 mt -57.58 -46.73 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 123.933 0.893 . . . . 0.0 109.162 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -60.83 -21.56 63.31 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.06 0.544 . . . . 0.0 112.257 -175.559 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -96.27 -32.41 12.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.376 0.67 . . . . 0.0 111.572 173.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -18.3 65.0 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -134.12 149.97 72.95 Favored Pre-proline 0 C--O 1.236 0.384 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.12 107.2 2.43 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 N-CA-C 105.704 -2.46 . . . . 0.0 105.704 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -99.08 178.32 4.96 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -62.74 152.36 35.9 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.144 -0.973 . . . . 0.0 109.986 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -58.59 159.86 6.1 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.894 0.477 . . . . 0.0 109.908 164.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.16 9.44 29.22 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.9 mmt-85 -73.45 165.03 25.83 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 118.726 1.263 . . . . 0.0 110.484 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -132.14 158.71 40.95 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.56 -36.01 77.43 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 m -63.18 -27.71 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 124.135 0.974 . . . . 0.0 112.164 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -61.81 -40.58 95.75 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.41 ' HB3' HD21 ' A' ' 19' ' ' LEU . 34.2 mt -66.42 -47.96 71.56 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.154 1.382 . . . . 0.0 110.103 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.75 -46.57 88.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -61.31 -53.05 61.76 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 118.934 -0.555 . . . . 0.0 110.232 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.559 ' HZ3' HD21 ' A' ' 55' ' ' LEU . 2.6 tmtt? -50.22 -54.75 18.83 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.766 1.226 . . . . 0.0 109.318 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -57.59 -44.72 85.58 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 125.239 1.416 . . . . 0.0 111.812 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -57.93 -48.49 79.76 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -63.31 -25.62 68.39 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.749 0.704 . . . . 0.0 111.566 175.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.559 HD21 ' HZ3' ' A' ' 51' ' ' LYS . 70.5 mt -80.17 -15.88 56.08 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 175.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.9 pt . . . . . 0 CA--C 1.539 0.557 0 CA-C-N 119.808 1.185 . . . . 0.0 111.646 169.055 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.47 ' CD2' ' HG2' ' A' ' 51' ' ' LYS . 4.7 m-85 . . . . . 0 C--O 1.233 0.237 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -69.15 167.64 15.72 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.885 0.766 . . . . 0.0 111.787 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -32.65 74.39 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.476 -1.39 . . . . 0.0 110.592 175.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -67.46 -47.2 70.81 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -59.87 -44.71 94.02 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.753 -0.641 . . . . 0.0 110.541 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.09 -40.9 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 119.067 0.848 . . . . 0.0 109.468 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -60.19 -49.82 76.13 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 119.77 -0.157 . . . . 0.0 111.31 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -55.13 -40.96 71.13 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.8 0.84 . . . . 0.0 110.295 173.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.441 ' CD2' HD22 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -54.49 -51.56 64.7 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.538 -1.351 . . . . 0.0 109.808 -175.192 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -63.43 -47.6 81.25 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.745 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -55.11 -48.58 73.43 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.783 0.833 . . . . 0.0 110.912 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.43 -56.49 24.17 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 125.343 1.449 . . . . 0.0 109.865 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.5 t -60.7 -16.63 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 117.881 0.84 . . . . 0.0 112.684 -176.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -68.33 -57.23 6.24 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 120.434 -1.416 . . . . 0.0 109.191 172.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.0 t -80.83 -42.38 21.71 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.778 0.831 . . . . 0.0 109.566 -173.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -77.55 -27.71 51.64 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.45 -0.786 . . . . 0.0 112.809 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.8 -143.59 48.69 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -156.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -73.99 7.13 2.82 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.33 98.32 3.21 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 121.325 1.875 . . . . 0.0 109.446 -175.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -71.82 -45.11 62.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 119.185 -0.435 . . . . 0.0 109.914 -178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -48.92 -53.88 17.8 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.371 1.068 . . . . 0.0 111.967 176.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.6 m -55.24 -49.63 71.52 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.884 0.874 . . . . 0.0 111.317 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.1 mt -57.85 -49.94 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 125.818 1.647 . . . . 0.0 110.105 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -34.54 74.27 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.742 1.217 . . . . 0.0 111.583 -173.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -73.58 -47.86 37.27 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.839 -0.538 . . . . 0.0 111.077 166.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.436 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 5.4 t -62.63 -28.76 70.13 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -167.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 64.1 m-85 -134.28 148.85 69.46 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 119.62 1.1 . . . . 0.0 108.654 -174.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.52 110.55 2.45 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.869 2.379 . . . . 0.0 110.603 -174.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -111.51 113.51 25.98 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.849 1.26 . . . . 0.0 109.473 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 31.09 -141.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.891 2.476 . . . . 0.0 111.121 -166.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -106.83 160.52 15.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 144.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 61.74 49.08 79.8 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 124.864 1.221 . . . . 0.0 114.315 166.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.524 ' HA ' ' HE ' ' A' ' 43' ' ' ARG . 1.5 mmp_? -105.1 165.56 11.0 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.581 1.19 . . . . 0.0 111.511 174.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -122.36 161.75 22.85 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.772 1.629 . . . . 0.0 107.588 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.05 -44.17 70.83 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.137 0.426 . . . . 0.0 110.722 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 m -62.29 -27.25 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.572 0.749 . . . . 0.0 112.722 -176.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.38 -41.35 84.64 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.441 HD22 ' CD2' ' A' ' 19' ' ' LEU . 35.2 mt -66.78 -39.22 87.74 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.794 1.238 . . . . 0.0 109.838 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.04 -54.15 29.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.261 1.024 . . . . 0.0 108.342 -177.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.97 -50.46 64.05 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 122.674 0.39 . . . . 0.0 111.351 174.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 42.6 tptt -56.67 -54.19 49.02 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -54.89 -48.53 72.89 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.029 1.332 . . . . 0.0 110.234 -173.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -55.77 -48.03 76.0 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -62.75 -34.42 77.19 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.403 -0.81 . . . . 0.0 112.884 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.3 mt -68.42 -39.13 81.71 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 119.53 1.059 . . . . 0.0 111.414 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.9 pt . . . . . 0 CA--C 1.534 0.349 0 CA-C-N 118.842 0.746 . . . . 0.0 111.965 -174.533 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t -73.37 164.85 26.09 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.157 1.383 . . . . 0.0 108.773 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -52.94 -36.37 59.71 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 118.607 -0.711 . . . . 0.0 112.729 -172.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.25 -54.97 18.63 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -174.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.45 -37.09 82.29 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 124.236 1.014 . . . . 0.0 110.784 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.13 -36.43 73.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 O-C-N 121.405 -0.809 . . . . 0.0 110.582 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -68.45 -45.28 72.91 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 117.782 -1.104 . . . . 0.0 109.392 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -59.74 -35.16 74.0 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 119.689 1.131 . . . . 0.0 111.47 174.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.96 -56.02 27.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.709 0.804 . . . . 0.0 108.881 175.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.482 ' CZ ' HD13 ' A' ' 55' ' ' LEU . 31.2 m-85 -62.35 -44.38 96.6 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 119.049 -0.5 . . . . 0.0 110.73 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -53.44 -44.8 69.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.568 1.147 . . . . 0.0 110.073 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.85 -56.63 15.41 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 126.649 2.071 . . . . 0.0 111.58 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.3 t -65.23 -16.97 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 121.359 -1.083 . . . . 0.0 110.934 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -80.74 -39.89 26.19 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.124 -1.61 . . . . 0.0 109.924 174.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.6 t -95.69 -12.22 25.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.164 0.986 . . . . 0.0 112.292 -170.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 33.2 mtt -125.62 -48.48 1.66 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.146 1.378 . . . . 0.0 111.327 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.21 -154.67 19.86 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -165.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -61.97 15.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.492 2.317 . . . . 0.0 116.32 -175.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -78.8 97.37 5.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 120.447 1.476 . . . . 0.0 107.455 170.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -76.3 -47.15 24.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.7 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -62.57 -43.35 99.03 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.358 0.663 . . . . 0.0 109.299 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.9 m -59.78 -49.81 76.28 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.698 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.8 mt -58.33 -44.58 88.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 119.665 1.12 . . . . 0.0 109.241 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.11 -47.29 65.37 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.413 1.485 . . . . 0.0 110.555 -177.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -85.86 -28.57 24.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 119.322 -0.37 . . . . 0.0 111.143 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 t -59.32 -69.97 0.18 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.464 0.706 . . . . 0.0 109.932 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -84.99 148.9 51.92 Favored Pre-proline 0 C--O 1.235 0.335 0 O-C-N 121.313 -0.867 . . . . 0.0 109.179 -171.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.57 108.43 1.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 N-CA-C 108.628 -1.336 . . . . 0.0 108.628 -173.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -111.02 154.46 24.15 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.352 0.661 . . . . 0.0 110.317 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -54.9 130.49 41.51 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.381 1.072 . . . . 0.0 110.123 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -64.07 117.73 7.5 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.33 -24.34 4.72 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.064 1.792 . . . . 0.0 110.681 -166.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 145.05 56.6 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.449 1.124 . . . . 0.0 110.664 173.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -120.09 175.17 6.06 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.468 1.907 . . . . 0.0 107.6 167.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.31 -41.33 84.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.483 -0.761 . . . . 0.0 109.972 166.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.5 m -65.02 -31.4 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.183 0.593 . . . . 0.0 112.285 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.14 -50.08 65.27 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.0 mt -64.95 -50.27 67.07 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.104 1.762 . . . . 0.0 109.767 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.79 -49.2 78.57 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 124.71 1.256 . . . . 0.0 107.662 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -60.66 -51.86 67.61 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.184 0.594 . . . . 0.0 111.029 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HZ3' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -54.49 -48.61 71.64 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.571 0.748 . . . . 0.0 109.3 -177.153 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -63.77 -49.85 71.37 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.453 1.101 . . . . 0.0 110.686 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -57.37 -38.11 73.7 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.307 1.443 . . . . 0.0 111.397 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -65.66 -53.59 39.18 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 118.339 -0.839 . . . . 0.0 109.728 167.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.482 HD13 ' CZ ' ' A' ' 20' ' ' PHE . 22.6 mt -57.78 -27.68 63.31 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -175.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.1 pt . . . . . 0 CA--C 1.532 0.285 0 CA-C-N 119.656 1.116 . . . . 0.0 112.01 176.73 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 t -62.92 154.94 28.66 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 161.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.16 -29.48 68.7 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.343 -0.848 . . . . 0.0 111.367 -173.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -58.84 -50.27 74.62 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.747 0.819 . . . . 0.0 110.286 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -62.41 -30.68 71.39 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.089 -0.481 . . . . 0.0 110.903 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.1 t -70.15 -31.56 47.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 119.477 1.035 . . . . 0.0 111.477 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -66.45 -52.3 47.78 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 174.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -60.71 -33.14 72.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.339 0.656 . . . . 0.0 111.619 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -58.14 9.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.844 0.858 . . . . 0.0 109.345 173.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -57.95 -48.34 80.24 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 122.945 0.498 . . . . 0.0 110.562 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -58.82 -38.6 79.0 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.396 0.678 . . . . 0.0 110.992 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.11 -55.62 25.31 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 125.246 1.403 . . . . 0.0 110.806 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.64 -23.81 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 118.464 1.132 . . . . 0.0 111.285 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -72.28 -41.44 66.68 Favored 'General case' 0 C--O 1.224 -0.253 0 O-C-N 120.922 -1.111 . . . . 0.0 109.991 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 t -96.32 -37.2 10.6 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.578 0.751 . . . . 0.0 111.207 -172.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -86.29 -105.22 0.06 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 167.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.17 -81.92 0.15 Allowed Glycine 0 C--O 1.226 -0.406 0 CA-C-O 118.335 -1.259 . . . . 0.0 110.759 -173.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.68 4.29 9.52 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.437 2.119 . . . . 0.0 112.396 173.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -75.9 98.73 4.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -79.41 -35.2 40.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.869 1.268 . . . . 0.0 110.534 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -55.05 -47.26 75.03 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.941 0.896 . . . . 0.0 110.44 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.6 m -55.55 -59.27 5.06 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.773 1.629 . . . . 0.0 111.224 174.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 76.6 mt -53.08 -44.6 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 125.666 1.587 . . . . 0.0 110.165 -173.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -17.18 40.71 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -174.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -111.89 -29.51 7.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.681 1.192 . . . . 0.0 111.499 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.14 -19.92 65.62 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.054 0.942 . . . . 0.0 113.059 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -139.31 155.0 72.43 Favored Pre-proline 0 C--O 1.235 0.29 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.85 110.05 3.01 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.843 1.695 . . . . 0.0 110.061 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -115.72 157.24 24.58 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.906 1.282 . . . . 0.0 109.131 174.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -49.7 149.65 2.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.612 1.165 . . . . 0.0 112.549 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -61.72 144.78 54.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.66 -2.4 40.04 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.819 -1.545 . . . . 0.0 114.415 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -58.41 153.39 15.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 120.266 2.033 . . . . 0.0 110.283 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -112.31 160.8 17.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.04 0.936 . . . . 0.0 108.69 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.44 -30.99 63.52 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 122.192 -0.317 . . . . 0.0 110.651 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.1 m -65.02 -29.06 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 C-N-CA 123.723 0.809 . . . . 0.0 112.544 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -57.16 -41.52 79.37 Favored 'General case' 0 CA--C 1.516 -0.36 0 O-C-N 124.363 1.04 . . . . 0.0 109.517 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.7 mt -65.63 -48.95 70.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.737 1.215 . . . . 0.0 109.584 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.17 -44.19 95.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.845 0.858 . . . . 0.0 108.796 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -67.03 -46.38 74.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.143 0.577 . . . . 0.0 111.324 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -60.52 -39.66 88.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 119.512 1.051 . . . . 0.0 110.889 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.68 -42.94 99.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.475 0.71 . . . . 0.0 110.257 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -60.13 -47.76 84.57 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.77 172.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -52.09 -42.73 63.46 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.47 1.032 . . . . 0.0 109.986 173.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.6 mt -68.09 -60.62 2.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 119.049 -0.5 . . . . 0.0 111.091 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt . . . . . 0 N--CA 1.468 0.441 0 CA-C-N 118.97 0.804 . . . . 0.0 112.242 -172.846 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.515 ' CG ' ' HE2' ' A' ' 51' ' ' LYS . 2.4 m-30 . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 122.899 1.333 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 p -69.59 163.21 26.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.235 1.414 . . . . 0.0 108.28 160.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -57.93 -34.42 69.85 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.478 164.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -56.03 -59.86 4.3 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 126.056 1.743 . . . . 0.0 110.338 172.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -37.45 82.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.598 1.09 . . . . 0.0 111.01 -176.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.45 -41.08 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 118.606 0.639 . . . . 0.0 110.758 173.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -60.68 -47.73 84.94 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.57 0.748 . . . . 0.0 110.465 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -66.98 -31.95 72.86 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.83 0.452 . . . . 0.0 111.566 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.42 ' CD2' HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -56.08 -53.07 61.43 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 170.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.16 -46.24 89.84 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.466 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -55.56 -41.94 74.0 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.427 0.691 . . . . 0.0 110.896 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.04 -54.24 22.3 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 126.651 2.072 . . . . 0.0 111.369 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.1 t -64.67 -22.97 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 121.166 -1.196 . . . . 0.0 111.417 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -67.91 -45.89 73.1 Favored 'General case' 0 C--O 1.225 -0.191 0 O-C-N 121.041 -1.037 . . . . 0.0 109.82 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 t -95.58 -40.97 9.16 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.665 0.786 . . . . 0.0 110.957 -162.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -80.47 -66.19 0.91 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 166.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.81 -164.0 12.1 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 -146.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -78.89 23.47 0.34 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.84 0.856 . . . . 0.0 111.944 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -75.06 96.75 3.28 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 120.969 1.713 . . . . 0.0 107.122 165.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -72.62 -36.34 68.04 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.011 -1.449 . . . . 0.0 109.621 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -13.59 62.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.358 0.663 . . . . 0.0 112.184 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -86.29 -58.1 2.76 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 124.296 1.038 . . . . 0.0 108.805 169.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 92.4 mt -52.04 -44.9 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 C-N-CA 126.672 1.989 . . . . 0.0 111.372 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.91 -23.36 52.96 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.572 1.149 . . . . 0.0 112.72 -175.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -109.91 -35.88 6.04 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.885 1.274 . . . . 0.0 111.281 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.93 -29.57 69.69 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.962 0.801 . . . . 0.0 112.167 175.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -127.0 150.99 73.47 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 124.331 1.052 . . . . 0.0 108.629 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -87.82 107.55 0.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 CA-C-N 119.836 0.977 . . . . 0.0 110.004 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -94.11 161.14 14.4 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.414 -0.804 . . . . 0.0 109.405 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -66.0 147.1 53.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 173.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -53.68 146.04 14.21 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.511 0.725 . . . . 0.0 109.852 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.85 -15.13 56.67 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.373 -1.237 . . . . 0.0 112.32 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.2 111.05 3.25 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 120.421 2.11 . . . . 0.0 106.999 160.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -83.15 175.35 10.03 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 159.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.62 78.12 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.875 -1.14 . . . . 0.0 110.838 170.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.5 m -65.15 -30.32 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.025 0.93 . . . . 0.0 112.46 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.56 -41.45 90.15 Favored 'General case' 0 C--O 1.222 -0.371 0 O-C-N 124.133 0.896 . . . . 0.0 108.994 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.42 HD22 ' CD2' ' A' ' 19' ' ' LEU . 31.4 mt -65.98 -43.39 87.98 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.226 0.61 . . . . 0.0 109.641 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.06 -49.04 77.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -58.38 -51.76 68.45 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.953 0.901 . . . . 0.0 111.155 178.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HE2' ' CG ' ' A' ' 11' ' ' PHE . 48.0 tptt -55.92 -50.14 71.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.718 1.207 . . . . 0.0 110.091 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -61.62 -50.46 72.48 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.867 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -50.6 -47.87 58.03 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.037 0.835 . . . . 0.0 110.722 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.7 mmt-85 -65.88 -36.86 84.59 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 118.17 -0.919 . . . . 0.0 112.817 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.2 mt -65.97 -53.05 43.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.528 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.7 pt . . . . . 0 CA--C 1.529 0.138 0 CA-C-N 119.11 0.868 . . . . 0.0 111.58 -175.998 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.58 ' CZ ' HD23 ' A' ' 48' ' ' LEU . 6.9 m-30 . . . . . 0 C--O 1.237 0.437 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.0 p -61.91 164.47 6.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.45 173.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -55.01 -31.85 61.37 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.545 -0.722 . . . . 0.0 110.587 170.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.41 -50.99 61.59 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.563 1.545 . . . . 0.0 108.654 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -63.92 -38.1 89.84 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.306 -0.871 . . . . 0.0 110.454 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.95 -25.31 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.459 1.027 . . . . 0.0 110.193 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -60.15 -60.02 4.48 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.468 -0.77 . . . . 0.0 109.096 169.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -63.94 -28.56 69.91 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.245 1.018 . . . . 0.0 112.556 -174.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.48 -56.23 24.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.952 0.901 . . . . 0.0 109.925 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -67.41 -42.36 83.39 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -52.17 -35.44 48.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.941 0.897 . . . . 0.0 111.337 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.54 -49.55 4.1 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 126.695 2.093 . . . . 0.0 111.825 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.5 t -61.46 -36.83 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 119.244 1.522 . . . . 0.0 110.007 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -63.7 -28.38 69.86 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.548 -0.72 . . . . 0.0 110.833 -174.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -95.2 -59.07 1.97 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.085 0.954 . . . . 0.0 108.81 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 33.8 mtt -71.3 -28.0 63.81 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.058 -1.026 . . . . 0.0 113.555 -170.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.33 -157.46 52.07 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -150.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -83.44 33.07 0.46 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.586 1.154 . . . . 0.0 111.963 -162.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -82.23 96.47 7.87 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -79.29 -46.21 18.19 Favored 'General case' 0 C--O 1.224 -0.255 0 O-C-N 121.778 -0.576 . . . . 0.0 110.194 -170.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -49.26 -52.22 28.71 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.647 1.579 . . . . 0.0 110.829 172.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.3 m -55.74 -54.55 43.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.035 0.934 . . . . 0.0 111.01 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.8 mt -54.27 -45.46 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.781 1.232 . . . . 0.0 110.518 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -22.66 20.52 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.98 1.312 . . . . 0.0 112.245 -177.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -106.54 -34.57 7.33 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.397 1.079 . . . . 0.0 111.575 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 t -60.93 -30.48 70.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.516 0.727 . . . . 0.0 111.246 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -133.88 152.01 77.88 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -176.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.86 110.57 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.942 2.428 . . . . 0.0 110.996 -172.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -110.03 170.63 7.95 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.556 0.742 . . . . 0.0 110.202 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -58.58 160.43 5.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 123.043 1.401 . . . . 0.0 112.884 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.12 138.68 57.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.041 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.8 6.8 57.19 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 117.895 -1.503 . . . . 0.0 114.543 175.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -61.82 158.3 16.19 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 120.286 2.043 . . . . 0.0 110.064 173.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -112.33 161.36 16.73 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.066 1.347 . . . . 0.0 107.472 170.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.21 -35.01 69.13 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.934 -0.479 . . . . 0.0 110.997 176.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 m -61.13 -25.14 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.469 1.108 . . . . 0.0 112.746 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -64.21 -33.37 75.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.58 HD23 ' CZ ' ' A' ' 11' ' ' PHE . 41.8 mt -71.41 -41.06 70.06 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.633 1.573 . . . . 0.0 110.476 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.28 -52.3 64.25 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 172.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -59.89 -53.51 57.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.674 -0.641 . . . . 0.0 112.205 -167.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -64.71 -40.48 95.43 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.165 -173.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -56.82 -53.43 58.0 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.982 1.713 . . . . 0.0 110.34 174.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -53.73 -47.07 70.95 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.435 1.094 . . . . 0.0 109.526 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -64.82 -42.64 94.82 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.148 -0.93 . . . . 0.0 110.727 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.4 mt -61.05 -53.49 56.55 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.932 1.242 . . . . 0.0 112.023 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 CA--C 1.535 0.371 0 CA-C-N 119.357 0.981 . . . . 0.0 110.197 -178.744 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.502 ' CD2' ' HG3' ' A' ' 51' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 t -68.83 160.08 31.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.336 1.054 . . . . 0.0 110.262 -170.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -58.56 -31.43 67.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.224 1.01 . . . . 0.0 111.995 -168.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 14' ' ' GLU . 25.0 mp0 -68.67 -51.08 45.77 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 127.899 2.48 . . . . 0.0 108.639 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -60.94 -33.58 73.39 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 119.332 -0.366 . . . . 0.0 110.676 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.03 -32.91 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 120.486 -1.384 . . . . 0.0 109.707 176.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -61.94 -52.12 65.33 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -62.55 -36.89 84.08 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.434 1.094 . . . . 0.0 111.899 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.03 -54.8 42.84 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -63.26 -40.84 98.54 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.139 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -56.66 -57.55 11.91 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.814 0.734 . . . . 0.0 109.435 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -50.83 -55.24 18.76 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 125.653 1.597 . . . . 0.0 111.828 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.44 -24.21 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 118.148 0.974 . . . . 0.0 111.097 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -75.13 -33.72 61.59 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 120.87 -1.144 . . . . 0.0 111.213 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 t -90.56 -47.85 7.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.73 1.15 . . . . 0.0 109.487 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.9 mtt -80.72 -66.37 0.89 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.682 0.674 . . . . 0.0 109.537 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.07 -152.62 16.76 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 -158.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -72.41 16.1 0.15 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.553 2.341 . . . . 0.0 112.645 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -78.53 97.76 5.85 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 120.205 1.366 . . . . 0.0 107.324 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -79.22 -51.38 9.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.045 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -56.74 -45.49 81.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.165 0.439 . . . . 0.0 110.952 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.2 m -58.25 -51.97 67.54 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.051 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.2 mt -56.14 -44.4 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 119.736 1.153 . . . . 0.0 110.075 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.07 -30.35 15.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.082 1.353 . . . . 0.0 111.487 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.4 m0 -103.38 -35.25 8.45 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.771 1.228 . . . . 0.0 111.545 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -63.45 -24.17 67.71 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.207 1.403 . . . . 0.0 112.762 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -123.19 153.12 64.72 Favored Pre-proline 0 C--O 1.236 0.389 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 175.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -79.45 109.35 2.47 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 N-CA-C 107.774 -1.664 . . . . 0.0 107.774 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -106.31 156.37 18.57 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.462 0.705 . . . . 0.0 109.623 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -59.3 154.82 15.71 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.15 0.98 . . . . 0.0 111.443 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 167.88 18.19 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.561 0.696 . . . . 0.0 112.321 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.98 -7.2 29.88 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.695 1.14 . . . . 0.0 112.864 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.6 165.6 12.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.396 1.478 . . . . 0.0 113.163 -176.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -141.6 165.7 26.78 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.658 1.983 . . . . 0.0 107.288 171.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.84 -32.16 67.35 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.003 -1.06 . . . . 0.0 111.048 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 m -75.54 -20.0 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.056 1.343 . . . . 0.0 112.55 -174.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.63 -53.39 58.69 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 171.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 43.1 mt -53.29 -54.31 38.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.565 1.946 . . . . 0.0 110.343 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.48 -48.12 80.98 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.924 1.289 . . . . 0.0 108.989 -173.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -64.71 -46.96 80.1 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.502 ' HG3' ' CD2' ' A' ' 11' ' ' PHE . 1.3 tmtm? -58.99 -49.71 76.86 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 124.726 1.21 . . . . 0.0 109.308 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.45 -47.92 78.13 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.154 0.982 . . . . 0.0 110.616 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -54.33 -48.5 71.3 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.457 -0.782 . . . . 0.0 110.439 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 mtt85 -62.87 -26.6 68.86 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.818 1.247 . . . . 0.0 113.273 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 74.8 mt -76.67 -52.35 9.8 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.347 -0.846 . . . . 0.0 111.088 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.3 pt . . . . . 0 CA--C 1.536 0.441 0 CA-C-N 118.616 0.644 . . . . 0.0 110.922 -173.319 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.434 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -164.29 104.73 0.86 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.361 1.464 . . . . 0.0 107.152 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 t -136.11 170.8 15.43 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 121.551 -0.718 . . . . 0.0 110.656 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.01 169.09 37.82 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.612 1.577 . . . . 0.0 111.21 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.9 p -157.66 23.0 0.28 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.582 1.153 . . . . 0.0 112.43 -162.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.7 m -80.45 117.24 21.01 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.456 -1.402 . . . . 0.0 109.125 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.05 53.45 1.88 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.476 1.036 . . . . 0.0 110.876 -177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -154.1 172.65 17.2 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.908 0.854 . . . . 0.0 110.389 -172.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -51.72 92.4 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.121 2.168 . . . . 0.0 111.087 174.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -153.65 -179.84 8.17 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.894 2.878 . . . . 0.0 105.361 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -73.91 138.33 44.23 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 119.995 -1.69 . . . . 0.0 109.15 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.77 158.81 31.55 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 162.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -55.34 -26.96 44.11 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.276 -1.345 . . . . 0.0 111.706 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -67.41 -46.45 73.17 Favored 'General case' 0 CA--C 1.526 0.05 0 CA-C-N 119.735 1.152 . . . . 0.0 111.377 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -38.74 91.99 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.397 0.999 . . . . 0.0 109.189 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.7 t -67.19 -27.45 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 119.265 0.939 . . . . 0.0 110.855 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -57.46 -60.2 4.01 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -61.14 -30.38 70.35 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -58.77 -58.86 6.75 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -71.96 -35.7 69.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 118.383 -0.818 . . . . 0.0 111.736 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -54.61 -45.2 73.63 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.273 0.942 . . . . 0.0 109.494 176.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.95 -64.36 3.72 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 125.464 1.506 . . . . 0.0 110.364 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.8 t -54.42 -27.93 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 118.964 1.382 . . . . 0.0 112.045 -174.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -67.02 -29.73 69.62 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.208 1.403 . . . . 0.0 111.518 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.1 t -97.17 -55.85 2.73 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.003 1.321 . . . . 0.0 112.085 167.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.0 mmt -61.36 -29.34 69.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.825 2.05 . . . . 0.0 113.171 -168.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.49 -153.82 48.79 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -153.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -76.07 19.89 0.21 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.137 1.375 . . . . 0.0 112.782 -168.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -81.55 97.77 7.99 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.299 -1.5 . . . . 0.0 108.733 -171.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -81.72 -47.9 12.34 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.033 -164.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -58.18 -43.51 87.55 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.656 0.662 . . . . 0.0 109.48 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.2 m -54.93 -49.93 70.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.781 1.632 . . . . 0.0 111.532 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 60.6 mt -58.56 -48.65 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 124.399 1.08 . . . . 0.0 109.562 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.73 -37.15 63.05 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.504 1.121 . . . . 0.0 111.423 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 14.3 m0 -85.08 -34.6 22.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.032 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.8 t -69.81 -30.41 67.93 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.672 1.124 . . . . 0.0 113.224 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -124.94 154.37 71.08 Favored Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 119.804 1.184 . . . . 0.0 110.355 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.08 117.81 5.32 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 121.867 1.711 . . . . 0.0 109.478 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -129.25 161.93 29.06 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.033 1.333 . . . . 0.0 110.616 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -47.64 129.3 13.66 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.689 1.596 . . . . 0.0 111.298 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -57.84 150.8 19.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.488 0.661 . . . . 0.0 109.573 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.6 4.25 44.98 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 117.685 -1.619 . . . . 0.0 114.634 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -53.22 164.01 0.49 Allowed 'General case' 0 C--N 1.343 0.308 0 CA-C-N 119.557 1.679 . . . . 0.0 110.649 170.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -121.45 158.5 28.26 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 163.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.35 -25.79 68.09 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.388 0.54 . . . . 0.0 111.327 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.71 -34.75 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.55 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -56.87 -35.14 68.57 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.95 0.5 . . . . 0.0 109.921 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.8 mt -66.18 -53.97 31.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.02 0.928 . . . . 0.0 109.297 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.23 -38.51 76.98 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.841 1.256 . . . . 0.0 110.379 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -75.48 -42.89 51.86 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.714 1.606 . . . . 0.0 110.623 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -65.59 -45.78 81.9 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.386 -0.821 . . . . 0.0 109.347 172.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -54.9 -48.6 72.83 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 126.099 1.759 . . . . 0.0 110.722 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -46.51 -58.14 4.06 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.386 1.074 . . . . 0.0 109.784 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -61.92 -33.4 74.18 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.216 -0.927 . . . . 0.0 112.519 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 mt -63.71 -44.32 93.97 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.959 0.799 . . . . 0.0 110.071 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.0 pt -81.29 -8.23 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 119.485 1.039 . . . . 0.0 112.479 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.8 m -80.04 -4.92 54.7 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.68 1.192 . . . . 0.0 113.013 161.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.33 -166.66 14.38 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 118.849 0.75 . . . . 0.0 113.401 167.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -83.41 152.5 13.7 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.873 3.049 . . . . 0.0 111.415 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.2 m 55.2 174.6 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.849 1.66 . . . . 0.0 113.263 -174.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.1 m 48.28 74.97 0.15 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.532 1.533 . . . . 0.0 112.255 -172.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.336 0 CA-C-O 116.527 -2.263 . . . . 0.0 112.306 171.076 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.931 0 N-CA-C 112.571 -0.212 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 t -155.62 112.23 3.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 172.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 t -143.11 169.66 17.17 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 158.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.81 -71.94 0.11 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 125.929 1.728 . . . . 0.0 109.438 -177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.0 t -94.99 17.88 13.08 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.594 1.158 . . . . 0.0 112.08 -173.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.6 m -121.28 82.43 1.93 Allowed 'General case' 0 CA--C 1.521 -0.15 0 O-C-N 120.275 -1.516 . . . . 0.0 109.979 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.98 137.27 11.05 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 162.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -157.51 -49.41 0.07 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.807 1.243 . . . . 0.0 110.728 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -136.96 -178.83 5.36 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.825 1.25 . . . . 0.0 112.103 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.5 t70 47.13 -152.72 0.08 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -141.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -91.54 136.45 33.11 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 120.976 1.716 . . . . 0.0 108.72 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 p -68.33 167.41 14.58 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.476 0.58 . . . . 0.0 110.153 170.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -57.76 -34.24 69.34 Favored 'General case' 0 N--CA 1.462 0.139 0 O-C-N 121.129 -0.982 . . . . 0.0 110.29 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.96 -54.73 37.64 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.053 0.941 . . . . 0.0 109.658 175.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -60.49 -42.69 96.82 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 123.031 0.532 . . . . 0.0 110.841 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.2 t -65.21 -35.1 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 O-C-N 121.367 -0.833 . . . . 0.0 110.885 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -63.67 -50.66 68.37 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 172.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -61.07 -33.32 73.15 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 118.771 0.714 . . . . 0.0 111.333 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -58.82 -56.28 24.28 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.92 0.888 . . . . 0.0 108.923 174.287 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -60.36 -44.73 95.31 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.152 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -56.99 -44.36 82.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.96 0.904 . . . . 0.0 109.721 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.84 -63.1 5.6 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 126.679 2.085 . . . . 0.0 110.423 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.23 -22.03 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 118.895 1.347 . . . . 0.0 111.162 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -73.7 -30.46 62.88 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 119.972 -1.705 . . . . 0.0 110.974 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.7 t -95.59 -57.71 2.31 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.709 0.804 . . . . 0.0 109.45 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -70.0 -27.14 64.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.413 1.485 . . . . 0.0 112.659 -174.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.93 -148.69 45.47 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -153.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -76.82 15.27 0.68 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.67 1.188 . . . . 0.0 113.994 -159.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -84.5 97.46 9.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 120.144 1.338 . . . . 0.0 110.093 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -71.82 -42.42 67.04 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.502 0.721 . . . . 0.0 112.455 -175.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -64.39 -40.91 96.73 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 118.619 0.645 . . . . 0.0 109.666 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.16 -54.53 38.49 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 123.4 0.68 . . . . 0.0 109.435 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.9 mt -54.57 -52.05 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 126.111 1.765 . . . . 0.0 109.831 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -47.16 69.33 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.299 1.44 . . . . 0.0 110.836 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -74.99 -39.79 61.06 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.696 -0.668 . . . . 0.0 110.602 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -59.92 -71.6 0.13 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.581 1.152 . . . . 0.0 110.565 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -87.17 153.15 53.87 Favored Pre-proline 0 N--CA 1.453 -0.301 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -166.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.15 110.52 3.13 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.588 1.525 . . . . 0.0 109.081 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -111.11 174.17 5.99 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.071 0.948 . . . . 0.0 108.698 172.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -63.98 155.85 29.73 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.939 0.876 . . . . 0.0 111.358 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -62.55 139.03 58.6 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.453 1.101 . . . . 0.0 109.043 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.55 23.31 76.66 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 117.689 0.222 . . . . 0.0 112.599 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -70.47 165.42 22.63 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 121.406 -1.055 . . . . 0.0 111.495 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -118.13 161.25 20.17 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.698 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.03 86.05 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 165.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.43 -26.34 33.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 O-C-N 121.546 -0.721 . . . . 0.0 111.761 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.6 -41.81 86.69 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HB3' HD21 ' A' ' 19' ' ' LEU . 55.6 mt -65.14 -52.26 56.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.14 1.776 . . . . 0.0 109.111 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.02 -46.43 82.34 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.521 1.128 . . . . 0.0 108.089 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -63.72 -54.43 35.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.96 1.304 . . . . 0.0 110.899 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.88 -47.2 77.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.772 0.715 . . . . 0.0 109.299 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -60.07 -49.94 75.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.581 1.552 . . . . 0.0 111.193 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -55.59 -41.2 73.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.82 1.248 . . . . 0.0 111.059 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mmm-85 -68.86 -42.96 76.33 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.936 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.9 mt -58.27 -49.99 75.18 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.886 1.221 . . . . 0.0 112.527 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -73.24 -4.56 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.093 0.557 . . . . 0.0 112.045 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 32.6 79.65 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 129.534 3.134 . . . . 0.0 111.608 -167.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -46.61 131.26 11.99 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.011 -1.438 . . . . 0.0 110.474 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.39 165.42 29.01 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.003 2.469 . . . . 0.0 112.338 -168.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.5 p -147.63 132.92 18.46 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.77 1.228 . . . . 0.0 108.858 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.9 t 55.83 178.05 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.593 2.357 . . . . 0.0 114.298 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.966 0 C-N-CA 125.356 1.455 . . . . 0.0 110.039 174.547 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.778 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.8 t -172.16 -147.77 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.52 2.328 . . . . 0.0 104.823 170.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -58.0 168.01 1.08 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.927 1.691 . . . . 0.0 112.25 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.8 80.47 1.48 Allowed Glycine 0 C--N 1.334 0.458 0 N-CA-C 108.494 -1.843 . . . . 0.0 108.494 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.1 p -62.04 166.09 5.01 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 117.283 0.542 . . . . 0.0 111.282 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.9 m 59.57 156.69 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.547 1.939 . . . . 0.0 114.057 -171.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.56 -87.67 1.28 Allowed Glycine 0 C--N 1.333 0.407 0 N-CA-C 108.048 -2.021 . . . . 0.0 108.048 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.22 -62.53 0.79 Allowed 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 148.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -137.48 -78.55 0.38 Allowed 'General case' 0 N--CA 1.461 0.092 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 174.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -53.49 123.24 11.52 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.752 1.221 . . . . 0.0 109.498 169.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 54.68 94.75 0.02 OUTLIER 'General case' 0 C--O 1.243 0.72 0 C-N-CA 126.78 2.032 . . . . 0.0 113.194 -174.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.4 p -61.7 176.64 0.5 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.453 1.121 . . . . 0.0 110.719 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -58.92 -42.73 90.38 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 120.656 -1.278 . . . . 0.0 110.487 173.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -55.93 -54.47 44.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 124.708 1.255 . . . . 0.0 108.741 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -62.04 -41.79 98.49 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.332 1.053 . . . . 0.0 111.517 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.1 t -64.34 -38.02 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.029 0.831 . . . . 0.0 109.917 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -62.78 -47.95 81.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -60.36 -34.47 73.91 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.338 0.655 . . . . 0.0 112.389 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -57.0 -55.24 37.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -60.79 -46.95 88.49 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.813 0.445 . . . . 0.0 111.256 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -35.05 71.0 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.712 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -78.36 -51.54 5.61 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 125.923 1.725 . . . . 0.0 111.171 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.0 t -58.66 -28.99 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 118.249 1.024 . . . . 0.0 110.468 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -49.72 74.62 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 124.265 1.026 . . . . 0.0 110.34 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 t -96.77 -21.63 17.43 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.847 1.659 . . . . 0.0 113.647 -167.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.8 mtp -128.53 -6.56 5.22 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.204 1.002 . . . . 0.0 112.587 -170.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.86 -158.07 53.45 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 119.232 0.923 . . . . 0.0 111.385 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -72.0 21.54 0.06 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.289 1.036 . . . . 0.0 112.193 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -82.91 97.72 8.83 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -176.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -82.37 -45.07 15.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.047 -163.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -50.11 -49.5 51.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.598 0.759 . . . . 0.0 109.282 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -54.8 -54.78 37.69 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 128.063 2.545 . . . . 0.0 110.351 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 67.6 mt -59.21 -44.91 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.084 0.954 . . . . 0.0 110.355 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -34.64 64.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.379 1.472 . . . . 0.0 110.925 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -88.74 -37.26 15.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.101 0.96 . . . . 0.0 111.848 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 t -67.3 -18.66 65.27 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -140.68 154.09 68.64 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 119.881 1.218 . . . . 0.0 110.021 -173.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.12 109.58 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.159 1.906 . . . . 0.0 110.823 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -107.58 -178.53 3.65 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.668 1.187 . . . . 0.0 109.67 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -67.7 162.95 22.61 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.671 -0.643 . . . . 0.0 110.785 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.9 147.58 50.09 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 121.669 -0.644 . . . . 0.0 109.931 176.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.4 5.8 37.71 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.107 -0.83 . . . . 0.0 113.759 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -59.49 135.79 57.78 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 118.348 1.074 . . . . 0.0 108.299 169.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -90.5 167.06 12.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 171.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.81 -38.48 78.71 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.712 -0.617 . . . . 0.0 110.614 169.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.1 m -63.75 -27.58 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 123.386 0.674 . . . . 0.0 112.081 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -59.65 -37.69 79.4 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.422 ' HB3' HD21 ' A' ' 19' ' ' LEU . 47.6 mt -65.85 -50.01 66.1 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.738 1.215 . . . . 0.0 109.713 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.39 -41.7 90.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.922 0.889 . . . . 0.0 109.337 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -68.19 -52.54 33.2 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 124.114 0.966 . . . . 0.0 110.259 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -44.21 93.58 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 120.868 -1.145 . . . . 0.0 108.985 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -55.34 -50.59 69.24 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.567 1.147 . . . . 0.0 111.13 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -51.42 -46.13 62.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.557 1.143 . . . . 0.0 110.081 175.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -71.91 -26.33 62.26 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.465 1.106 . . . . 0.0 112.477 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.8 mt -70.57 -58.53 3.59 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.918 1.236 . . . . 0.0 109.028 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 pt -64.63 -28.23 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.154 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.5 m 68.93 -77.41 0.05 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.238 2.215 . . . . 0.0 109.335 -167.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.42 172.8 13.86 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 119.466 1.03 . . . . 0.0 113.015 171.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -80.91 62.52 8.57 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.986 3.124 . . . . 0.0 111.59 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.2 t -83.03 98.14 9.12 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 120.551 -1.343 . . . . 0.0 107.981 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.9 t 65.01 85.09 0.14 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.377 1.871 . . . . 0.0 110.032 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.356 0 CA-C-O 116.186 -2.452 . . . . 0.0 107.272 165.8 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.664 0 CA-C-O 118.739 -1.034 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.6 m 38.98 94.34 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.162 2.585 . . . . 0.0 114.288 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 m 64.29 84.22 0.15 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.942 1.697 . . . . 0.0 110.331 175.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.04 165.14 39.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 167.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.5 m -138.75 58.13 1.66 Allowed 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.339 0.656 . . . . 0.0 110.313 -168.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.9 m -55.63 161.94 1.87 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.936 -0.477 . . . . 0.0 111.707 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.02 -177.01 30.72 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 171.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -132.33 -45.33 0.91 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.464 1.106 . . . . 0.0 110.532 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -135.0 142.83 46.53 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.109 1.364 . . . . 0.0 108.221 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.3 t70 65.72 104.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 127.841 2.457 . . . . 0.0 108.524 -169.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.463 ' CD2' ' HG2' ' A' ' 51' ' ' LYS . 34.0 m-85 67.62 88.79 0.11 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.63 1.572 . . . . 0.0 111.264 -175.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.8 p -65.6 155.13 36.78 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.761 -0.587 . . . . 0.0 110.675 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -52.48 -37.25 56.75 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.069 -1.019 . . . . 0.0 111.554 174.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.58 -50.98 70.45 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 124.954 1.302 . . . . 0.0 110.224 176.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -63.67 -28.19 69.73 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.943 -1.098 . . . . 0.0 110.856 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.6 t -69.33 -35.91 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 120.388 1.449 . . . . 0.0 109.311 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -50.29 -60.59 2.82 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 170.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -61.99 -31.04 71.37 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.033 0.933 . . . . 0.0 112.715 -176.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -59.55 -61.9 2.28 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -64.14 -47.94 77.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.736 0.414 . . . . 0.0 110.585 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.92 -40.65 70.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.187 1.395 . . . . 0.0 110.3 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.55 -56.91 11.23 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 125.337 1.446 . . . . 0.0 111.022 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.7 t -56.69 -32.17 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 118.598 1.199 . . . . 0.0 111.427 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -61.04 -42.0 97.64 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 119.665 1.121 . . . . 0.0 110.405 -175.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.7 t -95.43 -44.88 7.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.787 0.835 . . . . 0.0 109.689 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 6.8 mmt -69.78 -25.58 63.86 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.129 1.372 . . . . 0.0 112.022 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.39 -161.25 34.92 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -151.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -72.67 8.51 1.43 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -166.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -70.0 97.8 1.2 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 121.056 1.753 . . . . 0.0 110.472 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -71.12 -40.91 71.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.806 0.842 . . . . 0.0 111.06 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -57.48 -46.5 83.64 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.869 0.868 . . . . 0.0 109.749 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.07 -61.11 2.53 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.718 0.807 . . . . 0.0 109.472 173.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.0 mt -52.26 -48.4 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 126.125 1.77 . . . . 0.0 110.905 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -24.02 63.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.706 0.802 . . . . 0.0 112.038 -174.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -100.67 -41.32 6.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.65 0.78 . . . . 0.0 111.231 175.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.3 -15.69 60.73 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -176.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -134.25 155.01 80.28 Favored Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 125.26 1.424 . . . . 0.0 108.313 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.0 110.62 2.35 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.803 2.336 . . . . 0.0 109.778 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -118.27 159.43 23.38 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.56 1.144 . . . . 0.0 109.012 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -54.0 145.93 15.58 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.546 1.138 . . . . 0.0 112.084 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -61.43 133.75 56.13 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.75 -8.42 73.91 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 118.838 -0.979 . . . . 0.0 112.579 176.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.6 mmp_? -61.48 153.49 27.14 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 118.867 1.333 . . . . 0.0 108.676 162.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.7 mtm105 -124.96 174.08 8.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.32 1.448 . . . . 0.0 107.401 167.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.53 -33.41 69.84 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 122.278 0.231 . . . . 0.0 110.639 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 m -63.8 -33.9 64.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 C-N-CA 123.473 0.709 . . . . 0.0 112.471 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.94 -41.11 86.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.44 ' HB3' HD21 ' A' ' 19' ' ' LEU . 53.8 mt -63.1 -52.0 64.37 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.982 1.313 . . . . 0.0 109.633 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.82 -45.07 82.53 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.743 1.217 . . . . 0.0 109.266 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -63.52 -54.34 37.72 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.716 1.207 . . . . 0.0 110.432 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.463 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 52.9 tptt -61.19 -44.75 96.79 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.97 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -56.58 -54.81 41.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.568 1.147 . . . . 0.0 110.383 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -50.28 60.77 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 123.558 0.536 . . . . 0.0 109.68 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -56.57 -45.6 81.2 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.473 1.109 . . . . 0.0 111.777 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.0 mt -63.33 -56.22 18.17 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.797 0.839 . . . . 0.0 110.759 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.5 pt -63.62 -13.18 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 118.014 0.37 . . . . 0.0 111.195 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 m 67.81 19.71 9.53 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.44 1.896 . . . . 0.0 112.402 168.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.65 166.4 39.25 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.187 0.899 . . . . 0.0 111.922 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.7 174.53 8.42 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.183 2.589 . . . . 0.0 112.567 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 m 27.66 73.07 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.438 2.695 . . . . 0.0 114.356 157.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.8 t -54.9 -47.87 73.78 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.918 0.887 . . . . 0.0 110.243 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 N-CA-C 105.846 -2.902 . . . . 0.0 105.846 177.829 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.642 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.2 m -129.66 149.1 51.56 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.536 1.534 . . . . 0.0 109.163 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.1 t -67.14 151.41 47.62 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.31 -82.02 0.07 OUTLIER Glycine 0 CA--C 1.52 0.348 0 N-CA-C 106.886 -2.486 . . . . 0.0 106.886 173.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.5 t 61.86 25.94 15.65 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.203 1.401 . . . . 0.0 111.928 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 t -122.74 173.49 7.71 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.436 1.094 . . . . 0.0 110.404 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.58 -166.14 38.3 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 129.602 3.477 . . . . 0.0 106.28 -162.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 73.53 156.36 0.17 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.314 2.245 . . . . 0.0 109.262 -170.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp 45.18 84.48 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 127.743 2.417 . . . . 0.0 110.471 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 59.28 103.08 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 126.314 1.846 . . . . 0.0 110.029 -170.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 104.93 132.87 0.01 OUTLIER 'General case' 0 C--O 1.237 0.399 0 C-N-CA 129.902 3.281 . . . . 0.0 107.087 169.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.444 HG22 ' OE1' ' A' ' 15' ' ' GLU . 8.8 t -83.47 178.44 8.02 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 164.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -55.27 -35.05 64.6 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-O 117.607 -1.187 . . . . 0.0 111.462 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.06 -57.66 11.87 Favored 'General case' 0 C--O 1.225 -0.197 0 O-C-N 123.827 0.705 . . . . 0.0 112.067 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.444 ' OE1' HG22 ' A' ' 12' ' ' THR . 3.0 mp0 -59.46 -40.22 86.18 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.688 1.131 . . . . 0.0 111.732 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.2 t -60.56 -40.62 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 118.839 -0.601 . . . . 0.0 111.374 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -57.42 -52.18 66.43 Favored 'General case' 0 C--O 1.226 -0.141 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.5 m-30 -61.03 -33.56 73.48 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.417 1.087 . . . . 0.0 111.716 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -61.38 -56.82 16.04 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.082 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -64.15 -43.1 96.26 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 117.791 -1.1 . . . . 0.0 111.769 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -55.52 -54.42 44.21 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.875 1.27 . . . . 0.0 109.262 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.85 -59.25 10.61 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 125.425 1.488 . . . . 0.0 111.648 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.4 t -61.74 -21.99 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 O-C-N 121.561 -0.964 . . . . 0.0 111.562 -177.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -76.1 -44.18 39.87 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 120.117 -1.614 . . . . 0.0 109.499 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.9 t -95.36 -16.58 22.25 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.571 0.749 . . . . 0.0 112.195 -169.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.4 mtp -126.71 -9.77 6.15 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.599 1.16 . . . . 0.0 112.257 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.04 -152.83 42.84 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -167.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -73.22 18.88 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.735 1.614 . . . . 0.0 113.648 -164.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -75.94 97.28 3.94 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.789 1.632 . . . . 0.0 109.482 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -75.15 -44.21 48.09 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.28 -0.888 . . . . 0.0 112.218 -171.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -62.33 -48.16 81.07 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.2 m -53.85 -47.03 71.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.903 0.881 . . . . 0.0 111.037 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.88 -46.65 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 119.926 1.239 . . . . 0.0 110.268 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.28 -24.09 17.59 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.027 1.331 . . . . 0.0 112.016 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -108.61 -31.64 7.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.681 1.192 . . . . 0.0 110.73 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -58.73 -23.2 59.36 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.274 1.429 . . . . 0.0 112.15 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -138.16 157.86 72.05 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 125.711 1.605 . . . . 0.0 108.003 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.87 109.12 1.94 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 N-CA-C 107.776 -1.663 . . . . 0.0 107.776 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -101.54 164.89 11.53 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.282 -0.886 . . . . 0.0 109.102 175.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -53.47 142.54 21.82 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -70.51 158.97 35.13 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.494 0.664 . . . . 0.0 110.261 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.2 -3.39 22.88 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.755 -1.581 . . . . 0.0 113.543 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.418 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 7.7 mmp_? -64.57 141.19 58.86 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 120.479 2.139 . . . . 0.0 109.566 176.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.6 mtt85 -82.8 159.87 22.37 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.04 78.51 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.262 -0.899 . . . . 0.0 109.903 166.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 m -65.15 -24.42 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 118.334 -0.841 . . . . 0.0 111.974 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -61.59 -31.73 71.8 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' HB3' HD21 ' A' ' 19' ' ' LEU . 59.7 mt -68.62 -49.76 56.75 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.507 1.523 . . . . 0.0 109.709 175.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.34 98.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.468 1.107 . . . . 0.0 109.758 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -65.71 -46.53 78.63 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.364 1.466 . . . . 0.0 110.197 178.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -60.9 -47.12 87.85 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -56.81 -45.27 82.36 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.783 1.233 . . . . 0.0 111.471 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -51.61 -39.82 58.71 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.647 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -81.4 -20.21 40.94 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.857 1.662 . . . . 0.0 113.288 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.6 mt -74.96 -11.42 60.11 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.406 -0.809 . . . . 0.0 111.47 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.5 pt -110.18 -25.25 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 119.612 1.096 . . . . 0.0 111.67 168.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 m -104.83 72.47 1.02 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 127.223 2.209 . . . . 0.0 108.721 171.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.48 153.86 17.34 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 169.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.12 3.2 7.83 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 CA-C-N 119.874 1.837 . . . . 0.0 113.222 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.8 t -149.85 143.77 25.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.935 1.243 . . . . 0.0 108.437 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.6 m -154.5 77.88 1.06 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.441 2.296 . . . . 0.0 106.595 171.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 117.752 -1.582 . . . . 0.0 111.574 -176.892 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.503 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -148.38 -171.17 3.78 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.573 1.149 . . . . 0.0 108.529 -169.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.1 m 49.79 -97.26 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.144 1.778 . . . . 0.0 111.966 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.27 -106.45 1.12 Allowed Glycine 0 C--N 1.335 0.521 0 CA-C-N 119.983 1.265 . . . . 0.0 110.845 170.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.3 t 27.62 82.11 0.02 OUTLIER 'General case' 0 C--O 1.233 0.195 0 C-N-CA 129.596 3.158 . . . . 0.0 111.225 -176.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.4 p -156.98 133.9 10.26 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.27 165.17 36.01 Favored Glycine 0 CA--C 1.524 0.606 0 O-C-N 121.005 -1.059 . . . . 0.0 112.753 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -142.21 67.66 1.32 Allowed 'General case' 0 C--O 1.234 0.287 0 O-C-N 121.751 -0.852 . . . . 0.0 109.257 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -138.83 -70.04 0.42 Allowed 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -144.18 -79.83 0.19 Allowed 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -172.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -54.45 114.59 1.72 Allowed 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.742 1.217 . . . . 0.0 108.578 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 t -72.7 168.95 17.67 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -40.05 62.05 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.092 0.957 . . . . 0.0 112.196 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -56.81 -50.85 71.11 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.811 1.244 . . . . 0.0 108.033 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -70.13 -25.39 63.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.123 0.969 . . . . 0.0 111.889 -174.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.6 t -73.96 -41.61 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 118.82 0.736 . . . . 0.0 109.341 173.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -58.76 -48.33 81.57 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.738 -0.649 . . . . 0.0 109.359 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -60.22 -35.35 75.24 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.966 0.906 . . . . 0.0 111.451 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.43 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -59.36 -53.94 52.4 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.598 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -72.14 -24.9 61.53 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -66.1 -55.06 18.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 170.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.84 -62.14 6.18 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 125.891 1.71 . . . . 0.0 111.319 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.6 t -61.75 -25.38 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 118.182 0.991 . . . . 0.0 111.65 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -70.71 -46.51 62.96 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 121.011 -1.056 . . . . 0.0 109.27 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -95.08 -20.32 19.41 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.354 0.525 . . . . 0.0 111.544 -168.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.3 mtp -124.09 -9.24 7.66 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.905 1.282 . . . . 0.0 111.997 -172.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.35 -154.14 50.45 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -73.55 14.68 0.32 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.31 1.044 . . . . 0.0 113.69 -166.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -78.71 96.87 5.67 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 120.797 1.635 . . . . 0.0 107.84 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -76.16 -42.42 46.64 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.729 -0.607 . . . . 0.0 110.423 -173.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -59.32 -42.66 91.95 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 m -60.66 -54.35 46.33 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.605 1.162 . . . . 0.0 112.35 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.3 mt -56.79 -43.27 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 125.407 1.483 . . . . 0.0 110.565 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -14.98 37.74 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -175.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -110.38 -29.17 8.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.024 1.329 . . . . 0.0 111.356 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 3.1 t -60.75 -18.17 53.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.593 0.757 . . . . 0.0 112.471 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 70.3 m-85 -144.58 158.03 54.5 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 125.098 1.359 . . . . 0.0 108.049 -176.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.4 109.89 3.0 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.734 1.623 . . . . 0.0 109.385 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -113.17 166.38 11.5 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.218 1.407 . . . . 0.0 109.596 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -56.87 151.38 14.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.99 1.316 . . . . 0.0 111.009 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.3 142.28 50.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -176.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.05 8.15 57.82 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.009 -1.439 . . . . 0.0 113.965 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -64.35 165.26 9.92 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 120.822 2.311 . . . . 0.0 109.661 169.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -120.72 159.58 25.09 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.645 1.178 . . . . 0.0 108.11 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.26 -40.35 64.56 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.626 0.37 . . . . 0.0 110.744 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.3 m -62.62 -27.98 43.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 C-N-CA 123.688 0.795 . . . . 0.0 112.336 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -62.09 -35.06 77.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.43 ' HB3' HD21 ' A' ' 19' ' ' LEU . 54.9 mt -66.95 -46.29 75.17 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 126.493 1.917 . . . . 0.0 110.129 175.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.02 -51.07 69.49 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -55.78 -48.4 75.38 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.466 1.107 . . . . 0.0 110.594 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -61.79 -48.02 82.51 Favored 'General case' 0 C--O 1.223 -0.29 0 O-C-N 121.234 -0.916 . . . . 0.0 110.998 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -55.48 -46.48 76.89 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 125.475 1.51 . . . . 0.0 110.991 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 49.3 m170 -53.77 -54.76 33.69 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.475 1.11 . . . . 0.0 109.028 172.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -55.77 -38.64 70.16 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 121.442 -0.786 . . . . 0.0 112.397 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.3 mt -68.33 -39.15 82.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 117.642 -1.17 . . . . 0.0 111.521 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -72.56 -20.42 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 120.164 1.347 . . . . 0.0 111.569 173.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.8 t 64.04 8.56 4.05 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.376 1.47 . . . . 0.0 112.436 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.5 -177.71 51.81 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.949 1.261 . . . . 0.0 112.285 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.1 171.86 10.74 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.542 2.828 . . . . 0.0 111.824 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t 85.62 99.12 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 128.43 2.692 . . . . 0.0 105.702 -170.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.7 m 58.92 19.98 7.65 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.457 1.503 . . . . 0.0 112.848 -173.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.213 0 C-N-CA 125.673 1.606 . . . . 0.0 111.686 -176.506 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.52 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.3 m -131.13 -4.89 3.89 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.587 0.755 . . . . 0.0 112.093 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.1 m -144.63 138.6 27.49 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.62 60.91 0.29 Allowed Glycine 0 C--N 1.333 0.405 0 CA-C-N 118.292 0.497 . . . . 0.0 111.977 -171.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.34 105.96 0.34 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.437 1.495 . . . . 0.0 110.836 176.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.5 m -153.69 168.98 24.43 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 128.217 2.607 . . . . 0.0 107.555 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.55 157.65 42.41 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -99.01 -10.66 22.36 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 127.236 2.214 . . . . 0.0 112.36 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -82.65 106.66 14.68 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.3 t70 130.96 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 131.45 3.9 . . . . 0.0 110.366 171.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.422 ' CD2' ' HG2' ' A' ' 51' ' ' LYS . 10.7 m-85 -141.23 134.27 29.2 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 167.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -84.1 -166.96 1.57 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.811 0.844 . . . . 0.0 109.957 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -74.05 -24.77 59.58 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 120.97 -1.081 . . . . 0.0 111.116 161.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -77.19 -49.48 15.07 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 119.23 0.923 . . . . 0.0 109.193 -171.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -41.36 92.07 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.6 t -59.78 -38.0 74.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 C-N-CA 124.151 0.98 . . . . 0.0 110.337 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -56.09 -54.56 43.58 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -65.8 -26.86 67.88 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -62.68 -52.43 63.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.027 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -59.28 -44.84 92.45 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.24 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -51.46 -52.85 42.89 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.638 1.175 . . . . 0.0 111.064 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.34 -58.54 8.52 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 124.23 0.919 . . . . 0.0 111.162 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -56.98 -25.56 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 118.507 1.154 . . . . 0.0 110.877 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -59.4 -45.71 90.73 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 121.317 -0.865 . . . . 0.0 110.52 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.2 t -96.5 -21.61 17.6 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.936 1.294 . . . . 0.0 112.065 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.3 mtp -116.86 -1.91 11.92 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.75 -1.219 . . . . 0.0 113.707 -166.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.27 -113.0 1.99 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -104.73 8.58 35.07 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.513 0.725 . . . . 0.0 112.698 -168.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -76.55 96.48 4.13 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 120.094 1.315 . . . . 0.0 109.514 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -78.7 -44.84 22.66 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.642 -172.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -61.35 -41.19 96.65 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 119.502 -0.285 . . . . 0.0 110.581 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 m -56.57 -53.92 51.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.207 0.603 . . . . 0.0 110.609 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 55.0 mt -53.3 -45.14 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.024 1.33 . . . . 0.0 110.893 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -31.06 68.0 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.325 0.65 . . . . 0.0 112.167 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -86.88 -35.09 19.19 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.947 0.499 . . . . 0.0 111.247 171.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.442 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 8.3 t -60.32 -31.05 69.92 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.128 1.371 . . . . 0.0 113.33 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 74.1 m-85 -135.27 155.14 79.0 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 123.93 0.892 . . . . 0.0 109.058 -171.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.89 109.3 2.19 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.852 1.701 . . . . 0.0 109.638 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -109.04 176.2 5.18 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.982 0.913 . . . . 0.0 111.036 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -56.55 155.9 6.8 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.481 1.112 . . . . 0.0 111.018 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.46 121.75 20.12 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -172.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.75 21.84 65.36 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.416 -0.658 . . . . 0.0 113.952 169.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -57.47 163.37 2.4 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 122.105 0.955 . . . . 0.0 111.389 171.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -103.05 167.58 9.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.948 162.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.5 -34.63 78.67 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.641 -0.662 . . . . 0.0 109.3 166.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 m -62.43 -29.34 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 O-C-N 121.701 -0.624 . . . . 0.0 112.259 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -55.97 -43.1 77.25 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.402 ' HB3' HD21 ' A' ' 19' ' ' LEU . 46.0 mt -67.05 -44.28 80.59 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.8 0.84 . . . . 0.0 110.061 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.84 -45.97 87.12 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.431 0.693 . . . . 0.0 109.374 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -60.39 -52.98 62.93 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.066 1.347 . . . . 0.0 109.063 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 57.7 tptt -59.94 -39.98 87.4 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.687 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -62.29 -46.28 89.49 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 119.68 1.127 . . . . 0.0 111.206 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -51.76 -54.2 31.23 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -53.81 -42.12 68.07 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.666 0.666 . . . . 0.0 112.307 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.69 -37.24 85.91 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 117.882 -1.056 . . . . 0.0 110.98 -176.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.5 pt -75.51 -48.98 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 119.491 1.042 . . . . 0.0 110.253 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 t -156.96 132.89 9.55 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.951 1.3 . . . . 0.0 108.755 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.59 151.91 48.62 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 120.77 -1.206 . . . . 0.0 110.3 168.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -81.7 -12.87 10.93 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.676 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.6 t -144.82 18.27 1.63 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.74 1.616 . . . . 0.0 110.059 -166.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.03 -57.55 9.33 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.168 1.387 . . . . 0.0 109.519 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 1 N-CA-C 102.223 -4.351 . . . . 0.0 102.223 -155.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.642 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.7 m 59.02 -33.34 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.534 2.334 . . . . 0.0 117.091 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.9 m -57.21 130.3 45.58 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 120.45 1.477 . . . . 0.0 111.353 -169.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.68 7.41 65.51 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.274 -1.292 . . . . 0.0 112.951 -173.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.2 m -61.34 166.58 3.78 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.964 1.382 . . . . 0.0 112.522 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 p -159.91 165.01 33.0 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.894 1.278 . . . . 0.0 108.572 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.19 142.95 14.06 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 108.649 -1.781 . . . . 0.0 108.649 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -161.6 164.99 29.03 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.933 1.693 . . . . 0.0 106.704 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 9' ' ' LYS . 5.5 mmpt? 56.76 -92.75 0.03 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-O 117.54 -1.219 . . . . 0.0 109.439 -176.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -101.67 121.23 41.64 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 124.768 1.227 . . . . 0.0 108.101 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 70.64 122.07 0.03 OUTLIER 'General case' 0 C--O 1.235 0.337 0 C-N-CA 128.443 2.697 . . . . 0.0 108.564 -166.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.9 p -74.1 173.14 10.5 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 120.574 -1.329 . . . . 0.0 108.064 169.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -55.23 -21.55 14.55 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.022 0.929 . . . . 0.0 112.232 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.07 -32.74 17.41 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.626 1.171 . . . . 0.0 112.037 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.48 -41.98 75.43 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 119.842 1.201 . . . . 0.0 108.329 171.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.54 -29.42 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 122.004 -0.435 . . . . 0.0 110.206 174.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -57.78 -59.0 5.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 118.817 -0.611 . . . . 0.0 109.599 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -60.41 -28.3 68.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.82 -58.17 5.57 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -68.17 -28.41 67.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 119.312 -0.375 . . . . 0.0 111.607 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.91 -43.28 93.33 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.866 0.866 . . . . 0.0 109.674 173.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.77 -44.07 8.62 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 124.101 0.858 . . . . 0.0 111.062 -168.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.7 t -62.7 -26.62 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.603 0.702 . . . . 0.0 110.39 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -64.04 -33.55 76.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.495 1.043 . . . . 0.0 110.739 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . 0.252 11.5 t -95.75 -61.73 1.41 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -23.76 56.21 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -167.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.7 -150.95 48.78 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -160.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -69.51 9.17 0.51 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.013 2.525 . . . . 0.0 114.88 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -71.44 96.96 1.55 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 121.199 1.818 . . . . 0.0 108.876 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.2 m95 -81.14 -46.03 15.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.364 -0.826 . . . . 0.0 111.453 -170.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -54.52 -41.81 70.1 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.281 0.946 . . . . 0.0 109.96 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -53.53 57.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 123.503 0.721 . . . . 0.0 110.623 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 59.9 mt -55.5 -46.1 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.607 1.163 . . . . 0.0 109.617 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -16.36 43.0 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.961 1.304 . . . . 0.0 112.782 -176.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -109.94 -29.68 8.15 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.447 1.099 . . . . 0.0 112.186 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.4 ' HB3' ' CD2' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -63.78 -26.49 68.66 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.951 0.796 . . . . 0.0 112.101 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 36' ' ' SER . 84.4 m-85 -135.31 156.42 78.0 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 124.557 1.143 . . . . 0.0 109.994 -174.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.8 138.48 31.74 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 N-CA-C 108.552 -1.365 . . . . 0.0 108.552 170.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -132.23 -174.5 3.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 170.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -71.26 171.95 10.18 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.307 -0.871 . . . . 0.0 111.067 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.415 ' CA ' ' HE3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -68.63 165.14 19.94 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.783 -0.573 . . . . 0.0 110.291 171.687 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.65 -3.15 1.48 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.378 1.466 . . . . 0.0 115.483 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -63.09 157.83 21.21 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 119.072 1.436 . . . . 0.0 110.356 -175.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -120.84 166.66 13.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.687 1.595 . . . . 0.0 107.51 168.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.9 77.52 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.707 -0.621 . . . . 0.0 110.802 169.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.3 m -63.14 -24.86 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 123.53 0.732 . . . . 0.0 112.373 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -65.46 -42.25 92.49 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 mt -62.31 -36.58 82.6 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.12 -43.81 86.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 119.256 0.935 . . . . 0.0 109.944 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.43 -55.4 12.0 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.949 1.299 . . . . 0.0 112.308 -172.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -58.56 -47.45 84.21 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -54.81 -48.42 72.8 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 125.106 1.362 . . . . 0.0 110.156 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -51.86 -47.42 64.47 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.957 0.503 . . . . 0.0 110.843 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -67.33 -31.19 71.3 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.736 -0.602 . . . . 0.0 110.713 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.2 mt -71.44 -41.16 69.82 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.186 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.7 pt -76.52 -16.27 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 120.638 1.563 . . . . 0.0 112.5 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.0 m -111.65 66.36 0.63 Allowed 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.25 1.42 . . . . 0.0 108.608 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.43 -179.35 6.57 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.217 1.389 . . . . 0.0 112.105 173.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -58.89 -48.43 14.57 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.597 2.198 . . . . 0.0 111.551 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.6 p -75.14 111.18 10.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 165.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 72.1 p -135.35 88.0 2.38 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.527 0.603 . . . . 0.0 110.126 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.838 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 178.059 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.748 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 m -116.35 153.71 31.52 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.822 0.811 . . . . 0.0 109.061 167.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.0 p -146.81 169.25 19.48 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.542 1.537 . . . . 0.0 107.764 175.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.91 133.07 43.55 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 174.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.1 m -157.47 -176.01 5.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.542 1.937 . . . . 0.0 108.527 -176.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.1 p -62.71 175.24 0.85 Allowed 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.271 -0.893 . . . . 0.0 110.54 158.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.92 -49.19 0.17 Allowed Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 171.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.0 mtp-105 -133.85 162.15 32.8 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.183 0.593 . . . . 0.0 110.856 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -70.65 -166.57 0.15 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.86 0.864 . . . . 0.0 110.446 165.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 56.89 -101.89 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.54 1.936 . . . . 0.0 108.276 -162.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -58.6 135.01 57.24 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 119.185 0.902 . . . . 0.0 111.879 -168.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.7 p -72.16 170.63 13.59 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.707 0.803 . . . . 0.0 109.377 167.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -56.39 -27.98 57.92 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.456 -0.778 . . . . 0.0 110.886 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -68.78 -56.18 8.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.335 -0.853 . . . . 0.0 109.399 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -59.37 -34.4 72.36 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.041 0.536 . . . . 0.0 111.304 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.651 HG22 ' HE2' ' A' ' 51' ' ' LYS . 54.0 t -66.42 -40.2 85.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.012 175.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -65.03 -45.16 86.61 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 118.468 0.577 . . . . 0.0 109.448 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -60.15 -37.74 81.04 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.084 0.954 . . . . 0.0 110.811 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.77 -56.89 13.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.933 0.893 . . . . 0.0 109.235 171.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -69.69 -29.94 67.48 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.601 -0.714 . . . . 0.0 112.536 -175.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -61.51 -58.55 7.71 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.81 1.187 . . . . 0.0 108.129 170.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.22 -60.96 4.8 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 125.868 1.699 . . . . 0.0 111.756 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.5 t -63.38 -20.04 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.423 1.112 . . . . 0.0 112.238 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.02 -40.62 45.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 120.322 -1.486 . . . . 0.0 109.635 177.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.8 t -95.82 -19.9 19.24 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.234 0.925 . . . . 0.0 113.087 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 10.0 mtt -117.88 0.4 11.91 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.254 1.422 . . . . 0.0 112.751 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.71 -103.63 0.12 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.586 1.089 . . . . 0.0 111.957 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -114.78 12.47 17.02 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 118.224 1.012 . . . . 0.0 110.506 -167.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.06 97.68 4.77 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 173.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -81.66 -46.61 14.1 Favored 'General case' 0 CA--C 1.521 -0.143 0 O-C-N 121.178 -0.951 . . . . 0.0 110.992 -172.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -54.7 -44.98 73.92 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.841 0.856 . . . . 0.0 109.918 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.7 m -57.48 -48.62 78.74 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.948 1.699 . . . . 0.0 111.803 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.9 mt -59.28 -45.3 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 O-C-N 120.909 -1.119 . . . . 0.0 109.94 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -23.94 48.17 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 125.542 1.537 . . . . 0.0 112.58 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 3.8 m0 -112.11 -29.6 7.54 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.522 -0.752 . . . . 0.0 111.086 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 t -68.87 -22.21 64.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.152 0.887 . . . . 0.0 111.981 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -121.85 156.01 59.75 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 123.951 0.9 . . . . 0.0 108.583 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.84 110.25 3.08 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.957 1.771 . . . . 0.0 108.174 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -111.18 168.18 9.71 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.137 0.975 . . . . 0.0 108.749 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -55.68 163.49 1.35 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.577 1.551 . . . . 0.0 111.468 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -64.68 161.4 17.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.366 164.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.79 -15.63 2.93 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.775 1.179 . . . . 0.0 114.242 170.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -63.4 163.21 11.13 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 124.509 1.124 . . . . 0.0 111.455 -174.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -127.88 170.36 12.9 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.756 1.222 . . . . 0.0 109.548 171.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.4 -34.97 69.43 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.96 0.504 . . . . 0.0 110.939 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.78 -30.85 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 CA-C-N 118.224 0.465 . . . . 0.0 112.084 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.04 -38.14 72.79 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.412 0.445 . . . . 0.0 110.581 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.2 mt -67.41 -49.51 63.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.015 1.726 . . . . 0.0 110.548 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.98 -52.96 63.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -54.16 -46.55 72.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.476 1.11 . . . . 0.0 111.781 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.651 ' HE2' HG22 ' A' ' 16' ' ' VAL . 7.0 tptt -54.98 -60.27 3.6 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.11 0.564 . . . . 0.0 110.202 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -54.78 -46.02 74.35 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 126.331 1.852 . . . . 0.0 110.933 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -59.92 -47.05 87.38 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.153 0.981 . . . . 0.0 110.128 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -56.54 -41.1 76.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.461 1.028 . . . . 0.0 110.75 171.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.5 mt -74.71 -7.03 52.04 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.4 pt -105.18 -12.24 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 120.415 1.462 . . . . 0.0 111.772 166.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 m -75.27 68.21 1.97 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.054 1.342 . . . . 0.0 110.061 162.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 138.35 159.28 8.05 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.969 1.271 . . . . 0.0 111.947 168.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.46 -32.47 4.86 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.32 2.68 . . . . 0.0 111.24 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.3 t -168.87 121.88 0.81 Allowed 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.9 m -121.63 90.47 3.32 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.409 1.084 . . . . 0.0 108.481 -169.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 174.365 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.81 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.2 m 56.01 84.72 0.08 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.971 1.708 . . . . 0.0 113.441 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.0 t 58.14 -154.98 0.35 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.452 1.101 . . . . 0.0 110.337 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.13 -178.41 51.4 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 123.963 0.792 . . . . 0.0 113.205 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.1 t 119.17 139.29 0.0 OUTLIER 'General case' 0 C--O 1.236 0.381 1 C-N-CA 132.848 4.459 . . . . 0.0 107.007 -175.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.2 m -77.96 106.25 9.69 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 170.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.37 178.71 46.94 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -126.46 -49.02 1.54 Allowed 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.561 1.944 . . . . 0.0 110.767 -174.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.538 ' HA ' ' HE2' ' A' ' 9' ' ' LYS . 9.1 mmpt? -141.86 17.39 2.14 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.794 1.237 . . . . 0.0 111.298 -175.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.76 51.58 1.32 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 128.337 2.655 . . . . 0.0 110.746 -161.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 97.17 123.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 1 C-N-CA 133.712 4.805 . . . . 0.0 106.985 -170.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 p -62.31 166.77 4.68 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.412 0.685 . . . . 0.0 110.097 167.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -61.69 -25.66 67.55 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.114 -0.992 . . . . 0.0 110.083 168.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -62.27 -49.36 75.98 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 122.085 0.945 . . . . 0.0 108.527 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -72.46 -36.99 68.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.562 0.745 . . . . 0.0 110.917 -174.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.63 -32.0 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 119.372 0.987 . . . . 0.0 109.744 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -59.38 -59.07 6.03 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 170.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -57.0 -32.08 65.75 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.58 1.152 . . . . 0.0 112.189 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -57.2 -63.03 1.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.79 0.836 . . . . 0.0 108.845 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -68.92 -31.66 70.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.452 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -59.31 -49.38 78.03 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 120.204 1.366 . . . . 0.0 109.334 175.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.46 -63.27 5.46 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 124.764 1.173 . . . . 0.0 110.495 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.2 t -55.46 -23.33 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 118.267 1.033 . . . . 0.0 111.603 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -71.22 -53.72 13.41 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 120.134 1.334 . . . . 0.0 109.618 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.6 t -81.47 -8.51 59.74 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.845 0.858 . . . . 0.0 111.107 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.5 mtp -128.86 -93.82 0.44 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.282 1.833 . . . . 0.0 108.033 -171.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.16 -126.44 2.1 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -168.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.57 7.91 17.53 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 117.498 0.649 . . . . 0.0 111.715 -172.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -69.94 98.67 1.3 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.994 1.27 . . . . 0.0 108.414 167.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -74.92 -42.43 57.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.308 -0.377 . . . . 0.0 111.073 -170.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -54.9 -36.62 65.39 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 118.746 -0.645 . . . . 0.0 112.058 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.4 m -61.77 -55.13 33.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.222 0.609 . . . . 0.0 110.06 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.6 mt -53.04 -47.9 53.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 125.988 1.715 . . . . 0.0 110.167 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -31.36 64.92 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.843 1.257 . . . . 0.0 111.32 -175.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -85.31 -42.95 14.14 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.516 0.726 . . . . 0.0 112.105 170.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.424 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 9.6 t -57.19 -35.63 69.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.881 1.273 . . . . 0.0 111.93 -167.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 57.3 m-85 -127.37 157.91 71.21 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 124.132 0.973 . . . . 0.0 108.524 -174.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.46 108.65 2.18 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 CA-C-N 119.747 0.946 . . . . 0.0 109.934 -175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -104.1 166.64 10.28 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.466 1.106 . . . . 0.0 108.864 173.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -52.16 162.73 0.45 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.46 1.104 . . . . 0.0 111.705 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 160.32 24.6 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.3 7.68 20.31 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.293 -0.726 . . . . 0.0 114.427 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.7 mmp_? -71.26 161.31 31.29 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 119.025 1.412 . . . . 0.0 108.938 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -118.41 162.99 17.4 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 174.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.71 -36.17 66.89 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.314 -0.866 . . . . 0.0 111.282 170.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 m -66.55 -23.78 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.004 0.922 . . . . 0.0 112.605 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.57 -46.49 70.29 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.642 0.734 . . . . 0.0 109.145 176.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.411 HD22 ' CD2' ' A' ' 19' ' ' LEU . 35.9 mt -65.84 -44.79 84.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.323 1.449 . . . . 0.0 109.119 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.1 -49.57 75.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.051 1.341 . . . . 0.0 108.847 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -55.02 -61.72 2.13 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.871 1.268 . . . . 0.0 110.09 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -52.94 -54.14 39.32 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 122.586 0.355 . . . . 0.0 110.131 -174.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -52.12 -51.38 58.15 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 126.196 1.799 . . . . 0.0 111.231 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -57.03 -49.06 76.96 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.852 0.296 . . . . 0.0 110.491 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -58.14 -43.22 87.19 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.662 -0.685 . . . . 0.0 109.3 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.7 mt -62.43 -53.47 54.39 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.805 0.842 . . . . 0.0 111.643 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.0 pt -62.17 -25.88 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 119.403 1.001 . . . . 0.0 110.653 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.0 m 55.62 37.47 28.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.174 1.39 . . . . 0.0 111.088 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.86 169.82 52.46 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.787 0.708 . . . . 0.0 112.609 -171.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.18 120.78 6.15 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.616 2.877 . . . . 0.0 109.234 174.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.7 m -154.06 173.12 16.45 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.466 1.506 . . . . 0.0 108.08 165.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.1 t 75.06 -43.8 0.52 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 127.379 2.272 . . . . 0.0 112.246 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 N-CA-C 105.93 -2.868 . . . . 0.0 105.93 -166.754 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.594 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p -150.41 -22.42 0.24 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 m 46.9 49.12 14.83 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.366 1.866 . . . . 0.0 114.14 165.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.91 112.02 4.17 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.1 p -152.24 166.12 32.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.794 2.038 . . . . 0.0 109.353 -173.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 p -69.05 157.3 37.08 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.813 0.845 . . . . 0.0 111.41 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.56 161.66 33.99 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -149.57 149.48 30.76 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.838 1.255 . . . . 0.0 108.461 172.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt 60.7 -41.9 0.11 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 129.814 3.246 . . . . 0.0 114.843 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -64.6 175.6 1.37 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 123.009 1.385 . . . . 0.0 109.397 166.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.11 130.52 44.31 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -74.17 173.17 10.49 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -48.06 -50.27 28.58 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.284 1.034 . . . . 0.0 109.797 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.08 -37.07 73.79 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.612 -172.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -35.3 43.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 119.692 -0.803 . . . . 0.0 108.946 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.5 t -62.88 -37.99 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 121.134 -0.979 . . . . 0.0 109.873 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -53.53 -51.31 63.28 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.443 0.697 . . . . 0.0 109.689 172.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -67.62 -29.09 68.33 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -61.46 -53.77 52.1 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 175.149 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -60.54 -50.67 72.59 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 118.578 -0.725 . . . . 0.0 111.62 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.18 -49.27 74.5 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.013 0.925 . . . . 0.0 110.551 -177.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.95 -53.31 43.96 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 124.74 1.162 . . . . 0.0 110.656 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.3 t -60.1 -28.55 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 117.622 0.711 . . . . 0.0 110.228 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -70.89 -37.9 73.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 120.964 -1.085 . . . . 0.0 110.403 -176.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.6 t -95.39 -19.37 19.97 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.905 0.882 . . . . 0.0 112.21 -176.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 41.3 mtt -116.37 -20.6 9.65 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.47 1.032 . . . . 0.0 113.777 -175.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.31 -151.17 39.75 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -160.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -68.93 24.32 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.607 2.763 . . . . 0.0 116.441 -169.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -81.05 103.14 10.66 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 165.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -84.62 -39.02 19.17 Favored 'General case' 0 CA--C 1.527 0.091 0 O-C-N 121.129 -0.982 . . . . 0.0 111.25 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -58.71 -48.9 79.56 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.045 0.538 . . . . 0.0 110.864 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.3 m -56.95 -49.11 76.66 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.51 1.124 . . . . 0.0 112.346 176.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.1 mt -55.29 -47.47 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.049 1.339 . . . . 0.0 109.566 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -30.04 44.63 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.035 0.934 . . . . 0.0 111.987 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -98.84 -26.74 14.2 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.434 0.694 . . . . 0.0 112.253 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 t -63.04 -22.22 66.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.618 1.167 . . . . 0.0 112.352 -173.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -134.61 161.95 60.65 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 125.009 1.324 . . . . 0.0 107.443 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.65 109.13 2.56 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 N-CA-C 107.239 -1.87 . . . . 0.0 107.239 170.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -99.67 172.15 7.46 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -55.91 149.98 14.11 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.433 1.093 . . . . 0.0 109.237 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.08 155.82 39.87 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 121.291 -0.881 . . . . 0.0 110.335 -176.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.15 21.22 71.75 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.718 1.152 . . . . 0.0 113.89 173.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -82.25 162.58 22.28 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.426 1.09 . . . . 0.0 111.039 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -112.54 162.51 15.56 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.645 1.978 . . . . 0.0 107.43 167.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.91 -26.8 67.78 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.491 -0.756 . . . . 0.0 111.161 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.3 m -67.63 -24.4 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 O-C-N 120.793 -1.192 . . . . 0.0 112.753 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -62.85 -38.0 89.05 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.307 0.643 . . . . 0.0 109.293 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.436 ' HB3' HD21 ' A' ' 19' ' ' LEU . 67.4 mt -62.22 -50.87 70.03 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 126.755 2.022 . . . . 0.0 109.479 175.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.33 -37.88 89.05 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.957 0.903 . . . . 0.0 109.177 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -60.78 -54.42 45.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 122.05 -0.406 . . . . 0.0 110.093 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -56.56 -42.09 78.01 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 118.644 0.657 . . . . 0.0 111.071 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -58.72 -49.28 78.18 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.755 1.622 . . . . 0.0 111.107 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -20.73 64.64 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.827 -0.606 . . . . 0.0 112.328 175.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -77.66 -49.7 13.98 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.89 1.677 . . . . 0.0 109.685 165.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.5 mt -55.26 -56.19 22.82 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.508 0.594 . . . . 0.0 112.038 -173.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -65.87 -22.57 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 O-C-N 121.968 -0.458 . . . . 0.0 111.758 -173.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -72.05 -8.86 56.97 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.605 1.162 . . . . 0.0 112.175 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.78 -162.8 16.31 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 119.267 0.94 . . . . 0.0 111.213 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.37 58.1 6.74 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 124.533 3.488 . . . . 0.0 112.539 -165.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.1 t -56.26 118.61 4.9 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.362 1.065 . . . . 0.0 110.037 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.3 t -155.0 -61.16 0.12 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.206 1.402 . . . . 0.0 108.473 173.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.403 0 CA-C-O 118.614 -1.103 . . . . 0.0 110.813 -176.475 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.503 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.7 m 63.15 96.25 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.887 1.675 . . . . 0.0 113.004 168.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.5 m 58.09 -161.52 0.23 Allowed 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.607 1.163 . . . . 0.0 110.688 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.63 164.55 23.14 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 123.253 0.454 . . . . 0.0 112.147 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -154.24 124.66 6.97 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.55 1.54 . . . . 0.0 107.733 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.7 m -145.46 172.85 12.61 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.714 1.605 . . . . 0.0 108.685 170.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.92 -174.7 13.83 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 125.863 1.697 . . . . 0.0 110.486 173.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -134.17 -67.41 0.58 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.564 2.345 . . . . 0.0 107.333 166.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -147.41 -50.55 0.19 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.477 1.511 . . . . 0.0 108.989 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.31 117.41 5.17 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.588 1.155 . . . . 0.0 108.834 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 70.09 115.26 0.04 OUTLIER 'General case' 0 C--O 1.238 0.465 0 C-N-CA 129.532 3.133 . . . . 0.0 112.218 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.1 t -61.6 154.43 25.04 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.488 163.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -59.31 -20.75 57.0 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.396 1.078 . . . . 0.0 113.013 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.45 -58.57 5.53 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.264 1.026 . . . . 0.0 108.441 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -36.22 78.81 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.308 1.043 . . . . 0.0 110.94 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.49 -39.41 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 120.952 -1.092 . . . . 0.0 110.921 176.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -59.91 -46.38 89.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.227 -0.892 . . . . 0.0 109.761 173.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -61.57 -29.36 69.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.507 1.049 . . . . 0.0 112.558 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -63.32 -58.03 8.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.79 0.723 . . . . 0.0 109.859 175.493 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -64.94 -32.8 74.7 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.684 0.394 . . . . 0.0 111.327 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -65.15 -44.13 89.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.663 1.185 . . . . 0.0 109.858 174.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.02 -56.96 19.43 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 127.027 2.251 . . . . 0.0 110.924 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.8 t -63.13 -25.43 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 118.389 1.095 . . . . 0.0 110.593 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -68.31 -39.3 82.07 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 120.585 -1.322 . . . . 0.0 110.08 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.2 t -94.98 -28.69 15.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.137 0.575 . . . . 0.0 111.573 -172.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -107.94 -26.28 10.78 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.161 0.984 . . . . 0.0 112.687 -174.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.8 -155.11 52.73 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -162.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.96 38.49 0.08 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.555 1.542 . . . . 0.0 113.214 -172.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -109.16 97.79 7.34 Favored 'General case' 0 C--N 1.338 0.105 0 O-C-N 120.598 -1.314 . . . . 0.0 107.69 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -81.15 -38.91 26.38 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.383 -167.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -62.33 -42.87 99.74 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 123.669 0.606 . . . . 0.0 109.853 -175.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.3 t -55.67 -57.47 11.86 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 124.382 1.073 . . . . 0.0 111.046 171.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.7 mt -48.01 -51.92 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.631 1.572 . . . . 0.0 110.351 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.56 -37.95 52.04 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.568 1.547 . . . . 0.0 111.689 -177.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -85.81 -40.28 16.19 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.593 0.757 . . . . 0.0 111.454 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 t -62.92 -20.88 65.61 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -168.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -134.46 155.58 79.58 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 124.757 1.223 . . . . 0.0 107.863 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.63 110.43 2.31 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 N-CA-C 107.326 -1.836 . . . . 0.0 107.326 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -110.14 172.37 6.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 162.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.79 146.97 54.12 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -65.63 173.56 2.71 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.594 0.758 . . . . 0.0 110.058 169.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.56 -13.0 0.45 Allowed Glycine 0 CA--C 1.537 1.427 0 CA-C-O 119.197 -0.78 . . . . 0.0 114.014 -176.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 mmt85 -58.3 134.82 56.9 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.569 1.684 . . . . 0.0 108.061 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -87.41 165.87 15.25 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 162.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.17 -27.92 69.29 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.0 -1.062 . . . . 0.0 111.023 171.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 m -67.31 -27.75 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.313 1.045 . . . . 0.0 112.093 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.88 -45.52 64.18 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.898 0.879 . . . . 0.0 109.009 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.5 mt -66.1 -49.6 66.97 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.794 1.638 . . . . 0.0 109.966 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.7 -40.14 91.97 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.972 1.309 . . . . 0.0 109.875 -173.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -68.47 -51.36 44.33 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.957 0.903 . . . . 0.0 110.249 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -55.0 -45.08 75.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.824 0.738 . . . . 0.0 110.608 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -58.14 -47.43 83.35 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.041 1.337 . . . . 0.0 110.942 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -56.89 -43.08 80.96 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 118.947 -0.549 . . . . 0.0 111.196 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -71.2 -28.85 64.51 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.355 0.662 . . . . 0.0 112.069 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.72 -57.04 12.38 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.042 0.837 . . . . 0.0 109.596 171.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.2 pt -63.41 -44.07 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 118.958 0.799 . . . . 0.0 111.663 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 t -92.44 80.67 4.89 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.97 -118.84 0.07 OUTLIER Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.649 1.595 . . . . 0.0 110.538 169.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.24 86.42 0.65 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.527 3.485 . . . . 0.0 108.889 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.4 m -157.76 148.8 21.26 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 127.472 2.309 . . . . 0.0 107.114 -175.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 p -170.61 162.93 8.11 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 126.472 1.909 . . . . 0.0 109.419 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -179.907 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.454 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 m -68.09 154.15 42.26 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.638 0.719 . . . . 0.0 110.297 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -162.82 -174.79 4.08 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.814 2.446 . . . . 0.0 105.741 169.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.74 77.29 0.18 Allowed Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.302 0.953 . . . . 0.0 113.214 164.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.9 t -160.95 165.5 29.87 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.285 1.043 . . . . 0.0 109.337 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.7 m -53.82 -20.57 5.96 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.116 1.766 . . . . 0.0 115.503 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 52.83 62.05 6.26 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.392 0.996 . . . . 0.0 111.131 -173.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -145.42 137.87 25.84 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.161 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt 128.27 -163.86 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 1 C-N-CA 132.496 4.319 . . . . 0.0 106.037 -170.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -71.13 161.61 30.83 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 167.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 68.15 111.55 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.467 1.507 . . . . 0.0 111.351 173.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.98 159.36 32.84 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 130.611 3.565 . . . . 0.0 113.836 -169.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -54.08 -46.49 72.04 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 126.253 1.821 . . . . 0.0 111.868 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -71.54 -42.04 68.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.559 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -34.85 74.52 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.894 0.478 . . . . 0.0 109.941 -175.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.4 t -58.56 -41.62 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.03 -50.52 73.16 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.769 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -60.21 -34.48 73.71 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 118.514 0.597 . . . . 0.0 112.248 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.88 -53.36 59.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.145 0.978 . . . . 0.0 108.644 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -65.83 -47.82 73.73 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.652 -0.69 . . . . 0.0 111.393 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -56.74 -35.17 68.29 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.039 0.836 . . . . 0.0 110.409 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.39 -67.89 1.9 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 127.49 2.471 . . . . 0.0 110.849 170.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.1 t -56.23 -27.61 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.999 1.9 . . . . 0.0 111.466 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -62.1 -40.46 95.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.248 -0.907 . . . . 0.0 109.643 -177.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 t -96.07 -42.41 8.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.686 1.194 . . . . 0.0 111.379 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.74 -26.0 40.91 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 124.437 1.095 . . . . 0.0 113.918 -172.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.42 -116.54 8.04 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -164.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.91 12.16 32.77 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.191 1.495 . . . . 0.0 113.444 -172.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -73.76 97.11 2.65 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -80.36 -43.0 21.86 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 121.225 -0.922 . . . . 0.0 109.598 176.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -54.38 -41.18 68.92 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.215 0.606 . . . . 0.0 110.66 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.8 m -74.45 -38.49 62.97 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.661 1.184 . . . . 0.0 111.814 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 60.7 mt -59.92 -45.11 95.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -28.47 64.73 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.089 0.956 . . . . 0.0 112.227 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -85.14 -41.54 15.6 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.782 0.833 . . . . 0.0 110.084 173.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.3 t -67.22 -14.16 62.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 117.255 -1.355 . . . . 0.0 114.578 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.413 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 73.2 m-85 -151.93 160.84 30.95 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 120.737 1.608 . . . . 0.0 109.715 -177.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -74.68 143.57 30.38 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.604 1.536 . . . . 0.0 109.526 168.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' A' ' 37' ' ' PHE . 90.5 m-85 -137.38 113.51 9.91 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 169.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.25 45.4 mt-30 37.36 -124.94 0.21 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.967 1.707 . . . . 0.0 108.998 -168.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -133.56 143.01 48.43 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 158.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.93 62.32 5.33 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.085 0.85 . . . . 0.0 112.155 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -109.48 164.5 12.45 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.897 0.856 . . . . 0.0 113.258 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -99.53 165.78 11.47 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.941 1.696 . . . . 0.0 108.574 168.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.56 -31.83 73.21 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.589 -0.695 . . . . 0.0 109.935 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.6 m -64.08 -24.7 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.201 -0.937 . . . . 0.0 112.357 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.48 -11.74 61.08 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.824 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.3 mt -94.89 -18.87 20.76 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.162 1.385 . . . . 0.0 112.071 169.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.8 -43.57 22.19 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.039 171.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -74.63 -57.75 3.73 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -164.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -59.06 -39.39 81.93 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 116.412 -1.756 . . . . 0.0 110.867 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -50.79 -47.75 59.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 121.42 1.918 . . . . 0.0 110.891 168.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.49 -37.81 65.72 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.122 0.569 . . . . 0.0 112.006 176.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -76.59 -35.24 58.26 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.897 0.879 . . . . 0.0 112.167 173.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.2 mt -61.34 -45.93 92.37 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.522 1.055 . . . . 0.0 109.409 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 pt -70.04 -6.83 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.0 71.65 5.47 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.822 1.192 . . . . 0.0 109.159 175.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.2 -178.96 48.68 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.857 1.218 . . . . 0.0 111.892 176.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.11 -28.82 23.09 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.913 2.409 . . . . 0.0 113.169 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.74 135.56 13.66 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 -167.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . 0.258 6.6 m 52.07 -83.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 128.333 2.653 . . . . 0.0 114.003 -175.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 -158.337 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.656 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 p -149.5 167.35 26.49 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 122.012 -0.699 . . . . 0.0 111.145 -163.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 t -156.94 152.06 26.23 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.33 0.652 . . . . 0.0 110.096 162.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.36 -160.31 18.86 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.606 2.05 . . . . 0.0 112.638 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.0 m -57.06 123.66 16.01 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.707 0.753 . . . . 0.0 109.619 174.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.3 m -149.69 106.0 3.49 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.73 1.612 . . . . 0.0 108.244 170.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.54 56.75 4.16 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 170.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -76.37 -72.56 0.32 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 167.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 47.24 53.88 10.2 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.91 1.284 . . . . 0.0 108.937 175.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -65.47 -54.89 21.88 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.563 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -69.03 143.95 54.17 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.2 p -75.72 178.96 5.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.356 1.062 . . . . 0.0 109.804 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 pttt -63.07 -31.75 72.96 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 120.189 -1.57 . . . . 0.0 112.24 165.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.62 -54.0 9.16 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.692 0.797 . . . . 0.0 108.923 -168.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -63.53 -23.75 67.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.461 -175.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.3 t -74.49 -39.21 47.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 119.078 0.854 . . . . 0.0 110.059 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -60.27 -47.93 83.9 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.6 m-30 -64.21 -30.9 71.94 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.799 0.84 . . . . 0.0 113.008 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.41 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -57.48 -54.79 42.87 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 174.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -61.45 -47.81 84.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.843 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.432 ' O ' ' HE3' ' A' ' 24' ' ' LYS . 4.0 m-70 -59.88 -36.08 76.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.268 0.94 . . . . 0.0 111.21 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.18 -54.46 20.58 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 125.684 1.612 . . . . 0.0 110.518 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.3 t -59.57 -28.13 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 118.296 1.048 . . . . 0.0 110.903 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -66.07 -36.98 84.66 Favored 'General case' 0 CA--C 1.521 -0.142 0 O-C-N 120.81 -1.181 . . . . 0.0 110.002 -178.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 t -95.46 -35.45 11.7 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.203 0.601 . . . . 0.0 111.84 -176.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -95.29 -11.98 26.96 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.908 0.883 . . . . 0.0 112.782 -173.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 57.82 -144.12 41.79 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 107.965 -2.054 . . . . 0.0 107.965 -157.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -61.86 -1.8 0.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -174.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -82.48 97.36 8.37 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 122.24 2.291 . . . . 0.0 109.831 -157.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -68.01 -41.88 81.54 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.573 -170.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -61.62 -43.05 99.58 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.8 m -60.03 -47.23 86.73 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.477 1.511 . . . . 0.0 112.008 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.2 mt -57.58 -46.73 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 123.933 0.893 . . . . 0.0 109.162 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -60.83 -21.56 63.31 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.06 0.544 . . . . 0.0 112.257 -175.559 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -96.27 -32.41 12.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.376 0.67 . . . . 0.0 111.572 173.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -18.3 65.0 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -134.12 149.97 72.95 Favored Pre-proline 0 C--O 1.236 0.384 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.12 107.2 2.43 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 N-CA-C 105.704 -2.46 . . . . 0.0 105.704 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -99.08 178.32 4.96 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -62.74 152.36 35.9 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.144 -0.973 . . . . 0.0 109.986 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -58.59 159.86 6.1 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.894 0.477 . . . . 0.0 109.908 164.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.16 9.44 29.22 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.9 mmt-85 -73.45 165.03 25.83 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 118.726 1.263 . . . . 0.0 110.484 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -132.14 158.71 40.95 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.56 -36.01 77.43 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 m -63.18 -27.71 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 124.135 0.974 . . . . 0.0 112.164 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -61.81 -40.58 95.75 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.41 ' HB3' HD21 ' A' ' 19' ' ' LEU . 34.2 mt -66.42 -47.96 71.56 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.154 1.382 . . . . 0.0 110.103 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.75 -46.57 88.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -61.31 -53.05 61.76 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 118.934 -0.555 . . . . 0.0 110.232 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.559 ' HZ3' HD21 ' A' ' 55' ' ' LEU . 2.6 tmtt? -50.22 -54.75 18.83 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.766 1.226 . . . . 0.0 109.318 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -57.59 -44.72 85.58 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 125.239 1.416 . . . . 0.0 111.812 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -57.93 -48.49 79.76 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -63.31 -25.62 68.39 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.749 0.704 . . . . 0.0 111.566 175.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.559 HD21 ' HZ3' ' A' ' 51' ' ' LYS . 70.5 mt -80.17 -15.88 56.08 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 175.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.9 pt -99.88 -20.83 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 119.808 1.185 . . . . 0.0 111.646 169.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 t -162.45 83.54 0.54 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.496 1.919 . . . . 0.0 107.163 -171.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.19 -168.54 30.45 Favored Glycine 0 CA--C 1.527 0.813 0 O-C-N 121.36 -0.837 . . . . 0.0 112.815 -175.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -81.41 44.35 1.72 Allowed 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 124.85 3.7 . . . . 0.0 110.522 176.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.1 t -61.73 122.73 16.07 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.343 -0.848 . . . . 0.0 108.872 -172.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.3 m -161.09 165.06 30.25 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 127.389 2.275 . . . . 0.0 106.774 174.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.911 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -178.129 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.534 ' HA2' ' CD2' ' A' ' 20' ' ' PHE . . . . . . . . 0 N--CA 1.469 0.883 0 CA-C-O 119.392 -0.671 . . . . 0.0 112.377 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m -68.61 166.78 16.46 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.164 0.986 . . . . 0.0 112.586 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.7 p -65.11 143.26 58.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.131 0.973 . . . . 0.0 111.257 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.71 33.32 2.59 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.333 0.968 . . . . 0.0 111.888 170.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.6 m -59.62 -64.46 0.94 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-N 119.364 1.582 . . . . 0.0 110.79 -174.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.8 t -77.72 79.25 4.21 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -175.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.07 -92.37 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 O-C-N 120.903 -1.123 . . . . 0.0 110.832 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 61.68 -43.08 0.14 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 129.943 3.297 . . . . 0.0 116.517 171.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -65.34 -57.28 8.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.412 1.46 . . . . 0.0 110.103 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.67 -23.88 58.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.596 1.558 . . . . 0.0 110.058 -171.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.47 ' CD2' ' HG2' ' A' ' 51' ' ' LYS . 4.7 m-85 -145.39 110.46 5.2 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.53 1.532 . . . . 0.0 107.079 -168.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -69.15 167.64 15.72 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.885 0.766 . . . . 0.0 111.787 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -32.65 74.39 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.476 -1.39 . . . . 0.0 110.592 175.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -67.46 -47.2 70.81 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -59.87 -44.71 94.02 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.753 -0.641 . . . . 0.0 110.541 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.09 -40.9 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 119.067 0.848 . . . . 0.0 109.468 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -60.19 -49.82 76.13 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 119.77 -0.157 . . . . 0.0 111.31 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -55.13 -40.96 71.13 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.8 0.84 . . . . 0.0 110.295 173.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.441 ' CD2' HD22 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -54.49 -51.56 64.7 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.538 -1.351 . . . . 0.0 109.808 -175.192 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.534 ' CD2' ' HA2' ' A' ' 1' ' ' GLY . 65.4 m-85 -63.43 -47.6 81.25 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.745 177.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -55.11 -48.58 73.43 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.783 0.833 . . . . 0.0 110.912 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.43 -56.49 24.17 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 125.343 1.449 . . . . 0.0 109.865 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.5 t -60.7 -16.63 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 117.881 0.84 . . . . 0.0 112.684 -176.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -68.33 -57.23 6.24 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 120.434 -1.416 . . . . 0.0 109.191 172.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.0 t -80.83 -42.38 21.71 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.778 0.831 . . . . 0.0 109.566 -173.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -77.55 -27.71 51.64 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.45 -0.786 . . . . 0.0 112.809 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.8 -143.59 48.69 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -156.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -73.99 7.13 2.82 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.33 98.32 3.21 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 121.325 1.875 . . . . 0.0 109.446 -175.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -71.82 -45.11 62.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 119.185 -0.435 . . . . 0.0 109.914 -178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -48.92 -53.88 17.8 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.371 1.068 . . . . 0.0 111.967 176.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.6 m -55.24 -49.63 71.52 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.884 0.874 . . . . 0.0 111.317 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.1 mt -57.85 -49.94 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 125.818 1.647 . . . . 0.0 110.105 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -34.54 74.27 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.742 1.217 . . . . 0.0 111.583 -173.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -73.58 -47.86 37.27 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.839 -0.538 . . . . 0.0 111.077 166.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.436 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 5.4 t -62.63 -28.76 70.13 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -167.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 64.1 m-85 -134.28 148.85 69.46 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 119.62 1.1 . . . . 0.0 108.654 -174.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.52 110.55 2.45 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.869 2.379 . . . . 0.0 110.603 -174.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -111.51 113.51 25.98 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.849 1.26 . . . . 0.0 109.473 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 31.09 -141.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.891 2.476 . . . . 0.0 111.121 -166.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -106.83 160.52 15.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 144.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 61.74 49.08 79.8 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 124.864 1.221 . . . . 0.0 114.315 166.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.524 ' HA ' ' HE ' ' A' ' 43' ' ' ARG . 1.5 mmp_? -105.1 165.56 11.0 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.581 1.19 . . . . 0.0 111.511 174.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -122.36 161.75 22.85 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.772 1.629 . . . . 0.0 107.588 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.05 -44.17 70.83 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.137 0.426 . . . . 0.0 110.722 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 m -62.29 -27.25 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.572 0.749 . . . . 0.0 112.722 -176.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.38 -41.35 84.64 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.441 HD22 ' CD2' ' A' ' 19' ' ' LEU . 35.2 mt -66.78 -39.22 87.74 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.794 1.238 . . . . 0.0 109.838 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.04 -54.15 29.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.261 1.024 . . . . 0.0 108.342 -177.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.97 -50.46 64.05 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 122.674 0.39 . . . . 0.0 111.351 174.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 42.6 tptt -56.67 -54.19 49.02 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -54.89 -48.53 72.89 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.029 1.332 . . . . 0.0 110.234 -173.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -55.77 -48.03 76.0 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -62.75 -34.42 77.19 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.403 -0.81 . . . . 0.0 112.884 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.3 mt -68.42 -39.13 81.71 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 119.53 1.059 . . . . 0.0 111.414 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.9 pt -93.56 -26.33 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 118.842 0.746 . . . . 0.0 111.965 -174.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.4 m -138.98 75.36 1.51 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.17 146.56 18.17 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.79 -1.005 . . . . 0.0 111.881 -169.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.96 65.64 6.88 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.452 2.768 . . . . 0.0 109.528 169.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.9 m -66.0 160.15 24.27 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.567 0.747 . . . . 0.0 109.188 173.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 t -145.07 10.55 1.32 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -161.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.628 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -159.403 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.649 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.7 m 62.06 73.2 0.48 Allowed 'General case' 0 C--O 1.231 0.117 0 C-N-CA 124.202 1.001 . . . . 0.0 109.046 -163.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 p -95.26 -28.81 14.82 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.256 1.422 . . . . 0.0 111.093 173.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.7 -54.33 4.92 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 120.464 -1.398 . . . . 0.0 111.79 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.3 m 40.42 72.81 0.14 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.439 2.296 . . . . 0.0 114.892 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.1 m -134.72 147.18 50.01 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.877 1.271 . . . . 0.0 108.372 161.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 150.42 143.6 3.77 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 126.168 1.842 . . . . 0.0 110.685 175.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -146.84 -87.27 0.1 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.021 1.411 . . . . 0.0 110.834 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 mttp -57.28 -53.88 53.14 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.595 1.158 . . . . 0.0 110.128 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -68.35 -49.11 62.54 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.865 -166.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -141.83 95.73 2.86 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 -176.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t -73.37 164.85 26.09 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.157 1.383 . . . . 0.0 108.773 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -52.94 -36.37 59.71 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 118.607 -0.711 . . . . 0.0 112.729 -172.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.25 -54.97 18.63 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -174.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.45 -37.09 82.29 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 124.236 1.014 . . . . 0.0 110.784 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.13 -36.43 73.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 O-C-N 121.405 -0.809 . . . . 0.0 110.582 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -68.45 -45.28 72.91 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 117.782 -1.104 . . . . 0.0 109.392 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -59.74 -35.16 74.0 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 119.689 1.131 . . . . 0.0 111.47 174.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.96 -56.02 27.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.709 0.804 . . . . 0.0 108.881 175.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.482 ' CZ ' HD13 ' A' ' 55' ' ' LEU . 31.2 m-85 -62.35 -44.38 96.6 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 119.049 -0.5 . . . . 0.0 110.73 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -53.44 -44.8 69.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.568 1.147 . . . . 0.0 110.073 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.85 -56.63 15.41 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 126.649 2.071 . . . . 0.0 111.58 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.3 t -65.23 -16.97 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 121.359 -1.083 . . . . 0.0 110.934 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -80.74 -39.89 26.19 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.124 -1.61 . . . . 0.0 109.924 174.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.6 t -95.69 -12.22 25.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.164 0.986 . . . . 0.0 112.292 -170.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 33.2 mtt -125.62 -48.48 1.66 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.146 1.378 . . . . 0.0 111.327 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.21 -154.67 19.86 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -165.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -61.97 15.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.492 2.317 . . . . 0.0 116.32 -175.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -78.8 97.37 5.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 120.447 1.476 . . . . 0.0 107.455 170.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -76.3 -47.15 24.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.7 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -62.57 -43.35 99.03 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.358 0.663 . . . . 0.0 109.299 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.9 m -59.78 -49.81 76.28 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.698 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.8 mt -58.33 -44.58 88.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 119.665 1.12 . . . . 0.0 109.241 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.11 -47.29 65.37 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.413 1.485 . . . . 0.0 110.555 -177.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -85.86 -28.57 24.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 119.322 -0.37 . . . . 0.0 111.143 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 t -59.32 -69.97 0.18 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.464 0.706 . . . . 0.0 109.932 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -84.99 148.9 51.92 Favored Pre-proline 0 C--O 1.235 0.335 0 O-C-N 121.313 -0.867 . . . . 0.0 109.179 -171.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.57 108.43 1.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 N-CA-C 108.628 -1.336 . . . . 0.0 108.628 -173.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -111.02 154.46 24.15 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.352 0.661 . . . . 0.0 110.317 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -54.9 130.49 41.51 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.381 1.072 . . . . 0.0 110.123 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -64.07 117.73 7.5 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.33 -24.34 4.72 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.064 1.792 . . . . 0.0 110.681 -166.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 145.05 56.6 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.449 1.124 . . . . 0.0 110.664 173.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -120.09 175.17 6.06 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.468 1.907 . . . . 0.0 107.6 167.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.31 -41.33 84.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.483 -0.761 . . . . 0.0 109.972 166.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.5 m -65.02 -31.4 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.183 0.593 . . . . 0.0 112.285 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.14 -50.08 65.27 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.0 mt -64.95 -50.27 67.07 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.104 1.762 . . . . 0.0 109.767 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.79 -49.2 78.57 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 124.71 1.256 . . . . 0.0 107.662 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -60.66 -51.86 67.61 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.184 0.594 . . . . 0.0 111.029 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HZ3' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -54.49 -48.61 71.64 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.571 0.748 . . . . 0.0 109.3 -177.153 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -63.77 -49.85 71.37 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.453 1.101 . . . . 0.0 110.686 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -57.37 -38.11 73.7 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.307 1.443 . . . . 0.0 111.397 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -65.66 -53.59 39.18 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 118.339 -0.839 . . . . 0.0 109.728 167.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.482 HD13 ' CZ ' ' A' ' 20' ' ' PHE . 22.6 mt -57.78 -27.68 63.31 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -175.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.1 pt -82.79 -12.59 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 119.656 1.116 . . . . 0.0 112.01 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 m 51.53 21.77 1.35 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.265 1.426 . . . . 0.0 113.679 -177.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.2 162.88 54.39 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.926 -0.93 . . . . 0.0 112.387 -164.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.78 99.73 0.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.726 2.95 . . . . 0.0 108.859 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.7 t -179.17 108.2 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.532 1.933 . . . . 0.0 106.165 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.4 m 44.93 61.34 2.54 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.404 1.882 . . . . 0.0 110.434 172.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 117.545 -1.697 . . . . 0.0 109.159 -175.617 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.551 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -159.21 104.67 1.68 Allowed 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 166.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.1 m -60.39 160.82 8.14 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.452 0.701 . . . . 0.0 110.879 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.33 163.09 26.45 Favored Glycine 0 C--N 1.331 0.302 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 p -141.29 138.45 33.18 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.645 1.578 . . . . 0.0 108.444 -170.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m -148.56 -33.05 0.23 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.077 0.951 . . . . 0.0 110.92 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.12 -75.0 0.35 Allowed Glycine 0 C--N 1.337 0.617 0 C-N-CA 125.483 1.516 . . . . 0.0 109.488 -161.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -136.21 173.43 11.72 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.265 1.426 . . . . 0.0 109.449 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt 54.16 -169.16 0.06 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.019 1.328 . . . . 0.0 110.118 -174.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 47.29 -155.77 0.05 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.216 1.406 . . . . 0.0 109.175 -161.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -83.74 126.92 33.39 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 155.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 t -62.92 154.94 28.66 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 161.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.16 -29.48 68.7 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.343 -0.848 . . . . 0.0 111.367 -173.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -58.84 -50.27 74.62 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.747 0.819 . . . . 0.0 110.286 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -62.41 -30.68 71.39 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.089 -0.481 . . . . 0.0 110.903 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.1 t -70.15 -31.56 47.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 119.477 1.035 . . . . 0.0 111.477 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -66.45 -52.3 47.78 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 174.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -60.71 -33.14 72.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.339 0.656 . . . . 0.0 111.619 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -58.14 9.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.844 0.858 . . . . 0.0 109.345 173.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -57.95 -48.34 80.24 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 122.945 0.498 . . . . 0.0 110.562 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -58.82 -38.6 79.0 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.396 0.678 . . . . 0.0 110.992 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.11 -55.62 25.31 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 125.246 1.403 . . . . 0.0 110.806 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.64 -23.81 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 118.464 1.132 . . . . 0.0 111.285 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -72.28 -41.44 66.68 Favored 'General case' 0 C--O 1.224 -0.253 0 O-C-N 120.922 -1.111 . . . . 0.0 109.991 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 t -96.32 -37.2 10.6 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.578 0.751 . . . . 0.0 111.207 -172.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -86.29 -105.22 0.06 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 167.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.17 -81.92 0.15 Allowed Glycine 0 C--O 1.226 -0.406 0 CA-C-O 118.335 -1.259 . . . . 0.0 110.759 -173.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.68 4.29 9.52 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.437 2.119 . . . . 0.0 112.396 173.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -75.9 98.73 4.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -79.41 -35.2 40.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.869 1.268 . . . . 0.0 110.534 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -55.05 -47.26 75.03 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.941 0.896 . . . . 0.0 110.44 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.6 m -55.55 -59.27 5.06 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.773 1.629 . . . . 0.0 111.224 174.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 76.6 mt -53.08 -44.6 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 125.666 1.587 . . . . 0.0 110.165 -173.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -17.18 40.71 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -174.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -111.89 -29.51 7.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.681 1.192 . . . . 0.0 111.499 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.14 -19.92 65.62 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.054 0.942 . . . . 0.0 113.059 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -139.31 155.0 72.43 Favored Pre-proline 0 C--O 1.235 0.29 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.85 110.05 3.01 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.843 1.695 . . . . 0.0 110.061 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -115.72 157.24 24.58 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.906 1.282 . . . . 0.0 109.131 174.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -49.7 149.65 2.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.612 1.165 . . . . 0.0 112.549 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -61.72 144.78 54.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.66 -2.4 40.04 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.819 -1.545 . . . . 0.0 114.415 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -58.41 153.39 15.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 120.266 2.033 . . . . 0.0 110.283 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -112.31 160.8 17.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.04 0.936 . . . . 0.0 108.69 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.44 -30.99 63.52 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 122.192 -0.317 . . . . 0.0 110.651 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.1 m -65.02 -29.06 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 C-N-CA 123.723 0.809 . . . . 0.0 112.544 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -57.16 -41.52 79.37 Favored 'General case' 0 CA--C 1.516 -0.36 0 O-C-N 124.363 1.04 . . . . 0.0 109.517 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.7 mt -65.63 -48.95 70.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.737 1.215 . . . . 0.0 109.584 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.17 -44.19 95.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.845 0.858 . . . . 0.0 108.796 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -67.03 -46.38 74.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.143 0.577 . . . . 0.0 111.324 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -60.52 -39.66 88.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 119.512 1.051 . . . . 0.0 110.889 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.68 -42.94 99.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.475 0.71 . . . . 0.0 110.257 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -60.13 -47.76 84.57 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.77 172.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -52.09 -42.73 63.46 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.47 1.032 . . . . 0.0 109.986 173.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.6 mt -68.09 -60.62 2.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 119.049 -0.5 . . . . 0.0 111.091 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -63.06 -30.49 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 118.97 0.804 . . . . 0.0 112.242 -172.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.8 m -149.37 105.4 3.48 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 177.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.16 173.39 20.56 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 123.642 0.639 . . . . 0.0 112.213 -173.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.77 108.75 1.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.441 3.427 . . . . 0.0 109.501 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.8 m -141.36 161.41 37.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.491 0.716 . . . . 0.0 110.073 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.0 p -74.94 169.04 18.77 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.805 0.842 . . . . 0.0 111.811 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.313 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.799 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.9 m -57.83 129.37 41.59 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.459 1.104 . . . . 0.0 110.195 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 t -138.67 -85.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 172.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.99 -66.41 2.11 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 118.986 0.812 . . . . 0.0 112.256 -173.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 m -60.41 -63.88 1.14 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.24 1.016 . . . . 0.0 111.428 -175.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t 55.57 -164.57 0.13 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.997 0.919 . . . . 0.0 113.23 172.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.48 97.3 0.96 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 174.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -127.09 -19.47 4.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 117.906 -1.045 . . . . 0.0 113.676 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HA ' ' HE2' ' A' ' 9' ' ' LYS . 4.7 mmpt? -137.46 86.53 2.2 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -175.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 t0 56.4 162.69 0.02 OUTLIER 'General case' 0 C--O 1.236 0.359 0 C-N-CA 128.491 2.717 . . . . 0.0 112.293 -162.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.515 ' CG ' ' HE2' ' A' ' 51' ' ' LYS . 2.4 m-30 62.39 144.57 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 130.528 3.531 . . . . 0.0 111.073 -169.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 p -69.59 163.21 26.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.235 1.414 . . . . 0.0 108.28 160.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -57.93 -34.42 69.85 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.478 164.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -56.03 -59.86 4.3 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 126.056 1.743 . . . . 0.0 110.338 172.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -37.45 82.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.598 1.09 . . . . 0.0 111.01 -176.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.45 -41.08 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 118.606 0.639 . . . . 0.0 110.758 173.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -60.68 -47.73 84.94 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.57 0.748 . . . . 0.0 110.465 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -66.98 -31.95 72.86 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.83 0.452 . . . . 0.0 111.566 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.42 ' CD2' HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -56.08 -53.07 61.43 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 170.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.16 -46.24 89.84 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.466 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -55.56 -41.94 74.0 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.427 0.691 . . . . 0.0 110.896 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.04 -54.24 22.3 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 126.651 2.072 . . . . 0.0 111.369 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.1 t -64.67 -22.97 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 121.166 -1.196 . . . . 0.0 111.417 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -67.91 -45.89 73.1 Favored 'General case' 0 C--O 1.225 -0.191 0 O-C-N 121.041 -1.037 . . . . 0.0 109.82 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 t -95.58 -40.97 9.16 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.665 0.786 . . . . 0.0 110.957 -162.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -80.47 -66.19 0.91 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 166.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.81 -164.0 12.1 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 -146.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -78.89 23.47 0.34 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.84 0.856 . . . . 0.0 111.944 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -75.06 96.75 3.28 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 120.969 1.713 . . . . 0.0 107.122 165.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -72.62 -36.34 68.04 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.011 -1.449 . . . . 0.0 109.621 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -13.59 62.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.358 0.663 . . . . 0.0 112.184 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -86.29 -58.1 2.76 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 124.296 1.038 . . . . 0.0 108.805 169.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 92.4 mt -52.04 -44.9 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 C-N-CA 126.672 1.989 . . . . 0.0 111.372 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.91 -23.36 52.96 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.572 1.149 . . . . 0.0 112.72 -175.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -109.91 -35.88 6.04 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.885 1.274 . . . . 0.0 111.281 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.93 -29.57 69.69 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.962 0.801 . . . . 0.0 112.167 175.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -127.0 150.99 73.47 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 124.331 1.052 . . . . 0.0 108.629 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -87.82 107.55 0.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 CA-C-N 119.836 0.977 . . . . 0.0 110.004 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -94.11 161.14 14.4 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.414 -0.804 . . . . 0.0 109.405 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -66.0 147.1 53.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 173.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -53.68 146.04 14.21 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.511 0.725 . . . . 0.0 109.852 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.85 -15.13 56.67 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.373 -1.237 . . . . 0.0 112.32 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.2 111.05 3.25 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 120.421 2.11 . . . . 0.0 106.999 160.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -83.15 175.35 10.03 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 159.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.62 78.12 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.875 -1.14 . . . . 0.0 110.838 170.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.5 m -65.15 -30.32 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.025 0.93 . . . . 0.0 112.46 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.56 -41.45 90.15 Favored 'General case' 0 C--O 1.222 -0.371 0 O-C-N 124.133 0.896 . . . . 0.0 108.994 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.42 HD22 ' CD2' ' A' ' 19' ' ' LEU . 31.4 mt -65.98 -43.39 87.98 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.226 0.61 . . . . 0.0 109.641 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.06 -49.04 77.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -58.38 -51.76 68.45 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.953 0.901 . . . . 0.0 111.155 178.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HE2' ' CG ' ' A' ' 11' ' ' PHE . 48.0 tptt -55.92 -50.14 71.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.718 1.207 . . . . 0.0 110.091 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -61.62 -50.46 72.48 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.867 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -50.6 -47.87 58.03 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.037 0.835 . . . . 0.0 110.722 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.7 mmt-85 -65.88 -36.86 84.59 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 118.17 -0.919 . . . . 0.0 112.817 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.2 mt -65.97 -53.05 43.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.528 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.7 pt -62.97 -36.73 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 119.11 0.868 . . . . 0.0 111.58 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.0 m -160.22 118.44 2.63 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.521 1.055 . . . . 0.0 109.271 169.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.94 -171.47 15.57 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 123.513 0.577 . . . . 0.0 112.282 174.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.13 71.54 1.19 Allowed 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.481 2.788 . . . . 0.0 108.9 163.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.4 m -143.21 16.39 1.89 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.338 2.255 . . . . 0.0 110.875 -159.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.7 m -65.79 -11.13 43.61 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.332 1.453 . . . . 0.0 113.651 -172.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 N-CA-C 104.817 -3.313 . . . . 0.0 104.817 153.678 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.874 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.74 85.96 1.19 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.005 0.907 . . . . 0.0 110.123 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.7 m -65.98 167.37 9.86 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 159.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.04 -25.56 4.1 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 118.018 -1.434 . . . . 0.0 113.49 173.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.2 m -96.88 115.04 26.74 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.292 1.546 . . . . 0.0 109.449 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 t -129.57 137.41 50.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.395 1.478 . . . . 0.0 109.415 -162.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.33 147.12 4.9 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -133.21 -36.38 1.0 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 117.973 -1.013 . . . . 0.0 112.54 -175.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -83.84 164.75 19.3 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.612 1.096 . . . . 0.0 110.464 176.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 64.95 -53.45 0.32 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 130.106 3.362 . . . . 0.0 113.093 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.58 ' CZ ' HD23 ' A' ' 48' ' ' LEU . 6.9 m-30 -133.95 124.83 27.01 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 161.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.0 p -61.91 164.47 6.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.45 173.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -55.01 -31.85 61.37 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.545 -0.722 . . . . 0.0 110.587 170.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.41 -50.99 61.59 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.563 1.545 . . . . 0.0 108.654 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -63.92 -38.1 89.84 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.306 -0.871 . . . . 0.0 110.454 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.95 -25.31 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.459 1.027 . . . . 0.0 110.193 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -60.15 -60.02 4.48 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.468 -0.77 . . . . 0.0 109.096 169.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -63.94 -28.56 69.91 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.245 1.018 . . . . 0.0 112.556 -174.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.48 -56.23 24.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.952 0.901 . . . . 0.0 109.925 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -67.41 -42.36 83.39 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -52.17 -35.44 48.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.941 0.897 . . . . 0.0 111.337 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.54 -49.55 4.1 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 126.695 2.093 . . . . 0.0 111.825 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.5 t -61.46 -36.83 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 119.244 1.522 . . . . 0.0 110.007 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -63.7 -28.38 69.86 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.548 -0.72 . . . . 0.0 110.833 -174.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -95.2 -59.07 1.97 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.085 0.954 . . . . 0.0 108.81 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 33.8 mtt -71.3 -28.0 63.81 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.058 -1.026 . . . . 0.0 113.555 -170.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.33 -157.46 52.07 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -150.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -83.44 33.07 0.46 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.586 1.154 . . . . 0.0 111.963 -162.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -82.23 96.47 7.87 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -79.29 -46.21 18.19 Favored 'General case' 0 C--O 1.224 -0.255 0 O-C-N 121.778 -0.576 . . . . 0.0 110.194 -170.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -49.26 -52.22 28.71 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.647 1.579 . . . . 0.0 110.829 172.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.3 m -55.74 -54.55 43.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.035 0.934 . . . . 0.0 111.01 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.8 mt -54.27 -45.46 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.781 1.232 . . . . 0.0 110.518 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -22.66 20.52 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.98 1.312 . . . . 0.0 112.245 -177.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -106.54 -34.57 7.33 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.397 1.079 . . . . 0.0 111.575 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 t -60.93 -30.48 70.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.516 0.727 . . . . 0.0 111.246 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -133.88 152.01 77.88 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -176.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.86 110.57 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.942 2.428 . . . . 0.0 110.996 -172.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -110.03 170.63 7.95 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.556 0.742 . . . . 0.0 110.202 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -58.58 160.43 5.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 123.043 1.401 . . . . 0.0 112.884 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.12 138.68 57.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.041 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.8 6.8 57.19 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 117.895 -1.503 . . . . 0.0 114.543 175.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -61.82 158.3 16.19 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 120.286 2.043 . . . . 0.0 110.064 173.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -112.33 161.36 16.73 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.066 1.347 . . . . 0.0 107.472 170.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.21 -35.01 69.13 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.934 -0.479 . . . . 0.0 110.997 176.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 m -61.13 -25.14 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.469 1.108 . . . . 0.0 112.746 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -64.21 -33.37 75.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.58 HD23 ' CZ ' ' A' ' 11' ' ' PHE . 41.8 mt -71.41 -41.06 70.06 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.633 1.573 . . . . 0.0 110.476 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.28 -52.3 64.25 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 172.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -59.89 -53.51 57.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.674 -0.641 . . . . 0.0 112.205 -167.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -64.71 -40.48 95.43 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.165 -173.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -56.82 -53.43 58.0 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.982 1.713 . . . . 0.0 110.34 174.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -53.73 -47.07 70.95 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.435 1.094 . . . . 0.0 109.526 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -64.82 -42.64 94.82 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.148 -0.93 . . . . 0.0 110.727 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.4 mt -61.05 -53.49 56.55 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.932 1.242 . . . . 0.0 112.023 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.1 pt -60.48 -36.62 70.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 119.357 0.981 . . . . 0.0 110.197 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.7 m -58.95 -60.72 3.41 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.833 0.853 . . . . 0.0 110.592 173.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.6 -175.13 16.76 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.654 1.597 . . . . 0.0 111.19 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.81 -47.99 2.31 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.37 2.713 . . . . 0.0 111.559 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.6 p -80.81 76.02 7.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.3 1.04 . . . . 0.0 109.883 -174.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t 62.36 -170.57 0.17 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.532 1.133 . . . . 0.0 111.341 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.816 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 145.58 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.498 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.59 167.63 21.79 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.732 1.213 . . . . 0.0 108.508 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -69.27 136.34 51.78 Favored 'General case' 0 C--O 1.239 0.546 0 O-C-N 121.426 -0.797 . . . . 0.0 110.078 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.01 88.14 0.25 Allowed Glycine 0 C--O 1.224 -0.484 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.7 m 55.5 -2.89 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.943 2.497 . . . . 0.0 117.714 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -68.68 -85.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.994 1.724 . . . . 0.0 110.678 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.07 175.93 30.59 Favored Glycine 0 C--N 1.338 0.655 0 O-C-N 120.493 -1.38 . . . . 0.0 112.202 -175.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.5 ttp-105 -127.34 -13.24 5.56 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.81 1.244 . . . . 0.0 112.291 -176.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -123.91 143.74 50.19 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 119.91 1.232 . . . . 0.0 109.371 173.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -152.31 49.47 0.77 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.03 2.132 . . . . 0.0 106.165 168.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.502 ' CD2' ' HG3' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -141.79 104.01 4.45 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 -176.833 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 t -68.83 160.08 31.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.336 1.054 . . . . 0.0 110.262 -170.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -58.56 -31.43 67.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.224 1.01 . . . . 0.0 111.995 -168.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 14' ' ' GLU . 25.0 mp0 -68.67 -51.08 45.77 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 127.899 2.48 . . . . 0.0 108.639 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -60.94 -33.58 73.39 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 119.332 -0.366 . . . . 0.0 110.676 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.03 -32.91 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 120.486 -1.384 . . . . 0.0 109.707 176.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -61.94 -52.12 65.33 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -62.55 -36.89 84.08 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.434 1.094 . . . . 0.0 111.899 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.03 -54.8 42.84 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -63.26 -40.84 98.54 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.139 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -56.66 -57.55 11.91 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.814 0.734 . . . . 0.0 109.435 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -50.83 -55.24 18.76 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 125.653 1.597 . . . . 0.0 111.828 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.44 -24.21 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 118.148 0.974 . . . . 0.0 111.097 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -75.13 -33.72 61.59 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 120.87 -1.144 . . . . 0.0 111.213 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 t -90.56 -47.85 7.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.73 1.15 . . . . 0.0 109.487 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.9 mtt -80.72 -66.37 0.89 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.682 0.674 . . . . 0.0 109.537 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.07 -152.62 16.76 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 -158.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -72.41 16.1 0.15 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.553 2.341 . . . . 0.0 112.645 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -78.53 97.76 5.85 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 120.205 1.366 . . . . 0.0 107.324 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -79.22 -51.38 9.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.045 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -56.74 -45.49 81.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.165 0.439 . . . . 0.0 110.952 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.2 m -58.25 -51.97 67.54 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.051 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.2 mt -56.14 -44.4 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 119.736 1.153 . . . . 0.0 110.075 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.07 -30.35 15.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.082 1.353 . . . . 0.0 111.487 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.4 m0 -103.38 -35.25 8.45 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.771 1.228 . . . . 0.0 111.545 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -63.45 -24.17 67.71 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.207 1.403 . . . . 0.0 112.762 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -123.19 153.12 64.72 Favored Pre-proline 0 C--O 1.236 0.389 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 175.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -79.45 109.35 2.47 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 N-CA-C 107.774 -1.664 . . . . 0.0 107.774 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -106.31 156.37 18.57 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.462 0.705 . . . . 0.0 109.623 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -59.3 154.82 15.71 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.15 0.98 . . . . 0.0 111.443 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 167.88 18.19 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.561 0.696 . . . . 0.0 112.321 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.98 -7.2 29.88 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.695 1.14 . . . . 0.0 112.864 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.6 165.6 12.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.396 1.478 . . . . 0.0 113.163 -176.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -141.6 165.7 26.78 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.658 1.983 . . . . 0.0 107.288 171.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.84 -32.16 67.35 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.003 -1.06 . . . . 0.0 111.048 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 m -75.54 -20.0 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.056 1.343 . . . . 0.0 112.55 -174.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.63 -53.39 58.69 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 171.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 43.1 mt -53.29 -54.31 38.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.565 1.946 . . . . 0.0 110.343 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.48 -48.12 80.98 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.924 1.289 . . . . 0.0 108.989 -173.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -64.71 -46.96 80.1 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.502 ' HG3' ' CD2' ' A' ' 11' ' ' PHE . 1.3 tmtm? -58.99 -49.71 76.86 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 124.726 1.21 . . . . 0.0 109.308 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.45 -47.92 78.13 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.154 0.982 . . . . 0.0 110.616 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -54.33 -48.5 71.3 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.457 -0.782 . . . . 0.0 110.439 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 mtt85 -62.87 -26.6 68.86 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.818 1.247 . . . . 0.0 113.273 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 74.8 mt -76.67 -52.35 9.8 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.347 -0.846 . . . . 0.0 111.088 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.3 pt -64.75 -30.67 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 118.616 0.644 . . . . 0.0 110.922 -173.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -159.2 -179.49 8.04 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.86 1.209 . . . . 0.0 108.223 158.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.03 176.07 44.86 Favored Glycine 0 CA--C 1.521 0.469 0 O-C-N 120.394 -1.441 . . . . 0.0 112.774 174.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.9 -9.21 22.13 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.254 2.636 . . . . 0.0 113.573 -172.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.8 t 49.53 -137.29 1.04 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -163.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 p -105.69 151.73 24.04 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 145.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 N-CA-C 105.403 -3.079 . . . . 0.0 105.403 161.811 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.77 158.81 31.55 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 162.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -55.34 -26.96 44.11 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.276 -1.345 . . . . 0.0 111.706 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -67.41 -46.45 73.17 Favored 'General case' 0 CA--C 1.526 0.05 0 CA-C-N 119.735 1.152 . . . . 0.0 111.377 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -38.74 91.99 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.397 0.999 . . . . 0.0 109.189 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.7 t -67.19 -27.45 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 119.265 0.939 . . . . 0.0 110.855 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -57.46 -60.2 4.01 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -61.14 -30.38 70.35 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -58.77 -58.86 6.75 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -71.96 -35.7 69.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 118.383 -0.818 . . . . 0.0 111.736 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -54.61 -45.2 73.63 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.273 0.942 . . . . 0.0 109.494 176.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.95 -64.36 3.72 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 125.464 1.506 . . . . 0.0 110.364 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.8 t -54.42 -27.93 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 118.964 1.382 . . . . 0.0 112.045 -174.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -67.02 -29.73 69.62 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.208 1.403 . . . . 0.0 111.518 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.1 t -97.17 -55.85 2.73 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.003 1.321 . . . . 0.0 112.085 167.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.0 mmt -61.36 -29.34 69.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.825 2.05 . . . . 0.0 113.171 -168.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.49 -153.82 48.79 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -153.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -76.07 19.89 0.21 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.137 1.375 . . . . 0.0 112.782 -168.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -81.55 97.77 7.99 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.299 -1.5 . . . . 0.0 108.733 -171.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -81.72 -47.9 12.34 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.033 -164.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -58.18 -43.51 87.55 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.656 0.662 . . . . 0.0 109.48 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.2 m -54.93 -49.93 70.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.781 1.632 . . . . 0.0 111.532 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 60.6 mt -58.56 -48.65 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 124.399 1.08 . . . . 0.0 109.562 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.73 -37.15 63.05 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.504 1.121 . . . . 0.0 111.423 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 14.3 m0 -85.08 -34.6 22.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.032 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.8 t -69.81 -30.41 67.93 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.672 1.124 . . . . 0.0 113.224 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -124.94 154.37 71.08 Favored Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 119.804 1.184 . . . . 0.0 110.355 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.08 117.81 5.32 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 121.867 1.711 . . . . 0.0 109.478 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -129.25 161.93 29.06 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.033 1.333 . . . . 0.0 110.616 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -47.64 129.3 13.66 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.689 1.596 . . . . 0.0 111.298 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -57.84 150.8 19.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.488 0.661 . . . . 0.0 109.573 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.6 4.25 44.98 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 117.685 -1.619 . . . . 0.0 114.634 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -53.22 164.01 0.49 Allowed 'General case' 0 C--N 1.343 0.308 0 CA-C-N 119.557 1.679 . . . . 0.0 110.649 170.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -121.45 158.5 28.26 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 163.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.35 -25.79 68.09 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.388 0.54 . . . . 0.0 111.327 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.71 -34.75 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.55 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -56.87 -35.14 68.57 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.95 0.5 . . . . 0.0 109.921 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.8 mt -66.18 -53.97 31.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.02 0.928 . . . . 0.0 109.297 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.23 -38.51 76.98 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.841 1.256 . . . . 0.0 110.379 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -75.48 -42.89 51.86 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.714 1.606 . . . . 0.0 110.623 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -65.59 -45.78 81.9 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.386 -0.821 . . . . 0.0 109.347 172.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -54.9 -48.6 72.83 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 126.099 1.759 . . . . 0.0 110.722 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -46.51 -58.14 4.06 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.386 1.074 . . . . 0.0 109.784 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -61.92 -33.4 74.18 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.216 -0.927 . . . . 0.0 112.519 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 mt -63.71 -44.32 93.97 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.959 0.799 . . . . 0.0 110.071 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.0 pt . . . . . 0 CA--C 1.542 0.644 0 CA-C-N 119.485 1.039 . . . . 0.0 112.479 178.277 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 . . . . . 0 C--O 1.238 0.475 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 p -68.33 167.41 14.58 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.476 0.58 . . . . 0.0 110.153 170.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -57.76 -34.24 69.34 Favored 'General case' 0 N--CA 1.462 0.139 0 O-C-N 121.129 -0.982 . . . . 0.0 110.29 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.96 -54.73 37.64 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.053 0.941 . . . . 0.0 109.658 175.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -60.49 -42.69 96.82 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 123.031 0.532 . . . . 0.0 110.841 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.2 t -65.21 -35.1 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 O-C-N 121.367 -0.833 . . . . 0.0 110.885 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -63.67 -50.66 68.37 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 172.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -61.07 -33.32 73.15 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 118.771 0.714 . . . . 0.0 111.333 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -58.82 -56.28 24.28 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.92 0.888 . . . . 0.0 108.923 174.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -60.36 -44.73 95.31 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.152 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -56.99 -44.36 82.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.96 0.904 . . . . 0.0 109.721 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.84 -63.1 5.6 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 126.679 2.085 . . . . 0.0 110.423 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.23 -22.03 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 118.895 1.347 . . . . 0.0 111.162 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -73.7 -30.46 62.88 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 119.972 -1.705 . . . . 0.0 110.974 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.7 t -95.59 -57.71 2.31 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.709 0.804 . . . . 0.0 109.45 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -70.0 -27.14 64.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.413 1.485 . . . . 0.0 112.659 -174.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.93 -148.69 45.47 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -153.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -76.82 15.27 0.68 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.67 1.188 . . . . 0.0 113.994 -159.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -84.5 97.46 9.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 120.144 1.338 . . . . 0.0 110.093 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -71.82 -42.42 67.04 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.502 0.721 . . . . 0.0 112.455 -175.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -64.39 -40.91 96.73 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 118.619 0.645 . . . . 0.0 109.666 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.16 -54.53 38.49 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 123.4 0.68 . . . . 0.0 109.435 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.9 mt -54.57 -52.05 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 126.111 1.765 . . . . 0.0 109.831 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -47.16 69.33 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.299 1.44 . . . . 0.0 110.836 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -74.99 -39.79 61.06 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.696 -0.668 . . . . 0.0 110.602 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -59.92 -71.6 0.13 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.581 1.152 . . . . 0.0 110.565 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -87.17 153.15 53.87 Favored Pre-proline 0 N--CA 1.453 -0.301 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -166.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.15 110.52 3.13 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.588 1.525 . . . . 0.0 109.081 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -111.11 174.17 5.99 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.071 0.948 . . . . 0.0 108.698 172.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -63.98 155.85 29.73 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.939 0.876 . . . . 0.0 111.358 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -62.55 139.03 58.6 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.453 1.101 . . . . 0.0 109.043 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.55 23.31 76.66 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 117.689 0.222 . . . . 0.0 112.599 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -70.47 165.42 22.63 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 121.406 -1.055 . . . . 0.0 111.495 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -118.13 161.25 20.17 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.698 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.03 86.05 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 165.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.43 -26.34 33.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 O-C-N 121.546 -0.721 . . . . 0.0 111.761 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.6 -41.81 86.69 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HB3' HD21 ' A' ' 19' ' ' LEU . 55.6 mt -65.14 -52.26 56.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.14 1.776 . . . . 0.0 109.111 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.02 -46.43 82.34 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.521 1.128 . . . . 0.0 108.089 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -63.72 -54.43 35.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.96 1.304 . . . . 0.0 110.899 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.88 -47.2 77.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.772 0.715 . . . . 0.0 109.299 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -60.07 -49.94 75.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.581 1.552 . . . . 0.0 111.193 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -55.59 -41.2 73.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.82 1.248 . . . . 0.0 111.059 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mmm-85 -68.86 -42.96 76.33 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.936 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.9 mt -58.27 -49.99 75.18 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.886 1.221 . . . . 0.0 112.527 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt . . . . . 0 CA--C 1.539 0.557 0 C-N-CA 123.093 0.557 . . . . 0.0 112.045 176.331 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 . . . . . 0 C--O 1.243 0.72 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.4 p -61.7 176.64 0.5 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.453 1.121 . . . . 0.0 110.719 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -58.92 -42.73 90.38 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 120.656 -1.278 . . . . 0.0 110.487 173.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -55.93 -54.47 44.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 124.708 1.255 . . . . 0.0 108.741 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -62.04 -41.79 98.49 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.332 1.053 . . . . 0.0 111.517 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.1 t -64.34 -38.02 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.029 0.831 . . . . 0.0 109.917 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -62.78 -47.95 81.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -60.36 -34.47 73.91 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.338 0.655 . . . . 0.0 112.389 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -57.0 -55.24 37.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -60.79 -46.95 88.49 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.813 0.445 . . . . 0.0 111.256 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -35.05 71.0 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.712 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -78.36 -51.54 5.61 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 125.923 1.725 . . . . 0.0 111.171 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.0 t -58.66 -28.99 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 118.249 1.024 . . . . 0.0 110.468 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -49.72 74.62 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 124.265 1.026 . . . . 0.0 110.34 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 t -96.77 -21.63 17.43 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.847 1.659 . . . . 0.0 113.647 -167.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.8 mtp -128.53 -6.56 5.22 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.204 1.002 . . . . 0.0 112.587 -170.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.86 -158.07 53.45 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 119.232 0.923 . . . . 0.0 111.385 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -72.0 21.54 0.06 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.289 1.036 . . . . 0.0 112.193 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -82.91 97.72 8.83 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -176.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -82.37 -45.07 15.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.047 -163.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -50.11 -49.5 51.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.598 0.759 . . . . 0.0 109.282 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -54.8 -54.78 37.69 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 128.063 2.545 . . . . 0.0 110.351 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 67.6 mt -59.21 -44.91 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.084 0.954 . . . . 0.0 110.355 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -34.64 64.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.379 1.472 . . . . 0.0 110.925 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -88.74 -37.26 15.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.101 0.96 . . . . 0.0 111.848 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 t -67.3 -18.66 65.27 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -140.68 154.09 68.64 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 119.881 1.218 . . . . 0.0 110.021 -173.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.12 109.58 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.159 1.906 . . . . 0.0 110.823 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -107.58 -178.53 3.65 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.668 1.187 . . . . 0.0 109.67 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -67.7 162.95 22.61 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.671 -0.643 . . . . 0.0 110.785 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.9 147.58 50.09 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 121.669 -0.644 . . . . 0.0 109.931 176.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.4 5.8 37.71 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.107 -0.83 . . . . 0.0 113.759 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -59.49 135.79 57.78 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 118.348 1.074 . . . . 0.0 108.299 169.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -90.5 167.06 12.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 171.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.81 -38.48 78.71 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.712 -0.617 . . . . 0.0 110.614 169.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.1 m -63.75 -27.58 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 123.386 0.674 . . . . 0.0 112.081 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -59.65 -37.69 79.4 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.422 ' HB3' HD21 ' A' ' 19' ' ' LEU . 47.6 mt -65.85 -50.01 66.1 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.738 1.215 . . . . 0.0 109.713 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.39 -41.7 90.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.922 0.889 . . . . 0.0 109.337 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -68.19 -52.54 33.2 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 124.114 0.966 . . . . 0.0 110.259 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -44.21 93.58 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 120.868 -1.145 . . . . 0.0 108.985 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -55.34 -50.59 69.24 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.567 1.147 . . . . 0.0 111.13 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -51.42 -46.13 62.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.557 1.143 . . . . 0.0 110.081 175.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -71.91 -26.33 62.26 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.465 1.106 . . . . 0.0 112.477 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.8 mt -70.57 -58.53 3.59 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.918 1.236 . . . . 0.0 109.028 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 pt . . . . . 0 CA--C 1.537 0.461 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.154 -177.446 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.463 ' CD2' ' HG2' ' A' ' 51' ' ' LYS . 34.0 m-85 . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 121.469 0.652 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.8 p -65.6 155.13 36.78 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.761 -0.587 . . . . 0.0 110.675 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -52.48 -37.25 56.75 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.069 -1.019 . . . . 0.0 111.554 174.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.58 -50.98 70.45 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 124.954 1.302 . . . . 0.0 110.224 176.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -63.67 -28.19 69.73 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.943 -1.098 . . . . 0.0 110.856 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.6 t -69.33 -35.91 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 120.388 1.449 . . . . 0.0 109.311 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -50.29 -60.59 2.82 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 170.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -61.99 -31.04 71.37 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.033 0.933 . . . . 0.0 112.715 -176.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -59.55 -61.9 2.28 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -64.14 -47.94 77.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.736 0.414 . . . . 0.0 110.585 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.92 -40.65 70.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.187 1.395 . . . . 0.0 110.3 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.55 -56.91 11.23 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 125.337 1.446 . . . . 0.0 111.022 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.7 t -56.69 -32.17 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 118.598 1.199 . . . . 0.0 111.427 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -61.04 -42.0 97.64 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 119.665 1.121 . . . . 0.0 110.405 -175.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.7 t -95.43 -44.88 7.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.787 0.835 . . . . 0.0 109.689 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 6.8 mmt -69.78 -25.58 63.86 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.129 1.372 . . . . 0.0 112.022 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.39 -161.25 34.92 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -151.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -72.67 8.51 1.43 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -166.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -70.0 97.8 1.2 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 121.056 1.753 . . . . 0.0 110.472 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -71.12 -40.91 71.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.806 0.842 . . . . 0.0 111.06 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -57.48 -46.5 83.64 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.869 0.868 . . . . 0.0 109.749 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.07 -61.11 2.53 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.718 0.807 . . . . 0.0 109.472 173.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.0 mt -52.26 -48.4 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 126.125 1.77 . . . . 0.0 110.905 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -24.02 63.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.706 0.802 . . . . 0.0 112.038 -174.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -100.67 -41.32 6.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.65 0.78 . . . . 0.0 111.231 175.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.3 -15.69 60.73 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -176.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -134.25 155.01 80.28 Favored Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 125.26 1.424 . . . . 0.0 108.313 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.0 110.62 2.35 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.803 2.336 . . . . 0.0 109.778 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -118.27 159.43 23.38 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.56 1.144 . . . . 0.0 109.012 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -54.0 145.93 15.58 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.546 1.138 . . . . 0.0 112.084 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -61.43 133.75 56.13 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.75 -8.42 73.91 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 118.838 -0.979 . . . . 0.0 112.579 176.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.6 mmp_? -61.48 153.49 27.14 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 118.867 1.333 . . . . 0.0 108.676 162.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.7 mtm105 -124.96 174.08 8.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.32 1.448 . . . . 0.0 107.401 167.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.53 -33.41 69.84 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 122.278 0.231 . . . . 0.0 110.639 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 m -63.8 -33.9 64.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 C-N-CA 123.473 0.709 . . . . 0.0 112.471 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.94 -41.11 86.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.44 ' HB3' HD21 ' A' ' 19' ' ' LEU . 53.8 mt -63.1 -52.0 64.37 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.982 1.313 . . . . 0.0 109.633 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.82 -45.07 82.53 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.743 1.217 . . . . 0.0 109.266 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -63.52 -54.34 37.72 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.716 1.207 . . . . 0.0 110.432 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.463 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 52.9 tptt -61.19 -44.75 96.79 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.97 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -56.58 -54.81 41.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.568 1.147 . . . . 0.0 110.383 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -50.28 60.77 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 123.558 0.536 . . . . 0.0 109.68 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -56.57 -45.6 81.2 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.473 1.109 . . . . 0.0 111.777 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.0 mt -63.33 -56.22 18.17 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.797 0.839 . . . . 0.0 110.759 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.5 pt . . . . . 0 CA--C 1.538 0.516 0 CA-C-N 118.014 0.37 . . . . 0.0 111.195 177.117 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 . . . . . 0 C--O 1.237 0.399 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.444 HG22 ' OE1' ' A' ' 15' ' ' GLU . 8.8 t -83.47 178.44 8.02 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 164.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -55.27 -35.05 64.6 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-O 117.607 -1.187 . . . . 0.0 111.462 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.06 -57.66 11.87 Favored 'General case' 0 C--O 1.225 -0.197 0 O-C-N 123.827 0.705 . . . . 0.0 112.067 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.444 ' OE1' HG22 ' A' ' 12' ' ' THR . 3.0 mp0 -59.46 -40.22 86.18 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.688 1.131 . . . . 0.0 111.732 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.2 t -60.56 -40.62 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 118.839 -0.601 . . . . 0.0 111.374 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -57.42 -52.18 66.43 Favored 'General case' 0 C--O 1.226 -0.141 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.5 m-30 -61.03 -33.56 73.48 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.417 1.087 . . . . 0.0 111.716 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -61.38 -56.82 16.04 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.082 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -64.15 -43.1 96.26 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 117.791 -1.1 . . . . 0.0 111.769 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -55.52 -54.42 44.21 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.875 1.27 . . . . 0.0 109.262 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.85 -59.25 10.61 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 125.425 1.488 . . . . 0.0 111.648 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.4 t -61.74 -21.99 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 O-C-N 121.561 -0.964 . . . . 0.0 111.562 -177.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -76.1 -44.18 39.87 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 120.117 -1.614 . . . . 0.0 109.499 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.9 t -95.36 -16.58 22.25 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.571 0.749 . . . . 0.0 112.195 -169.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.4 mtp -126.71 -9.77 6.15 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.599 1.16 . . . . 0.0 112.257 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.04 -152.83 42.84 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -167.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -73.22 18.88 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.735 1.614 . . . . 0.0 113.648 -164.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -75.94 97.28 3.94 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.789 1.632 . . . . 0.0 109.482 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -75.15 -44.21 48.09 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.28 -0.888 . . . . 0.0 112.218 -171.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -62.33 -48.16 81.07 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.2 m -53.85 -47.03 71.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.903 0.881 . . . . 0.0 111.037 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.88 -46.65 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 119.926 1.239 . . . . 0.0 110.268 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.28 -24.09 17.59 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.027 1.331 . . . . 0.0 112.016 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -108.61 -31.64 7.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.681 1.192 . . . . 0.0 110.73 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -58.73 -23.2 59.36 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.274 1.429 . . . . 0.0 112.15 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -138.16 157.86 72.05 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 125.711 1.605 . . . . 0.0 108.003 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.87 109.12 1.94 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 N-CA-C 107.776 -1.663 . . . . 0.0 107.776 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -101.54 164.89 11.53 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.282 -0.886 . . . . 0.0 109.102 175.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -53.47 142.54 21.82 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -70.51 158.97 35.13 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.494 0.664 . . . . 0.0 110.261 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.2 -3.39 22.88 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.755 -1.581 . . . . 0.0 113.543 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.418 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 7.7 mmp_? -64.57 141.19 58.86 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 120.479 2.139 . . . . 0.0 109.566 176.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.6 mtt85 -82.8 159.87 22.37 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.04 78.51 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.262 -0.899 . . . . 0.0 109.903 166.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 m -65.15 -24.42 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 118.334 -0.841 . . . . 0.0 111.974 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -61.59 -31.73 71.8 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' HB3' HD21 ' A' ' 19' ' ' LEU . 59.7 mt -68.62 -49.76 56.75 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.507 1.523 . . . . 0.0 109.709 175.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.34 98.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.468 1.107 . . . . 0.0 109.758 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -65.71 -46.53 78.63 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.364 1.466 . . . . 0.0 110.197 178.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -60.9 -47.12 87.85 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -56.81 -45.27 82.36 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.783 1.233 . . . . 0.0 111.471 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -51.61 -39.82 58.71 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.647 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -81.4 -20.21 40.94 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.857 1.662 . . . . 0.0 113.288 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.6 mt -74.96 -11.42 60.11 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.406 -0.809 . . . . 0.0 111.47 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.5 pt . . . . . 0 CA--C 1.541 0.604 0 CA-C-N 119.612 1.096 . . . . 0.0 111.67 168.881 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 . . . . . 0 C--O 1.238 0.45 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 t -72.7 168.95 17.67 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -40.05 62.05 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.092 0.957 . . . . 0.0 112.196 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -56.81 -50.85 71.11 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.811 1.244 . . . . 0.0 108.033 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -70.13 -25.39 63.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.123 0.969 . . . . 0.0 111.889 -174.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.6 t -73.96 -41.61 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 118.82 0.736 . . . . 0.0 109.341 173.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -58.76 -48.33 81.57 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.738 -0.649 . . . . 0.0 109.359 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -60.22 -35.35 75.24 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.966 0.906 . . . . 0.0 111.451 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.43 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -59.36 -53.94 52.4 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -72.14 -24.9 61.53 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -66.1 -55.06 18.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 170.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.84 -62.14 6.18 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 125.891 1.71 . . . . 0.0 111.319 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.6 t -61.75 -25.38 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 118.182 0.991 . . . . 0.0 111.65 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -70.71 -46.51 62.96 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 121.011 -1.056 . . . . 0.0 109.27 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -95.08 -20.32 19.41 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.354 0.525 . . . . 0.0 111.544 -168.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.3 mtp -124.09 -9.24 7.66 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.905 1.282 . . . . 0.0 111.997 -172.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.35 -154.14 50.45 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -73.55 14.68 0.32 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.31 1.044 . . . . 0.0 113.69 -166.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -78.71 96.87 5.67 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 120.797 1.635 . . . . 0.0 107.84 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -76.16 -42.42 46.64 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.729 -0.607 . . . . 0.0 110.423 -173.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -59.32 -42.66 91.95 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 m -60.66 -54.35 46.33 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.605 1.162 . . . . 0.0 112.35 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.3 mt -56.79 -43.27 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 125.407 1.483 . . . . 0.0 110.565 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -14.98 37.74 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -175.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -110.38 -29.17 8.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.024 1.329 . . . . 0.0 111.356 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 3.1 t -60.75 -18.17 53.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.593 0.757 . . . . 0.0 112.471 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 70.3 m-85 -144.58 158.03 54.5 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 125.098 1.359 . . . . 0.0 108.049 -176.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.4 109.89 3.0 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.734 1.623 . . . . 0.0 109.385 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -113.17 166.38 11.5 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.218 1.407 . . . . 0.0 109.596 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -56.87 151.38 14.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.99 1.316 . . . . 0.0 111.009 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.3 142.28 50.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -176.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.05 8.15 57.82 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.009 -1.439 . . . . 0.0 113.965 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -64.35 165.26 9.92 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 120.822 2.311 . . . . 0.0 109.661 169.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -120.72 159.58 25.09 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.645 1.178 . . . . 0.0 108.11 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.26 -40.35 64.56 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.626 0.37 . . . . 0.0 110.744 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.3 m -62.62 -27.98 43.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 C-N-CA 123.688 0.795 . . . . 0.0 112.336 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -62.09 -35.06 77.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.43 ' HB3' HD21 ' A' ' 19' ' ' LEU . 54.9 mt -66.95 -46.29 75.17 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 126.493 1.917 . . . . 0.0 110.129 175.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.02 -51.07 69.49 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -55.78 -48.4 75.38 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.466 1.107 . . . . 0.0 110.594 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -61.79 -48.02 82.51 Favored 'General case' 0 C--O 1.223 -0.29 0 O-C-N 121.234 -0.916 . . . . 0.0 110.998 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -55.48 -46.48 76.89 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 125.475 1.51 . . . . 0.0 110.991 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 49.3 m170 -53.77 -54.76 33.69 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.475 1.11 . . . . 0.0 109.028 172.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -55.77 -38.64 70.16 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 121.442 -0.786 . . . . 0.0 112.397 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.3 mt -68.33 -39.15 82.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 117.642 -1.17 . . . . 0.0 111.521 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt . . . . . 0 N--CA 1.469 0.479 0 CA-C-N 120.164 1.347 . . . . 0.0 111.569 173.424 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.422 ' CD2' ' HG2' ' A' ' 51' ' ' LYS . 10.7 m-85 . . . . . 0 C--O 1.232 0.149 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -84.1 -166.96 1.57 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.811 0.844 . . . . 0.0 109.957 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -74.05 -24.77 59.58 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 120.97 -1.081 . . . . 0.0 111.116 161.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -77.19 -49.48 15.07 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 119.23 0.923 . . . . 0.0 109.193 -171.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -41.36 92.07 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.6 t -59.78 -38.0 74.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 C-N-CA 124.151 0.98 . . . . 0.0 110.337 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -56.09 -54.56 43.58 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -65.8 -26.86 67.88 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -62.68 -52.43 63.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.027 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -59.28 -44.84 92.45 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.24 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -51.46 -52.85 42.89 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.638 1.175 . . . . 0.0 111.064 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.34 -58.54 8.52 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 124.23 0.919 . . . . 0.0 111.162 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -56.98 -25.56 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 118.507 1.154 . . . . 0.0 110.877 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -59.4 -45.71 90.73 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 121.317 -0.865 . . . . 0.0 110.52 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.2 t -96.5 -21.61 17.6 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.936 1.294 . . . . 0.0 112.065 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.3 mtp -116.86 -1.91 11.92 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.75 -1.219 . . . . 0.0 113.707 -166.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.27 -113.0 1.99 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -104.73 8.58 35.07 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.513 0.725 . . . . 0.0 112.698 -168.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -76.55 96.48 4.13 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 120.094 1.315 . . . . 0.0 109.514 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -78.7 -44.84 22.66 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.642 -172.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -61.35 -41.19 96.65 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 119.502 -0.285 . . . . 0.0 110.581 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 m -56.57 -53.92 51.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.207 0.603 . . . . 0.0 110.609 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 55.0 mt -53.3 -45.14 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.024 1.33 . . . . 0.0 110.893 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -31.06 68.0 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.325 0.65 . . . . 0.0 112.167 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -86.88 -35.09 19.19 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.947 0.499 . . . . 0.0 111.247 171.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.442 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 8.3 t -60.32 -31.05 69.92 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.128 1.371 . . . . 0.0 113.33 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 74.1 m-85 -135.27 155.14 79.0 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 123.93 0.892 . . . . 0.0 109.058 -171.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.89 109.3 2.19 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.852 1.701 . . . . 0.0 109.638 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -109.04 176.2 5.18 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.982 0.913 . . . . 0.0 111.036 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -56.55 155.9 6.8 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.481 1.112 . . . . 0.0 111.018 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.46 121.75 20.12 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -172.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.75 21.84 65.36 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.416 -0.658 . . . . 0.0 113.952 169.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -57.47 163.37 2.4 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 122.105 0.955 . . . . 0.0 111.389 171.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -103.05 167.58 9.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.948 162.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.5 -34.63 78.67 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.641 -0.662 . . . . 0.0 109.3 166.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 m -62.43 -29.34 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 O-C-N 121.701 -0.624 . . . . 0.0 112.259 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -55.97 -43.1 77.25 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.402 ' HB3' HD21 ' A' ' 19' ' ' LEU . 46.0 mt -67.05 -44.28 80.59 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.8 0.84 . . . . 0.0 110.061 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.84 -45.97 87.12 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.431 0.693 . . . . 0.0 109.374 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -60.39 -52.98 62.93 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.066 1.347 . . . . 0.0 109.063 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 57.7 tptt -59.94 -39.98 87.4 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.687 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -62.29 -46.28 89.49 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 119.68 1.127 . . . . 0.0 111.206 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -51.76 -54.2 31.23 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -53.81 -42.12 68.07 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.666 0.666 . . . . 0.0 112.307 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.69 -37.24 85.91 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 117.882 -1.056 . . . . 0.0 110.98 -176.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.5 pt . . . . . 0 CA--C 1.536 0.432 0 CA-C-N 119.491 1.042 . . . . 0.0 110.253 174.909 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 C--O 1.235 0.337 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.9 p -74.1 173.14 10.5 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 120.574 -1.329 . . . . 0.0 108.064 169.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -55.23 -21.55 14.55 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.022 0.929 . . . . 0.0 112.232 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.07 -32.74 17.41 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.626 1.171 . . . . 0.0 112.037 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.48 -41.98 75.43 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 119.842 1.201 . . . . 0.0 108.329 171.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.54 -29.42 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 122.004 -0.435 . . . . 0.0 110.206 174.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -57.78 -59.0 5.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 118.817 -0.611 . . . . 0.0 109.599 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -60.41 -28.3 68.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.82 -58.17 5.57 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -68.17 -28.41 67.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 119.312 -0.375 . . . . 0.0 111.607 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.91 -43.28 93.33 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.866 0.866 . . . . 0.0 109.674 173.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.77 -44.07 8.62 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 124.101 0.858 . . . . 0.0 111.062 -168.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.7 t -62.7 -26.62 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.603 0.702 . . . . 0.0 110.39 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -64.04 -33.55 76.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.495 1.043 . . . . 0.0 110.739 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . 0.252 11.5 t -95.75 -61.73 1.41 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -23.76 56.21 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -167.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.7 -150.95 48.78 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -160.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -69.51 9.17 0.51 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.013 2.525 . . . . 0.0 114.88 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -71.44 96.96 1.55 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 121.199 1.818 . . . . 0.0 108.876 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.2 m95 -81.14 -46.03 15.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.364 -0.826 . . . . 0.0 111.453 -170.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -54.52 -41.81 70.1 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.281 0.946 . . . . 0.0 109.96 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -53.53 57.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 123.503 0.721 . . . . 0.0 110.623 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 59.9 mt -55.5 -46.1 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.607 1.163 . . . . 0.0 109.617 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -16.36 43.0 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.961 1.304 . . . . 0.0 112.782 -176.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -109.94 -29.68 8.15 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.447 1.099 . . . . 0.0 112.186 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.4 ' HB3' ' CD2' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -63.78 -26.49 68.66 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.951 0.796 . . . . 0.0 112.101 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 36' ' ' SER . 84.4 m-85 -135.31 156.42 78.0 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 124.557 1.143 . . . . 0.0 109.994 -174.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.8 138.48 31.74 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 N-CA-C 108.552 -1.365 . . . . 0.0 108.552 170.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -132.23 -174.5 3.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 170.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -71.26 171.95 10.18 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.307 -0.871 . . . . 0.0 111.067 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.415 ' HE3' ' CA ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -68.63 165.14 19.94 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.783 -0.573 . . . . 0.0 110.291 171.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.65 -3.15 1.48 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.378 1.466 . . . . 0.0 115.483 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -63.09 157.83 21.21 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 119.072 1.436 . . . . 0.0 110.356 -175.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -120.84 166.66 13.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.687 1.595 . . . . 0.0 107.51 168.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.9 77.52 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.707 -0.621 . . . . 0.0 110.802 169.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.3 m -63.14 -24.86 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 123.53 0.732 . . . . 0.0 112.373 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -65.46 -42.25 92.49 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 mt -62.31 -36.58 82.6 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.12 -43.81 86.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 119.256 0.935 . . . . 0.0 109.944 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.43 -55.4 12.0 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.949 1.299 . . . . 0.0 112.308 -172.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -58.56 -47.45 84.21 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -54.81 -48.42 72.8 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 125.106 1.362 . . . . 0.0 110.156 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -51.86 -47.42 64.47 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.957 0.503 . . . . 0.0 110.843 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -67.33 -31.19 71.3 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.736 -0.602 . . . . 0.0 110.713 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.2 mt -71.44 -41.16 69.82 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.186 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.7 pt . . . . . 0 N--CA 1.475 0.8 0 CA-C-N 120.638 1.563 . . . . 0.0 112.5 178.385 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 . . . . . 0 C--O 1.239 0.52 0 CA-C-O 120.812 0.339 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.7 p -72.16 170.63 13.59 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.707 0.803 . . . . 0.0 109.377 167.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -56.39 -27.98 57.92 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.456 -0.778 . . . . 0.0 110.886 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -68.78 -56.18 8.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.335 -0.853 . . . . 0.0 109.399 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -59.37 -34.4 72.36 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.041 0.536 . . . . 0.0 111.304 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.651 HG22 ' HE2' ' A' ' 51' ' ' LYS . 54.0 t -66.42 -40.2 85.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.012 175.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -65.03 -45.16 86.61 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 118.468 0.577 . . . . 0.0 109.448 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -60.15 -37.74 81.04 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.084 0.954 . . . . 0.0 110.811 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.77 -56.89 13.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.933 0.893 . . . . 0.0 109.235 171.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -69.69 -29.94 67.48 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.601 -0.714 . . . . 0.0 112.536 -175.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -61.51 -58.55 7.71 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.81 1.187 . . . . 0.0 108.129 170.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.22 -60.96 4.8 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 125.868 1.699 . . . . 0.0 111.756 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.5 t -63.38 -20.04 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.423 1.112 . . . . 0.0 112.238 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.02 -40.62 45.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 120.322 -1.486 . . . . 0.0 109.635 177.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.8 t -95.82 -19.9 19.24 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.234 0.925 . . . . 0.0 113.087 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 10.0 mtt -117.88 0.4 11.91 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.254 1.422 . . . . 0.0 112.751 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.71 -103.63 0.12 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.586 1.089 . . . . 0.0 111.957 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -114.78 12.47 17.02 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 118.224 1.012 . . . . 0.0 110.506 -167.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.06 97.68 4.77 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 173.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -81.66 -46.61 14.1 Favored 'General case' 0 CA--C 1.521 -0.143 0 O-C-N 121.178 -0.951 . . . . 0.0 110.992 -172.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -54.7 -44.98 73.92 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.841 0.856 . . . . 0.0 109.918 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.7 m -57.48 -48.62 78.74 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.948 1.699 . . . . 0.0 111.803 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.9 mt -59.28 -45.3 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 O-C-N 120.909 -1.119 . . . . 0.0 109.94 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -23.94 48.17 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 125.542 1.537 . . . . 0.0 112.58 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 3.8 m0 -112.11 -29.6 7.54 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.522 -0.752 . . . . 0.0 111.086 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 t -68.87 -22.21 64.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.152 0.887 . . . . 0.0 111.981 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -121.85 156.01 59.75 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 123.951 0.9 . . . . 0.0 108.583 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.84 110.25 3.08 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.957 1.771 . . . . 0.0 108.174 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -111.18 168.18 9.71 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.137 0.975 . . . . 0.0 108.749 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -55.68 163.49 1.35 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.577 1.551 . . . . 0.0 111.468 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -64.68 161.4 17.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.366 164.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.79 -15.63 2.93 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.775 1.179 . . . . 0.0 114.242 170.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -63.4 163.21 11.13 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 124.509 1.124 . . . . 0.0 111.455 -174.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -127.88 170.36 12.9 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.756 1.222 . . . . 0.0 109.548 171.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.4 -34.97 69.43 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.96 0.504 . . . . 0.0 110.939 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.78 -30.85 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 CA-C-N 118.224 0.465 . . . . 0.0 112.084 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.04 -38.14 72.79 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.412 0.445 . . . . 0.0 110.581 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.2 mt -67.41 -49.51 63.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.015 1.726 . . . . 0.0 110.548 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.98 -52.96 63.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -54.16 -46.55 72.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.476 1.11 . . . . 0.0 111.781 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.651 ' HE2' HG22 ' A' ' 16' ' ' VAL . 7.0 tptt -54.98 -60.27 3.6 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.11 0.564 . . . . 0.0 110.202 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -54.78 -46.02 74.35 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 126.331 1.852 . . . . 0.0 110.933 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -59.92 -47.05 87.38 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.153 0.981 . . . . 0.0 110.128 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -56.54 -41.1 76.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.461 1.028 . . . . 0.0 110.75 171.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.5 mt -74.71 -7.03 52.04 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.4 pt . . . . . 0 N--CA 1.471 0.623 0 CA-C-N 120.415 1.462 . . . . 0.0 111.772 166.08 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 p -62.31 166.77 4.68 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.412 0.685 . . . . 0.0 110.097 167.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -61.69 -25.66 67.55 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.114 -0.992 . . . . 0.0 110.083 168.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -62.27 -49.36 75.98 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 122.085 0.945 . . . . 0.0 108.527 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -72.46 -36.99 68.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.562 0.745 . . . . 0.0 110.917 -174.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.63 -32.0 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 119.372 0.987 . . . . 0.0 109.744 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -59.38 -59.07 6.03 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 170.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -57.0 -32.08 65.75 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.58 1.152 . . . . 0.0 112.189 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -57.2 -63.03 1.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.79 0.836 . . . . 0.0 108.845 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -68.92 -31.66 70.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.452 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -59.31 -49.38 78.03 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 120.204 1.366 . . . . 0.0 109.334 175.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.46 -63.27 5.46 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 124.764 1.173 . . . . 0.0 110.495 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.2 t -55.46 -23.33 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 118.267 1.033 . . . . 0.0 111.603 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -71.22 -53.72 13.41 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 120.134 1.334 . . . . 0.0 109.618 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.6 t -81.47 -8.51 59.74 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.845 0.858 . . . . 0.0 111.107 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.5 mtp -128.86 -93.82 0.44 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.282 1.833 . . . . 0.0 108.033 -171.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.16 -126.44 2.1 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -168.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.57 7.91 17.53 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 117.498 0.649 . . . . 0.0 111.715 -172.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -69.94 98.67 1.3 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.994 1.27 . . . . 0.0 108.414 167.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -74.92 -42.43 57.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.308 -0.377 . . . . 0.0 111.073 -170.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -54.9 -36.62 65.39 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 118.746 -0.645 . . . . 0.0 112.058 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.4 m -61.77 -55.13 33.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.222 0.609 . . . . 0.0 110.06 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.6 mt -53.04 -47.9 53.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 125.988 1.715 . . . . 0.0 110.167 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -31.36 64.92 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.843 1.257 . . . . 0.0 111.32 -175.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -85.31 -42.95 14.14 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.516 0.726 . . . . 0.0 112.105 170.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.424 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 9.6 t -57.19 -35.63 69.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.881 1.273 . . . . 0.0 111.93 -167.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 57.3 m-85 -127.37 157.91 71.21 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 124.132 0.973 . . . . 0.0 108.524 -174.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.46 108.65 2.18 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 CA-C-N 119.747 0.946 . . . . 0.0 109.934 -175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -104.1 166.64 10.28 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.466 1.106 . . . . 0.0 108.864 173.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -52.16 162.73 0.45 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.46 1.104 . . . . 0.0 111.705 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 160.32 24.6 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.3 7.68 20.31 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.293 -0.726 . . . . 0.0 114.427 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.7 mmp_? -71.26 161.31 31.29 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 119.025 1.412 . . . . 0.0 108.938 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -118.41 162.99 17.4 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 174.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.71 -36.17 66.89 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.314 -0.866 . . . . 0.0 111.282 170.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 m -66.55 -23.78 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.004 0.922 . . . . 0.0 112.605 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.57 -46.49 70.29 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.642 0.734 . . . . 0.0 109.145 176.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.411 HD22 ' CD2' ' A' ' 19' ' ' LEU . 35.9 mt -65.84 -44.79 84.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.323 1.449 . . . . 0.0 109.119 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.1 -49.57 75.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.051 1.341 . . . . 0.0 108.847 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -55.02 -61.72 2.13 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.871 1.268 . . . . 0.0 110.09 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -52.94 -54.14 39.32 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 122.586 0.355 . . . . 0.0 110.131 -174.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -52.12 -51.38 58.15 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 126.196 1.799 . . . . 0.0 111.231 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -57.03 -49.06 76.96 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.852 0.296 . . . . 0.0 110.491 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -58.14 -43.22 87.19 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.662 -0.685 . . . . 0.0 109.3 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.7 mt -62.43 -53.47 54.39 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.805 0.842 . . . . 0.0 111.643 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.0 pt . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 119.403 1.001 . . . . 0.0 110.653 176.79 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -74.17 173.17 10.49 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -48.06 -50.27 28.58 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.284 1.034 . . . . 0.0 109.797 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.08 -37.07 73.79 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.612 -172.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -35.3 43.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 119.692 -0.803 . . . . 0.0 108.946 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.5 t -62.88 -37.99 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 121.134 -0.979 . . . . 0.0 109.873 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -53.53 -51.31 63.28 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.443 0.697 . . . . 0.0 109.689 172.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -67.62 -29.09 68.33 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -61.46 -53.77 52.1 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 175.149 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -60.54 -50.67 72.59 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 118.578 -0.725 . . . . 0.0 111.62 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.18 -49.27 74.5 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.013 0.925 . . . . 0.0 110.551 -177.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.95 -53.31 43.96 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 124.74 1.162 . . . . 0.0 110.656 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.3 t -60.1 -28.55 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 117.622 0.711 . . . . 0.0 110.228 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -70.89 -37.9 73.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 120.964 -1.085 . . . . 0.0 110.403 -176.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.6 t -95.39 -19.37 19.97 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.905 0.882 . . . . 0.0 112.21 -176.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 41.3 mtt -116.37 -20.6 9.65 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.47 1.032 . . . . 0.0 113.777 -175.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.31 -151.17 39.75 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -160.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -68.93 24.32 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.607 2.763 . . . . 0.0 116.441 -169.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -81.05 103.14 10.66 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 165.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -84.62 -39.02 19.17 Favored 'General case' 0 CA--C 1.527 0.091 0 O-C-N 121.129 -0.982 . . . . 0.0 111.25 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -58.71 -48.9 79.56 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.045 0.538 . . . . 0.0 110.864 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.3 m -56.95 -49.11 76.66 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.51 1.124 . . . . 0.0 112.346 176.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.1 mt -55.29 -47.47 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.049 1.339 . . . . 0.0 109.566 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -30.04 44.63 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.035 0.934 . . . . 0.0 111.987 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -98.84 -26.74 14.2 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.434 0.694 . . . . 0.0 112.253 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 t -63.04 -22.22 66.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.618 1.167 . . . . 0.0 112.352 -173.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -134.61 161.95 60.65 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 125.009 1.324 . . . . 0.0 107.443 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.65 109.13 2.56 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 N-CA-C 107.239 -1.87 . . . . 0.0 107.239 170.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -99.67 172.15 7.46 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -55.91 149.98 14.11 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.433 1.093 . . . . 0.0 109.237 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.08 155.82 39.87 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 121.291 -0.881 . . . . 0.0 110.335 -176.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.15 21.22 71.75 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.718 1.152 . . . . 0.0 113.89 173.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -82.25 162.58 22.28 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.426 1.09 . . . . 0.0 111.039 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -112.54 162.51 15.56 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.645 1.978 . . . . 0.0 107.43 167.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.91 -26.8 67.78 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.491 -0.756 . . . . 0.0 111.161 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.3 m -67.63 -24.4 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 O-C-N 120.793 -1.192 . . . . 0.0 112.753 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -62.85 -38.0 89.05 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.307 0.643 . . . . 0.0 109.293 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.436 ' HB3' HD21 ' A' ' 19' ' ' LEU . 67.4 mt -62.22 -50.87 70.03 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 126.755 2.022 . . . . 0.0 109.479 175.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.33 -37.88 89.05 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.957 0.903 . . . . 0.0 109.177 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -60.78 -54.42 45.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 122.05 -0.406 . . . . 0.0 110.093 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -56.56 -42.09 78.01 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 118.644 0.657 . . . . 0.0 111.071 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -58.72 -49.28 78.18 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.755 1.622 . . . . 0.0 111.107 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -20.73 64.64 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.827 -0.606 . . . . 0.0 112.328 175.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -77.66 -49.7 13.98 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.89 1.677 . . . . 0.0 109.685 165.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.5 mt -55.26 -56.19 22.82 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.508 0.594 . . . . 0.0 112.038 -173.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt . . . . . 0 N--CA 1.468 0.448 0 O-C-N 121.968 -0.458 . . . . 0.0 111.758 -173.787 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 . . . . . 0 C--O 1.238 0.465 0 CA-C-O 122.149 0.976 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.1 t -61.6 154.43 25.04 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.488 163.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -59.31 -20.75 57.0 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.396 1.078 . . . . 0.0 113.013 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.45 -58.57 5.53 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.264 1.026 . . . . 0.0 108.441 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -36.22 78.81 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.308 1.043 . . . . 0.0 110.94 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.49 -39.41 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 120.952 -1.092 . . . . 0.0 110.921 176.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -59.91 -46.38 89.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.227 -0.892 . . . . 0.0 109.761 173.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -61.57 -29.36 69.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.507 1.049 . . . . 0.0 112.558 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -63.32 -58.03 8.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.79 0.723 . . . . 0.0 109.859 175.493 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -64.94 -32.8 74.7 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.684 0.394 . . . . 0.0 111.327 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -65.15 -44.13 89.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.663 1.185 . . . . 0.0 109.858 174.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.02 -56.96 19.43 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 127.027 2.251 . . . . 0.0 110.924 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.8 t -63.13 -25.43 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 118.389 1.095 . . . . 0.0 110.593 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -68.31 -39.3 82.07 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 120.585 -1.322 . . . . 0.0 110.08 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.2 t -94.98 -28.69 15.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.137 0.575 . . . . 0.0 111.573 -172.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -107.94 -26.28 10.78 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.161 0.984 . . . . 0.0 112.687 -174.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.8 -155.11 52.73 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -162.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.96 38.49 0.08 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.555 1.542 . . . . 0.0 113.214 -172.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -109.16 97.79 7.34 Favored 'General case' 0 C--N 1.338 0.105 0 O-C-N 120.598 -1.314 . . . . 0.0 107.69 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -81.15 -38.91 26.38 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.383 -167.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -62.33 -42.87 99.74 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 123.669 0.606 . . . . 0.0 109.853 -175.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.3 t -55.67 -57.47 11.86 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 124.382 1.073 . . . . 0.0 111.046 171.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.7 mt -48.01 -51.92 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.631 1.572 . . . . 0.0 110.351 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.56 -37.95 52.04 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.568 1.547 . . . . 0.0 111.689 -177.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -85.81 -40.28 16.19 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.593 0.757 . . . . 0.0 111.454 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 t -62.92 -20.88 65.61 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -168.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -134.46 155.58 79.58 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 124.757 1.223 . . . . 0.0 107.863 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.63 110.43 2.31 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 N-CA-C 107.326 -1.836 . . . . 0.0 107.326 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -110.14 172.37 6.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 162.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.79 146.97 54.12 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -65.63 173.56 2.71 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.594 0.758 . . . . 0.0 110.058 169.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.56 -13.0 0.45 Allowed Glycine 0 CA--C 1.537 1.427 0 CA-C-O 119.197 -0.78 . . . . 0.0 114.014 -176.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 mmt85 -58.3 134.82 56.9 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.569 1.684 . . . . 0.0 108.061 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -87.41 165.87 15.25 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 162.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.17 -27.92 69.29 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.0 -1.062 . . . . 0.0 111.023 171.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 m -67.31 -27.75 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.313 1.045 . . . . 0.0 112.093 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.88 -45.52 64.18 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.898 0.879 . . . . 0.0 109.009 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.5 mt -66.1 -49.6 66.97 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.794 1.638 . . . . 0.0 109.966 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.7 -40.14 91.97 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.972 1.309 . . . . 0.0 109.875 -173.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -68.47 -51.36 44.33 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.957 0.903 . . . . 0.0 110.249 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -55.0 -45.08 75.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.824 0.738 . . . . 0.0 110.608 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -58.14 -47.43 83.35 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.041 1.337 . . . . 0.0 110.942 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -56.89 -43.08 80.96 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 118.947 -0.549 . . . . 0.0 111.196 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -71.2 -28.85 64.51 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.355 0.662 . . . . 0.0 112.069 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.72 -57.04 12.38 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.042 0.837 . . . . 0.0 109.596 171.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.2 pt . . . . . 0 CA--C 1.542 0.651 0 CA-C-N 118.958 0.799 . . . . 0.0 111.663 -179.577 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 122.561 1.172 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.98 159.36 32.84 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 130.611 3.565 . . . . 0.0 113.836 -169.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -54.08 -46.49 72.04 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 126.253 1.821 . . . . 0.0 111.868 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -71.54 -42.04 68.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.559 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -34.85 74.52 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.894 0.478 . . . . 0.0 109.941 -175.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.4 t -58.56 -41.62 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.03 -50.52 73.16 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.769 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -60.21 -34.48 73.71 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 118.514 0.597 . . . . 0.0 112.248 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.88 -53.36 59.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.145 0.978 . . . . 0.0 108.644 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -65.83 -47.82 73.73 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.652 -0.69 . . . . 0.0 111.393 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -56.74 -35.17 68.29 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.039 0.836 . . . . 0.0 110.409 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.39 -67.89 1.9 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 127.49 2.471 . . . . 0.0 110.849 170.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.1 t -56.23 -27.61 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.999 1.9 . . . . 0.0 111.466 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -62.1 -40.46 95.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.248 -0.907 . . . . 0.0 109.643 -177.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 t -96.07 -42.41 8.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.686 1.194 . . . . 0.0 111.379 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.74 -26.0 40.91 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 124.437 1.095 . . . . 0.0 113.918 -172.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.42 -116.54 8.04 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -164.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.91 12.16 32.77 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.191 1.495 . . . . 0.0 113.444 -172.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -73.76 97.11 2.65 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -80.36 -43.0 21.86 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 121.225 -0.922 . . . . 0.0 109.598 176.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -54.38 -41.18 68.92 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.215 0.606 . . . . 0.0 110.66 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.8 m -74.45 -38.49 62.97 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.661 1.184 . . . . 0.0 111.814 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 60.7 mt -59.92 -45.11 95.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -28.47 64.73 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.089 0.956 . . . . 0.0 112.227 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -85.14 -41.54 15.6 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.782 0.833 . . . . 0.0 110.084 173.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.3 t -67.22 -14.16 62.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 117.255 -1.355 . . . . 0.0 114.578 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.413 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 73.2 m-85 -151.93 160.84 30.95 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 120.737 1.608 . . . . 0.0 109.715 -177.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -74.68 143.57 30.38 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.604 1.536 . . . . 0.0 109.526 168.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' A' ' 37' ' ' PHE . 90.5 m-85 -137.38 113.51 9.91 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 169.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.25 45.4 mt-30 37.36 -124.94 0.21 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.967 1.707 . . . . 0.0 108.998 -168.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -133.56 143.01 48.43 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 158.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.93 62.32 5.33 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.085 0.85 . . . . 0.0 112.155 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -109.48 164.5 12.45 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.897 0.856 . . . . 0.0 113.258 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -99.53 165.78 11.47 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.941 1.696 . . . . 0.0 108.574 168.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.56 -31.83 73.21 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.589 -0.695 . . . . 0.0 109.935 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.6 m -64.08 -24.7 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.201 -0.937 . . . . 0.0 112.357 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.48 -11.74 61.08 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.824 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.3 mt -94.89 -18.87 20.76 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.162 1.385 . . . . 0.0 112.071 169.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.8 -43.57 22.19 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.039 171.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -74.63 -57.75 3.73 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -164.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -59.06 -39.39 81.93 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 116.412 -1.756 . . . . 0.0 110.867 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -50.79 -47.75 59.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 121.42 1.918 . . . . 0.0 110.891 168.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.49 -37.81 65.72 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.122 0.569 . . . . 0.0 112.006 176.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -76.59 -35.24 58.26 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.897 0.879 . . . . 0.0 112.167 173.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.2 mt -61.34 -45.93 92.37 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.522 1.055 . . . . 0.0 109.409 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 pt . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 175.344 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 . . . . . 0 C--O 1.238 0.49 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.2 p -75.72 178.96 5.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.356 1.062 . . . . 0.0 109.804 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 pttt -63.07 -31.75 72.96 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 120.189 -1.57 . . . . 0.0 112.24 165.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.62 -54.0 9.16 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.692 0.797 . . . . 0.0 108.923 -168.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -63.53 -23.75 67.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.461 -175.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.3 t -74.49 -39.21 47.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 119.078 0.854 . . . . 0.0 110.059 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -60.27 -47.93 83.9 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.6 m-30 -64.21 -30.9 71.94 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.799 0.84 . . . . 0.0 113.008 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.41 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -57.48 -54.79 42.87 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 174.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -61.45 -47.81 84.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.843 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.432 ' O ' ' HE3' ' A' ' 24' ' ' LYS . 4.0 m-70 -59.88 -36.08 76.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.268 0.94 . . . . 0.0 111.21 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.18 -54.46 20.58 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 125.684 1.612 . . . . 0.0 110.518 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.3 t -59.57 -28.13 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 118.296 1.048 . . . . 0.0 110.903 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -66.07 -36.98 84.66 Favored 'General case' 0 CA--C 1.521 -0.142 0 O-C-N 120.81 -1.181 . . . . 0.0 110.002 -178.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 t -95.46 -35.45 11.7 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.203 0.601 . . . . 0.0 111.84 -176.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -95.29 -11.98 26.96 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.908 0.883 . . . . 0.0 112.782 -173.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 57.82 -144.12 41.79 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 107.965 -2.054 . . . . 0.0 107.965 -157.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -61.86 -1.8 0.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -174.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -82.48 97.36 8.37 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 122.24 2.291 . . . . 0.0 109.831 -157.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -68.01 -41.88 81.54 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.573 -170.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -61.62 -43.05 99.58 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.8 m -60.03 -47.23 86.73 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.477 1.511 . . . . 0.0 112.008 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.2 mt -57.58 -46.73 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 123.933 0.893 . . . . 0.0 109.162 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -60.83 -21.56 63.31 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.06 0.544 . . . . 0.0 112.257 -175.559 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -96.27 -32.41 12.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.376 0.67 . . . . 0.0 111.572 173.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -18.3 65.0 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -134.12 149.97 72.95 Favored Pre-proline 0 C--O 1.236 0.384 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.12 107.2 2.43 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 N-CA-C 105.704 -2.46 . . . . 0.0 105.704 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -99.08 178.32 4.96 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -62.74 152.36 35.9 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.144 -0.973 . . . . 0.0 109.986 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -58.59 159.86 6.1 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.894 0.477 . . . . 0.0 109.908 164.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.16 9.44 29.22 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.9 mmt-85 -73.45 165.03 25.83 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 118.726 1.263 . . . . 0.0 110.484 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -132.14 158.71 40.95 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.56 -36.01 77.43 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 m -63.18 -27.71 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 124.135 0.974 . . . . 0.0 112.164 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -61.81 -40.58 95.75 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.41 ' HB3' HD21 ' A' ' 19' ' ' LEU . 34.2 mt -66.42 -47.96 71.56 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.154 1.382 . . . . 0.0 110.103 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.75 -46.57 88.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -61.31 -53.05 61.76 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 118.934 -0.555 . . . . 0.0 110.232 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.559 ' HZ3' HD21 ' A' ' 55' ' ' LEU . 2.6 tmtt? -50.22 -54.75 18.83 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.766 1.226 . . . . 0.0 109.318 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -57.59 -44.72 85.58 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 125.239 1.416 . . . . 0.0 111.812 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -57.93 -48.49 79.76 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -63.31 -25.62 68.39 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.749 0.704 . . . . 0.0 111.566 175.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.559 HD21 ' HZ3' ' A' ' 51' ' ' LYS . 70.5 mt -80.17 -15.88 56.08 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 175.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.9 pt . . . . . 0 CA--C 1.539 0.557 0 CA-C-N 119.808 1.185 . . . . 0.0 111.646 169.055 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.47 ' CD2' ' HG2' ' A' ' 51' ' ' LYS . 4.7 m-85 . . . . . 0 C--O 1.233 0.237 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -69.15 167.64 15.72 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.885 0.766 . . . . 0.0 111.787 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -32.65 74.39 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.476 -1.39 . . . . 0.0 110.592 175.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -67.46 -47.2 70.81 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -59.87 -44.71 94.02 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.753 -0.641 . . . . 0.0 110.541 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.09 -40.9 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 119.067 0.848 . . . . 0.0 109.468 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -60.19 -49.82 76.13 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 119.77 -0.157 . . . . 0.0 111.31 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -55.13 -40.96 71.13 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.8 0.84 . . . . 0.0 110.295 173.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.441 ' CD2' HD22 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -54.49 -51.56 64.7 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.538 -1.351 . . . . 0.0 109.808 -175.192 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -63.43 -47.6 81.25 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.745 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -55.11 -48.58 73.43 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.783 0.833 . . . . 0.0 110.912 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.43 -56.49 24.17 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 125.343 1.449 . . . . 0.0 109.865 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.5 t -60.7 -16.63 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 117.881 0.84 . . . . 0.0 112.684 -176.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -68.33 -57.23 6.24 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 120.434 -1.416 . . . . 0.0 109.191 172.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.0 t -80.83 -42.38 21.71 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.778 0.831 . . . . 0.0 109.566 -173.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -77.55 -27.71 51.64 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.45 -0.786 . . . . 0.0 112.809 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.8 -143.59 48.69 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -156.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -73.99 7.13 2.82 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.33 98.32 3.21 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 121.325 1.875 . . . . 0.0 109.446 -175.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -71.82 -45.11 62.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 119.185 -0.435 . . . . 0.0 109.914 -178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -48.92 -53.88 17.8 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.371 1.068 . . . . 0.0 111.967 176.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.6 m -55.24 -49.63 71.52 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.884 0.874 . . . . 0.0 111.317 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.1 mt -57.85 -49.94 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 125.818 1.647 . . . . 0.0 110.105 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -34.54 74.27 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.742 1.217 . . . . 0.0 111.583 -173.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -73.58 -47.86 37.27 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.839 -0.538 . . . . 0.0 111.077 166.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.436 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 5.4 t -62.63 -28.76 70.13 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -167.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 64.1 m-85 -134.28 148.85 69.46 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 119.62 1.1 . . . . 0.0 108.654 -174.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.52 110.55 2.45 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.869 2.379 . . . . 0.0 110.603 -174.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -111.51 113.51 25.98 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.849 1.26 . . . . 0.0 109.473 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 31.09 -141.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.891 2.476 . . . . 0.0 111.121 -166.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -106.83 160.52 15.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 144.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 61.74 49.08 79.8 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 124.864 1.221 . . . . 0.0 114.315 166.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.524 ' HE ' ' HA ' ' A' ' 43' ' ' ARG . 1.5 mmp_? -105.1 165.56 11.0 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.581 1.19 . . . . 0.0 111.511 174.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -122.36 161.75 22.85 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.772 1.629 . . . . 0.0 107.588 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.05 -44.17 70.83 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.137 0.426 . . . . 0.0 110.722 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 m -62.29 -27.25 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.572 0.749 . . . . 0.0 112.722 -176.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.38 -41.35 84.64 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.441 HD22 ' CD2' ' A' ' 19' ' ' LEU . 35.2 mt -66.78 -39.22 87.74 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.794 1.238 . . . . 0.0 109.838 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.04 -54.15 29.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.261 1.024 . . . . 0.0 108.342 -177.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.97 -50.46 64.05 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 122.674 0.39 . . . . 0.0 111.351 174.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 42.6 tptt -56.67 -54.19 49.02 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -54.89 -48.53 72.89 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.029 1.332 . . . . 0.0 110.234 -173.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -55.77 -48.03 76.0 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -62.75 -34.42 77.19 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.403 -0.81 . . . . 0.0 112.884 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.3 mt -68.42 -39.13 81.71 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 119.53 1.059 . . . . 0.0 111.414 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.9 pt . . . . . 0 CA--C 1.534 0.349 0 CA-C-N 118.842 0.746 . . . . 0.0 111.965 -174.533 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t -73.37 164.85 26.09 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.157 1.383 . . . . 0.0 108.773 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -52.94 -36.37 59.71 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 118.607 -0.711 . . . . 0.0 112.729 -172.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.25 -54.97 18.63 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -174.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.45 -37.09 82.29 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 124.236 1.014 . . . . 0.0 110.784 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.13 -36.43 73.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 O-C-N 121.405 -0.809 . . . . 0.0 110.582 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -68.45 -45.28 72.91 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 117.782 -1.104 . . . . 0.0 109.392 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -59.74 -35.16 74.0 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 119.689 1.131 . . . . 0.0 111.47 174.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.96 -56.02 27.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.709 0.804 . . . . 0.0 108.881 175.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.482 ' CZ ' HD13 ' A' ' 55' ' ' LEU . 31.2 m-85 -62.35 -44.38 96.6 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 119.049 -0.5 . . . . 0.0 110.73 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -53.44 -44.8 69.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.568 1.147 . . . . 0.0 110.073 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.85 -56.63 15.41 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 126.649 2.071 . . . . 0.0 111.58 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.3 t -65.23 -16.97 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 121.359 -1.083 . . . . 0.0 110.934 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -80.74 -39.89 26.19 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.124 -1.61 . . . . 0.0 109.924 174.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.6 t -95.69 -12.22 25.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.164 0.986 . . . . 0.0 112.292 -170.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 33.2 mtt -125.62 -48.48 1.66 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.146 1.378 . . . . 0.0 111.327 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.21 -154.67 19.86 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -165.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -61.97 15.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.492 2.317 . . . . 0.0 116.32 -175.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -78.8 97.37 5.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 120.447 1.476 . . . . 0.0 107.455 170.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -76.3 -47.15 24.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.7 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -62.57 -43.35 99.03 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.358 0.663 . . . . 0.0 109.299 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.9 m -59.78 -49.81 76.28 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.698 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.8 mt -58.33 -44.58 88.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 119.665 1.12 . . . . 0.0 109.241 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.11 -47.29 65.37 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.413 1.485 . . . . 0.0 110.555 -177.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -85.86 -28.57 24.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 119.322 -0.37 . . . . 0.0 111.143 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 t -59.32 -69.97 0.18 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.464 0.706 . . . . 0.0 109.932 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -84.99 148.9 51.92 Favored Pre-proline 0 C--O 1.235 0.335 0 O-C-N 121.313 -0.867 . . . . 0.0 109.179 -171.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.57 108.43 1.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 N-CA-C 108.628 -1.336 . . . . 0.0 108.628 -173.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -111.02 154.46 24.15 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.352 0.661 . . . . 0.0 110.317 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -54.9 130.49 41.51 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.381 1.072 . . . . 0.0 110.123 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -64.07 117.73 7.5 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.33 -24.34 4.72 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.064 1.792 . . . . 0.0 110.681 -166.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 145.05 56.6 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.449 1.124 . . . . 0.0 110.664 173.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -120.09 175.17 6.06 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.468 1.907 . . . . 0.0 107.6 167.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.31 -41.33 84.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.483 -0.761 . . . . 0.0 109.972 166.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.5 m -65.02 -31.4 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.183 0.593 . . . . 0.0 112.285 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.14 -50.08 65.27 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.0 mt -64.95 -50.27 67.07 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.104 1.762 . . . . 0.0 109.767 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.79 -49.2 78.57 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 124.71 1.256 . . . . 0.0 107.662 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -60.66 -51.86 67.61 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.184 0.594 . . . . 0.0 111.029 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HZ3' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -54.49 -48.61 71.64 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.571 0.748 . . . . 0.0 109.3 -177.153 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -63.77 -49.85 71.37 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.453 1.101 . . . . 0.0 110.686 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -57.37 -38.11 73.7 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.307 1.443 . . . . 0.0 111.397 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -65.66 -53.59 39.18 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 118.339 -0.839 . . . . 0.0 109.728 167.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.482 HD13 ' CZ ' ' A' ' 20' ' ' PHE . 22.6 mt -57.78 -27.68 63.31 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -175.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.1 pt . . . . . 0 CA--C 1.532 0.285 0 CA-C-N 119.656 1.116 . . . . 0.0 112.01 176.73 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 t -62.92 154.94 28.66 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 161.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.16 -29.48 68.7 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.343 -0.848 . . . . 0.0 111.367 -173.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -58.84 -50.27 74.62 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.747 0.819 . . . . 0.0 110.286 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -62.41 -30.68 71.39 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.089 -0.481 . . . . 0.0 110.903 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.1 t -70.15 -31.56 47.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 119.477 1.035 . . . . 0.0 111.477 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -66.45 -52.3 47.78 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 174.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -60.71 -33.14 72.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.339 0.656 . . . . 0.0 111.619 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -58.14 9.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.844 0.858 . . . . 0.0 109.345 173.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -57.95 -48.34 80.24 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 122.945 0.498 . . . . 0.0 110.562 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -58.82 -38.6 79.0 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.396 0.678 . . . . 0.0 110.992 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.11 -55.62 25.31 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 125.246 1.403 . . . . 0.0 110.806 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.64 -23.81 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 118.464 1.132 . . . . 0.0 111.285 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -72.28 -41.44 66.68 Favored 'General case' 0 C--O 1.224 -0.253 0 O-C-N 120.922 -1.111 . . . . 0.0 109.991 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 t -96.32 -37.2 10.6 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.578 0.751 . . . . 0.0 111.207 -172.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -86.29 -105.22 0.06 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 167.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.17 -81.92 0.15 Allowed Glycine 0 C--O 1.226 -0.406 0 CA-C-O 118.335 -1.259 . . . . 0.0 110.759 -173.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.68 4.29 9.52 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.437 2.119 . . . . 0.0 112.396 173.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -75.9 98.73 4.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -79.41 -35.2 40.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.869 1.268 . . . . 0.0 110.534 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -55.05 -47.26 75.03 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.941 0.896 . . . . 0.0 110.44 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.6 m -55.55 -59.27 5.06 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.773 1.629 . . . . 0.0 111.224 174.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 76.6 mt -53.08 -44.6 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 125.666 1.587 . . . . 0.0 110.165 -173.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -17.18 40.71 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -174.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -111.89 -29.51 7.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.681 1.192 . . . . 0.0 111.499 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.14 -19.92 65.62 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.054 0.942 . . . . 0.0 113.059 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -139.31 155.0 72.43 Favored Pre-proline 0 C--O 1.235 0.29 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.85 110.05 3.01 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.843 1.695 . . . . 0.0 110.061 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -115.72 157.24 24.58 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.906 1.282 . . . . 0.0 109.131 174.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -49.7 149.65 2.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.612 1.165 . . . . 0.0 112.549 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -61.72 144.78 54.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.66 -2.4 40.04 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.819 -1.545 . . . . 0.0 114.415 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -58.41 153.39 15.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 120.266 2.033 . . . . 0.0 110.283 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -112.31 160.8 17.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.04 0.936 . . . . 0.0 108.69 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.44 -30.99 63.52 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 122.192 -0.317 . . . . 0.0 110.651 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.1 m -65.02 -29.06 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 C-N-CA 123.723 0.809 . . . . 0.0 112.544 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -57.16 -41.52 79.37 Favored 'General case' 0 CA--C 1.516 -0.36 0 O-C-N 124.363 1.04 . . . . 0.0 109.517 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.7 mt -65.63 -48.95 70.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.737 1.215 . . . . 0.0 109.584 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.17 -44.19 95.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.845 0.858 . . . . 0.0 108.796 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -67.03 -46.38 74.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.143 0.577 . . . . 0.0 111.324 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -60.52 -39.66 88.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 119.512 1.051 . . . . 0.0 110.889 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.68 -42.94 99.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.475 0.71 . . . . 0.0 110.257 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -60.13 -47.76 84.57 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.77 172.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -52.09 -42.73 63.46 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.47 1.032 . . . . 0.0 109.986 173.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.6 mt -68.09 -60.62 2.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 119.049 -0.5 . . . . 0.0 111.091 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt . . . . . 0 N--CA 1.468 0.441 0 CA-C-N 118.97 0.804 . . . . 0.0 112.242 -172.846 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.515 ' CG ' ' HE2' ' A' ' 51' ' ' LYS . 2.4 m-30 . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 122.899 1.333 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 p -69.59 163.21 26.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.235 1.414 . . . . 0.0 108.28 160.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -57.93 -34.42 69.85 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.478 164.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -56.03 -59.86 4.3 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 126.056 1.743 . . . . 0.0 110.338 172.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -37.45 82.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.598 1.09 . . . . 0.0 111.01 -176.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.45 -41.08 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 118.606 0.639 . . . . 0.0 110.758 173.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -60.68 -47.73 84.94 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.57 0.748 . . . . 0.0 110.465 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -66.98 -31.95 72.86 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.83 0.452 . . . . 0.0 111.566 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.42 ' CD2' HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -56.08 -53.07 61.43 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 170.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.16 -46.24 89.84 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.466 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -55.56 -41.94 74.0 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.427 0.691 . . . . 0.0 110.896 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.04 -54.24 22.3 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 126.651 2.072 . . . . 0.0 111.369 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.1 t -64.67 -22.97 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 121.166 -1.196 . . . . 0.0 111.417 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -67.91 -45.89 73.1 Favored 'General case' 0 C--O 1.225 -0.191 0 O-C-N 121.041 -1.037 . . . . 0.0 109.82 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 t -95.58 -40.97 9.16 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.665 0.786 . . . . 0.0 110.957 -162.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -80.47 -66.19 0.91 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 166.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.81 -164.0 12.1 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 -146.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -78.89 23.47 0.34 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.84 0.856 . . . . 0.0 111.944 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -75.06 96.75 3.28 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 120.969 1.713 . . . . 0.0 107.122 165.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -72.62 -36.34 68.04 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.011 -1.449 . . . . 0.0 109.621 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -13.59 62.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.358 0.663 . . . . 0.0 112.184 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -86.29 -58.1 2.76 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 124.296 1.038 . . . . 0.0 108.805 169.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 92.4 mt -52.04 -44.9 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 C-N-CA 126.672 1.989 . . . . 0.0 111.372 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.91 -23.36 52.96 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.572 1.149 . . . . 0.0 112.72 -175.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -109.91 -35.88 6.04 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.885 1.274 . . . . 0.0 111.281 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.93 -29.57 69.69 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.962 0.801 . . . . 0.0 112.167 175.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -127.0 150.99 73.47 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 124.331 1.052 . . . . 0.0 108.629 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -87.82 107.55 0.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 CA-C-N 119.836 0.977 . . . . 0.0 110.004 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -94.11 161.14 14.4 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.414 -0.804 . . . . 0.0 109.405 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -66.0 147.1 53.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 173.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -53.68 146.04 14.21 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.511 0.725 . . . . 0.0 109.852 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.85 -15.13 56.67 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.373 -1.237 . . . . 0.0 112.32 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.2 111.05 3.25 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 120.421 2.11 . . . . 0.0 106.999 160.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -83.15 175.35 10.03 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 159.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.62 78.12 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.875 -1.14 . . . . 0.0 110.838 170.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.5 m -65.15 -30.32 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.025 0.93 . . . . 0.0 112.46 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.56 -41.45 90.15 Favored 'General case' 0 C--O 1.222 -0.371 0 O-C-N 124.133 0.896 . . . . 0.0 108.994 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.42 HD22 ' CD2' ' A' ' 19' ' ' LEU . 31.4 mt -65.98 -43.39 87.98 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.226 0.61 . . . . 0.0 109.641 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.06 -49.04 77.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -58.38 -51.76 68.45 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.953 0.901 . . . . 0.0 111.155 178.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HE2' ' CG ' ' A' ' 11' ' ' PHE . 48.0 tptt -55.92 -50.14 71.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.718 1.207 . . . . 0.0 110.091 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -61.62 -50.46 72.48 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.867 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -50.6 -47.87 58.03 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.037 0.835 . . . . 0.0 110.722 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.7 mmt-85 -65.88 -36.86 84.59 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 118.17 -0.919 . . . . 0.0 112.817 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.2 mt -65.97 -53.05 43.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.528 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.7 pt . . . . . 0 CA--C 1.529 0.138 0 CA-C-N 119.11 0.868 . . . . 0.0 111.58 -175.998 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.58 ' CZ ' HD23 ' A' ' 48' ' ' LEU . 6.9 m-30 . . . . . 0 C--O 1.237 0.437 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.0 p -61.91 164.47 6.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.45 173.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -55.01 -31.85 61.37 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.545 -0.722 . . . . 0.0 110.587 170.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.41 -50.99 61.59 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.563 1.545 . . . . 0.0 108.654 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -63.92 -38.1 89.84 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.306 -0.871 . . . . 0.0 110.454 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.95 -25.31 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.459 1.027 . . . . 0.0 110.193 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -60.15 -60.02 4.48 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.468 -0.77 . . . . 0.0 109.096 169.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -63.94 -28.56 69.91 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.245 1.018 . . . . 0.0 112.556 -174.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.48 -56.23 24.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.952 0.901 . . . . 0.0 109.925 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -67.41 -42.36 83.39 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -52.17 -35.44 48.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.941 0.897 . . . . 0.0 111.337 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.54 -49.55 4.1 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 126.695 2.093 . . . . 0.0 111.825 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.5 t -61.46 -36.83 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 119.244 1.522 . . . . 0.0 110.007 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -63.7 -28.38 69.86 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.548 -0.72 . . . . 0.0 110.833 -174.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -95.2 -59.07 1.97 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.085 0.954 . . . . 0.0 108.81 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 33.8 mtt -71.3 -28.0 63.81 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.058 -1.026 . . . . 0.0 113.555 -170.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.33 -157.46 52.07 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -150.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -83.44 33.07 0.46 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.586 1.154 . . . . 0.0 111.963 -162.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -82.23 96.47 7.87 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -79.29 -46.21 18.19 Favored 'General case' 0 C--O 1.224 -0.255 0 O-C-N 121.778 -0.576 . . . . 0.0 110.194 -170.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -49.26 -52.22 28.71 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.647 1.579 . . . . 0.0 110.829 172.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.3 m -55.74 -54.55 43.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.035 0.934 . . . . 0.0 111.01 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.8 mt -54.27 -45.46 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.781 1.232 . . . . 0.0 110.518 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -22.66 20.52 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.98 1.312 . . . . 0.0 112.245 -177.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -106.54 -34.57 7.33 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.397 1.079 . . . . 0.0 111.575 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 t -60.93 -30.48 70.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.516 0.727 . . . . 0.0 111.246 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -133.88 152.01 77.88 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -176.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.86 110.57 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.942 2.428 . . . . 0.0 110.996 -172.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -110.03 170.63 7.95 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.556 0.742 . . . . 0.0 110.202 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -58.58 160.43 5.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 123.043 1.401 . . . . 0.0 112.884 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.12 138.68 57.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.041 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.8 6.8 57.19 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 117.895 -1.503 . . . . 0.0 114.543 175.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -61.82 158.3 16.19 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 120.286 2.043 . . . . 0.0 110.064 173.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -112.33 161.36 16.73 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.066 1.347 . . . . 0.0 107.472 170.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.21 -35.01 69.13 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.934 -0.479 . . . . 0.0 110.997 176.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 m -61.13 -25.14 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.469 1.108 . . . . 0.0 112.746 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -64.21 -33.37 75.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.58 HD23 ' CZ ' ' A' ' 11' ' ' PHE . 41.8 mt -71.41 -41.06 70.06 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.633 1.573 . . . . 0.0 110.476 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.28 -52.3 64.25 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 172.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -59.89 -53.51 57.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.674 -0.641 . . . . 0.0 112.205 -167.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -64.71 -40.48 95.43 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.165 -173.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -56.82 -53.43 58.0 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.982 1.713 . . . . 0.0 110.34 174.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -53.73 -47.07 70.95 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.435 1.094 . . . . 0.0 109.526 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -64.82 -42.64 94.82 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.148 -0.93 . . . . 0.0 110.727 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.4 mt -61.05 -53.49 56.55 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.932 1.242 . . . . 0.0 112.023 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 CA--C 1.535 0.371 0 CA-C-N 119.357 0.981 . . . . 0.0 110.197 -178.744 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.502 ' CD2' ' HG3' ' A' ' 51' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 t -68.83 160.08 31.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.336 1.054 . . . . 0.0 110.262 -170.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -58.56 -31.43 67.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.224 1.01 . . . . 0.0 111.995 -168.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 14' ' ' GLU . 25.0 mp0 -68.67 -51.08 45.77 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 127.899 2.48 . . . . 0.0 108.639 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -60.94 -33.58 73.39 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 119.332 -0.366 . . . . 0.0 110.676 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.03 -32.91 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 120.486 -1.384 . . . . 0.0 109.707 176.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -61.94 -52.12 65.33 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -62.55 -36.89 84.08 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.434 1.094 . . . . 0.0 111.899 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.03 -54.8 42.84 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -63.26 -40.84 98.54 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.139 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -56.66 -57.55 11.91 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.814 0.734 . . . . 0.0 109.435 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -50.83 -55.24 18.76 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 125.653 1.597 . . . . 0.0 111.828 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.44 -24.21 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 118.148 0.974 . . . . 0.0 111.097 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -75.13 -33.72 61.59 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 120.87 -1.144 . . . . 0.0 111.213 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 t -90.56 -47.85 7.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.73 1.15 . . . . 0.0 109.487 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.9 mtt -80.72 -66.37 0.89 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.682 0.674 . . . . 0.0 109.537 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.07 -152.62 16.76 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 -158.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -72.41 16.1 0.15 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.553 2.341 . . . . 0.0 112.645 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -78.53 97.76 5.85 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 120.205 1.366 . . . . 0.0 107.324 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -79.22 -51.38 9.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.045 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -56.74 -45.49 81.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.165 0.439 . . . . 0.0 110.952 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.2 m -58.25 -51.97 67.54 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.051 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.2 mt -56.14 -44.4 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 119.736 1.153 . . . . 0.0 110.075 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.07 -30.35 15.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.082 1.353 . . . . 0.0 111.487 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.4 m0 -103.38 -35.25 8.45 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.771 1.228 . . . . 0.0 111.545 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -63.45 -24.17 67.71 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.207 1.403 . . . . 0.0 112.762 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -123.19 153.12 64.72 Favored Pre-proline 0 C--O 1.236 0.389 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 175.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -79.45 109.35 2.47 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 N-CA-C 107.774 -1.664 . . . . 0.0 107.774 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -106.31 156.37 18.57 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.462 0.705 . . . . 0.0 109.623 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -59.3 154.82 15.71 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.15 0.98 . . . . 0.0 111.443 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 167.88 18.19 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.561 0.696 . . . . 0.0 112.321 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.98 -7.2 29.88 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.695 1.14 . . . . 0.0 112.864 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.6 165.6 12.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.396 1.478 . . . . 0.0 113.163 -176.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -141.6 165.7 26.78 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.658 1.983 . . . . 0.0 107.288 171.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.84 -32.16 67.35 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.003 -1.06 . . . . 0.0 111.048 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 m -75.54 -20.0 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.056 1.343 . . . . 0.0 112.55 -174.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.63 -53.39 58.69 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 171.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 43.1 mt -53.29 -54.31 38.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.565 1.946 . . . . 0.0 110.343 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.48 -48.12 80.98 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.924 1.289 . . . . 0.0 108.989 -173.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -64.71 -46.96 80.1 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.502 ' HG3' ' CD2' ' A' ' 11' ' ' PHE . 1.3 tmtm? -58.99 -49.71 76.86 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 124.726 1.21 . . . . 0.0 109.308 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.45 -47.92 78.13 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.154 0.982 . . . . 0.0 110.616 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -54.33 -48.5 71.3 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.457 -0.782 . . . . 0.0 110.439 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 mtt85 -62.87 -26.6 68.86 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.818 1.247 . . . . 0.0 113.273 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 74.8 mt -76.67 -52.35 9.8 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.347 -0.846 . . . . 0.0 111.088 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.3 pt . . . . . 0 CA--C 1.536 0.441 0 CA-C-N 118.616 0.644 . . . . 0.0 110.922 -173.319 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.434 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -164.29 104.73 0.86 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.361 1.464 . . . . 0.0 107.152 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 t -136.11 170.8 15.43 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 121.551 -0.718 . . . . 0.0 110.656 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.01 169.09 37.82 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.612 1.577 . . . . 0.0 111.21 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.9 p -157.66 23.0 0.28 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.582 1.153 . . . . 0.0 112.43 -162.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.7 m -80.45 117.24 21.01 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.456 -1.402 . . . . 0.0 109.125 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.05 53.45 1.88 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.476 1.036 . . . . 0.0 110.876 -177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -154.1 172.65 17.2 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.908 0.854 . . . . 0.0 110.389 -172.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -51.72 92.4 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.121 2.168 . . . . 0.0 111.087 174.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -153.65 -179.84 8.17 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.894 2.878 . . . . 0.0 105.361 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -73.91 138.33 44.23 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 119.995 -1.69 . . . . 0.0 109.15 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.77 158.81 31.55 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 162.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -55.34 -26.96 44.11 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.276 -1.345 . . . . 0.0 111.706 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -67.41 -46.45 73.17 Favored 'General case' 0 CA--C 1.526 0.05 0 CA-C-N 119.735 1.152 . . . . 0.0 111.377 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -38.74 91.99 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.397 0.999 . . . . 0.0 109.189 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.7 t -67.19 -27.45 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 119.265 0.939 . . . . 0.0 110.855 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -57.46 -60.2 4.01 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -61.14 -30.38 70.35 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -58.77 -58.86 6.75 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -71.96 -35.7 69.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 118.383 -0.818 . . . . 0.0 111.736 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -54.61 -45.2 73.63 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.273 0.942 . . . . 0.0 109.494 176.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.95 -64.36 3.72 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 125.464 1.506 . . . . 0.0 110.364 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.8 t -54.42 -27.93 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 118.964 1.382 . . . . 0.0 112.045 -174.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -67.02 -29.73 69.62 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.208 1.403 . . . . 0.0 111.518 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.1 t -97.17 -55.85 2.73 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.003 1.321 . . . . 0.0 112.085 167.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.0 mmt -61.36 -29.34 69.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.825 2.05 . . . . 0.0 113.171 -168.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.49 -153.82 48.79 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -153.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -76.07 19.89 0.21 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.137 1.375 . . . . 0.0 112.782 -168.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -81.55 97.77 7.99 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.299 -1.5 . . . . 0.0 108.733 -171.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -81.72 -47.9 12.34 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.033 -164.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -58.18 -43.51 87.55 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.656 0.662 . . . . 0.0 109.48 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.2 m -54.93 -49.93 70.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.781 1.632 . . . . 0.0 111.532 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 60.6 mt -58.56 -48.65 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 124.399 1.08 . . . . 0.0 109.562 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.73 -37.15 63.05 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.504 1.121 . . . . 0.0 111.423 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 14.3 m0 -85.08 -34.6 22.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.032 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.8 t -69.81 -30.41 67.93 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.672 1.124 . . . . 0.0 113.224 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -124.94 154.37 71.08 Favored Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 119.804 1.184 . . . . 0.0 110.355 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.08 117.81 5.32 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 121.867 1.711 . . . . 0.0 109.478 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -129.25 161.93 29.06 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.033 1.333 . . . . 0.0 110.616 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -47.64 129.3 13.66 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.689 1.596 . . . . 0.0 111.298 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -57.84 150.8 19.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.488 0.661 . . . . 0.0 109.573 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.6 4.25 44.98 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 117.685 -1.619 . . . . 0.0 114.634 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -53.22 164.01 0.49 Allowed 'General case' 0 C--N 1.343 0.308 0 CA-C-N 119.557 1.679 . . . . 0.0 110.649 170.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -121.45 158.5 28.26 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 163.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.35 -25.79 68.09 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.388 0.54 . . . . 0.0 111.327 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.71 -34.75 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.55 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -56.87 -35.14 68.57 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.95 0.5 . . . . 0.0 109.921 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.8 mt -66.18 -53.97 31.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.02 0.928 . . . . 0.0 109.297 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.23 -38.51 76.98 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.841 1.256 . . . . 0.0 110.379 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -75.48 -42.89 51.86 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.714 1.606 . . . . 0.0 110.623 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -65.59 -45.78 81.9 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.386 -0.821 . . . . 0.0 109.347 172.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -54.9 -48.6 72.83 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 126.099 1.759 . . . . 0.0 110.722 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -46.51 -58.14 4.06 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.386 1.074 . . . . 0.0 109.784 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -61.92 -33.4 74.18 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.216 -0.927 . . . . 0.0 112.519 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 mt -63.71 -44.32 93.97 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.959 0.799 . . . . 0.0 110.071 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.0 pt -81.29 -8.23 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 119.485 1.039 . . . . 0.0 112.479 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.8 m -80.04 -4.92 54.7 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.68 1.192 . . . . 0.0 113.013 161.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.33 -166.66 14.38 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 118.849 0.75 . . . . 0.0 113.401 167.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -83.41 152.5 13.7 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.873 3.049 . . . . 0.0 111.415 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.2 m 55.2 174.6 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.849 1.66 . . . . 0.0 113.263 -174.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.1 m 48.28 74.97 0.15 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.532 1.533 . . . . 0.0 112.255 -172.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.336 0 CA-C-O 116.527 -2.263 . . . . 0.0 112.306 171.076 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.931 0 N-CA-C 112.571 -0.212 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 t -155.62 112.23 3.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 172.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 t -143.11 169.66 17.17 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 158.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.81 -71.94 0.11 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 125.929 1.728 . . . . 0.0 109.438 -177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.0 t -94.99 17.88 13.08 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.594 1.158 . . . . 0.0 112.08 -173.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.6 m -121.28 82.43 1.93 Allowed 'General case' 0 CA--C 1.521 -0.15 0 O-C-N 120.275 -1.516 . . . . 0.0 109.979 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.98 137.27 11.05 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 162.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -157.51 -49.41 0.07 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.807 1.243 . . . . 0.0 110.728 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -136.96 -178.83 5.36 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.825 1.25 . . . . 0.0 112.103 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.5 t70 47.13 -152.72 0.08 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -141.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -91.54 136.45 33.11 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 120.976 1.716 . . . . 0.0 108.72 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 p -68.33 167.41 14.58 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.476 0.58 . . . . 0.0 110.153 170.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -57.76 -34.24 69.34 Favored 'General case' 0 N--CA 1.462 0.139 0 O-C-N 121.129 -0.982 . . . . 0.0 110.29 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.96 -54.73 37.64 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.053 0.941 . . . . 0.0 109.658 175.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -60.49 -42.69 96.82 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 123.031 0.532 . . . . 0.0 110.841 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.2 t -65.21 -35.1 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 O-C-N 121.367 -0.833 . . . . 0.0 110.885 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -63.67 -50.66 68.37 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 172.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -61.07 -33.32 73.15 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 118.771 0.714 . . . . 0.0 111.333 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -58.82 -56.28 24.28 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.92 0.888 . . . . 0.0 108.923 174.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -60.36 -44.73 95.31 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.152 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -56.99 -44.36 82.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.96 0.904 . . . . 0.0 109.721 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.84 -63.1 5.6 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 126.679 2.085 . . . . 0.0 110.423 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.23 -22.03 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 118.895 1.347 . . . . 0.0 111.162 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -73.7 -30.46 62.88 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 119.972 -1.705 . . . . 0.0 110.974 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.7 t -95.59 -57.71 2.31 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.709 0.804 . . . . 0.0 109.45 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -70.0 -27.14 64.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.413 1.485 . . . . 0.0 112.659 -174.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.93 -148.69 45.47 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -153.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -76.82 15.27 0.68 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.67 1.188 . . . . 0.0 113.994 -159.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -84.5 97.46 9.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 120.144 1.338 . . . . 0.0 110.093 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -71.82 -42.42 67.04 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.502 0.721 . . . . 0.0 112.455 -175.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -64.39 -40.91 96.73 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 118.619 0.645 . . . . 0.0 109.666 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.16 -54.53 38.49 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 123.4 0.68 . . . . 0.0 109.435 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.9 mt -54.57 -52.05 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 126.111 1.765 . . . . 0.0 109.831 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -47.16 69.33 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.299 1.44 . . . . 0.0 110.836 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -74.99 -39.79 61.06 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.696 -0.668 . . . . 0.0 110.602 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -59.92 -71.6 0.13 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.581 1.152 . . . . 0.0 110.565 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -87.17 153.15 53.87 Favored Pre-proline 0 N--CA 1.453 -0.301 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -166.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.15 110.52 3.13 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.588 1.525 . . . . 0.0 109.081 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -111.11 174.17 5.99 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.071 0.948 . . . . 0.0 108.698 172.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -63.98 155.85 29.73 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.939 0.876 . . . . 0.0 111.358 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -62.55 139.03 58.6 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.453 1.101 . . . . 0.0 109.043 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.55 23.31 76.66 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 117.689 0.222 . . . . 0.0 112.599 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -70.47 165.42 22.63 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 121.406 -1.055 . . . . 0.0 111.495 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -118.13 161.25 20.17 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.698 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.03 86.05 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 165.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.43 -26.34 33.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 O-C-N 121.546 -0.721 . . . . 0.0 111.761 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.6 -41.81 86.69 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HB3' HD21 ' A' ' 19' ' ' LEU . 55.6 mt -65.14 -52.26 56.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.14 1.776 . . . . 0.0 109.111 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.02 -46.43 82.34 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.521 1.128 . . . . 0.0 108.089 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -63.72 -54.43 35.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.96 1.304 . . . . 0.0 110.899 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.88 -47.2 77.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.772 0.715 . . . . 0.0 109.299 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -60.07 -49.94 75.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.581 1.552 . . . . 0.0 111.193 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -55.59 -41.2 73.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.82 1.248 . . . . 0.0 111.059 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mmm-85 -68.86 -42.96 76.33 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.936 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.9 mt -58.27 -49.99 75.18 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.886 1.221 . . . . 0.0 112.527 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -73.24 -4.56 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.093 0.557 . . . . 0.0 112.045 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 32.6 79.65 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 129.534 3.134 . . . . 0.0 111.608 -167.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -46.61 131.26 11.99 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.011 -1.438 . . . . 0.0 110.474 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.39 165.42 29.01 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.003 2.469 . . . . 0.0 112.338 -168.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.5 p -147.63 132.92 18.46 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.77 1.228 . . . . 0.0 108.858 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.9 t 55.83 178.05 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.593 2.357 . . . . 0.0 114.298 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.966 0 C-N-CA 125.356 1.455 . . . . 0.0 110.039 174.547 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.778 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.8 t -172.16 -147.77 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.52 2.328 . . . . 0.0 104.823 170.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -58.0 168.01 1.08 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.927 1.691 . . . . 0.0 112.25 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.8 80.47 1.48 Allowed Glycine 0 C--N 1.334 0.458 0 N-CA-C 108.494 -1.843 . . . . 0.0 108.494 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.1 p -62.04 166.09 5.01 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 117.283 0.542 . . . . 0.0 111.282 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.9 m 59.57 156.69 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.547 1.939 . . . . 0.0 114.057 -171.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.56 -87.67 1.28 Allowed Glycine 0 C--N 1.333 0.407 0 N-CA-C 108.048 -2.021 . . . . 0.0 108.048 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.22 -62.53 0.79 Allowed 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 148.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -137.48 -78.55 0.38 Allowed 'General case' 0 N--CA 1.461 0.092 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 174.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -53.49 123.24 11.52 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.752 1.221 . . . . 0.0 109.498 169.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 54.68 94.75 0.02 OUTLIER 'General case' 0 C--O 1.243 0.72 0 C-N-CA 126.78 2.032 . . . . 0.0 113.194 -174.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.4 p -61.7 176.64 0.5 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.453 1.121 . . . . 0.0 110.719 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -58.92 -42.73 90.38 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 120.656 -1.278 . . . . 0.0 110.487 173.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -55.93 -54.47 44.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 124.708 1.255 . . . . 0.0 108.741 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -62.04 -41.79 98.49 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.332 1.053 . . . . 0.0 111.517 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.1 t -64.34 -38.02 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.029 0.831 . . . . 0.0 109.917 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -62.78 -47.95 81.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -60.36 -34.47 73.91 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.338 0.655 . . . . 0.0 112.389 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -57.0 -55.24 37.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -60.79 -46.95 88.49 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.813 0.445 . . . . 0.0 111.256 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -35.05 71.0 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.712 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -78.36 -51.54 5.61 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 125.923 1.725 . . . . 0.0 111.171 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.0 t -58.66 -28.99 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 118.249 1.024 . . . . 0.0 110.468 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -49.72 74.62 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 124.265 1.026 . . . . 0.0 110.34 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 t -96.77 -21.63 17.43 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.847 1.659 . . . . 0.0 113.647 -167.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.8 mtp -128.53 -6.56 5.22 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.204 1.002 . . . . 0.0 112.587 -170.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.86 -158.07 53.45 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 119.232 0.923 . . . . 0.0 111.385 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -72.0 21.54 0.06 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.289 1.036 . . . . 0.0 112.193 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -82.91 97.72 8.83 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -176.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -82.37 -45.07 15.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.047 -163.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -50.11 -49.5 51.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.598 0.759 . . . . 0.0 109.282 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -54.8 -54.78 37.69 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 128.063 2.545 . . . . 0.0 110.351 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 67.6 mt -59.21 -44.91 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.084 0.954 . . . . 0.0 110.355 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -34.64 64.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.379 1.472 . . . . 0.0 110.925 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -88.74 -37.26 15.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.101 0.96 . . . . 0.0 111.848 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 t -67.3 -18.66 65.27 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -140.68 154.09 68.64 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 119.881 1.218 . . . . 0.0 110.021 -173.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.12 109.58 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.159 1.906 . . . . 0.0 110.823 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -107.58 -178.53 3.65 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.668 1.187 . . . . 0.0 109.67 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -67.7 162.95 22.61 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.671 -0.643 . . . . 0.0 110.785 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.9 147.58 50.09 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 121.669 -0.644 . . . . 0.0 109.931 176.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.4 5.8 37.71 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.107 -0.83 . . . . 0.0 113.759 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -59.49 135.79 57.78 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 118.348 1.074 . . . . 0.0 108.299 169.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -90.5 167.06 12.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 171.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.81 -38.48 78.71 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.712 -0.617 . . . . 0.0 110.614 169.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.1 m -63.75 -27.58 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 123.386 0.674 . . . . 0.0 112.081 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -59.65 -37.69 79.4 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.422 ' HB3' HD21 ' A' ' 19' ' ' LEU . 47.6 mt -65.85 -50.01 66.1 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.738 1.215 . . . . 0.0 109.713 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.39 -41.7 90.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.922 0.889 . . . . 0.0 109.337 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -68.19 -52.54 33.2 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 124.114 0.966 . . . . 0.0 110.259 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -44.21 93.58 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 120.868 -1.145 . . . . 0.0 108.985 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -55.34 -50.59 69.24 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.567 1.147 . . . . 0.0 111.13 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -51.42 -46.13 62.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.557 1.143 . . . . 0.0 110.081 175.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -71.91 -26.33 62.26 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.465 1.106 . . . . 0.0 112.477 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.8 mt -70.57 -58.53 3.59 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.918 1.236 . . . . 0.0 109.028 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 pt -64.63 -28.23 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.154 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.5 m 68.93 -77.41 0.05 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.238 2.215 . . . . 0.0 109.335 -167.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.42 172.8 13.86 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 119.466 1.03 . . . . 0.0 113.015 171.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -80.91 62.52 8.57 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.986 3.124 . . . . 0.0 111.59 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.2 t -83.03 98.14 9.12 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 120.551 -1.343 . . . . 0.0 107.981 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.9 t 65.01 85.09 0.14 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.377 1.871 . . . . 0.0 110.032 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.356 0 CA-C-O 116.186 -2.452 . . . . 0.0 107.272 165.8 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.664 0 CA-C-O 118.739 -1.034 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.6 m 38.98 94.34 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.162 2.585 . . . . 0.0 114.288 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 m 64.29 84.22 0.15 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.942 1.697 . . . . 0.0 110.331 175.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.04 165.14 39.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 167.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.5 m -138.75 58.13 1.66 Allowed 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.339 0.656 . . . . 0.0 110.313 -168.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.9 m -55.63 161.94 1.87 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.936 -0.477 . . . . 0.0 111.707 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.02 -177.01 30.72 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 171.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -132.33 -45.33 0.91 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.464 1.106 . . . . 0.0 110.532 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -135.0 142.83 46.53 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.109 1.364 . . . . 0.0 108.221 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.3 t70 65.72 104.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 127.841 2.457 . . . . 0.0 108.524 -169.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.463 ' CD2' ' HG2' ' A' ' 51' ' ' LYS . 34.0 m-85 67.62 88.79 0.11 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.63 1.572 . . . . 0.0 111.264 -175.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.8 p -65.6 155.13 36.78 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.761 -0.587 . . . . 0.0 110.675 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -52.48 -37.25 56.75 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.069 -1.019 . . . . 0.0 111.554 174.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.58 -50.98 70.45 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 124.954 1.302 . . . . 0.0 110.224 176.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -63.67 -28.19 69.73 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.943 -1.098 . . . . 0.0 110.856 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.6 t -69.33 -35.91 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 120.388 1.449 . . . . 0.0 109.311 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -50.29 -60.59 2.82 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 170.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -61.99 -31.04 71.37 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.033 0.933 . . . . 0.0 112.715 -176.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -59.55 -61.9 2.28 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -64.14 -47.94 77.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.736 0.414 . . . . 0.0 110.585 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.92 -40.65 70.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.187 1.395 . . . . 0.0 110.3 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.55 -56.91 11.23 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 125.337 1.446 . . . . 0.0 111.022 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.7 t -56.69 -32.17 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 118.598 1.199 . . . . 0.0 111.427 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -61.04 -42.0 97.64 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 119.665 1.121 . . . . 0.0 110.405 -175.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.7 t -95.43 -44.88 7.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.787 0.835 . . . . 0.0 109.689 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 6.8 mmt -69.78 -25.58 63.86 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.129 1.372 . . . . 0.0 112.022 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.39 -161.25 34.92 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -151.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -72.67 8.51 1.43 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -166.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -70.0 97.8 1.2 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 121.056 1.753 . . . . 0.0 110.472 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -71.12 -40.91 71.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.806 0.842 . . . . 0.0 111.06 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -57.48 -46.5 83.64 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.869 0.868 . . . . 0.0 109.749 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.07 -61.11 2.53 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.718 0.807 . . . . 0.0 109.472 173.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.0 mt -52.26 -48.4 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 126.125 1.77 . . . . 0.0 110.905 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -24.02 63.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.706 0.802 . . . . 0.0 112.038 -174.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -100.67 -41.32 6.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.65 0.78 . . . . 0.0 111.231 175.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.3 -15.69 60.73 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -176.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -134.25 155.01 80.28 Favored Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 125.26 1.424 . . . . 0.0 108.313 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.0 110.62 2.35 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.803 2.336 . . . . 0.0 109.778 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -118.27 159.43 23.38 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.56 1.144 . . . . 0.0 109.012 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -54.0 145.93 15.58 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.546 1.138 . . . . 0.0 112.084 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -61.43 133.75 56.13 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.75 -8.42 73.91 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 118.838 -0.979 . . . . 0.0 112.579 176.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.6 mmp_? -61.48 153.49 27.14 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 118.867 1.333 . . . . 0.0 108.676 162.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.7 mtm105 -124.96 174.08 8.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.32 1.448 . . . . 0.0 107.401 167.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.53 -33.41 69.84 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 122.278 0.231 . . . . 0.0 110.639 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 m -63.8 -33.9 64.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 C-N-CA 123.473 0.709 . . . . 0.0 112.471 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.94 -41.11 86.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.44 ' HB3' HD21 ' A' ' 19' ' ' LEU . 53.8 mt -63.1 -52.0 64.37 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.982 1.313 . . . . 0.0 109.633 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.82 -45.07 82.53 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.743 1.217 . . . . 0.0 109.266 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -63.52 -54.34 37.72 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.716 1.207 . . . . 0.0 110.432 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.463 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 52.9 tptt -61.19 -44.75 96.79 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.97 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -56.58 -54.81 41.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.568 1.147 . . . . 0.0 110.383 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -50.28 60.77 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 123.558 0.536 . . . . 0.0 109.68 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -56.57 -45.6 81.2 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.473 1.109 . . . . 0.0 111.777 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.0 mt -63.33 -56.22 18.17 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.797 0.839 . . . . 0.0 110.759 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.5 pt -63.62 -13.18 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 118.014 0.37 . . . . 0.0 111.195 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 m 67.81 19.71 9.53 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.44 1.896 . . . . 0.0 112.402 168.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.65 166.4 39.25 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.187 0.899 . . . . 0.0 111.922 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.7 174.53 8.42 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.183 2.589 . . . . 0.0 112.567 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 m 27.66 73.07 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.438 2.695 . . . . 0.0 114.356 157.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.8 t -54.9 -47.87 73.78 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.918 0.887 . . . . 0.0 110.243 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 N-CA-C 105.846 -2.902 . . . . 0.0 105.846 177.829 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.642 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.2 m -129.66 149.1 51.56 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.536 1.534 . . . . 0.0 109.163 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.1 t -67.14 151.41 47.62 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.31 -82.02 0.07 OUTLIER Glycine 0 CA--C 1.52 0.348 0 N-CA-C 106.886 -2.486 . . . . 0.0 106.886 173.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.5 t 61.86 25.94 15.65 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.203 1.401 . . . . 0.0 111.928 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 t -122.74 173.49 7.71 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.436 1.094 . . . . 0.0 110.404 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.58 -166.14 38.3 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 129.602 3.477 . . . . 0.0 106.28 -162.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 73.53 156.36 0.17 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.314 2.245 . . . . 0.0 109.262 -170.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp 45.18 84.48 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 127.743 2.417 . . . . 0.0 110.471 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 59.28 103.08 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 126.314 1.846 . . . . 0.0 110.029 -170.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 104.93 132.87 0.01 OUTLIER 'General case' 0 C--O 1.237 0.399 0 C-N-CA 129.902 3.281 . . . . 0.0 107.087 169.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.444 HG22 ' OE1' ' A' ' 15' ' ' GLU . 8.8 t -83.47 178.44 8.02 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 164.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -55.27 -35.05 64.6 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-O 117.607 -1.187 . . . . 0.0 111.462 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.06 -57.66 11.87 Favored 'General case' 0 C--O 1.225 -0.197 0 O-C-N 123.827 0.705 . . . . 0.0 112.067 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.444 ' OE1' HG22 ' A' ' 12' ' ' THR . 3.0 mp0 -59.46 -40.22 86.18 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.688 1.131 . . . . 0.0 111.732 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.2 t -60.56 -40.62 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 118.839 -0.601 . . . . 0.0 111.374 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -57.42 -52.18 66.43 Favored 'General case' 0 C--O 1.226 -0.141 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.5 m-30 -61.03 -33.56 73.48 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.417 1.087 . . . . 0.0 111.716 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -61.38 -56.82 16.04 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.082 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -64.15 -43.1 96.26 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 117.791 -1.1 . . . . 0.0 111.769 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -55.52 -54.42 44.21 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.875 1.27 . . . . 0.0 109.262 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.85 -59.25 10.61 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 125.425 1.488 . . . . 0.0 111.648 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.4 t -61.74 -21.99 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 O-C-N 121.561 -0.964 . . . . 0.0 111.562 -177.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -76.1 -44.18 39.87 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 120.117 -1.614 . . . . 0.0 109.499 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.9 t -95.36 -16.58 22.25 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.571 0.749 . . . . 0.0 112.195 -169.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.4 mtp -126.71 -9.77 6.15 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.599 1.16 . . . . 0.0 112.257 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.04 -152.83 42.84 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -167.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -73.22 18.88 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.735 1.614 . . . . 0.0 113.648 -164.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -75.94 97.28 3.94 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.789 1.632 . . . . 0.0 109.482 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -75.15 -44.21 48.09 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.28 -0.888 . . . . 0.0 112.218 -171.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -62.33 -48.16 81.07 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.2 m -53.85 -47.03 71.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.903 0.881 . . . . 0.0 111.037 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.88 -46.65 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 119.926 1.239 . . . . 0.0 110.268 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.28 -24.09 17.59 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.027 1.331 . . . . 0.0 112.016 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -108.61 -31.64 7.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.681 1.192 . . . . 0.0 110.73 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -58.73 -23.2 59.36 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.274 1.429 . . . . 0.0 112.15 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -138.16 157.86 72.05 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 125.711 1.605 . . . . 0.0 108.003 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.87 109.12 1.94 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 N-CA-C 107.776 -1.663 . . . . 0.0 107.776 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -101.54 164.89 11.53 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.282 -0.886 . . . . 0.0 109.102 175.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -53.47 142.54 21.82 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -70.51 158.97 35.13 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.494 0.664 . . . . 0.0 110.261 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.2 -3.39 22.88 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.755 -1.581 . . . . 0.0 113.543 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.418 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 7.7 mmp_? -64.57 141.19 58.86 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 120.479 2.139 . . . . 0.0 109.566 176.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.6 mtt85 -82.8 159.87 22.37 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.04 78.51 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.262 -0.899 . . . . 0.0 109.903 166.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 m -65.15 -24.42 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 118.334 -0.841 . . . . 0.0 111.974 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -61.59 -31.73 71.8 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' HB3' HD21 ' A' ' 19' ' ' LEU . 59.7 mt -68.62 -49.76 56.75 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.507 1.523 . . . . 0.0 109.709 175.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.34 98.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.468 1.107 . . . . 0.0 109.758 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -65.71 -46.53 78.63 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.364 1.466 . . . . 0.0 110.197 178.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -60.9 -47.12 87.85 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -56.81 -45.27 82.36 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.783 1.233 . . . . 0.0 111.471 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -51.61 -39.82 58.71 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.647 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -81.4 -20.21 40.94 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.857 1.662 . . . . 0.0 113.288 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.6 mt -74.96 -11.42 60.11 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.406 -0.809 . . . . 0.0 111.47 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.5 pt -110.18 -25.25 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 119.612 1.096 . . . . 0.0 111.67 168.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 m -104.83 72.47 1.02 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 127.223 2.209 . . . . 0.0 108.721 171.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.48 153.86 17.34 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 169.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.12 3.2 7.83 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 CA-C-N 119.874 1.837 . . . . 0.0 113.222 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.8 t -149.85 143.77 25.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.935 1.243 . . . . 0.0 108.437 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.6 m -154.5 77.88 1.06 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.441 2.296 . . . . 0.0 106.595 171.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 117.752 -1.582 . . . . 0.0 111.574 -176.892 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.503 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -148.38 -171.17 3.78 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.573 1.149 . . . . 0.0 108.529 -169.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.1 m 49.79 -97.26 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.144 1.778 . . . . 0.0 111.966 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.27 -106.45 1.12 Allowed Glycine 0 C--N 1.335 0.521 0 CA-C-N 119.983 1.265 . . . . 0.0 110.845 170.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.3 t 27.62 82.11 0.02 OUTLIER 'General case' 0 C--O 1.233 0.195 0 C-N-CA 129.596 3.158 . . . . 0.0 111.225 -176.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.4 p -156.98 133.9 10.26 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.27 165.17 36.01 Favored Glycine 0 CA--C 1.524 0.606 0 O-C-N 121.005 -1.059 . . . . 0.0 112.753 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -142.21 67.66 1.32 Allowed 'General case' 0 C--O 1.234 0.287 0 O-C-N 121.751 -0.852 . . . . 0.0 109.257 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -138.83 -70.04 0.42 Allowed 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -144.18 -79.83 0.19 Allowed 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -172.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -54.45 114.59 1.72 Allowed 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.742 1.217 . . . . 0.0 108.578 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 t -72.7 168.95 17.67 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -40.05 62.05 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.092 0.957 . . . . 0.0 112.196 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -56.81 -50.85 71.11 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.811 1.244 . . . . 0.0 108.033 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -70.13 -25.39 63.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.123 0.969 . . . . 0.0 111.889 -174.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.6 t -73.96 -41.61 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 118.82 0.736 . . . . 0.0 109.341 173.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -58.76 -48.33 81.57 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.738 -0.649 . . . . 0.0 109.359 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -60.22 -35.35 75.24 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.966 0.906 . . . . 0.0 111.451 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.43 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -59.36 -53.94 52.4 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -72.14 -24.9 61.53 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -66.1 -55.06 18.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 170.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.84 -62.14 6.18 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 125.891 1.71 . . . . 0.0 111.319 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.6 t -61.75 -25.38 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 118.182 0.991 . . . . 0.0 111.65 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -70.71 -46.51 62.96 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 121.011 -1.056 . . . . 0.0 109.27 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -95.08 -20.32 19.41 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.354 0.525 . . . . 0.0 111.544 -168.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.3 mtp -124.09 -9.24 7.66 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.905 1.282 . . . . 0.0 111.997 -172.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.35 -154.14 50.45 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -73.55 14.68 0.32 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.31 1.044 . . . . 0.0 113.69 -166.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -78.71 96.87 5.67 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 120.797 1.635 . . . . 0.0 107.84 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -76.16 -42.42 46.64 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.729 -0.607 . . . . 0.0 110.423 -173.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -59.32 -42.66 91.95 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 m -60.66 -54.35 46.33 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.605 1.162 . . . . 0.0 112.35 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.3 mt -56.79 -43.27 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 125.407 1.483 . . . . 0.0 110.565 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -14.98 37.74 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -175.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -110.38 -29.17 8.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.024 1.329 . . . . 0.0 111.356 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 3.1 t -60.75 -18.17 53.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.593 0.757 . . . . 0.0 112.471 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 70.3 m-85 -144.58 158.03 54.5 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 125.098 1.359 . . . . 0.0 108.049 -176.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.4 109.89 3.0 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.734 1.623 . . . . 0.0 109.385 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -113.17 166.38 11.5 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.218 1.407 . . . . 0.0 109.596 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -56.87 151.38 14.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.99 1.316 . . . . 0.0 111.009 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.3 142.28 50.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -176.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.05 8.15 57.82 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.009 -1.439 . . . . 0.0 113.965 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -64.35 165.26 9.92 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 120.822 2.311 . . . . 0.0 109.661 169.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -120.72 159.58 25.09 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.645 1.178 . . . . 0.0 108.11 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.26 -40.35 64.56 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.626 0.37 . . . . 0.0 110.744 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.3 m -62.62 -27.98 43.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 C-N-CA 123.688 0.795 . . . . 0.0 112.336 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -62.09 -35.06 77.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.43 ' HB3' HD21 ' A' ' 19' ' ' LEU . 54.9 mt -66.95 -46.29 75.17 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 126.493 1.917 . . . . 0.0 110.129 175.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.02 -51.07 69.49 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -55.78 -48.4 75.38 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.466 1.107 . . . . 0.0 110.594 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -61.79 -48.02 82.51 Favored 'General case' 0 C--O 1.223 -0.29 0 O-C-N 121.234 -0.916 . . . . 0.0 110.998 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -55.48 -46.48 76.89 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 125.475 1.51 . . . . 0.0 110.991 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 49.3 m170 -53.77 -54.76 33.69 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.475 1.11 . . . . 0.0 109.028 172.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -55.77 -38.64 70.16 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 121.442 -0.786 . . . . 0.0 112.397 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.3 mt -68.33 -39.15 82.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 117.642 -1.17 . . . . 0.0 111.521 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -72.56 -20.42 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 120.164 1.347 . . . . 0.0 111.569 173.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.8 t 64.04 8.56 4.05 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.376 1.47 . . . . 0.0 112.436 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.5 -177.71 51.81 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.949 1.261 . . . . 0.0 112.285 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.1 171.86 10.74 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.542 2.828 . . . . 0.0 111.824 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t 85.62 99.12 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 128.43 2.692 . . . . 0.0 105.702 -170.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.7 m 58.92 19.98 7.65 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.457 1.503 . . . . 0.0 112.848 -173.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.213 0 C-N-CA 125.673 1.606 . . . . 0.0 111.686 -176.506 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.52 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.3 m -131.13 -4.89 3.89 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.587 0.755 . . . . 0.0 112.093 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.1 m -144.63 138.6 27.49 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.62 60.91 0.29 Allowed Glycine 0 C--N 1.333 0.405 0 CA-C-N 118.292 0.497 . . . . 0.0 111.977 -171.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.34 105.96 0.34 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.437 1.495 . . . . 0.0 110.836 176.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.5 m -153.69 168.98 24.43 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 128.217 2.607 . . . . 0.0 107.555 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.55 157.65 42.41 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -99.01 -10.66 22.36 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 127.236 2.214 . . . . 0.0 112.36 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -82.65 106.66 14.68 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.3 t70 130.96 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 131.45 3.9 . . . . 0.0 110.366 171.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.422 ' CD2' ' HG2' ' A' ' 51' ' ' LYS . 10.7 m-85 -141.23 134.27 29.2 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 167.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -84.1 -166.96 1.57 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.811 0.844 . . . . 0.0 109.957 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -74.05 -24.77 59.58 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 120.97 -1.081 . . . . 0.0 111.116 161.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -77.19 -49.48 15.07 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 119.23 0.923 . . . . 0.0 109.193 -171.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -41.36 92.07 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.6 t -59.78 -38.0 74.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 C-N-CA 124.151 0.98 . . . . 0.0 110.337 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -56.09 -54.56 43.58 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -65.8 -26.86 67.88 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -62.68 -52.43 63.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.027 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -59.28 -44.84 92.45 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.24 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -51.46 -52.85 42.89 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.638 1.175 . . . . 0.0 111.064 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.34 -58.54 8.52 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 124.23 0.919 . . . . 0.0 111.162 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -56.98 -25.56 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 118.507 1.154 . . . . 0.0 110.877 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -59.4 -45.71 90.73 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 121.317 -0.865 . . . . 0.0 110.52 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.2 t -96.5 -21.61 17.6 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.936 1.294 . . . . 0.0 112.065 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.3 mtp -116.86 -1.91 11.92 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.75 -1.219 . . . . 0.0 113.707 -166.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.27 -113.0 1.99 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -104.73 8.58 35.07 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.513 0.725 . . . . 0.0 112.698 -168.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -76.55 96.48 4.13 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 120.094 1.315 . . . . 0.0 109.514 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -78.7 -44.84 22.66 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.642 -172.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -61.35 -41.19 96.65 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 119.502 -0.285 . . . . 0.0 110.581 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 m -56.57 -53.92 51.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.207 0.603 . . . . 0.0 110.609 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 55.0 mt -53.3 -45.14 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.024 1.33 . . . . 0.0 110.893 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -31.06 68.0 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.325 0.65 . . . . 0.0 112.167 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -86.88 -35.09 19.19 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.947 0.499 . . . . 0.0 111.247 171.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.442 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 8.3 t -60.32 -31.05 69.92 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.128 1.371 . . . . 0.0 113.33 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 74.1 m-85 -135.27 155.14 79.0 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 123.93 0.892 . . . . 0.0 109.058 -171.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.89 109.3 2.19 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.852 1.701 . . . . 0.0 109.638 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -109.04 176.2 5.18 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.982 0.913 . . . . 0.0 111.036 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -56.55 155.9 6.8 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.481 1.112 . . . . 0.0 111.018 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.46 121.75 20.12 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -172.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.75 21.84 65.36 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.416 -0.658 . . . . 0.0 113.952 169.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -57.47 163.37 2.4 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 122.105 0.955 . . . . 0.0 111.389 171.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -103.05 167.58 9.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.948 162.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.5 -34.63 78.67 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.641 -0.662 . . . . 0.0 109.3 166.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 m -62.43 -29.34 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 O-C-N 121.701 -0.624 . . . . 0.0 112.259 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -55.97 -43.1 77.25 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.402 ' HB3' HD21 ' A' ' 19' ' ' LEU . 46.0 mt -67.05 -44.28 80.59 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.8 0.84 . . . . 0.0 110.061 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.84 -45.97 87.12 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.431 0.693 . . . . 0.0 109.374 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -60.39 -52.98 62.93 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.066 1.347 . . . . 0.0 109.063 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 57.7 tptt -59.94 -39.98 87.4 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.687 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -62.29 -46.28 89.49 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 119.68 1.127 . . . . 0.0 111.206 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -51.76 -54.2 31.23 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -53.81 -42.12 68.07 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.666 0.666 . . . . 0.0 112.307 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.69 -37.24 85.91 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 117.882 -1.056 . . . . 0.0 110.98 -176.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.5 pt -75.51 -48.98 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 119.491 1.042 . . . . 0.0 110.253 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 t -156.96 132.89 9.55 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.951 1.3 . . . . 0.0 108.755 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.59 151.91 48.62 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 120.77 -1.206 . . . . 0.0 110.3 168.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -81.7 -12.87 10.93 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.786 2.324 . . . . 0.0 112.676 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.6 t -144.82 18.27 1.63 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.74 1.616 . . . . 0.0 110.059 -166.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.03 -57.55 9.33 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.168 1.387 . . . . 0.0 109.519 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 1 N-CA-C 102.223 -4.351 . . . . 0.0 102.223 -155.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.642 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.7 m 59.02 -33.34 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.534 2.334 . . . . 0.0 117.091 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.9 m -57.21 130.3 45.58 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 120.45 1.477 . . . . 0.0 111.353 -169.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.68 7.41 65.51 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.274 -1.292 . . . . 0.0 112.951 -173.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.2 m -61.34 166.58 3.78 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.964 1.382 . . . . 0.0 112.522 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 p -159.91 165.01 33.0 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.894 1.278 . . . . 0.0 108.572 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.19 142.95 14.06 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 108.649 -1.781 . . . . 0.0 108.649 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -161.6 164.99 29.03 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.933 1.693 . . . . 0.0 106.704 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 9' ' ' LYS . 5.5 mmpt? 56.76 -92.75 0.03 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-O 117.54 -1.219 . . . . 0.0 109.439 -176.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -101.67 121.23 41.64 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 124.768 1.227 . . . . 0.0 108.101 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 70.64 122.07 0.03 OUTLIER 'General case' 0 C--O 1.235 0.337 0 C-N-CA 128.443 2.697 . . . . 0.0 108.564 -166.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.9 p -74.1 173.14 10.5 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 120.574 -1.329 . . . . 0.0 108.064 169.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -55.23 -21.55 14.55 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.022 0.929 . . . . 0.0 112.232 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.07 -32.74 17.41 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.626 1.171 . . . . 0.0 112.037 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.48 -41.98 75.43 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 119.842 1.201 . . . . 0.0 108.329 171.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.54 -29.42 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 122.004 -0.435 . . . . 0.0 110.206 174.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -57.78 -59.0 5.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 118.817 -0.611 . . . . 0.0 109.599 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -60.41 -28.3 68.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.82 -58.17 5.57 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -68.17 -28.41 67.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 119.312 -0.375 . . . . 0.0 111.607 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.91 -43.28 93.33 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.866 0.866 . . . . 0.0 109.674 173.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.77 -44.07 8.62 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 124.101 0.858 . . . . 0.0 111.062 -168.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.7 t -62.7 -26.62 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.603 0.702 . . . . 0.0 110.39 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -64.04 -33.55 76.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.495 1.043 . . . . 0.0 110.739 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . 0.252 11.5 t -95.75 -61.73 1.41 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -23.76 56.21 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -167.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.7 -150.95 48.78 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -160.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -69.51 9.17 0.51 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.013 2.525 . . . . 0.0 114.88 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -71.44 96.96 1.55 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 121.199 1.818 . . . . 0.0 108.876 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.2 m95 -81.14 -46.03 15.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.364 -0.826 . . . . 0.0 111.453 -170.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -54.52 -41.81 70.1 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.281 0.946 . . . . 0.0 109.96 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -53.53 57.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 123.503 0.721 . . . . 0.0 110.623 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 59.9 mt -55.5 -46.1 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.607 1.163 . . . . 0.0 109.617 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -16.36 43.0 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.961 1.304 . . . . 0.0 112.782 -176.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -109.94 -29.68 8.15 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.447 1.099 . . . . 0.0 112.186 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.4 ' HB3' ' CD2' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -63.78 -26.49 68.66 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.951 0.796 . . . . 0.0 112.101 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 36' ' ' SER . 84.4 m-85 -135.31 156.42 78.0 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 124.557 1.143 . . . . 0.0 109.994 -174.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.8 138.48 31.74 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 N-CA-C 108.552 -1.365 . . . . 0.0 108.552 170.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -132.23 -174.5 3.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 170.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -71.26 171.95 10.18 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.307 -0.871 . . . . 0.0 111.067 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.415 ' HE3' ' CA ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -68.63 165.14 19.94 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.783 -0.573 . . . . 0.0 110.291 171.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.65 -3.15 1.48 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.378 1.466 . . . . 0.0 115.483 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -63.09 157.83 21.21 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 119.072 1.436 . . . . 0.0 110.356 -175.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -120.84 166.66 13.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.687 1.595 . . . . 0.0 107.51 168.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.9 77.52 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.707 -0.621 . . . . 0.0 110.802 169.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.3 m -63.14 -24.86 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 123.53 0.732 . . . . 0.0 112.373 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -65.46 -42.25 92.49 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 mt -62.31 -36.58 82.6 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.12 -43.81 86.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 119.256 0.935 . . . . 0.0 109.944 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.43 -55.4 12.0 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.949 1.299 . . . . 0.0 112.308 -172.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -58.56 -47.45 84.21 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -54.81 -48.42 72.8 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 125.106 1.362 . . . . 0.0 110.156 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -51.86 -47.42 64.47 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.957 0.503 . . . . 0.0 110.843 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -67.33 -31.19 71.3 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.736 -0.602 . . . . 0.0 110.713 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.2 mt -71.44 -41.16 69.82 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.186 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.7 pt -76.52 -16.27 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 120.638 1.563 . . . . 0.0 112.5 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.0 m -111.65 66.36 0.63 Allowed 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.25 1.42 . . . . 0.0 108.608 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.43 -179.35 6.57 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.217 1.389 . . . . 0.0 112.105 173.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -58.89 -48.43 14.57 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.597 2.198 . . . . 0.0 111.551 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.6 p -75.14 111.18 10.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 165.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 72.1 p -135.35 88.0 2.38 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.527 0.603 . . . . 0.0 110.126 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.838 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 178.059 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.748 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 m -116.35 153.71 31.52 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.822 0.811 . . . . 0.0 109.061 167.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.0 p -146.81 169.25 19.48 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.542 1.537 . . . . 0.0 107.764 175.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.91 133.07 43.55 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 174.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.1 m -157.47 -176.01 5.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.542 1.937 . . . . 0.0 108.527 -176.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.1 p -62.71 175.24 0.85 Allowed 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.271 -0.893 . . . . 0.0 110.54 158.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.92 -49.19 0.17 Allowed Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 171.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.0 mtp-105 -133.85 162.15 32.8 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.183 0.593 . . . . 0.0 110.856 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -70.65 -166.57 0.15 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.86 0.864 . . . . 0.0 110.446 165.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 56.89 -101.89 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.54 1.936 . . . . 0.0 108.276 -162.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -58.6 135.01 57.24 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 119.185 0.902 . . . . 0.0 111.879 -168.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.7 p -72.16 170.63 13.59 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.707 0.803 . . . . 0.0 109.377 167.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -56.39 -27.98 57.92 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.456 -0.778 . . . . 0.0 110.886 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -68.78 -56.18 8.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.335 -0.853 . . . . 0.0 109.399 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -59.37 -34.4 72.36 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.041 0.536 . . . . 0.0 111.304 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.651 HG22 ' HE2' ' A' ' 51' ' ' LYS . 54.0 t -66.42 -40.2 85.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.012 175.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -65.03 -45.16 86.61 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 118.468 0.577 . . . . 0.0 109.448 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -60.15 -37.74 81.04 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.084 0.954 . . . . 0.0 110.811 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.77 -56.89 13.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.933 0.893 . . . . 0.0 109.235 171.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -69.69 -29.94 67.48 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.601 -0.714 . . . . 0.0 112.536 -175.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -61.51 -58.55 7.71 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.81 1.187 . . . . 0.0 108.129 170.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.22 -60.96 4.8 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 125.868 1.699 . . . . 0.0 111.756 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.5 t -63.38 -20.04 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.423 1.112 . . . . 0.0 112.238 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.02 -40.62 45.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 120.322 -1.486 . . . . 0.0 109.635 177.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.8 t -95.82 -19.9 19.24 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.234 0.925 . . . . 0.0 113.087 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 10.0 mtt -117.88 0.4 11.91 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.254 1.422 . . . . 0.0 112.751 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.71 -103.63 0.12 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.586 1.089 . . . . 0.0 111.957 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -114.78 12.47 17.02 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 118.224 1.012 . . . . 0.0 110.506 -167.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.06 97.68 4.77 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 173.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -81.66 -46.61 14.1 Favored 'General case' 0 CA--C 1.521 -0.143 0 O-C-N 121.178 -0.951 . . . . 0.0 110.992 -172.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -54.7 -44.98 73.92 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.841 0.856 . . . . 0.0 109.918 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.7 m -57.48 -48.62 78.74 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.948 1.699 . . . . 0.0 111.803 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.9 mt -59.28 -45.3 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 O-C-N 120.909 -1.119 . . . . 0.0 109.94 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -23.94 48.17 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 125.542 1.537 . . . . 0.0 112.58 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 3.8 m0 -112.11 -29.6 7.54 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.522 -0.752 . . . . 0.0 111.086 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 t -68.87 -22.21 64.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.152 0.887 . . . . 0.0 111.981 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -121.85 156.01 59.75 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 123.951 0.9 . . . . 0.0 108.583 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.84 110.25 3.08 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.957 1.771 . . . . 0.0 108.174 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -111.18 168.18 9.71 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.137 0.975 . . . . 0.0 108.749 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -55.68 163.49 1.35 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.577 1.551 . . . . 0.0 111.468 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -64.68 161.4 17.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.366 164.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.79 -15.63 2.93 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.775 1.179 . . . . 0.0 114.242 170.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -63.4 163.21 11.13 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 124.509 1.124 . . . . 0.0 111.455 -174.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -127.88 170.36 12.9 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.756 1.222 . . . . 0.0 109.548 171.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.4 -34.97 69.43 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.96 0.504 . . . . 0.0 110.939 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.78 -30.85 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 CA-C-N 118.224 0.465 . . . . 0.0 112.084 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.04 -38.14 72.79 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.412 0.445 . . . . 0.0 110.581 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.2 mt -67.41 -49.51 63.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.015 1.726 . . . . 0.0 110.548 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.98 -52.96 63.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -54.16 -46.55 72.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.476 1.11 . . . . 0.0 111.781 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.651 ' HE2' HG22 ' A' ' 16' ' ' VAL . 7.0 tptt -54.98 -60.27 3.6 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.11 0.564 . . . . 0.0 110.202 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -54.78 -46.02 74.35 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 126.331 1.852 . . . . 0.0 110.933 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -59.92 -47.05 87.38 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.153 0.981 . . . . 0.0 110.128 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -56.54 -41.1 76.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.461 1.028 . . . . 0.0 110.75 171.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.5 mt -74.71 -7.03 52.04 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.4 pt -105.18 -12.24 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 120.415 1.462 . . . . 0.0 111.772 166.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 m -75.27 68.21 1.97 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.054 1.342 . . . . 0.0 110.061 162.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 138.35 159.28 8.05 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.969 1.271 . . . . 0.0 111.947 168.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.46 -32.47 4.86 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.32 2.68 . . . . 0.0 111.24 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.3 t -168.87 121.88 0.81 Allowed 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.9 m -121.63 90.47 3.32 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.409 1.084 . . . . 0.0 108.481 -169.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 174.365 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.81 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.2 m 56.01 84.72 0.08 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.971 1.708 . . . . 0.0 113.441 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.0 t 58.14 -154.98 0.35 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.452 1.101 . . . . 0.0 110.337 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.13 -178.41 51.4 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 123.963 0.792 . . . . 0.0 113.205 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.1 t 119.17 139.29 0.0 OUTLIER 'General case' 0 C--O 1.236 0.381 1 C-N-CA 132.848 4.459 . . . . 0.0 107.007 -175.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.2 m -77.96 106.25 9.69 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 170.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.37 178.71 46.94 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -126.46 -49.02 1.54 Allowed 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.561 1.944 . . . . 0.0 110.767 -174.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.538 ' HA ' ' HE2' ' A' ' 9' ' ' LYS . 9.1 mmpt? -141.86 17.39 2.14 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.794 1.237 . . . . 0.0 111.298 -175.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.76 51.58 1.32 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 128.337 2.655 . . . . 0.0 110.746 -161.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 97.17 123.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 1 C-N-CA 133.712 4.805 . . . . 0.0 106.985 -170.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 p -62.31 166.77 4.68 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.412 0.685 . . . . 0.0 110.097 167.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -61.69 -25.66 67.55 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.114 -0.992 . . . . 0.0 110.083 168.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -62.27 -49.36 75.98 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 122.085 0.945 . . . . 0.0 108.527 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -72.46 -36.99 68.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.562 0.745 . . . . 0.0 110.917 -174.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.63 -32.0 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 119.372 0.987 . . . . 0.0 109.744 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -59.38 -59.07 6.03 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 170.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -57.0 -32.08 65.75 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.58 1.152 . . . . 0.0 112.189 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -57.2 -63.03 1.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.79 0.836 . . . . 0.0 108.845 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -68.92 -31.66 70.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.452 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -59.31 -49.38 78.03 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 120.204 1.366 . . . . 0.0 109.334 175.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.46 -63.27 5.46 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 124.764 1.173 . . . . 0.0 110.495 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.2 t -55.46 -23.33 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 118.267 1.033 . . . . 0.0 111.603 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -71.22 -53.72 13.41 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 120.134 1.334 . . . . 0.0 109.618 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.6 t -81.47 -8.51 59.74 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.845 0.858 . . . . 0.0 111.107 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.5 mtp -128.86 -93.82 0.44 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.282 1.833 . . . . 0.0 108.033 -171.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.16 -126.44 2.1 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -168.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.57 7.91 17.53 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 117.498 0.649 . . . . 0.0 111.715 -172.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -69.94 98.67 1.3 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.994 1.27 . . . . 0.0 108.414 167.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -74.92 -42.43 57.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.308 -0.377 . . . . 0.0 111.073 -170.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -54.9 -36.62 65.39 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 118.746 -0.645 . . . . 0.0 112.058 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.4 m -61.77 -55.13 33.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.222 0.609 . . . . 0.0 110.06 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.6 mt -53.04 -47.9 53.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 125.988 1.715 . . . . 0.0 110.167 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -31.36 64.92 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.843 1.257 . . . . 0.0 111.32 -175.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -85.31 -42.95 14.14 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.516 0.726 . . . . 0.0 112.105 170.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.424 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 9.6 t -57.19 -35.63 69.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.881 1.273 . . . . 0.0 111.93 -167.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 57.3 m-85 -127.37 157.91 71.21 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 124.132 0.973 . . . . 0.0 108.524 -174.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.46 108.65 2.18 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 CA-C-N 119.747 0.946 . . . . 0.0 109.934 -175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -104.1 166.64 10.28 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.466 1.106 . . . . 0.0 108.864 173.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -52.16 162.73 0.45 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.46 1.104 . . . . 0.0 111.705 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 160.32 24.6 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.3 7.68 20.31 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.293 -0.726 . . . . 0.0 114.427 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.7 mmp_? -71.26 161.31 31.29 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 119.025 1.412 . . . . 0.0 108.938 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -118.41 162.99 17.4 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 174.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.71 -36.17 66.89 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.314 -0.866 . . . . 0.0 111.282 170.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 m -66.55 -23.78 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.004 0.922 . . . . 0.0 112.605 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.57 -46.49 70.29 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.642 0.734 . . . . 0.0 109.145 176.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.411 HD22 ' CD2' ' A' ' 19' ' ' LEU . 35.9 mt -65.84 -44.79 84.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.323 1.449 . . . . 0.0 109.119 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.1 -49.57 75.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.051 1.341 . . . . 0.0 108.847 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -55.02 -61.72 2.13 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.871 1.268 . . . . 0.0 110.09 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -52.94 -54.14 39.32 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 122.586 0.355 . . . . 0.0 110.131 -174.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -52.12 -51.38 58.15 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 126.196 1.799 . . . . 0.0 111.231 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -57.03 -49.06 76.96 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.852 0.296 . . . . 0.0 110.491 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -58.14 -43.22 87.19 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.662 -0.685 . . . . 0.0 109.3 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.7 mt -62.43 -53.47 54.39 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.805 0.842 . . . . 0.0 111.643 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.0 pt -62.17 -25.88 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 119.403 1.001 . . . . 0.0 110.653 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.0 m 55.62 37.47 28.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.174 1.39 . . . . 0.0 111.088 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.86 169.82 52.46 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.787 0.708 . . . . 0.0 112.609 -171.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.18 120.78 6.15 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.616 2.877 . . . . 0.0 109.234 174.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.7 m -154.06 173.12 16.45 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.466 1.506 . . . . 0.0 108.08 165.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.1 t 75.06 -43.8 0.52 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 127.379 2.272 . . . . 0.0 112.246 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 N-CA-C 105.93 -2.868 . . . . 0.0 105.93 -166.754 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.594 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p -150.41 -22.42 0.24 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 m 46.9 49.12 14.83 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.366 1.866 . . . . 0.0 114.14 165.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.91 112.02 4.17 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.1 p -152.24 166.12 32.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.794 2.038 . . . . 0.0 109.353 -173.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 p -69.05 157.3 37.08 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.813 0.845 . . . . 0.0 111.41 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.56 161.66 33.99 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -149.57 149.48 30.76 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.838 1.255 . . . . 0.0 108.461 172.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt 60.7 -41.9 0.11 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 129.814 3.246 . . . . 0.0 114.843 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -64.6 175.6 1.37 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 123.009 1.385 . . . . 0.0 109.397 166.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.11 130.52 44.31 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -74.17 173.17 10.49 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -48.06 -50.27 28.58 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.284 1.034 . . . . 0.0 109.797 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.08 -37.07 73.79 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.612 -172.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -35.3 43.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 119.692 -0.803 . . . . 0.0 108.946 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.5 t -62.88 -37.99 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 121.134 -0.979 . . . . 0.0 109.873 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -53.53 -51.31 63.28 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.443 0.697 . . . . 0.0 109.689 172.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -67.62 -29.09 68.33 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -61.46 -53.77 52.1 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 175.149 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -60.54 -50.67 72.59 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 118.578 -0.725 . . . . 0.0 111.62 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.18 -49.27 74.5 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.013 0.925 . . . . 0.0 110.551 -177.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.95 -53.31 43.96 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 124.74 1.162 . . . . 0.0 110.656 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.3 t -60.1 -28.55 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 117.622 0.711 . . . . 0.0 110.228 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -70.89 -37.9 73.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 120.964 -1.085 . . . . 0.0 110.403 -176.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.6 t -95.39 -19.37 19.97 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.905 0.882 . . . . 0.0 112.21 -176.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 41.3 mtt -116.37 -20.6 9.65 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.47 1.032 . . . . 0.0 113.777 -175.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.31 -151.17 39.75 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -160.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -68.93 24.32 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.607 2.763 . . . . 0.0 116.441 -169.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -81.05 103.14 10.66 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 165.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -84.62 -39.02 19.17 Favored 'General case' 0 CA--C 1.527 0.091 0 O-C-N 121.129 -0.982 . . . . 0.0 111.25 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -58.71 -48.9 79.56 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.045 0.538 . . . . 0.0 110.864 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.3 m -56.95 -49.11 76.66 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.51 1.124 . . . . 0.0 112.346 176.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.1 mt -55.29 -47.47 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.049 1.339 . . . . 0.0 109.566 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -30.04 44.63 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.035 0.934 . . . . 0.0 111.987 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -98.84 -26.74 14.2 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.434 0.694 . . . . 0.0 112.253 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 t -63.04 -22.22 66.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.618 1.167 . . . . 0.0 112.352 -173.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -134.61 161.95 60.65 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 125.009 1.324 . . . . 0.0 107.443 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.65 109.13 2.56 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 N-CA-C 107.239 -1.87 . . . . 0.0 107.239 170.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -99.67 172.15 7.46 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -55.91 149.98 14.11 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.433 1.093 . . . . 0.0 109.237 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.08 155.82 39.87 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 121.291 -0.881 . . . . 0.0 110.335 -176.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.15 21.22 71.75 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.718 1.152 . . . . 0.0 113.89 173.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -82.25 162.58 22.28 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.426 1.09 . . . . 0.0 111.039 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -112.54 162.51 15.56 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.645 1.978 . . . . 0.0 107.43 167.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.91 -26.8 67.78 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.491 -0.756 . . . . 0.0 111.161 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.3 m -67.63 -24.4 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 O-C-N 120.793 -1.192 . . . . 0.0 112.753 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -62.85 -38.0 89.05 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.307 0.643 . . . . 0.0 109.293 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.436 ' HB3' HD21 ' A' ' 19' ' ' LEU . 67.4 mt -62.22 -50.87 70.03 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 126.755 2.022 . . . . 0.0 109.479 175.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.33 -37.88 89.05 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.957 0.903 . . . . 0.0 109.177 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -60.78 -54.42 45.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 122.05 -0.406 . . . . 0.0 110.093 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -56.56 -42.09 78.01 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 118.644 0.657 . . . . 0.0 111.071 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -58.72 -49.28 78.18 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.755 1.622 . . . . 0.0 111.107 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -20.73 64.64 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.827 -0.606 . . . . 0.0 112.328 175.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -77.66 -49.7 13.98 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.89 1.677 . . . . 0.0 109.685 165.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.5 mt -55.26 -56.19 22.82 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.508 0.594 . . . . 0.0 112.038 -173.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -65.87 -22.57 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 O-C-N 121.968 -0.458 . . . . 0.0 111.758 -173.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -72.05 -8.86 56.97 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.605 1.162 . . . . 0.0 112.175 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.78 -162.8 16.31 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 119.267 0.94 . . . . 0.0 111.213 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.37 58.1 6.74 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 124.533 3.488 . . . . 0.0 112.539 -165.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.1 t -56.26 118.61 4.9 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.362 1.065 . . . . 0.0 110.037 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.3 t -155.0 -61.16 0.12 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.206 1.402 . . . . 0.0 108.473 173.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.403 0 CA-C-O 118.614 -1.103 . . . . 0.0 110.813 -176.475 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.503 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.7 m 63.15 96.25 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.887 1.675 . . . . 0.0 113.004 168.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.5 m 58.09 -161.52 0.23 Allowed 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.607 1.163 . . . . 0.0 110.688 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.63 164.55 23.14 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 123.253 0.454 . . . . 0.0 112.147 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -154.24 124.66 6.97 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.55 1.54 . . . . 0.0 107.733 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.7 m -145.46 172.85 12.61 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.714 1.605 . . . . 0.0 108.685 170.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.92 -174.7 13.83 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 125.863 1.697 . . . . 0.0 110.486 173.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -134.17 -67.41 0.58 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.564 2.345 . . . . 0.0 107.333 166.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -147.41 -50.55 0.19 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.477 1.511 . . . . 0.0 108.989 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.31 117.41 5.17 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.588 1.155 . . . . 0.0 108.834 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 70.09 115.26 0.04 OUTLIER 'General case' 0 C--O 1.238 0.465 0 C-N-CA 129.532 3.133 . . . . 0.0 112.218 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.1 t -61.6 154.43 25.04 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.488 163.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -59.31 -20.75 57.0 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.396 1.078 . . . . 0.0 113.013 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.45 -58.57 5.53 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.264 1.026 . . . . 0.0 108.441 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -36.22 78.81 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.308 1.043 . . . . 0.0 110.94 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.49 -39.41 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 120.952 -1.092 . . . . 0.0 110.921 176.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -59.91 -46.38 89.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.227 -0.892 . . . . 0.0 109.761 173.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -61.57 -29.36 69.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.507 1.049 . . . . 0.0 112.558 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -63.32 -58.03 8.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.79 0.723 . . . . 0.0 109.859 175.493 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -64.94 -32.8 74.7 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.684 0.394 . . . . 0.0 111.327 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -65.15 -44.13 89.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.663 1.185 . . . . 0.0 109.858 174.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.02 -56.96 19.43 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 127.027 2.251 . . . . 0.0 110.924 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.8 t -63.13 -25.43 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 118.389 1.095 . . . . 0.0 110.593 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -68.31 -39.3 82.07 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 120.585 -1.322 . . . . 0.0 110.08 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.2 t -94.98 -28.69 15.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.137 0.575 . . . . 0.0 111.573 -172.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -107.94 -26.28 10.78 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.161 0.984 . . . . 0.0 112.687 -174.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.8 -155.11 52.73 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -162.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.96 38.49 0.08 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.555 1.542 . . . . 0.0 113.214 -172.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -109.16 97.79 7.34 Favored 'General case' 0 C--N 1.338 0.105 0 O-C-N 120.598 -1.314 . . . . 0.0 107.69 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -81.15 -38.91 26.38 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.383 -167.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -62.33 -42.87 99.74 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 123.669 0.606 . . . . 0.0 109.853 -175.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.3 t -55.67 -57.47 11.86 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 124.382 1.073 . . . . 0.0 111.046 171.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.7 mt -48.01 -51.92 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.631 1.572 . . . . 0.0 110.351 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.56 -37.95 52.04 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.568 1.547 . . . . 0.0 111.689 -177.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -85.81 -40.28 16.19 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.593 0.757 . . . . 0.0 111.454 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 t -62.92 -20.88 65.61 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -168.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -134.46 155.58 79.58 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 124.757 1.223 . . . . 0.0 107.863 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.63 110.43 2.31 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 N-CA-C 107.326 -1.836 . . . . 0.0 107.326 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -110.14 172.37 6.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 162.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.79 146.97 54.12 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -65.63 173.56 2.71 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.594 0.758 . . . . 0.0 110.058 169.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.56 -13.0 0.45 Allowed Glycine 0 CA--C 1.537 1.427 0 CA-C-O 119.197 -0.78 . . . . 0.0 114.014 -176.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 mmt85 -58.3 134.82 56.9 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.569 1.684 . . . . 0.0 108.061 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -87.41 165.87 15.25 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 162.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.17 -27.92 69.29 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.0 -1.062 . . . . 0.0 111.023 171.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 m -67.31 -27.75 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.313 1.045 . . . . 0.0 112.093 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.88 -45.52 64.18 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.898 0.879 . . . . 0.0 109.009 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.5 mt -66.1 -49.6 66.97 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.794 1.638 . . . . 0.0 109.966 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.7 -40.14 91.97 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.972 1.309 . . . . 0.0 109.875 -173.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -68.47 -51.36 44.33 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.957 0.903 . . . . 0.0 110.249 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -55.0 -45.08 75.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.824 0.738 . . . . 0.0 110.608 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -58.14 -47.43 83.35 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.041 1.337 . . . . 0.0 110.942 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -56.89 -43.08 80.96 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 118.947 -0.549 . . . . 0.0 111.196 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -71.2 -28.85 64.51 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.355 0.662 . . . . 0.0 112.069 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.72 -57.04 12.38 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.042 0.837 . . . . 0.0 109.596 171.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.2 pt -63.41 -44.07 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 118.958 0.799 . . . . 0.0 111.663 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 t -92.44 80.67 4.89 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.97 -118.84 0.07 OUTLIER Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.649 1.595 . . . . 0.0 110.538 169.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.24 86.42 0.65 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.527 3.485 . . . . 0.0 108.889 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.4 m -157.76 148.8 21.26 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 127.472 2.309 . . . . 0.0 107.114 -175.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 p -170.61 162.93 8.11 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 126.472 1.909 . . . . 0.0 109.419 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -179.907 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.454 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 m -68.09 154.15 42.26 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.638 0.719 . . . . 0.0 110.297 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -162.82 -174.79 4.08 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.814 2.446 . . . . 0.0 105.741 169.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.74 77.29 0.18 Allowed Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.302 0.953 . . . . 0.0 113.214 164.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.9 t -160.95 165.5 29.87 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.285 1.043 . . . . 0.0 109.337 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.7 m -53.82 -20.57 5.96 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.116 1.766 . . . . 0.0 115.503 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 52.83 62.05 6.26 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.392 0.996 . . . . 0.0 111.131 -173.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -145.42 137.87 25.84 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.161 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt 128.27 -163.86 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 1 C-N-CA 132.496 4.319 . . . . 0.0 106.037 -170.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -71.13 161.61 30.83 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 167.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 68.15 111.55 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.467 1.507 . . . . 0.0 111.351 173.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.98 159.36 32.84 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 130.611 3.565 . . . . 0.0 113.836 -169.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -54.08 -46.49 72.04 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 126.253 1.821 . . . . 0.0 111.868 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -71.54 -42.04 68.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.559 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -34.85 74.52 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.894 0.478 . . . . 0.0 109.941 -175.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.4 t -58.56 -41.62 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.03 -50.52 73.16 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.769 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -60.21 -34.48 73.71 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 118.514 0.597 . . . . 0.0 112.248 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.88 -53.36 59.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.145 0.978 . . . . 0.0 108.644 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -65.83 -47.82 73.73 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.652 -0.69 . . . . 0.0 111.393 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -56.74 -35.17 68.29 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.039 0.836 . . . . 0.0 110.409 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.39 -67.89 1.9 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 127.49 2.471 . . . . 0.0 110.849 170.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.1 t -56.23 -27.61 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.999 1.9 . . . . 0.0 111.466 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -62.1 -40.46 95.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.248 -0.907 . . . . 0.0 109.643 -177.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 t -96.07 -42.41 8.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.686 1.194 . . . . 0.0 111.379 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.74 -26.0 40.91 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 124.437 1.095 . . . . 0.0 113.918 -172.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.42 -116.54 8.04 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -164.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.91 12.16 32.77 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.191 1.495 . . . . 0.0 113.444 -172.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -73.76 97.11 2.65 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -80.36 -43.0 21.86 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 121.225 -0.922 . . . . 0.0 109.598 176.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -54.38 -41.18 68.92 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.215 0.606 . . . . 0.0 110.66 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.8 m -74.45 -38.49 62.97 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.661 1.184 . . . . 0.0 111.814 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 60.7 mt -59.92 -45.11 95.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -28.47 64.73 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.089 0.956 . . . . 0.0 112.227 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -85.14 -41.54 15.6 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.782 0.833 . . . . 0.0 110.084 173.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.3 t -67.22 -14.16 62.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 117.255 -1.355 . . . . 0.0 114.578 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.413 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 73.2 m-85 -151.93 160.84 30.95 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 120.737 1.608 . . . . 0.0 109.715 -177.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -74.68 143.57 30.38 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.604 1.536 . . . . 0.0 109.526 168.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' A' ' 37' ' ' PHE . 90.5 m-85 -137.38 113.51 9.91 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 169.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.25 45.4 mt-30 37.36 -124.94 0.21 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.967 1.707 . . . . 0.0 108.998 -168.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -133.56 143.01 48.43 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 158.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.93 62.32 5.33 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.085 0.85 . . . . 0.0 112.155 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -109.48 164.5 12.45 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.897 0.856 . . . . 0.0 113.258 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -99.53 165.78 11.47 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.941 1.696 . . . . 0.0 108.574 168.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.56 -31.83 73.21 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.589 -0.695 . . . . 0.0 109.935 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.6 m -64.08 -24.7 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.201 -0.937 . . . . 0.0 112.357 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.48 -11.74 61.08 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.824 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.3 mt -94.89 -18.87 20.76 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.162 1.385 . . . . 0.0 112.071 169.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.8 -43.57 22.19 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.039 171.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -74.63 -57.75 3.73 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -164.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -59.06 -39.39 81.93 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 116.412 -1.756 . . . . 0.0 110.867 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -50.79 -47.75 59.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 121.42 1.918 . . . . 0.0 110.891 168.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.49 -37.81 65.72 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.122 0.569 . . . . 0.0 112.006 176.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -76.59 -35.24 58.26 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.897 0.879 . . . . 0.0 112.167 173.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.2 mt -61.34 -45.93 92.37 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.522 1.055 . . . . 0.0 109.409 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 pt -70.04 -6.83 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.0 71.65 5.47 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.822 1.192 . . . . 0.0 109.159 175.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.2 -178.96 48.68 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.857 1.218 . . . . 0.0 111.892 176.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.11 -28.82 23.09 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.913 2.409 . . . . 0.0 113.169 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.74 135.56 13.66 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 -167.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . 0.258 6.6 m 52.07 -83.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 128.333 2.653 . . . . 0.0 114.003 -175.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 -158.337 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.656 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 p -149.5 167.35 26.49 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 122.012 -0.699 . . . . 0.0 111.145 -163.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 t -156.94 152.06 26.23 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.33 0.652 . . . . 0.0 110.096 162.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.36 -160.31 18.86 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.606 2.05 . . . . 0.0 112.638 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.0 m -57.06 123.66 16.01 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.707 0.753 . . . . 0.0 109.619 174.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.3 m -149.69 106.0 3.49 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.73 1.612 . . . . 0.0 108.244 170.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.54 56.75 4.16 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 170.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -76.37 -72.56 0.32 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 167.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 47.24 53.88 10.2 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.91 1.284 . . . . 0.0 108.937 175.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -65.47 -54.89 21.88 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.563 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -69.03 143.95 54.17 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.2 p -75.72 178.96 5.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.356 1.062 . . . . 0.0 109.804 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 pttt -63.07 -31.75 72.96 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 120.189 -1.57 . . . . 0.0 112.24 165.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.62 -54.0 9.16 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.692 0.797 . . . . 0.0 108.923 -168.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -63.53 -23.75 67.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.461 -175.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.3 t -74.49 -39.21 47.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 119.078 0.854 . . . . 0.0 110.059 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -60.27 -47.93 83.9 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.6 m-30 -64.21 -30.9 71.94 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.799 0.84 . . . . 0.0 113.008 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.41 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -57.48 -54.79 42.87 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 174.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -61.45 -47.81 84.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.843 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.432 ' O ' ' HE3' ' A' ' 24' ' ' LYS . 4.0 m-70 -59.88 -36.08 76.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.268 0.94 . . . . 0.0 111.21 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.18 -54.46 20.58 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 125.684 1.612 . . . . 0.0 110.518 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.3 t -59.57 -28.13 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 118.296 1.048 . . . . 0.0 110.903 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -66.07 -36.98 84.66 Favored 'General case' 0 CA--C 1.521 -0.142 0 O-C-N 120.81 -1.181 . . . . 0.0 110.002 -178.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 t -95.46 -35.45 11.7 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.203 0.601 . . . . 0.0 111.84 -176.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -95.29 -11.98 26.96 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.908 0.883 . . . . 0.0 112.782 -173.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 57.82 -144.12 41.79 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 107.965 -2.054 . . . . 0.0 107.965 -157.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -61.86 -1.8 0.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -174.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -82.48 97.36 8.37 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 122.24 2.291 . . . . 0.0 109.831 -157.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -68.01 -41.88 81.54 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.573 -170.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -61.62 -43.05 99.58 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.8 m -60.03 -47.23 86.73 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.477 1.511 . . . . 0.0 112.008 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.2 mt -57.58 -46.73 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 123.933 0.893 . . . . 0.0 109.162 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -60.83 -21.56 63.31 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.06 0.544 . . . . 0.0 112.257 -175.559 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -96.27 -32.41 12.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.376 0.67 . . . . 0.0 111.572 173.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -18.3 65.0 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -134.12 149.97 72.95 Favored Pre-proline 0 C--O 1.236 0.384 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.12 107.2 2.43 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 N-CA-C 105.704 -2.46 . . . . 0.0 105.704 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -99.08 178.32 4.96 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -62.74 152.36 35.9 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.144 -0.973 . . . . 0.0 109.986 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -58.59 159.86 6.1 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.894 0.477 . . . . 0.0 109.908 164.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.16 9.44 29.22 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.9 mmt-85 -73.45 165.03 25.83 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 118.726 1.263 . . . . 0.0 110.484 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -132.14 158.71 40.95 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.56 -36.01 77.43 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 m -63.18 -27.71 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 124.135 0.974 . . . . 0.0 112.164 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -61.81 -40.58 95.75 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.41 ' HB3' HD21 ' A' ' 19' ' ' LEU . 34.2 mt -66.42 -47.96 71.56 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.154 1.382 . . . . 0.0 110.103 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.75 -46.57 88.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -61.31 -53.05 61.76 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 118.934 -0.555 . . . . 0.0 110.232 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.559 ' HZ3' HD21 ' A' ' 55' ' ' LEU . 2.6 tmtt? -50.22 -54.75 18.83 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.766 1.226 . . . . 0.0 109.318 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -57.59 -44.72 85.58 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 125.239 1.416 . . . . 0.0 111.812 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -57.93 -48.49 79.76 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -63.31 -25.62 68.39 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.749 0.704 . . . . 0.0 111.566 175.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.559 HD21 ' HZ3' ' A' ' 51' ' ' LYS . 70.5 mt -80.17 -15.88 56.08 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 175.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.9 pt -99.88 -20.83 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 119.808 1.185 . . . . 0.0 111.646 169.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 t -162.45 83.54 0.54 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.496 1.919 . . . . 0.0 107.163 -171.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.19 -168.54 30.45 Favored Glycine 0 CA--C 1.527 0.813 0 O-C-N 121.36 -0.837 . . . . 0.0 112.815 -175.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -81.41 44.35 1.72 Allowed 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 124.85 3.7 . . . . 0.0 110.522 176.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.1 t -61.73 122.73 16.07 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.343 -0.848 . . . . 0.0 108.872 -172.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.3 m -161.09 165.06 30.25 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 127.389 2.275 . . . . 0.0 106.774 174.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.911 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -178.129 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.534 ' HA2' ' CD2' ' A' ' 20' ' ' PHE . . . . . . . . 0 N--CA 1.469 0.883 0 CA-C-O 119.392 -0.671 . . . . 0.0 112.377 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m -68.61 166.78 16.46 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.164 0.986 . . . . 0.0 112.586 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.7 p -65.11 143.26 58.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.131 0.973 . . . . 0.0 111.257 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.71 33.32 2.59 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.333 0.968 . . . . 0.0 111.888 170.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.6 m -59.62 -64.46 0.94 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-N 119.364 1.582 . . . . 0.0 110.79 -174.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.8 t -77.72 79.25 4.21 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -175.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.07 -92.37 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 O-C-N 120.903 -1.123 . . . . 0.0 110.832 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 61.68 -43.08 0.14 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 129.943 3.297 . . . . 0.0 116.517 171.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -65.34 -57.28 8.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.412 1.46 . . . . 0.0 110.103 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.67 -23.88 58.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.596 1.558 . . . . 0.0 110.058 -171.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.47 ' CD2' ' HG2' ' A' ' 51' ' ' LYS . 4.7 m-85 -145.39 110.46 5.2 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.53 1.532 . . . . 0.0 107.079 -168.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -69.15 167.64 15.72 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.885 0.766 . . . . 0.0 111.787 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -32.65 74.39 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.476 -1.39 . . . . 0.0 110.592 175.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -67.46 -47.2 70.81 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -59.87 -44.71 94.02 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.753 -0.641 . . . . 0.0 110.541 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.09 -40.9 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 119.067 0.848 . . . . 0.0 109.468 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -60.19 -49.82 76.13 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 119.77 -0.157 . . . . 0.0 111.31 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -55.13 -40.96 71.13 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.8 0.84 . . . . 0.0 110.295 173.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.441 ' CD2' HD22 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -54.49 -51.56 64.7 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.538 -1.351 . . . . 0.0 109.808 -175.192 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.534 ' CD2' ' HA2' ' A' ' 1' ' ' GLY . 65.4 m-85 -63.43 -47.6 81.25 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.745 177.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -55.11 -48.58 73.43 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.783 0.833 . . . . 0.0 110.912 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.43 -56.49 24.17 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 125.343 1.449 . . . . 0.0 109.865 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.5 t -60.7 -16.63 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 117.881 0.84 . . . . 0.0 112.684 -176.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -68.33 -57.23 6.24 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 120.434 -1.416 . . . . 0.0 109.191 172.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.0 t -80.83 -42.38 21.71 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.778 0.831 . . . . 0.0 109.566 -173.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -77.55 -27.71 51.64 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.45 -0.786 . . . . 0.0 112.809 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.8 -143.59 48.69 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -156.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -73.99 7.13 2.82 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.33 98.32 3.21 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 121.325 1.875 . . . . 0.0 109.446 -175.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -71.82 -45.11 62.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 119.185 -0.435 . . . . 0.0 109.914 -178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -48.92 -53.88 17.8 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.371 1.068 . . . . 0.0 111.967 176.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.6 m -55.24 -49.63 71.52 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.884 0.874 . . . . 0.0 111.317 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.1 mt -57.85 -49.94 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 125.818 1.647 . . . . 0.0 110.105 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -34.54 74.27 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.742 1.217 . . . . 0.0 111.583 -173.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -73.58 -47.86 37.27 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.839 -0.538 . . . . 0.0 111.077 166.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.436 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 5.4 t -62.63 -28.76 70.13 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -167.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 64.1 m-85 -134.28 148.85 69.46 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 119.62 1.1 . . . . 0.0 108.654 -174.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.52 110.55 2.45 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.869 2.379 . . . . 0.0 110.603 -174.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -111.51 113.51 25.98 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.849 1.26 . . . . 0.0 109.473 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 31.09 -141.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.891 2.476 . . . . 0.0 111.121 -166.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -106.83 160.52 15.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 144.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 61.74 49.08 79.8 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 124.864 1.221 . . . . 0.0 114.315 166.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.524 ' HE ' ' HA ' ' A' ' 43' ' ' ARG . 1.5 mmp_? -105.1 165.56 11.0 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.581 1.19 . . . . 0.0 111.511 174.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -122.36 161.75 22.85 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.772 1.629 . . . . 0.0 107.588 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.05 -44.17 70.83 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.137 0.426 . . . . 0.0 110.722 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 m -62.29 -27.25 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.572 0.749 . . . . 0.0 112.722 -176.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.38 -41.35 84.64 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.441 HD22 ' CD2' ' A' ' 19' ' ' LEU . 35.2 mt -66.78 -39.22 87.74 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.794 1.238 . . . . 0.0 109.838 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.04 -54.15 29.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.261 1.024 . . . . 0.0 108.342 -177.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.97 -50.46 64.05 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 122.674 0.39 . . . . 0.0 111.351 174.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 42.6 tptt -56.67 -54.19 49.02 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -54.89 -48.53 72.89 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.029 1.332 . . . . 0.0 110.234 -173.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -55.77 -48.03 76.0 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -62.75 -34.42 77.19 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.403 -0.81 . . . . 0.0 112.884 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.3 mt -68.42 -39.13 81.71 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 119.53 1.059 . . . . 0.0 111.414 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.9 pt -93.56 -26.33 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 118.842 0.746 . . . . 0.0 111.965 -174.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.4 m -138.98 75.36 1.51 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.17 146.56 18.17 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.79 -1.005 . . . . 0.0 111.881 -169.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.96 65.64 6.88 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.452 2.768 . . . . 0.0 109.528 169.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.9 m -66.0 160.15 24.27 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.567 0.747 . . . . 0.0 109.188 173.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 t -145.07 10.55 1.32 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -161.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.628 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -159.403 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.649 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.7 m 62.06 73.2 0.48 Allowed 'General case' 0 C--O 1.231 0.117 0 C-N-CA 124.202 1.001 . . . . 0.0 109.046 -163.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 p -95.26 -28.81 14.82 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.256 1.422 . . . . 0.0 111.093 173.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.7 -54.33 4.92 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 120.464 -1.398 . . . . 0.0 111.79 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.3 m 40.42 72.81 0.14 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.439 2.296 . . . . 0.0 114.892 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.1 m -134.72 147.18 50.01 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.877 1.271 . . . . 0.0 108.372 161.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 150.42 143.6 3.77 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 126.168 1.842 . . . . 0.0 110.685 175.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -146.84 -87.27 0.1 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.021 1.411 . . . . 0.0 110.834 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 mttp -57.28 -53.88 53.14 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.595 1.158 . . . . 0.0 110.128 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -68.35 -49.11 62.54 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.865 -166.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -141.83 95.73 2.86 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 -176.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t -73.37 164.85 26.09 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.157 1.383 . . . . 0.0 108.773 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -52.94 -36.37 59.71 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 118.607 -0.711 . . . . 0.0 112.729 -172.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.25 -54.97 18.63 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -174.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.45 -37.09 82.29 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 124.236 1.014 . . . . 0.0 110.784 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.13 -36.43 73.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 O-C-N 121.405 -0.809 . . . . 0.0 110.582 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -68.45 -45.28 72.91 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 117.782 -1.104 . . . . 0.0 109.392 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -59.74 -35.16 74.0 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 119.689 1.131 . . . . 0.0 111.47 174.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.96 -56.02 27.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.709 0.804 . . . . 0.0 108.881 175.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.482 ' CZ ' HD13 ' A' ' 55' ' ' LEU . 31.2 m-85 -62.35 -44.38 96.6 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 119.049 -0.5 . . . . 0.0 110.73 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -53.44 -44.8 69.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.568 1.147 . . . . 0.0 110.073 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.85 -56.63 15.41 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 126.649 2.071 . . . . 0.0 111.58 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.3 t -65.23 -16.97 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 121.359 -1.083 . . . . 0.0 110.934 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -80.74 -39.89 26.19 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.124 -1.61 . . . . 0.0 109.924 174.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.6 t -95.69 -12.22 25.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.164 0.986 . . . . 0.0 112.292 -170.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 33.2 mtt -125.62 -48.48 1.66 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.146 1.378 . . . . 0.0 111.327 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.21 -154.67 19.86 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -165.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -61.97 15.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.492 2.317 . . . . 0.0 116.32 -175.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -78.8 97.37 5.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 120.447 1.476 . . . . 0.0 107.455 170.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -76.3 -47.15 24.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.7 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -62.57 -43.35 99.03 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.358 0.663 . . . . 0.0 109.299 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.9 m -59.78 -49.81 76.28 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.698 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.8 mt -58.33 -44.58 88.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 119.665 1.12 . . . . 0.0 109.241 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.11 -47.29 65.37 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.413 1.485 . . . . 0.0 110.555 -177.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -85.86 -28.57 24.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 119.322 -0.37 . . . . 0.0 111.143 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 t -59.32 -69.97 0.18 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.464 0.706 . . . . 0.0 109.932 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -84.99 148.9 51.92 Favored Pre-proline 0 C--O 1.235 0.335 0 O-C-N 121.313 -0.867 . . . . 0.0 109.179 -171.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.57 108.43 1.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 N-CA-C 108.628 -1.336 . . . . 0.0 108.628 -173.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -111.02 154.46 24.15 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.352 0.661 . . . . 0.0 110.317 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -54.9 130.49 41.51 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.381 1.072 . . . . 0.0 110.123 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -64.07 117.73 7.5 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.33 -24.34 4.72 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.064 1.792 . . . . 0.0 110.681 -166.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 145.05 56.6 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.449 1.124 . . . . 0.0 110.664 173.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -120.09 175.17 6.06 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.468 1.907 . . . . 0.0 107.6 167.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.31 -41.33 84.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.483 -0.761 . . . . 0.0 109.972 166.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.5 m -65.02 -31.4 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.183 0.593 . . . . 0.0 112.285 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.14 -50.08 65.27 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.0 mt -64.95 -50.27 67.07 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.104 1.762 . . . . 0.0 109.767 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.79 -49.2 78.57 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 124.71 1.256 . . . . 0.0 107.662 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -60.66 -51.86 67.61 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.184 0.594 . . . . 0.0 111.029 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HZ3' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -54.49 -48.61 71.64 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.571 0.748 . . . . 0.0 109.3 -177.153 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -63.77 -49.85 71.37 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.453 1.101 . . . . 0.0 110.686 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -57.37 -38.11 73.7 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.307 1.443 . . . . 0.0 111.397 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -65.66 -53.59 39.18 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 118.339 -0.839 . . . . 0.0 109.728 167.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.482 HD13 ' CZ ' ' A' ' 20' ' ' PHE . 22.6 mt -57.78 -27.68 63.31 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -175.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.1 pt -82.79 -12.59 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 119.656 1.116 . . . . 0.0 112.01 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 m 51.53 21.77 1.35 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.265 1.426 . . . . 0.0 113.679 -177.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.2 162.88 54.39 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.926 -0.93 . . . . 0.0 112.387 -164.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.78 99.73 0.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.726 2.95 . . . . 0.0 108.859 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.7 t -179.17 108.2 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.532 1.933 . . . . 0.0 106.165 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.4 m 44.93 61.34 2.54 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.404 1.882 . . . . 0.0 110.434 172.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 117.545 -1.697 . . . . 0.0 109.159 -175.617 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.551 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -159.21 104.67 1.68 Allowed 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 166.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.1 m -60.39 160.82 8.14 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.452 0.701 . . . . 0.0 110.879 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.33 163.09 26.45 Favored Glycine 0 C--N 1.331 0.302 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 p -141.29 138.45 33.18 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.645 1.578 . . . . 0.0 108.444 -170.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m -148.56 -33.05 0.23 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.077 0.951 . . . . 0.0 110.92 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.12 -75.0 0.35 Allowed Glycine 0 C--N 1.337 0.617 0 C-N-CA 125.483 1.516 . . . . 0.0 109.488 -161.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -136.21 173.43 11.72 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.265 1.426 . . . . 0.0 109.449 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt 54.16 -169.16 0.06 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.019 1.328 . . . . 0.0 110.118 -174.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 47.29 -155.77 0.05 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.216 1.406 . . . . 0.0 109.175 -161.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -83.74 126.92 33.39 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 155.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 t -62.92 154.94 28.66 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 161.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.16 -29.48 68.7 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.343 -0.848 . . . . 0.0 111.367 -173.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -58.84 -50.27 74.62 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.747 0.819 . . . . 0.0 110.286 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -62.41 -30.68 71.39 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.089 -0.481 . . . . 0.0 110.903 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.1 t -70.15 -31.56 47.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 119.477 1.035 . . . . 0.0 111.477 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -66.45 -52.3 47.78 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 174.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -60.71 -33.14 72.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.339 0.656 . . . . 0.0 111.619 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -58.14 9.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.844 0.858 . . . . 0.0 109.345 173.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -57.95 -48.34 80.24 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 122.945 0.498 . . . . 0.0 110.562 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -58.82 -38.6 79.0 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.396 0.678 . . . . 0.0 110.992 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.11 -55.62 25.31 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 125.246 1.403 . . . . 0.0 110.806 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.64 -23.81 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 118.464 1.132 . . . . 0.0 111.285 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -72.28 -41.44 66.68 Favored 'General case' 0 C--O 1.224 -0.253 0 O-C-N 120.922 -1.111 . . . . 0.0 109.991 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 t -96.32 -37.2 10.6 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.578 0.751 . . . . 0.0 111.207 -172.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -86.29 -105.22 0.06 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 167.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.17 -81.92 0.15 Allowed Glycine 0 C--O 1.226 -0.406 0 CA-C-O 118.335 -1.259 . . . . 0.0 110.759 -173.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.68 4.29 9.52 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.437 2.119 . . . . 0.0 112.396 173.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -75.9 98.73 4.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -79.41 -35.2 40.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.869 1.268 . . . . 0.0 110.534 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -55.05 -47.26 75.03 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.941 0.896 . . . . 0.0 110.44 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.6 m -55.55 -59.27 5.06 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.773 1.629 . . . . 0.0 111.224 174.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 76.6 mt -53.08 -44.6 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 125.666 1.587 . . . . 0.0 110.165 -173.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -17.18 40.71 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -174.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -111.89 -29.51 7.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.681 1.192 . . . . 0.0 111.499 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.14 -19.92 65.62 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.054 0.942 . . . . 0.0 113.059 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -139.31 155.0 72.43 Favored Pre-proline 0 C--O 1.235 0.29 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.85 110.05 3.01 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.843 1.695 . . . . 0.0 110.061 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -115.72 157.24 24.58 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.906 1.282 . . . . 0.0 109.131 174.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -49.7 149.65 2.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.612 1.165 . . . . 0.0 112.549 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -61.72 144.78 54.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.66 -2.4 40.04 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.819 -1.545 . . . . 0.0 114.415 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -58.41 153.39 15.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 120.266 2.033 . . . . 0.0 110.283 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -112.31 160.8 17.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.04 0.936 . . . . 0.0 108.69 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.44 -30.99 63.52 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 122.192 -0.317 . . . . 0.0 110.651 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.1 m -65.02 -29.06 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 C-N-CA 123.723 0.809 . . . . 0.0 112.544 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -57.16 -41.52 79.37 Favored 'General case' 0 CA--C 1.516 -0.36 0 O-C-N 124.363 1.04 . . . . 0.0 109.517 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.7 mt -65.63 -48.95 70.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.737 1.215 . . . . 0.0 109.584 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.17 -44.19 95.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.845 0.858 . . . . 0.0 108.796 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -67.03 -46.38 74.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.143 0.577 . . . . 0.0 111.324 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -60.52 -39.66 88.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 119.512 1.051 . . . . 0.0 110.889 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.68 -42.94 99.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.475 0.71 . . . . 0.0 110.257 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -60.13 -47.76 84.57 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.77 172.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -52.09 -42.73 63.46 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.47 1.032 . . . . 0.0 109.986 173.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.6 mt -68.09 -60.62 2.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 119.049 -0.5 . . . . 0.0 111.091 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -63.06 -30.49 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 118.97 0.804 . . . . 0.0 112.242 -172.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.8 m -149.37 105.4 3.48 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 177.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.16 173.39 20.56 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 123.642 0.639 . . . . 0.0 112.213 -173.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.77 108.75 1.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.441 3.427 . . . . 0.0 109.501 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.8 m -141.36 161.41 37.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.491 0.716 . . . . 0.0 110.073 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.0 p -74.94 169.04 18.77 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.805 0.842 . . . . 0.0 111.811 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.313 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.799 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.9 m -57.83 129.37 41.59 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.459 1.104 . . . . 0.0 110.195 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 t -138.67 -85.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 172.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.99 -66.41 2.11 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 118.986 0.812 . . . . 0.0 112.256 -173.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 m -60.41 -63.88 1.14 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.24 1.016 . . . . 0.0 111.428 -175.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t 55.57 -164.57 0.13 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.997 0.919 . . . . 0.0 113.23 172.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.48 97.3 0.96 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 174.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -127.09 -19.47 4.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 117.906 -1.045 . . . . 0.0 113.676 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HA ' ' HE2' ' A' ' 9' ' ' LYS . 4.7 mmpt? -137.46 86.53 2.2 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -175.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 t0 56.4 162.69 0.02 OUTLIER 'General case' 0 C--O 1.236 0.359 0 C-N-CA 128.491 2.717 . . . . 0.0 112.293 -162.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.515 ' CG ' ' HE2' ' A' ' 51' ' ' LYS . 2.4 m-30 62.39 144.57 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 130.528 3.531 . . . . 0.0 111.073 -169.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 p -69.59 163.21 26.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.235 1.414 . . . . 0.0 108.28 160.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -57.93 -34.42 69.85 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.478 164.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -56.03 -59.86 4.3 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 126.056 1.743 . . . . 0.0 110.338 172.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -37.45 82.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.598 1.09 . . . . 0.0 111.01 -176.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.45 -41.08 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 118.606 0.639 . . . . 0.0 110.758 173.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -60.68 -47.73 84.94 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.57 0.748 . . . . 0.0 110.465 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -66.98 -31.95 72.86 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.83 0.452 . . . . 0.0 111.566 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.42 ' CD2' HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -56.08 -53.07 61.43 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 170.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.16 -46.24 89.84 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.466 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -55.56 -41.94 74.0 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.427 0.691 . . . . 0.0 110.896 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.04 -54.24 22.3 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 126.651 2.072 . . . . 0.0 111.369 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.1 t -64.67 -22.97 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 121.166 -1.196 . . . . 0.0 111.417 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -67.91 -45.89 73.1 Favored 'General case' 0 C--O 1.225 -0.191 0 O-C-N 121.041 -1.037 . . . . 0.0 109.82 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 t -95.58 -40.97 9.16 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.665 0.786 . . . . 0.0 110.957 -162.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -80.47 -66.19 0.91 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 166.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.81 -164.0 12.1 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 -146.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -78.89 23.47 0.34 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.84 0.856 . . . . 0.0 111.944 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -75.06 96.75 3.28 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 120.969 1.713 . . . . 0.0 107.122 165.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -72.62 -36.34 68.04 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.011 -1.449 . . . . 0.0 109.621 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -13.59 62.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.358 0.663 . . . . 0.0 112.184 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -86.29 -58.1 2.76 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 124.296 1.038 . . . . 0.0 108.805 169.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 92.4 mt -52.04 -44.9 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 C-N-CA 126.672 1.989 . . . . 0.0 111.372 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.91 -23.36 52.96 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.572 1.149 . . . . 0.0 112.72 -175.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -109.91 -35.88 6.04 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.885 1.274 . . . . 0.0 111.281 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.93 -29.57 69.69 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.962 0.801 . . . . 0.0 112.167 175.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -127.0 150.99 73.47 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 124.331 1.052 . . . . 0.0 108.629 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -87.82 107.55 0.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 CA-C-N 119.836 0.977 . . . . 0.0 110.004 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -94.11 161.14 14.4 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.414 -0.804 . . . . 0.0 109.405 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -66.0 147.1 53.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 173.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -53.68 146.04 14.21 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.511 0.725 . . . . 0.0 109.852 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.85 -15.13 56.67 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.373 -1.237 . . . . 0.0 112.32 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.2 111.05 3.25 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 120.421 2.11 . . . . 0.0 106.999 160.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -83.15 175.35 10.03 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 159.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.62 78.12 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.875 -1.14 . . . . 0.0 110.838 170.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.5 m -65.15 -30.32 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.025 0.93 . . . . 0.0 112.46 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.56 -41.45 90.15 Favored 'General case' 0 C--O 1.222 -0.371 0 O-C-N 124.133 0.896 . . . . 0.0 108.994 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.42 HD22 ' CD2' ' A' ' 19' ' ' LEU . 31.4 mt -65.98 -43.39 87.98 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.226 0.61 . . . . 0.0 109.641 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.06 -49.04 77.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -58.38 -51.76 68.45 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.953 0.901 . . . . 0.0 111.155 178.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HE2' ' CG ' ' A' ' 11' ' ' PHE . 48.0 tptt -55.92 -50.14 71.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.718 1.207 . . . . 0.0 110.091 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -61.62 -50.46 72.48 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.867 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -50.6 -47.87 58.03 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.037 0.835 . . . . 0.0 110.722 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.7 mmt-85 -65.88 -36.86 84.59 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 118.17 -0.919 . . . . 0.0 112.817 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.2 mt -65.97 -53.05 43.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.528 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.7 pt -62.97 -36.73 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 119.11 0.868 . . . . 0.0 111.58 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.0 m -160.22 118.44 2.63 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.521 1.055 . . . . 0.0 109.271 169.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.94 -171.47 15.57 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 123.513 0.577 . . . . 0.0 112.282 174.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.13 71.54 1.19 Allowed 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.481 2.788 . . . . 0.0 108.9 163.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.4 m -143.21 16.39 1.89 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.338 2.255 . . . . 0.0 110.875 -159.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.7 m -65.79 -11.13 43.61 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.332 1.453 . . . . 0.0 113.651 -172.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 N-CA-C 104.817 -3.313 . . . . 0.0 104.817 153.678 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.874 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.74 85.96 1.19 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.005 0.907 . . . . 0.0 110.123 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.7 m -65.98 167.37 9.86 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 159.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.04 -25.56 4.1 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 118.018 -1.434 . . . . 0.0 113.49 173.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.2 m -96.88 115.04 26.74 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.292 1.546 . . . . 0.0 109.449 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 t -129.57 137.41 50.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.395 1.478 . . . . 0.0 109.415 -162.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.33 147.12 4.9 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -133.21 -36.38 1.0 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 117.973 -1.013 . . . . 0.0 112.54 -175.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -83.84 164.75 19.3 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.612 1.096 . . . . 0.0 110.464 176.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 64.95 -53.45 0.32 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 130.106 3.362 . . . . 0.0 113.093 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.58 ' CZ ' HD23 ' A' ' 48' ' ' LEU . 6.9 m-30 -133.95 124.83 27.01 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 161.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.0 p -61.91 164.47 6.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.45 173.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -55.01 -31.85 61.37 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.545 -0.722 . . . . 0.0 110.587 170.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.41 -50.99 61.59 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.563 1.545 . . . . 0.0 108.654 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -63.92 -38.1 89.84 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.306 -0.871 . . . . 0.0 110.454 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.95 -25.31 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.459 1.027 . . . . 0.0 110.193 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -60.15 -60.02 4.48 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.468 -0.77 . . . . 0.0 109.096 169.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -63.94 -28.56 69.91 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.245 1.018 . . . . 0.0 112.556 -174.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.48 -56.23 24.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.952 0.901 . . . . 0.0 109.925 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -67.41 -42.36 83.39 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -52.17 -35.44 48.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.941 0.897 . . . . 0.0 111.337 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.54 -49.55 4.1 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 126.695 2.093 . . . . 0.0 111.825 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.5 t -61.46 -36.83 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 119.244 1.522 . . . . 0.0 110.007 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -63.7 -28.38 69.86 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.548 -0.72 . . . . 0.0 110.833 -174.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -95.2 -59.07 1.97 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.085 0.954 . . . . 0.0 108.81 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 33.8 mtt -71.3 -28.0 63.81 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.058 -1.026 . . . . 0.0 113.555 -170.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.33 -157.46 52.07 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -150.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -83.44 33.07 0.46 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.586 1.154 . . . . 0.0 111.963 -162.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -82.23 96.47 7.87 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -79.29 -46.21 18.19 Favored 'General case' 0 C--O 1.224 -0.255 0 O-C-N 121.778 -0.576 . . . . 0.0 110.194 -170.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -49.26 -52.22 28.71 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.647 1.579 . . . . 0.0 110.829 172.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.3 m -55.74 -54.55 43.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.035 0.934 . . . . 0.0 111.01 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.8 mt -54.27 -45.46 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.781 1.232 . . . . 0.0 110.518 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -22.66 20.52 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.98 1.312 . . . . 0.0 112.245 -177.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -106.54 -34.57 7.33 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.397 1.079 . . . . 0.0 111.575 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 t -60.93 -30.48 70.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.516 0.727 . . . . 0.0 111.246 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -133.88 152.01 77.88 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -176.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.86 110.57 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.942 2.428 . . . . 0.0 110.996 -172.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -110.03 170.63 7.95 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.556 0.742 . . . . 0.0 110.202 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -58.58 160.43 5.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 123.043 1.401 . . . . 0.0 112.884 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.12 138.68 57.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.041 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.8 6.8 57.19 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 117.895 -1.503 . . . . 0.0 114.543 175.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -61.82 158.3 16.19 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 120.286 2.043 . . . . 0.0 110.064 173.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -112.33 161.36 16.73 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.066 1.347 . . . . 0.0 107.472 170.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.21 -35.01 69.13 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.934 -0.479 . . . . 0.0 110.997 176.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 m -61.13 -25.14 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.469 1.108 . . . . 0.0 112.746 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -64.21 -33.37 75.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.58 HD23 ' CZ ' ' A' ' 11' ' ' PHE . 41.8 mt -71.41 -41.06 70.06 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.633 1.573 . . . . 0.0 110.476 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.28 -52.3 64.25 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 172.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -59.89 -53.51 57.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.674 -0.641 . . . . 0.0 112.205 -167.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -64.71 -40.48 95.43 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.165 -173.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -56.82 -53.43 58.0 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.982 1.713 . . . . 0.0 110.34 174.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -53.73 -47.07 70.95 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.435 1.094 . . . . 0.0 109.526 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -64.82 -42.64 94.82 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.148 -0.93 . . . . 0.0 110.727 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.4 mt -61.05 -53.49 56.55 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.932 1.242 . . . . 0.0 112.023 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.1 pt -60.48 -36.62 70.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 119.357 0.981 . . . . 0.0 110.197 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.7 m -58.95 -60.72 3.41 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.833 0.853 . . . . 0.0 110.592 173.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.6 -175.13 16.76 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.654 1.597 . . . . 0.0 111.19 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.81 -47.99 2.31 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.37 2.713 . . . . 0.0 111.559 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.6 p -80.81 76.02 7.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.3 1.04 . . . . 0.0 109.883 -174.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t 62.36 -170.57 0.17 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.532 1.133 . . . . 0.0 111.341 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.816 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 145.58 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.498 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.59 167.63 21.79 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.732 1.213 . . . . 0.0 108.508 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -69.27 136.34 51.78 Favored 'General case' 0 C--O 1.239 0.546 0 O-C-N 121.426 -0.797 . . . . 0.0 110.078 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.01 88.14 0.25 Allowed Glycine 0 C--O 1.224 -0.484 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.7 m 55.5 -2.89 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.943 2.497 . . . . 0.0 117.714 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -68.68 -85.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.994 1.724 . . . . 0.0 110.678 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.07 175.93 30.59 Favored Glycine 0 C--N 1.338 0.655 0 O-C-N 120.493 -1.38 . . . . 0.0 112.202 -175.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.5 ttp-105 -127.34 -13.24 5.56 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.81 1.244 . . . . 0.0 112.291 -176.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -123.91 143.74 50.19 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 119.91 1.232 . . . . 0.0 109.371 173.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -152.31 49.47 0.77 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.03 2.132 . . . . 0.0 106.165 168.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.502 ' CD2' ' HG3' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -141.79 104.01 4.45 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 -176.833 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 t -68.83 160.08 31.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.336 1.054 . . . . 0.0 110.262 -170.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -58.56 -31.43 67.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.224 1.01 . . . . 0.0 111.995 -168.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 14' ' ' GLU . 25.0 mp0 -68.67 -51.08 45.77 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 127.899 2.48 . . . . 0.0 108.639 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -60.94 -33.58 73.39 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 119.332 -0.366 . . . . 0.0 110.676 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.03 -32.91 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 120.486 -1.384 . . . . 0.0 109.707 176.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -61.94 -52.12 65.33 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -62.55 -36.89 84.08 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.434 1.094 . . . . 0.0 111.899 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.03 -54.8 42.84 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -63.26 -40.84 98.54 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.139 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -56.66 -57.55 11.91 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.814 0.734 . . . . 0.0 109.435 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -50.83 -55.24 18.76 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 125.653 1.597 . . . . 0.0 111.828 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.44 -24.21 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 118.148 0.974 . . . . 0.0 111.097 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -75.13 -33.72 61.59 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 120.87 -1.144 . . . . 0.0 111.213 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 t -90.56 -47.85 7.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.73 1.15 . . . . 0.0 109.487 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.9 mtt -80.72 -66.37 0.89 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.682 0.674 . . . . 0.0 109.537 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.07 -152.62 16.76 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 -158.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -72.41 16.1 0.15 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.553 2.341 . . . . 0.0 112.645 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -78.53 97.76 5.85 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 120.205 1.366 . . . . 0.0 107.324 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -79.22 -51.38 9.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.045 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -56.74 -45.49 81.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.165 0.439 . . . . 0.0 110.952 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.2 m -58.25 -51.97 67.54 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.051 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.2 mt -56.14 -44.4 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 119.736 1.153 . . . . 0.0 110.075 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.07 -30.35 15.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.082 1.353 . . . . 0.0 111.487 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.4 m0 -103.38 -35.25 8.45 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.771 1.228 . . . . 0.0 111.545 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -63.45 -24.17 67.71 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.207 1.403 . . . . 0.0 112.762 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -123.19 153.12 64.72 Favored Pre-proline 0 C--O 1.236 0.389 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 175.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -79.45 109.35 2.47 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 N-CA-C 107.774 -1.664 . . . . 0.0 107.774 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -106.31 156.37 18.57 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.462 0.705 . . . . 0.0 109.623 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -59.3 154.82 15.71 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.15 0.98 . . . . 0.0 111.443 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 167.88 18.19 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.561 0.696 . . . . 0.0 112.321 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.98 -7.2 29.88 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.695 1.14 . . . . 0.0 112.864 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.6 165.6 12.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.396 1.478 . . . . 0.0 113.163 -176.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -141.6 165.7 26.78 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.658 1.983 . . . . 0.0 107.288 171.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.84 -32.16 67.35 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.003 -1.06 . . . . 0.0 111.048 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 m -75.54 -20.0 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.056 1.343 . . . . 0.0 112.55 -174.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.63 -53.39 58.69 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 171.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 43.1 mt -53.29 -54.31 38.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.565 1.946 . . . . 0.0 110.343 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.48 -48.12 80.98 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.924 1.289 . . . . 0.0 108.989 -173.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -64.71 -46.96 80.1 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.502 ' HG3' ' CD2' ' A' ' 11' ' ' PHE . 1.3 tmtm? -58.99 -49.71 76.86 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 124.726 1.21 . . . . 0.0 109.308 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.45 -47.92 78.13 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.154 0.982 . . . . 0.0 110.616 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -54.33 -48.5 71.3 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.457 -0.782 . . . . 0.0 110.439 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 mtt85 -62.87 -26.6 68.86 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.818 1.247 . . . . 0.0 113.273 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 74.8 mt -76.67 -52.35 9.8 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.347 -0.846 . . . . 0.0 111.088 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.3 pt -64.75 -30.67 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 118.616 0.644 . . . . 0.0 110.922 -173.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -159.2 -179.49 8.04 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.86 1.209 . . . . 0.0 108.223 158.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.03 176.07 44.86 Favored Glycine 0 CA--C 1.521 0.469 0 O-C-N 120.394 -1.441 . . . . 0.0 112.774 174.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.9 -9.21 22.13 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.254 2.636 . . . . 0.0 113.573 -172.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.8 t 49.53 -137.29 1.04 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -163.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 p -105.69 151.73 24.04 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 145.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 N-CA-C 105.403 -3.079 . . . . 0.0 105.403 161.811 . . . . . . . . 0 0 . 1 stop_ save_